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Thesis abstract  
The PhD thesis investigates the long-term effects of antenatal multiple micronutrient (MMN) 
supplementation. A growing body of evidence suggests that changes in early-life environment 
can have lasting effects on health and disease. To investigate this, we followed up children 
from a double-blind randomised controlled trial of MMN in pregnancy. The trial found that 
the intervention group were a mean 77 g heavier at birth and 204 g at 2.5 years, with a 2.5 
mmHg lower mean blood pressure. The project described in the thesis set out to investigate 
the role of antenatal MMN intervention in the programming of future health and disease risk 
factors in mid-childhood. It sought to determine whether the differences in anthropometry 
previously present were sustained into mid-childhood and if this was due to an increase in 
lean mass or fat mass. It also looked at whether antenatal MMN supplementation resulted in 
an improvement in lung function in the children. Finally, two secondary analyses were 
conducted to investigate the association between socioeconomic status and growth, and air 
pollution and asthma.  
We measured anthropometry, body composition using bioelectrical impedance (with 
population specific isotope calibration), blood pressure, kidney dimensions by ultrasound and 
lung function. Data were also collected on potential confounders: socieconomic status, food 
security and personal air pollution exposure estimates.  
We assessed 841 children (422 controls, 419 intervention) at a mean age 8.5 years. Other than 
maternal education and residence, children lost to follow-up were no different. The 
unadjusted differences (intervention minus control), were 0.05 z-scores (95% CI -0.09, 0.19) 
for weight-for-age, 0.02 z-scores (95% CI -0.10, 0.15) for height, -0.08 z scores (95% CI -
0.19, 0.04) for forced expiratory volume in the first second, and -0.05 (95% CI -0.17, 0.06) 
for forced vital capacity. There was no difference in blood pressure, body circumferences, 
lean mass, skinfold thicknesses or kidney measurements. The adjusted differences were 
similar for all outcomes. When considered together, just over half the children had low 
weight-for-age, and approximately one-third had stunting and low body mass index. Only 
1.4% of the children were overweight and mean fat mass proportion was 14.5%. When lung 
function was expressed in relation to predicted values for Caucasian children, FEV1 was 14% 
lower and FVC 12% lower. Our measures of socioeconomic status produced a 
multidimensional poverty index score of 0.155 and approximately one in ten households were 
considered food insecure in the previous year. The air pollution data showed a mean 24 hour 
time-weighted average of 168  µg/m3. We found an overall low prevalence of asthma, with air 
pollution associated with cough at night in boys only (odds ratio 1.15 per 10 µg/m3 increase in 
air pollution; 95% CI 1.05, 1.26). Socioeconomic status was associated with the growth of 
  6 
children when families owned more expensive assets and appeared to have the greatest effect 
on skeletal growth in early life.   
Differences in phenotype, body composition and lung function between children born to 
mothers who received antenatal MMN supplements and children whose mothers received iron 
and folate were not apparent at 8.5 years. While generally poor, households were comparable 
to those in more affluent regions of the country and were relatively food secure. The air 
pollution data showed that the children were exposed to levels much higher than national and 
international recommendations.   
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and allergies in children 
HFIAS = Household Food Insecurity 
Access Scale 
IUGR = Intra-uterine growth restriction 
LBW = Low birthweight 
LM = Lean mass 
LMIC = low- and middle-income 
countries 
LGA = Large for gestational age 
MCAR = Missing completely at random 
MIRA = Mother and Infant Research 
Activities 
MNAR = Missing not at random 
MPI = Multi-dimensional poverty index 
MUAC = Mid-upper arm circumference 
NGO = Non-governmental organisation 
OR = Odds ratio 
PCA = Principal components analysis 
R2 = coefficient of determination 
RDA = recommended daily allowance 
SEM = structural equation model 
SES = Socioeconomic status 
SGA = Small for gestational age 
TWA = time-weighted average 
UNICEF = United Nations  children’s  fund 
UNIMMAP = United Nations 
International Multiple Micronutrient 
Preparation 
USAID = United States Agency for 
International Development 
WAZ = Weight for age z score 
WFP = World Food Programme 
WHO = World Health Organisation 
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1 Introduction 
 
 
“If  we  knew  what  it  was  we  were  doing,  it  would  not  be  called  research,  would  it?”  
Albert Einstein 
 
 
 
The first chapter describes the rationale for conducting the study, the research question I set 
out to answer and the aims and objectives. It gives an outline of the thesis and summarizes the 
data collected within the study. I then describe my contribution to the work and the training I 
undertook within the PhD.  
 
  
Chapter 1 
 26 
1.1 Scope of thesis 
Micronutrient deficiency is common throughout the world, with pregnant women at particular 
risk due to their higher metabolic demands.1 Impaired antenatal nutrition can affect fetal 
development and growth in the short term and risk of chronic disease in the longer term. The 
importance of micronutrients in this process is becoming increasingly apparent, especially in 
resource-poor settings where women may enter pregnancy with multiple micronutrient 
deficiencies.2-4 In addition to its immediate effects on health, monitoring growth in early 
childhood is an important outcome because of its association with adult health and human 
capital. 5 
The study focuses on the role of multiple micronutrients (MMN) and summarises the second 
follow-up of a randomised controlled study (RCT) in Dhanusha district, Nepal, in which 
pregnant women received either daily multiple micronutrient supplements6 or a control 
supplement of iron and folic acid.7,8 The trial found that babies born in the MMN group were 
a little heavier at birth, with no difference in gestation or other anthropometric outcomes. It 
was one of several trials of the supplement,9-16 meta-analyses of which have shown an 
increase in birthweight of 22 to 54 g, a reduction in low birthweight and small-for-gestational 
(SGA) age, but no other changes in anthropometry, gestation or mortality.17-21 Follow-up of 
the children at 2.5 years found that the difference in weight was maintained, their body 
circumferences were a little larger and systolic blood pressure was 2.5 mmHg lower.  
It set out to investigate the role of antenatal MMN intervention in the programming of future 
health and disease risk factors in mid-childhood, and performs the important function of 
following up the children born in a RCT to look at the long-term effects of the intervention. 
Figure 1 shows a summary of the previous research findings and the current project.  
We collected anthropometry and body composition data to create a detailed picture of the 
child’s  phenotype.  In  addition,  kidney  measurements  and  lung  function  were collected to see 
whether there were differences in organ size and function. This has implications for both our 
understanding of growth and lung development and its potential epigenetic influences, and for 
the design of nutrition recommendations and programmes for pregnant women in low-
resource settings.22 In addition, saliva samples were collected for epigenetic analysis, but this 
is not covered in the thesis. 
 
In designing the study I thought it imperative to look at the anthropometry of the children as 
this followed directly from the previous work. I considered three other major body systems: 
respiratory, cardiovascular and cognitive. After consultation, it was decided that it would be 
possible to look at one of these adequately. I investigated the possibility of measuring 
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cardiovascular outcomes, involving blood markers and arterial distensibility. Cardiovascular 
changes, while important and a major cause of disease burden worldwide, tend to have health 
effects in middle and older age. While interested in investigating cognitive differences 
between the groups, we thought it better that this aspect be managed by someone with 
specialist knowledge, preferably a Nepalese researcher with whom I could work.  
 
 
 
Figure 1: Summary of previous and current work 
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1.2 Research questions, aims and objectives 
1.2.1 Research question 
x Does daily multiple micronutrient supplementation in pregnancy, compared with iron 
and folic acid, lead to a difference in size, body composition, lung function and blood 
pressure at 8 years of age? 
 
a) Anthropometry, body composition and blood pressure follow-up  
The study was designed to investigate the health of children born in the trial, focusing on their 
growth, respiratory outcomes and blood pressure. The primary focus of the research was to 
examine the lasting effects of the antenatal MMN supplement to see if differences in 
anthropometry and blood pressure, previously present, were sustained into childhood. This 
aspect of the research followed directly from the RCT and last follow-up, but went further by 
looking at the body composition of the children and their organ (kidney) size, which could 
provide additional information on long-term disease risk. The study will add to the evidence 
base for antenatal MMN supplementation, providing information that may help in 
recommending whether supplements should be given to pregnant women in similar settings. 
A difference in kidney size could potentially explain the mechanism by which differences in 
blood pressure might occur. To improve the accuracy of the bioelectrical impedance 
measurements, a population-specific isotope calibration study was conducted, with an 
exploration of methodological variations that may help improve the conduct of future studies.  
b) Respiratory follow-up 
The second aspect of the research question was to investigate whether the antenatal MMN 
supplements led to differences in respiratory outcomes. The study measured lung function 
using spirometry and questions about children’s   history of respiratory illness. I chose to 
concentrate on the respiratory system as this has immediate consequences for children 
worldwide. Improved lung function in childhood would be of benefit in coping with 
respiratory infectious disease and asthma. Increased birthweight has been shown to be 
associated with better lung function in later life,23,24 and antenatal micronutrient intake of 
vitamins A and D has been implicated in the pathways that affect respiratory function and 
disease.3 
c) Confounding variables  
In an attempt to improve precision, the study collected information on additional variables 
that were included in multivariable regression models. Using questionnaire data, estimates of 
food security and socioeconomic status were calculated. The study investigated exposure to 
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air pollution by microenvironment sampling in the locations in which children resided. Air 
pollution was measured in detail as it is an important environmental stressor affecting lung 
function and also growth. Indoor air pollution levels can be very high in countries like Nepal 
that have a high prevalence of biomass fuel usage. 
d) Health of children in Nepal 
In addition to the follow-up of the trial, the study was designed to look at the health of the 
children in southern Nepal and the situation in which they live. By keeping the data together, 
the study provided information on the growth of the children, their blood pressure and lung 
function.  
e) Secondary analyses  
Finally, two secondary analyses were conducted. The first was a cross-sectional analysis of 
air pollution and asthma symptoms to investigate whether the expected high exposure led to 
respiratory illness. The second analysis used the data as a cohort study to investigate the 
effect of socioeconomic status on growth. These secondary analyses do not provide data as 
robust as the trial results, but do provide additional evidence on these topics in a relatively 
understudied population, and it would not be possible to conduct randomised controlled trials 
to answer the questions.  
 
1.2.2 Aims and Objectives 
The main aim of the study was to investigate the long-term effects in children born after 
maternal antenatal MMN supplementation, to see if there are lasting effects in mid-childhood.   
The objectives were to: 
x Measure anthropometry, body composition, lung function and blood pressure 
outcomes in the children. 
x Investigate whether there was a difference in the measured outcomes between the 
multiple micronutrient and control groups. 
x Measure and create a personal estimate of exposure to air pollution.  
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1.3 Structure of thesis 
Background 
The background section starts with a description of the study setting. It then summarizes the 
previous research and discusses developmental origins of health and disease theory, growth 
and the effects of antenatal micronutrient supplementation. This is followed by meta-analyses 
of trials that used the same MMN supplement in pregnancy, and a consideration of the role of 
causal diagrams in analysis.  
Procedures 
I summarise the previous trial and the methods used in this follow-up. I describe the process 
of piloting and conducting the questionnaire, anthropometry, body composition (with 
population-specific isotope calibration), blood pressure, kidney dimensions, lung function and 
air pollution measurements. I discuss the ethical factors considered within the study. The 
variables collected are shown in Box 1. 
Analysis and results 
These chapters describe assessment of quality of data and technical error of measurement for 
anthropometry results. WHO reference ranges25 were applied to the anthropometry data to 
produce z scores for weight, height and BMI and the new Global Lung Initiative26 reference 
ranges were applied to the spirometry data. Bioelectrical impedance values were converted to 
fat and lean mass using equations derived from a population-specific isotope calibration. 
Measures of food security and socioeconomic status (multi-dimensional poverty index and 
principal components analysis) were developed. Particle mass concentrations were calculated 
for each of the six micro-environments, after which I used the time activity data to model a 24 
hour time-weighted average as an estimate of the exposure to air pollution for each child.  
I examined summary statistics for the major outcomes and longitudinal trends in growth. I 
then investigated whether the antenatal multiple micronutrients led to a difference in 
phenotype and a sustained difference in blood pressure. The primary analysis looked at the 
main outcome variables and performed independent t tests where appropriate. The secondary 
analysis performed multivariable regression, restricted the sample to children who were well 
and looked at effect modification by sex and maternal BMI. A directed acyclic graph was 
constructed to identify potential confounders that were controlled for using multiple linear 
regression models. Further analyses were conducted to investigate the association between air 
pollution and asthma, and socioeconomic status and conditional relative growth.  
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Public engagement 
We held a separate public engagement event, which is briefly summarized.  
Discussion 
The results of each section are considered separately. The overall results and their 
implications are considered together in the final section.  
Extra material  
Appendices include questionnaires and forms used, ethical approval and further reading. In 
addition, three films were produced that give descriptions of the isotope calibration study 
(http://youtu.be/pEKxWFhYGag), the main project (http://youtu.be/nFkLOI9UHyw) and the 
public engagement project (http://youtu.be/dHvlzrVBLOY). 
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Box 1: Indicators investigated in the project 
 
1.4 My contribution 
This study involved many people, mentioned in the acknowledgements section, over a 
number of years in the design of the project, data collection and analysis. A large number of 
people were also involved in setting up the initial trial and two-year follow-up. In the current 
project, data collection was carried out by nine members of staff from the non-government 
organization (NGO) Mother and Infant Research Activities (MIRA). We were lucky to have 
three of the data collection staff who had been involved in the initial trial and a further team 
x Questionnaire data 
o Demographic details 
o Recent and major illnesses  
o “International  Study  of  Asthma  and  Allergies  in  Childhood”  (ISAAC)   
o Socioeconomic status variables to create a Multi-dimensional Poverty 
Index score 
o Fuels used 
o House characteristics 
o Food security 
o Dietary diversity 
x Anthropometry:  
o weight (kg) 
o standing and sitting height (m)  
o triceps, biceps, subscapular and suprailiac skinfold thicknesses (mm) 
o circumferences of head, chest, waist, hip, upper leg and mid-upper arm 
(cm) 
x Bioelectrical impedance (Ohms) 
x Renal dimensions: length and anterior-posterior (cm) 
x Blood pressure (mmHg) 
x Spirometry 
o Forced expiratory volume in the first second (L) 
o Forced vital capacity (L) 
o Forced expiratory flow 25%-75% (L/s) 
x Air pollution personal air measurements for particle mass  
o Gravimetric sampling: 
Average particle mass less than 4 micrometres (PM4) per volume (μg/m3) 
o Photometric sampling 
Real-time changes in respirable particle mass 
o Carbon monoxide concentration 
x Total body water 
o Deuterium concentration in saliva samples  
x Saliva samples for DNA and epigenetic analysis 
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member who was involved in the 2-year follow-up. Two pairs of staff administered the 
questionnaire and took the air pollution measurements, two collected the anthropometry and 
spirometry data, and two were involved in data entry: one inputted the data and the other was 
in charge of data management for the site. Finally, one person ran the public engagement 
project. Senior members of MIRA and UCL were also involved in the management of the site, 
co-ordination of the project with other work, human resources and security considerations. In 
addition, a number of senior members of research staff at MIRA, UCL and other universities 
were involved in the design, management and analysis of the study. My contribution,  
highlighted below, was as coordinator of this large team.  
The initial idea for the follow-up came from my primary supervisor, Dr David Osrin, who 
also coordinated the original trial. I developed the research questions and designed the study 
in detail under his guidance. I sought specialist advice and input from Professor Jonathan 
Wells for anthropometry and body composition, Professor Jonathan Ayres for air pollution 
measurements and Professor Janet Stocks for the spirometry component.  
I sought funding and was awarded a Wellcome Trust Research Training Fellowship to 
conduct the project. I then applied for and received funds from the UCL Beacon public 
engagement  award  to  run  the  air  pollution  art  project  “Smokescreen”.   
I applied for ethical approval from the UCL research ethics board and the Nepal Health 
Research Council and completed all relevant documentation to register and run the project. I 
procured the equipment and transported it to Nepal. I then trained the data collection staff and 
supervised the data collection. This included a piloting and training phase at the start of the 
project and regular training throughout.  
I was present on-site in the first half of the project, when the majority of the children were 
seen, and less so in the second half. When on-site, I worked daily with all the data collection 
staff. While not taking the measurements myself, to avoid introducing potential bias from a 
third observer and because of my inability to communicate effectively for spirometry, I 
oversaw all aspects of the project and performed regular quality checks on the data. I cleaned 
the data and assessed all spirograms for acceptability. I conducted all the analyses, seeking 
statistical advice where necessary.  
I conducted regular teaching and training for members of the MIRA staff I worked with, both 
in relation to the project and wider research skills. I supervised three medical students during 
the PhD. Two, Suzanne Bartington and Sebastian Roberts, joined me in Janakpur during their 
medical electives, and the third, Dalvir Kular, helped with secondary analysis of data. 
Suzanne took detailed assessments of air pollution during cooking to create a calibration 
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factor for carbon monoxide to particle mass, and conducted qualitative work to explore the 
issues around fuel choice. Sebastian helped me to conduct the isotope calibration study and 
led on the creation of the film used for consent and the main project film. Dalvir joined me in 
a summer attachment to help analyse the food security data and presented a poster on it at the 
Nutrition Society conference in Lille, France.  
Personal training 
Anthropometry and spirometry 
My training involved one-to-one sessions with Dr Jane Williams in anthropometry and with 
Dr Jane Kirkby in spirometry, at the Institute of Child Health. I practised these skills during 
the piloting phase of the Size and Lung function In Children (SLIC) study in schools in north 
London.   
Statistical training 
In addition to my supervisors, general statistical advice was given by Dr Andrea Rehman and 
specific advice on the use of causal diagrams by Dr Rhian Daniel. Professors Caroline Fall 
and Clive Osmond advised on the creation of the conditional growth indicators.  
I also attended a number of statistics courses.  
x Introduction to Bayesian Analysis, UCL, 13/1/11 
x Analysis of 2x2 tables, UCL, 16/2/11 
x Principal Components Analysis and Factor Analysis, UCL, 2/6/11  
x Path Analysis and Structural Equation Models, UCL, 9/6/11  
x Causal Inference in Epidemiology, LSHTM, 7/11/11- 11/11/11 
I attended courses run by UCL on Management Skills for Researchers and Effective 
Negotiation Skills to help prepare me for managing a research team.  
To advise on the project, a group of experts in each aspect of the study was assembled from 
each of the participating organisations or departments. Meetings were held via teleconference 
(Skype) every 3 to 4 months. 
 
1.5 Funding 
The research project was supported by The Wellcome Trust. I sought funding for a personal 
fellowship to fund both the project and myself (ref 092121/Z/10/Z; see Appendix 1.1). The 
public engagement art project on air pollution was funded by the UCL Beacon award.  
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Chapter 2 Literature review  
 
“The  truth  is  rarely  pure  and  never  simple” 
Oscar Wilde 
 
 
Chapter 2 summarises my reading of the background literature. The section starts with a 
description of Nepal (its land, people and economy) and the study setting, Dhanusha. It then 
summarizes the Developmental Origins of Health and Disease theory, outlining the epigenetic 
mechanisms by which it may work. I briefly consider the main outcomes: fetal and child 
growth, lung function and blood pressure, discussing the role of antenatal micronutrients and 
air pollution. I try to summarize the main outcomes of trials or meta-analyses and include 
important observational and animal studies. The chapter then concentrates on multiple 
micronutrient supplementation in pregnancy. I perform meta-analyses of trials that have used 
the same supplement in pregnancy as our trial and summarise the follow-up studies. Finally, I 
consider the role of causal diagrams in epidemiological analysis. 
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2.1 Literature review introduction 
Both macronutrients and micronutrients are important for the short- and long-term health of 
mothers and children, especially in resource-poor settings in which women may have multiple 
deficiencies.2-4 In discussing the role of micronutrients in this chapter, it should be kept in 
mind that their supply is one aspect in a complex network of causes. Supplementation does 
not improve the underlying and basic causes of undernutrition. Potentially, if antenatal MMN 
supplementation has a lasting effect on health, it may be able to improve human capital.  
Malnutrition is caused by a lack of or poor quality of food, or disease resulting in increased 
metabolic demand. In some cases, disease can lead to malnutrition via reduced absorption of 
nutrients and malnutrition itself can lead to an increase in disease through reduced immune 
status. The reasons for a woman becoming undernourished are complex, with factors relating 
to herself, her close environment and the wider community in which she lives. The 
determinants of undernutrition have been identified by UNICEF (and modified by Black et al) 
in a framework for nutritional status.27 This categorises the basic (social, economic and 
political context), underlying (income poverty leading to food security, inadequate care and 
unhealthy environments) and immediate (disease and inadequate dietary intake) causes of 
maternal and child under-nutrition. The conceptual model in Figure 40 expands on the 
UNICEF model by showing the relationships between the causative variables. Figure 40 is, 
however, mostly limited to the data assessed in this research, with a focus only on the 
underlying and immediate causes. The basic causes are likely to have the greatest effect, but 
may not be related directly to the women and children in the study. An example is the move 
from civil war to peace within the lifetime of the children. As highlighted by the Food and 
Agriculture Organization, this resulted in a change in food security (mainly access to food 
and to a lesser extent the food supply) that was associated with lower proportions of 
underweight and stunting. In addition to food security, the economy in which food is 
delivered, societal and possibly family structures, as well as both local and national political 
organizations, have all undergone - sometimes dramatic - change. After a decline post-war, 
the country has seen a sharp rise in food prices since 2004. This imposes the greatest burden 
on the poorest who use a greater share of their income on food (nearly a quarter of the 
population spend >75% of their budget on food). 28 
Micronutrient deficiency is thought to affect approximately two billion people worldwide. 
While the diets of women in low resource settings are likely to be deficient in quantity, there 
is growing acknowledgement that they are also deficient in quality. A contrasting picture of 
high quantity, but still low quality, diet is seen in poorer communities in rich countries, where 
the prevalence of obesity in low socioeconomic groups is high, but women may still lack 
Chapter 2 
 37 
micronutrients. 29 The WHO considers iron, iodine and vitamin A deficiency to be of 
particular concern in developing countries. Iron deficiency is the main cause of anaemia, 
affecting   over   30%   of   the  world’s   population and 38% (32 million) of pregnant women.30 
Iodine deficiency is one of the main causes of impaired cognitive development in children, 
and vitamin A deficiency is the leading cause of preventable blindness in children and can 
increase the risk of disease and death from severe infections.1 More locally, research from 
Parsa district in the Terai (to the west of Dhanusha) showed that adult diets were deficient in 
most micronutrients tested, especially vitamin A, riboflavin and iron. Levels tended to be 
lower in women than in men. 31 In a recent analysis of the global burden of disease, child and 
maternal undernutrition were responsible for 6.7% (95% CI 5.7, 7.7) of global Disability 
Adjusted Life Years (DALYs). The largest percentage was due to underweight in children 
(3.1%). Iron deficiency anaemia made up 1.9% and other dietary risk factors contributed to a 
further 10% of DALYs. 32 
Current evidence on the developmental origins of health and disease suggests that early-life 
environment can have lasting effects on growth, physiology and health. The mechanisms 
involve interplay between environment, genes and hormones, in which epigenetic regulation 
plays a part.3,33,34 The evidence for this comes mostly from animal studies. Much of the 
evidence in humans is based on observational studies due to the difficulties, and sometimes 
ethical dilemmas, in conducting trials. Human trials have looked at three categories of 
nutrients: macronutrients, micronutrients (in the form of single nutrients or multiple nutrient 
combinations) or food. It is likely that both micro- and macronutrients are important, but the 
degree to which each one is needed would vary across individuals and populations. 
Micronutrient supplementation can only help to improve the quality of the diet. While 
important, it cannot address the additional energy requirements of the mother or provide the 
protein substrates. Macronutrients are particularly important in populations where the 
availability of food can be inadequate or disrupted, such as in Dhanusha district. An 
indication of this was given in the meta-analysis of antenatal MMN by Fall et al,17 which 
showed an interaction between MMN supplementation and maternal BMI, with a larger effect 
in women with greater BMI, with the exception on Guinea-Bissau. The extent to which this 
interaction existed varied across populations. The greatest effect was seen in the two Nepal 
studies, ours and Sarlahi.7,35 These two studies had the lowest maternal mean BMI of the 12 
studies included. 36 
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2.2 Nepal 
2.2.1 Geography 
Nepal is a relatively small, landlocked country situated between India and China (Figure 2). 
In terms of its flora and fauna, as well as its people, economy and politics, the country is 
largely a product of its diverse and spectacular environment. It lies at the boundary between 
the Indo-Australian and Eurasian tectonic plates. Movements of these plates towards each 
other push the land mass upwards, resulting in the Himalaya mountain range. This region 
borders China, contains eight of  the  world’s  ten  tallest  mountains and is home to the highest 
mountain in the world: Everest (8850m). Nepal’s   land  area  of  147  000  km2 is broadly split 
into three ecological belts: the northern mountain region, middle hills and plains (Terai) that 
make up the southern part of the country. The Terai accounts for approximately a quarter of 
the  country’s  area.  It  lies  at  low  altitude,  making  communications  relatively  easy.  The capital 
of Nepal and its major city is Kathmandu. It is found in the middle hills region in the centre of 
the country. The country is divided into five development regions made up of 75 districts. 
Districts are divided into smaller administrative units known as Village Development 
Committees, which are further divided into wards. 
 
 
Figure 2: Map of Nepal showing the three ecological regions 37 
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2.2.2 People 
According to the 2011 census, the population of Nepal was 26.6 million people. 
Approximately half live in the Terai, while 17% live in cities. Due to the large uninhabitable 
mountainous areas the population density varies widely. The highest density is 4408 
persons/km2 in Kathmandu, while the country average is a mere 181 persons/km2. Otherwise, 
the more densely populated cities tend to be located in the Terai. The demographics of Nepal 
show a classic pyramid-shaped population and the median age is a low 21. In addition to this, 
the total fertility rate is 2.36 children per woman, slightly lower than the replacement fertility 
ratea for South Asia of 2.43.38 Thought  to  be  a  marker  of  family  planning,  mothers’  mean  age  
at first delivery is 20.1 years. 39 
The annual population growth rate over the last ten years has been 1.4%.40 This is lower than 
expected and is in part explained by the emigration of people seeking work overseas: the 
population overseas has doubled since the last census in 2001. The vast majority (97.7%) are 
men who mostly go to Middle East countries or Malaysia, providing cheap unskilled labour. 
The people of Nepal are primarily made up of two ethnic groups: South Asians (a mix of East 
and West Eurasians) and Tibetans who migrated across the Himalayas. 41,42 The population is 
subdivided by a caste system that includes over 100 castes. The main ones (over one million 
people) are the Chhetri (16.6%), Hill Brahman (12.2%), Magar (7.1%), Tharu (6.6%), 
Tamang (5.8%), Newar (5.0%), Muslim (4.4%), Kami (4.8%) and Yadav (4.0%). In the Terai 
region the biggest group is the Tharu (12.5%). The caste of a person is closely linked to their 
wealth and socioeconomic status. The upper castes (Brahmins and Chhetris) tend to hold 
positions   of   power   in   the   government   and   civil   services.   The   “lower”   castes   have   poorer  
health outcomes, in part related to lower utilization of health services. Children from the Dalit 
group, for example, have the highest under-five mortality and malnutrition. The causes for 
this are wide ranging, with a lack of finances being just one problem. In the Terai, 83% of 
women from the Dalit group were found to have no education, compared to 40% of women 
nationwide. 43 
 
Nepali is spoken as the primary language by just under half the population. This is followed 
by Maithili, the primary language for 3 million people, mostly from the Terai.40 The main 
                                                     
a Replacement fertility is the total fertility rate at which a population remains stable (excluding 
migration). It takes into account mortality of women in childbearing age and sex ratio at birth. 
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language in Dhanusha is Maithili, though Nepali is also spoken by many. Maithili is an Indo 
Aryan language developed from Sanskrit that is widely spoken in eastern India as well as 
Nepal. 
 
2.2.3 Politics 
Nepal has recently emerged from a 10-year civil war. The war broadly pitted a group of 
Maoist insurgents against the government forces in 1996. It culminated in mass protests in 
April 2006 that triggered peace talks and the formation of a government following national 
elections. Elections were held in 2008 and the country became a federal democratic republic. 
After the deposition of the monarchy, the country is now led by the United Communist Party 
of Nepal (Maoists) in a coalition government. Led by the Nepal Supreme Court, the next step 
involves completing a new constitution. This has, however, been postponed on several 
occasions.  
The Nepalese people elected a new prime minister, Dr Baburam Bhattarai, in November 2011. 
The current president, Ram Baran Yadav, is from Dhanusha. This has the advantage of giving 
a voice to the people in the region. At the time of writing, Nepal was planning to have a 
general election, but there was resistance to this from some political parties.  
The two major religions, Hinduism and Buddhism, are followed by 81% and 9% of the 
population, respectively. Religion is generally not a source of conflict and it is not unusual for 
a Hindu to worship at a Buddhist shrine and vice versa. The third most common religion is 
Islam, making up 4% of the population, although in the Terai (8%) Islam is second to 
Hinduism.  40 
Being sandwiched between the two regional super-powers of India and China creates both 
opportunities and problems for Nepal. Both in population and economic terms, Nepal is tiny 
compared with its neighbours. While generally unable to resist the influence of these 
countries, it is not entirely reliant on one or the other.  
 
2.2.4 Economy 
Nepal is one of the poorest countries in the world. Its gross domestic product (GDP) is 
estimated to be US$19.42   billion   in   real   terms   or   $40.03   billion   (US$1500   per   capita)   in  
purchasing  power  parity,  ranking  it  102nd  in  the  world. 39,44 Agriculture  forms  the  mainstay  of  
the  economy,  followed  by  remittances  and  tourism.  Most  of  the  produce  is  grown  in  the  Terai  
region   as   it   is   flat   and   relatively   fertile.   Three   quarters   of   the   workforce   are   involved   in  
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agriculture   and   the   remainder   are   split   between   services   (18%)   and   industry   (7%).  Nepal’s  
main   exports   are   clothing,  pulses,   carpets,   textiles   and   juice   and   its  main   trading  partner   is  
India,  which   takes   62%  of   its   exports   and   provides  53%  of   its   imports.39  The  World  Bank  
estimates   that   25-30%  of  GDP   comes   from   remittances,   either   formal   or   informal.45  While  
Nepal   is   a   poor   country,   it   does   have   a   relatively   equal   distribution   of   wealth.   Its   Gini  
coefficientb  is  32,  ranking  it  at  100  in  the  world.  By  comparison,  India  has  a  Gini  coefficient  
of  37,  China  47  and  the  UK  40.  39 
The Nepalese rupee is pegged to the Indian rupee at a ratio of 1.6:1. Recent fluctuations in the 
Indian rupee have therefore affected Nepal, weakening the rupee from NPR110:£1 at the start 
of my PhD in 2011 to  NPR160  in  2013.  This  would  act  to  improve  the  country’s  exports,  but  
make commodities more expensive to import. That said, as previously mentioned, the 
majority of trade is with India, so the effect of fluctuations would be reduced.  
It is generally appreciated that poverty cannot be adequately expressed in a single indicator 
such as GDP. Research has moved towards using multiple indicators or conglomerate 
measures. An example is the annual Human Development Index (HDI) produced by the 
United Nations Development Programme (UNDP).c Nepal’s  HDI   (0.458)   is   ranked  157th in 
the world. It has gradually increased over the last three decades, from 0.242 in 1980, to 0.340 
in 1990, to 0.398 in 2000. 44 Life expectancy at birth is 68.2 years for women and 65.6 years 
for men, and children go to school for an average of 3.2 years.39 
 
2.2.5 Health  
Health expenditure is 5.4% of GDP (2011 figures covering total expenditure on health by 
institutions or individuals), ranking it 126th in the world. 39  The total per capita expenditure 
on health is a mere (International)$69. 46 Nepal’s  public health facilities are made up of 13 
central or tertiary hospitals, 15 zonal hospitals, 65 district hospitals and 4054 primary health 
centres, health posts and sub-health posts. Nepal also has large private for-profit and 
NGO/not-for-profit sectors of the health service. It is estimated that 50% of patients with 
acute illness are seen by private health providers. Figures from 2010-2011 show 8000 medical 
doctors, 2000 of whom were consultants/specialists, and 34 000 nurses or midwives. Only 
                                                     
b The  Gini  coefficient  is  a  scale  used  to  estimate  the  level  of  income  inequality  in  a  country,  where  zero  
is  no  inequality  and  100  is  maximum  inequality.  It  is  calculated  by  plotting  the  cumulative  number  of  
families  (arranged  from  poorest  to  richest)  on  the  x  axis  against  the  cumulative  share  of  income  on  the  
y  axis,  producing  a  Lorenz  curve.  The  index  is  given  by  the  area  between  the  Lorenz  curve  and  the  45°  
line  and  divided  by  the  area  of  the  triangle  below  the  45°  line. 
c The HDI is a composite score that includes life expectancy, education and per capita income and lies 
between 0 and 1. 
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17% of these doctors and 19% of the nurses work in the public sector. In addition, the public 
sector has 7500 paramedics and 4300 public health workers. 47 Including all registered 
doctors gives Nepal a ratio of 0.3 doctors/1000 population, well below the threshold limit of 
2.28 doctors/1000 population recommended by the WHO to achieve 80% coverage of health 
services.48 In addition, these health staff tend to be located in the urban areas. Recruitment to 
remote areas is a focus of government policy, but difficult to attain.   
Child mortality in Nepal is high. Current WHO figures show that the under five mortality rate 
is 54/1000 live births (equating to approximately 34 000 deaths) compared to the WHO South 
Asia regional average of 59/1000 livebirths.46 The infant mortality rate and neonatal mortality 
rates are 46/1000 and 33/1000 live births, respectively. 49 The pie chart in Figure 3 shows the 
main causes of mortality in children under five (U5MR) in Nepal in percentage terms.46 The 
major causes are diarrhoeal and respiratory diseases and those relating to the neonatal period. 
According to the Nepal Demographic Health Survey (DHS) 2011, in the two weeks preceding 
the survey 5% of children under five had symptoms of acute respiratory illness, 19% had a 
fever and 14% had diarrhoea. 49 An analysis of neonatal mortality was conducted by the 
Nepal Ministry of Health using the 2011 census data. Predictors of neonatal mortality were 
maternal education (categorised as no education and primary, OR 1.9), short stature (defined 
as <145cm and >145cm, OR 4.3) and use of solid fuels or cooking indoors (OR 2.5). 
Maternal BMI did not seem to be important. 50 Adult obesity prevalence, as defined by 
BMI>30, was very low at 1.4%. Only Bangladesh and Ethiopia have lower levels.  
 
 
Figure 3: Causes of under five mortality in Nepal 46 
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Growth of children 
The Nepal DHS 2011 showed that 41% of children under five were stunted (height for age <-
2 z scores from the median), 11% were wasted (weight-for-height <-2 z scores) and 29% were 
underweight (weight-for-age <-2 z scores). In all categories, boys fared slightly worse than 
girls and rural populations were worse off than urban ones. The Terai had a higher proportion 
of stunted children. For underweight and wasting, it was similar to the Middle Hills and lower 
than the Mountain region (Table 1). 49 
 
 
 Height-for-age  
(% children under 5) 
Weight-for-age  
(% children under 5) 
Weight-for-height  
(% children under 5) 
 -3 z score -2 z score -3 z score -2 z score -3 z score -2 z score 
Mountains 22.2 52.9 9.9 35.9 3.2 10.9 
Middle hills 16.7 42.1 7.1 26.6 1.7 10.6 
Terai  14.9 37.4 7.8 29.5 3.2 11.2 
Table 1: Proportions of children under five with stunting, underweight and wasting, by 
region of Nepal 49 
  
Chapter 2 
 44 
Air pollution 
Environmental air pollution is an important cause of ill health. In rural Nepal it is mostly 
caused by the burning of biomass fuels. Biomass fuel usage is very common, with estimates 
of use in 75% of households, particularly in poorer areas outside the major cities. 51 The 
burning of biomass in Nepal has been shown to adversely affect lung function in young adults 
52 and exacerbate respiratory disease in children.53 The link to respiratory illness is 
particularly important to study as it is estimated that in 2002 there were 4820 acute 
respiratory deaths in children under five in Nepal due to indoor air pollution. There were a 
further 2680 deaths from chronic obstructive pulmonary disease in adulthood. This led to 204 
000 DALYs lost and contributed to 2.7% of the national burden of disease.54  
The political situation is particularly important in determining the fuels people use. Nepal 
currently produces about 60% of its 5.3 billion kWh energy needs. Energy production is 
mostly from hydroelectric power (about 90%), which currently produces about 600 MW. 
Nepal has a huge potential for producing hydroelectric power: it is estimated that there is 
capacity to create 42 000 MW, depending on how efficiently the power plants run, equivalent 
to a little under 200 billion kWh. This issue leads to a great deal of debate within the country 
as the inability to realise it is largely seen as being due to ineffective government. The true 
benefit of maximising hydroelectric power in terms of income to the country is debated, 
especially as creating power plants would require foreign investment, leading the country 
further into debt. What does seem clear, though, is that Nepal should be able to service its 
own energy needs. 39,55 
The lack of electricity creates major problems for the population as electricity needs to be 
shared (load-shedding). This can result in power cuts of 18 hours a day, and some of the six 
available hours may well be in the middle of the night. In addition to the loss of productivity 
and convenience, the lack of clean power leads to the use of other forms of fuel such as 
firewood and animal dung. This is a problem mostly borne by the poor, who do not have the 
money to buy and run generators. To explore this further and to highlight some of the issues 
and impact on the people, I wrote a narrative essay, (which can be seen at: 
www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)70035-3). 56 
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2.2.6 Study setting 
The research was based in Janakpur, Dhanusha district, in the Central Terai region south-east 
of Kathmandu (Figure 2). Dhanusha is made up of 101 Village Development Committee 
geopolitical units (VDCs) and Janakpur municipality. Table 2 shows the demographics of 
Dhanusha and the adjoining districts of Mahottari and Siraha. The population of Dhanusha is 
made up of 674 000 Hindus, 11 200 Buddhists and 63 100 Muslims.40 
The male to female sex ratio is approximately 1:1, higher than the ratio of 94.4:100 for the 
country as a whole. The Nepal Central Bureau of Statistics explains this difference as being 
due to different rates of emigration for men and women. In Dhanusha, 6.8% of the population 
are thought to be working overseas, a similar figure to the whole country. Other factors would 
therefore need to account for the equal sex ratio. 40 
The weather in the Terai can broadly be split into four seasons: winter (Nepalese months Push, 
Magh and Phagun), spring/summer (Chait, Baisakh and Jyesth), monsoon (Ashadh, Shrawan 
and Bhadau) and post-monsoon (Asoj, Kartik and Mangsir). The winter low temperatures are 
on average in single figures (degrees Celsius), while summer highs can reach the forties.   
 
 
 Total 
population 
Number 
of males 
Number 
of 
females 
Male:female 
sex ratio  
Annual 
population 
growth 
rate (%) 
Population 
density 
(person/km2) 
Dhanusha 768 404 383 711 384 693 100 1.35 651 
Mahottari 646 405 320 886 325 519 99 1.55 645 
Siraha 643 136 313 292 329 362 95 1.17 541 
Table 2: Demographics of Dhanusha and the surrounding regions  
 
 
 
 
  
Chapter 2 
 46 
2.3 Developmental Origins of Health and Disease 
The developmental origins of health and disease (DOHaD) hypothesis proposes that critical 
or sensitive periods exist in the early development of an organism in which environmental 
influences can lead to long-term changes in the child or adult. In humans these critical periods 
are predominantly in prenatal life, but extend into early childhood. The theory brings together 
the interplay of both genetic predisposition and environmental influence, building on the idea 
that chronic disease cannot be explained fully by either.  
The initial focus of the DOHaD theory was on the influence of birth outcomes such as 
birthweight and early mortality on cardiovascular outcomes later in life. In the 1970s Forsdahl 
showed that cardiovascular disease was associated with infant mortality.57 Barker and 
colleagues from the University of Southampton then linked deficits in the intra-uterine 
environment to coronary heart disease in adults. In a landmark paper, they showed an 
association between adult ischaemic heart disease and birthweight in a retrospective study 
from the UK. Those with the lowest birthweights had the highest mortality later in life. 58 In a 
further study, Barker and Osmond subdivided the country into geographical regions and 
showed that infant mortality rates were associated with ischaemic heart disease. This 
association, they felt, was related to nutrition in early life.59 They hypothesized that, 
depending on when in pregnancy the deficit in nutrition occurs, the resulting phenotype of the 
fetus changes, mediated by hormonal changes.33 Extending  the  theory  from  “fetal  origins”  to  
“developmental  origins”  came  with  the  greater  understanding  that  later  periods  in  life  are  also  
important. Lucas proposed the idea of programming   in  which  stimuli   in  “critical  periods  of  
development  can  have  lasting  significance”.  In  particular,  he  singled  out  the  first  four  weeks  
of life as being one such period.60 The changes that occur are in these sensitive periods in 
early life, when the organism is still developing and undergoing rapid change, tend to be 
maintained throughout life via mitotic cell division. The term canalization,d described by 
Conrad Waddington in the 1940s, has been used to describe traits that are invariant to stresses. 
61 As described by Waterland and Michels, during these sensitive periods, genes that would 
undergo methylation under normal circumstances are prevented from doing so by 
environmental influences. 62 
Since these first studies, a huge amount of epidemiological research that has supported the 
hypothesis has been carried out. At first the DOHaD theory was based on observational 
                                                     
d Canalization  can  be  defined  as  “reduced  sensitivity  of  a  phenotype  to  changes  or  perturbations  in  the  
underlying genetic and nongenetic factors that determine its expression”.   In this context, I refer to 
environmental canalization where the phenotype shows resistance to environmental changes.  61. Flatt 
T. The evolutionary genetics of canalization. The Quarterly review of biology 2005; 80(3): 287-316.  
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retrospective studies, but since then prospective cohorts and randomised controlled trials have 
been conducted. These human studies have been complemented with experimental work on 
animals and more recently epigenetic studies that are beginning to decipher the mechanisms 
by which changes to phenotype and physiology may occur. Box 2 shows examples from 
famine situations in which dramatic reductions in population nutrition, particularly pregnant 
women, are associated with adverse heath consequences in future generations.  
Inheritance of phenotypic variation can occur via non-gametic processes or across meiosis, 
resulting in multi-generational changes that affect future offspring. Non-gametic processes 
are more common, for example poor maternal health during pregnancy (such as insulin 
resistance) that leads to illness in the offspring. Environmental exposure can also affect the 
germline cells, this being termed transgenerational epigenetic inheritance. 63 An example from 
Crews et al showed that exposure of pregnant rats to the fungicide vinclozolin, which acts as 
an anti-androgen (and endocrine-disruptor), resulted in disease in the offspring. The male 
offspring then passed this on to the two following generations (although the female offspring 
did not).64 In addition to molecular changes, multi-generational inheritance can also be via the 
phenotype itself; for example, a taller mother can give birth to a larger baby.  
Previous animal and human evidence has pointed to the potential for long-term effects of 
antenatal micronutrients. 2,3 With fifteen micronutrients, and a very large potential number of 
combinations and interactions, being able to work out a definitive mechanism is difficult. 
Outcomes such as weight are also multi-factorial. Christian and Stewart have set out potential 
mechanisms by which micronutrients may affect later disease.3 The two main pathways are 
through hormonal changes, often leading to a change in phenotype, and epigenetic changes. 
In addition to these, micronutrients may improve the immune system, reduce anaemia or 
improve energy metabolism and anabolic processes in the pregnant woman. 65 For example, 
animal studies with mice showed that a low zinc diet in pregnancy resulted in reduced 
immunity in the offspring. This continued to some extent to the two following generations. 66 
Whether these early life changes are adaptive, conferring an advantage to the organism, or 
maladaptive (or neither) has been debated. Broadly, there are two main evolutionary theories: 
the thrifty genotype and thrifty phenotype. Both these theories are based on an attempt to 
explain diabetes risk and prevalence, but have been extrapolated more widely.  
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1. Dutch Famine, 1944-45 
The best evidence for the long-term effects of famines comes from the Dutch famine in 
World War II. German blockade of food stocks into the Netherlands and the subsequent harsh 
winter conditions affected food transport and led to a dramatically reduced food supply for 
the population in the west of the country. At its worst the rations dropped to 400 calories per 
person per day. Pregnant women were entitled to extra food, but did not always receive it. In 
addition to the official rations some food was available through the black market and 
churches, for example. The food supply improved rapidly after liberation in May 1945. 67 
The long-term effects of the famine on the offspring depended on when in gestation the lack 
of nutrition occurred and the time for which there was a deficit. The effect appeared to be 
greatest for those in whom the insult was in late pregnancy, but peri-conceptional exposure 
was associated with hypomethylation of the Insulin-like Growth Factor II gene in adults. 68 
This gene is important in a number of growth related processes;69 for example, regulating 
placental growth and nutrient transport. It is inherited via paternal imprinting, while the IGF 
II receptor is maternally imprinted. 70 The detrimental effects of the Dutch famine extended 
into the next generation, with the offspring of women born in the famine found to have lower 
birthweight. 71 This may have been due to direct exposure of the   mother’s   ova   to   poor  
nutrition while she herself was a fetus.  63 
Cardiovascular effects 
Those affected in early gestation were found to have a higher risk of coronary heart disease, 
while those affected in mid- to late gestation had reduced glucose tolerance. 67  These 
differences may have been mediated by changes in placental size, which was associated with 
hypertension, but only in men.72  
Obesity 
Ravelli et al showed that, when following up 300 000 Dutch men in the army who were 
exposed to the Dutch famine prenatally, they differed in their levels of adiposity depending 
on the point at which this occurred. Being exposed to the famine in the last trimester was 
linked to lower levels of obesity later in life, while being exposed in the first half of 
pregnancy was associated with increased levels of adiposity. 73 Stein et al showed differences 
in long-term adiposity between men and women. With the exception of the waist-to-hip and 
waist-to-thigh ratios, all measures of adiposity were greater in female offspring who were 
exposed to famine in pregnancy. A similar effect was not seen in male offspring. The critical 
period appeared to be in the middle of pregnancy. 74 
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2. Leningrad (St. Petersburg) famine, 1941-44 
The siege of Leningrad occurred in World War II when German armies surrounded the city. 
Food supplies to the city were cut off, leading to the death of approximately 2.4 million 
people. Contrary to the previous example, Stanner and Yudkin found no association between 
in-utero exposure and cardiovascular outcomes as adults. In a cross-sectional study those who 
were exposed to in-utero malnutrition were compared to unexposed groups born before the 
famine (who were exposed to malnutrition in infancy) or born outside the area. No difference 
was found in glucose tolerance, lipid profile or blood pressure. The contrast with the findings 
from the Dutch famine may have been due to the longer time period of the famine, with 
exposure in childhood and hence reduced catch-up growth. 75,76 
 
3. Biafran famine, 1968-1970 
The Biafran famine occurred during the civil war in Nigeria when food supplies to the region 
of Biafra were inhibited. Similar results to the Dutch famine were seen on weight and blood 
pressure in those born during the famine. Hult et al found an increased risk of being over-
weight (OR 1.41; 95% CI 1.03, 1.93), having hypertension (OR adjusted for BMI 2.87; 95% 
CI 1.90, 4.34) and impaired glucose tolerance (OR adjusted for BMI 1.65; 95% CI 1.02, 2.69) 
in those born during the famine compared to those born after the famine. 77 
 
4. Chinese famine, 1959-61 
The   Chinese   famine   was   the   result   of   drought   combined   with   the   country’s   agricultural  
policies. Here the evidence for an increase in the risk factors for cardiovascular disease is 
mixed. Li et al showed a trebling in the odds of metabolic syndrome in those who were 
prenatally exposed to severe famine areas. 78 Zheng et al79, measuring metabolic disease, and 
Yang et al80, measuring BMI in adults, both showed an increased risk in women but not men. 
However, Huang et al who found evidence to the contrary in a small decrease in the BMI of 
those exposed prenatally. 81 
Box 2: Case studies on the long-term effects of famine situations on cardiovascular 
outcomes 
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2.3.1 Thrifty genotype hypothesis 
Described in 1962 by Neel82, the thrifty genotype hypothesis gives an explanation for how 
harmful conditions, such as diabetes, can be so common and increasing in prevalence. In this 
theory, the genotype that predisposes to diabetes was a selective benefit when humans needed 
to take advantage of the abundant food in preparation for scarce times. This genotype is 
maladapted to richer countries (and the more affluent populations in low- and middle-income 
countries) today where there is an abundance of food, leading to conditions such as diabetes. 
Prentice et al, amongst others, have proposed candidate genes in developing country settings, 
such as the ApoE gene, but in general the genetic basis for this theory is lacking. 83 
 
2.3.2 Thrifty phenotype hypothesis 
Hales   and   Barker   proposed   an   adaptation   of   the   hypothesis   that   they   called   the   “thrifty  
phenotype”.   This   states   that   in   early   life   the   fetus   “sacrifices”   growth   of   certain   organs   or  
systems due to a nutritional deficit. Their theory focused on fetal undernutrition, which would 
cause a reduction in the beta cells of the pancreas, leading to reduced insulin production. Poor 
nutrition in early life results in permanent changes in glucose metabolism (reduced insulin 
secretion and increased insulin resistance), leading to changes in both organ size and structure. 
This produces a phenotype that has a survival advantage in the immediate future, but when 
environmental conditions change, such as with an excess of food, leads to increased 
susceptibility to diseases such as II diabetes and metabolic syndrome. 84,85  
The interplay between the thrifty genotype and phenotype has been described by Prentice and 
Moore as cycles of under- and over-nutrition- see Figure 4. 86 Populations go through cycles 
of adaptation and maladaptation to their environments. In the current situation of a high 
incidence of diabetes in South Asian populations, we may currently be in the transitionally 
dis-adapted cycle with underweight infants and obese adults.  
Importantly, the thrifty phenotype needs to be combined with other environmental or 
behavioural factors such as obesity or reduced physical activity, at least in terms of when and 
how severely someone experiences disease. In the short-term the thrifty phenotype is adaptive, 
but it may be maladaptive later. These ideas were developed further by Wells, who proposed 
the capacity–load   theory,   whereby   stresses,   or   metabolic   loads,   challenge   the   body’s  
homeostatic mechanisms (capacity), leading to chronic disease when the body cannot cope. 87 
One example is lower birthweight associated with heat stress. 88 
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Gluckman and Hanson attempted to describe fetal changes in light of future adaptations, in 
their   “predictive   adaptive   response”   theory.   They   proposed   that   fetal   alterations   to  
metabolism or phenotype in relation to environmental cues are designed to confer future 
advantage.  The   fetus   “sees”   the   current   environment,   predicts  what   the   future   environment 
may be like and makes changes that will be beneficial.89 For this adaptation to current 
conditions to be beneficial in the long term, it would require that environmental conditions 
stay similar, but where a mis-match occurs between current and future conditions, disease can 
result. A counter argument was proposed by Wells, who states that the fetus in fact responds 
to the physiology and phenotype of the mother, who has herself adapted to cues to her 
ancestors and her environment. 90 I recently described how previous health and risk factors 
can combine with current stresses to affect health in the extreme conditions of war.91 
 
  
Figure 4: Cycles of under- and over-nutrition.  
Reused with permission for use in a dissertation from Prentice and Moore, Archives of 
Diseases in Childhood, 2005. 86 
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2.4 Epigenetics 
The primary mechanism for the DOHaD hypothesis is thought to be via epigenetic changes. 
The term epigenetics was defined by Waddington as “the  interactions  between  genes  and  their  
products  which  bring   the  phenotype   into  being”.92 The term is currently thought to refer to 
heritable changes to DNA that do not alter the base sequence but result in changes in 
expression, resulting in gene-environment interactions.34 Epigenetic mechanisms are 
important in normal physiology, for example in X chromosome deactivation in women, and 
also in pathological processes. Cancer cells, for example, are found to be globally 
demethylated, but with hyper-methylation of specific gene promoter regions.93 Further, 
epigenetics are believed to control genetic imprinting, where either the maternal or paternal 
cell lineage is preferentially expressed. This phenomenon occurs in conditions such as Prader-
Willi, Angelman and Russel-Silver syndrome.94 Epigenetics can also help to explain the 
differences between monozygotic twins. For example, Fraga et al showed that they have 
differences in DNA methylation, and went on to conclude that these differences arise over the 
lifetime, although this was based on the comparison of only two pairs of twins.95  
The actual epigenetic changes are poorly understood, but the three main mechanisms by 
which gene expression is thought to the be controlled in all eukaryotic cells are:  
1. DNA methylation. Hypermethylation halts gene transcription. 
2. Noncoding RNAs. These bind to DNA and interfere with transcription.  
3. Histone tail modification. The histones make up nucleosomes. These undergo methylation, 
acetylation  and  phosphorylation   to   form  a  number  of   “histone  codes”   that  affect   chromatin  
structure and alter gene expression.96-99 
The best researched of these mechanisms is DNA methylation. This involves addition of 
methyl groups from the conversion of S-adenylmethionine to cytosine. Most methylation 
occurs at the CpG dinucleotide, where cytosine is followed by guanine. Methyl groups are 
attached   to   the   5’   position   of   the   pyrimidine   ring   of   the   cytosine   base,   resulting   in   5-
methylcytosine. Methyl binding proteins (for example, methyl-CpG binding protein 2) 
mediate this process by attaching to the methyl groups and initiating chromatin-remodelling 
co-repressor complexes. The CpG (cytosine guanidine) methyl group prevents the DNA from 
binding protein. CpG sites are uncommon in humans (about 20% of predicted). They are 
normally methylated, but the unmethylated 20% tend to be located at CpG  “islands”,  often  in  
promoter regions where they tend to cluster. It is these sites and the surrounding  “CpG  island  
shores”  that  are  believed  to  be  important  in  the  transcription  processes.  93,98 
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The methyl groups for this process are provided by the maternal diet by metabolism of 
choline, betaine, folate and methionine. In addition to folate, micronutrients are important in 
this process. Vitamins B2, B6 and B12 are important enzyme cofactors in the C1 metabolism 
cycle that converts S-adenosyl-methionine to S-adenosylhomocysteine, releasing the methyl 
group that is attached to the DNA. 99 
Gametes are highly methylated. After fertilization, demethylation of the genome occurs. The 
paternally inherited genome undergoes rapid active demethylation (with the exception of 
imprinted genes) prior to implantation. Passive demethylation occurs in the next few weeks, 
where methylation is not preserved during replication. This is followed by differential cell 
lineage-specific methylation in the embryo. The trophoectoderm which goes on to form the 
placenta remains hypomethylated. 62,98,100 DNA methylation, particularly in early life, was 
believed to lead to lasting changes in the cells and lineage, but changes can occur throughout 
life, particularly in early life, puberty and old age. Most methylation changes, however, do 
occur peri-implantation. 62,98  
Evidence for the effects of epigenetic changes has been shown in Agouti mice given dietary 
supplements of vitamin B12, folic acid, betaine and choline prior to and during pregnancy. 
This resulted in a change in hair colour from yellow to brown. The supplements methylated 
the Agouti gene, switching it off and resulting in the colour change. Mice with brown fur 
went on to have lower rates of obesity, diabetes and cancer later in life. 101 
The evidence in humans for epigenetic changes is starting to emerge. As described in Box 2, 
reduction in methylation in the insulin-like growth factor II (IGF2) gene, which is partly 
responsible for placental nutrient regulation, occurred in the Dutch famine.68  Changes in fetal 
growth may have been due to methylation changes in the (maternally imprinted) IGF-II 
receptor, leading to changes in growth. 98 Recent evidence from a double blind randomised 
controlled trial of peri-conceptional micronutrient supplementation (UNIMMAP) in The 
Gambia showed sex-specific changes in methylation, specifically the IGF2 receptor gene in 
girls and the gene trap locus 2-2 gene in boys. 102,103 
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2.5 Growth 
Any long-term effects of MMN supplementation may be due to a direct effect, for example a 
structural change to an organ or system or to its effect on growth in early life. A detailed 
analysis of in-utero and child growth and the effect of different growth trajectories was 
beyond the scope of this thesis, but I will briefly outline the effect of both fetal and child 
growth on later health. The second part of the section looks at the influence of single 
micronutrient supplementation in pregnancy on growth, with subsequent sections focusing in 
more detail on the respiratory system and blood pressure, and the effect of multiple 
micronutrient supplements.  
 
2.5.1 Fetal growth.  
Growth restriction in-utero is a cause of both short-term and long-term ill health. For the fetus 
and neonate, it may lead to increased mortality and morbidity, while in adulthood, particularly 
when combined with rapid child growth, it may lead to chronic disease. Growth failure, 
meanwhile, is a composite result of poor nutritional availability at a cellular level and 
increased metabolic demands.2 
2.5.1.1 Small for gestational age (SGA) 
SGAe is usually used as a marker of intra-uterine growth restriction (IUGR)f as it takes 
gestational age into account.104 It is not ideal as it only compares a fetus with others of the 
same age, rather than with its own growth potential. A baby on the 50th centile may still be 
growth restricted if her potential weight was to be on the 90th centile. In 2010, 32 million 
infants were born SGA (10 million born at term). The situation is particularly common in 
South Asia, where two-fifths of livebirths were SGA.105 Another indicator of growth 
restriction is birthweight. This is less accurate than SGA in that it does not incorporate 
gestational age. A preterm infant may be low birthweight, but appropriately grown for her 
gestational age. Commonly, a cut-off of <2500 g is used to define low birthweight. In 
developing countries the majority of low birthweight is due to IUGR rather than 
prematurity.105 In a review of adverse outcomes in pregnancy, Kramer highlighted the main 
causes as prematurity and IUGR. Prematurity was associated with infection, multiple births, 
hypertension, low pre-pregnancy BMI, incompetent cervix, heavy work and smoking. IUGR 
was mainly associated with low energy intake, low pre-pregnancy BMI, short stature, 
primiparity, hypertension, smoking and, in primiparae, malaria. 106 The nutritional supply to 
                                                     
e SGA is defined as weight below the 10th centile for gestational age. It is a usually a population-
specific definition.   
f IUGR is defined as a fetus who has not reached its growth potential. (Mandy, UpToDate 2013)  
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the fetus depends on pre-existing maternal stores, diet and placental function. These depend 
in turn on the nutrition that a mother receives and how it is partitioned between herself and 
the embryo/fetus. Demand-side factors may also increase both maternal and fetal metabolic 
demands, which may, for example, increase with in-utero infections. 2 
Fetal growth can be split into two periods. Broadly, in the first trimester of pregnancy there is 
hyperplasia due to rapid mitosis, while in the third trimester growth occurs through 
hypertrophy. The second trimester involves a mixture of these two processes. Any action of 
MMN in our study would have been mainly through hypertrophy, as supplementation was 
started in the second trimester. Weight gain also changes over gestation: from 15-20 g/day at 
24 weeks to 30-35 g/day at 34 weeks.107  
Each organ or system has sensitive periods for growth, so stresses in certain time periods can 
have an exaggerated effect. A hierarchy is thought to exist between tissues related to the 
organ’s   importance   to   survival,   and   probably   also   reproduction.   There is preferential 
protection of the brain, for example, at the expense of other organs such as the kidney and 
lungs - which have minimal function in-utero. 108 In a situation of poor nutrition, fetal growth 
reduces, but not uniformly. An in-utero stress is more likely to affect tissues lower in the 
hierarchy as they are less important for immediate survival. These plastic tissues buffer the 
ones that are canalized and unable to adapt to immediate pressures.87 
Growth restriction can also lead to changes in metabolism. The best studied of these is insulin 
production and resistance. A systematic review of 48 studies, mostly from developed 
countries, by Newsome et al showed an inverse association with insulin secretion and glucose 
levels. Some discrepancies in the association with glucose (in glucose tolerance tests) were 
seen in child studies, but there was greater uniformity in adults. 109  
 
2.5.1.2 Effect of fetal growth on later phenotype 
The associations of birthweight with later outcomes are based on retrospective observational 
studies, but prospective studies and trials are increasingly being conducted. In a large study of 
19 birth cohorts (n = 44 374) from around the world, SGA was associated with an increased 
odds of stunting of 2.43 (95% CI 2.22, 2.66). The risk almost doubled when combined with 
being born preterm. Given the high prevalence of SGA, the population attributable risk for 
stunting in South Asia was 0.18 (95% CI 0.11, 0.24).110 
While fetal growth is positively associated with child and adult growth, it tends to be 
negatively associated with fat percentage.111,112 A review of the literature in developing 
countries by Yang and Huffman provided evidence for this, showing that low birthweight was 
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associated with both relatively higher fat mass and lower lean mass. 113 Higher weight gain 
early in life (infancy) is thought to be related to greater BMI later, but, at least in developing 
countries, the association is with lean rather than fat mass.114,115 This idea of low lean mass 
but relatively high fat mass was termed the Thin-Fat phenotype and is common amongst 
Indian babies. 116 
In a study of 1012 children from the Netherlands, in multivariable models including current 
weight, Ay et al showed an inverse association between estimated fetal weight at both 20 and 
30 weeks and subcutaneous fat at two years, measured by skinfold thickness. Interestingly, 
the strongest association was at 30 weeks gestation.117 Further studies from the same cohort 
examined the importance of growth in different trimesters of gestation. Jaddoe et al showed 
an inverse association between first trimester growth and fat mass in children aged six, 
specifically with waist, but not hip fat mass.118 Durmuş et al found a negative association 
between second trimester estimated fetal weight and preperitoneal fat, but not subcutaneous 
fat at two years of age.119 Programming of fat has thus been hypothesized to occur at different 
times in pregnancy: peritoneal fat related to the second trimester and subcutaneous fat to the 
third.112 In addition to the association with adiposity, low birthweight is associated with 
changes in insulin levels and resistance.120,121  
Studies in rats by Venu et al showed that reduction in vitamins (pyridoxine, B1, B2, folic acid, 
B12, A, D and E)122 and minerals123 (iron, zinc, magnesium and calcium) led to growth 
restriction in-utero. In both cases, the offspring went on to have greater fat percentage, but in 
the case of the vitamin restricted maternal diet, if a normal diet was commenced in the pups 
they did not develop increased fat percentage.  
 
2.5.1.3 Effect on subsequent generations 
There is evidence that the growth of a woman as a fetus is associated with that of her children. 
Understanding of how intergenerational causes can affect growth is complex. Martorell and 
Zongrone identify many factors that influence child health (Figure 5). Underpinning this is 
the concept of intergenerational poverty.124 Growth of a woman in early life affects her final 
adult size, which in turn has an effect on her offspring. Maternal size, most notably height, is 
associated with fetal outcomes. The best example of this is disproportion between the 
mother’s  pelvic  size  and  the  newborn’s  head  (cephalo-pelvic disproportion). In a study in the 
United States, Collins et al showed that mothers who were low birthweight were more likely 
to have low birthweight children. After controlling for economic and maternal factors 
(maternal age, education, marital status, parity, adequacy of prenatal care utilization, and 
cigarette smoking), they found an increased odds for offspring SGA of 1.8 (95% CI 1.5, 2.3). 
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125 Similar results were seen in a cohort study from Brazil by Horta et al, who found that 
maternal birthweight was associated with the birthweights of her children (P<0.001). Paternal 
birthweight was, however, not associated. 126 
 
 
 
 
Figure 5: Intergenerational influences on child nutrition 
Reused with permission for use in a dissertation from Martorell and Zongrone, Paediatric 
Perinatal Epidemiology, 2012. 124 
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2.5.2 Child growth 
Malnutrition in childhood is highly prevalent worldwide. Globally in 2011, 165 million 
children were estimated to be stunted and 43 million were overweight.127,128 Karlberg 
describes how growth can be divided into three phases: infant (a continuation of fetal growth), 
childhood and adolescent. The lowest musculoskeletal growth rate is in the late childhood 
period (6 years to puberty). Each phase is controlled by a different set of hormones: insulin 
and insulin-like growth factor in infancy, growth hormone in childhood and the sex steroids 
in adolescence. Sitting height (truncal) growth has a greater association with infant growth 
and puberty, while leg length is more associated with childhood growth (see Figure 4).  
Growth faltering may be due to problems in moving from one phase to another. Some of the 
difference between male and female height is explained by different growth in these phases. 
The female childhood growth period is shorter and leaves females with shorter limbs and 
overall height.129 
There are short-term consequences of malnutrition, such as increased risk of infection and 
mortality, and long-term consequences such as increased risk of chronic disease. Fat mass is a 
better predictor of long-term, particularly cardiovascular, health. 130 Even in populations with 
low mean BMI, the relative percentage of fat can be high, making the accurate assessment of 
nutritional status crucial.5,27 Obesity is also a growing problem worldwide, with an increasing 
prevalence in both low- and high-income countries. Obesity in childhood is related to obesity 
later in life, with a resulting increase in chronic disease. In addition to the high prevalence of 
underweight, 80% of overweight children are thought to live in developing countries,127 with 
many  countries  experiencing  the  “double-burden”  of  under- and over-weight children.131  
The risk of obesity is multifactorial and includes activity levels, an energy dense diet and a 
genetic propensity. It is increasingly being shown that early life diet also plays a key role.113 
Again, some recent evidence from epigenetic studies points to an association between 
methylation states at birth and childhood adiposity. 132 
Children who are obese in childhood are likely to be obese as adults. A review of the 
literature by Serdula et al found that about a third of obese pre-school children and half of 
obese school-aged children continued to be obese as adults. 133 Singh et al showed between a 
doubling and a tenfold increase in risk of an overweight child being overweight as an adult, 
compared with a normal weight child. In addition, the risk of being overweight increases as 
childhood weight increases. 134 
Body composition analysis in childhood is one method of measuring nutritional status.135 
Most   research   on   “obesity”   is   based   on   BMI,   but   body   composition   has   the   advantage   of  
being able to distinguish fat mass and lean mass. High-precision methods for the assessment 
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of body composition such as water or air displacement are currently deployed in clinics and 
research institutions. However, most of these methods are unsuitable for large-scale 
epidemiological studies as they are either impractical or expensive.136  
 
2.5.2.1 Catch-up growth 
While growth failure is greatest in early life - the most important determinant of adult stature 
- there appears to be some scope for catch-up growth. This can occur in-utero. If the growth 
of an embryo/fetus is affected early in gestation, it is possible that some degree of catch-up 
can occur, resulting in a normal or near-normal birthweight. Growth may, however, be 
disproportionate and the child may still have some of the problems resulting from growth 
faltering.137 
An attempt to compensate for poor weight gain in infancy is an earlier childhood component 
of growth. In childhood, there are two main ways in which catch-up growth can occur: 
through delayed or prolonged puberty.138 Prentice et al suggest that catch-up growth is due to 
maturation  and  adaptation  of  the  child’s  immune  system.  They  showed  that  linear  growth  in  
puberty can be prolonged, leading to greater adult height. Boys may continue to grow until 
aged 22-24 and girls until 18-19.139 Both they and the COHORTS study group investigated 
growth in populations in Brazil, Guatemala, India, the Philippines and South Africa. They 
showed that height was mostly lost in early life, with a nadir at the age of two years. By mid-
childhood some catch-up growth occurred (height-for-age z scores): Brazil=0.18, 
Guatemala=0.61, India=-0.01, Philippines=0.15 and South Africa=0.81 z scores. The one 
exception was India, where z scores continued to reduce. 140 
Catch-up growth in weight (independent of height) in childhood may, however, be 
detrimental to health. 5 The combination of being born growth restricted and undergoing rapid 
catch-up growth was associated with insulin resistance in the studies from Pune in India by 
Yajnik et al.141  
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Figure 6: Growth of organ systems in humans. 
Reprinted with permission for use in a thesis from Paulino et al, Seminars in radiation 
oncology. 2010. 142 
 
2.5.3 Role of micronutrients 
Micronutrients are likely to act on fetal growth in a number of ways. Christian and Stewart set 
out  potential  pathways  based  on  “hormonal  adaptations”,  particularly  via   the  hypothalamic-
pituitary-adrenal axis and  “epigenetic  regulation”.  These  result  in  changes  in  the  structure  of  
organs, fat metabolism and deposition and appetite and activity levels. 3  
I describe in detail the effects of multiple micronutrient supplementation in Section 2.9, as the 
UNIMMAP supplement containing 15 vitamins and minerals was used in the study. I have 
only briefly summarized the evidence for single micronutrients on growth because it is 
difficult to know how each micronutrient may act in combination with others. I have also 
limited myself to descriptions of supplementation trials or meta-analyses. A large amount of 
observational epidemiological evidence has looked at the effects of antenatal micronutrient 
supplementation. The results of this work can be misleading, as in addition to the complexity 
of clearly identifying the nutrient of interest, publication bias and residual confounding may 
lead to falsely positive results.143 Blinded randomised controlled trials are generally 
considered the best forms of evidence because trial evidence is less prone to confounding. 
The meta-analyses combine the trial data in a systematic way and should provide the most 
accurate and reliable answer to the question of whether micronutrients lead to an effect on 
growth.  
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In terms of fetal and child growth, in general, trials have not found associations between 
single nutrients given in pregnancy and growth.2 A discussion of micronutrients for which an 
association has been postulated follows (iron and folic acid are considered in section 2.8).  
Vitamin A and β  Carotene (its inactive precursor) 
A meta-analysis of three trials in HIV positive women from Malawi, South Africa and 
Tanzania by Thorne-Lyman and Fawzi showed a small, but not statistically significant, effect 
on mean birthweight (40g; 95% CI -10, 80g). Two of these studies found no effect of vitamin 
A on SGA (0.89; 95% CI 0.68, 1.17),144  and follow-up of one of them found no difference in 
weight, length, head circumference or mid-upper arm circumference (MUAC).145 
A recent trial from Indonesia of vitamin A in pregnancy by Prawirohartono et al  (n=2173) 
showed a small increase in birth length, but not birthweight, as compared with placebo (all 
participants received iron and folic acid). Interestingly, the combination of vitamin A and zinc 
did not show an effect on birth length. In this trial, zinc alone improved birthweight and 
length. 146 
Vitamin B6 
Vitamin B6 acts as a co-enzyme in numerous metabolic reactions. Meta-analysis by Dror and 
Allen found a positive effect on birthweight (217g; 95% CI 130, 304g), but this result should 
be treated with caution. Only three studies (two trials and one cohort) were included, with a 
total number of 247 participants, and in one study 90% were lost to follow-up. All studies 
were from developed countries.147 
Vitamins C and E 
Vitamin C is an anti-oxidant involved in the formation of collagen and carnitine, as well as 
hormones and neurotransmitters. The review by Dror and Allen included eight trials (five 
from developed countries), six of which also gave vitamin E. The results showed no effect (-
26g; 95% CI -0.82, 29). Although the studies showed high heterogeneity (I2 = 93%), the lack 
of effect was consistent across all of them.147 
Vitamin D 
A meta-analysis of three supplementation trials (n=507) of vitamin D (two from the UK and 
one from India) by Thorne-Lyman and Fawzi found a reduction in low birthweight of 60% 
(95% CI 0.23, 0.71).148 A Cochrane review by DeRegil et al had similar findings, but the 
results for low birthweight (n=463) did not attain significance: RR 0.48 (95% CI 0.23, 
1.01).149 The meta-analyses used the same trials but a different result for one. Thorne-Lyman 
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and Fawzi148 used the results from publication by Yu et al150 after personal correspondence 
with the authors. De-Regil et al referenced a poster from the same study.151 These results are 
difficult to verify because neither publication nor poster by Yu et al reports the results for 
birthweight or low birthweight. Nevertheless, both meta-analyses point to a beneficial effect 
of vitamin D supplementation on low birthweight.  
Zinc 
Zinc has wide-ranging effects in the body due to its interactions with numerous enzymes. It 
has been shown to affect skeletal growth in-utero in animal studies152 and was presumed to do 
so in humans. A meta-analysis of 13 trials of zinc supplementation in pregnancy showed no 
effect on birthweight (-9.9 g; 95% CI -35.7, 16.0) and no difference in SGA. It did, however, 
report a small reduction in the relative risk of preterm (0.86; 95% CI 0.76, 0.97).153 
Calcium 
A meta-analysis of 11 trials from both richer and poorer countries by Imdad and Bhutta 
showed that supplementation with calcium could increase birthweight by 85 g (95% CI 38, 
134 g). It may also reduce preterm birth (0.76; 95% CI 0.60, 0.97).154  
Magnesium 
A Cochrane review of antenatal magnesium supplementation by Makrides and Crowther 
showed an increase in birthweight, but the 95% confidence intervals just crossed zero (50.8g; 
-0.22, 101.9g). The meta-analysis included four trials, all from developed countries (n=1482). 
Two were included in a meta-analysis, which showed a reduction in the proportion of SGA 
infants (RR 0.70; 95% CI 0.53, 0.93).155 
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2.6 Respiratory 
To my knowledge, the long-term effects of antenatal MMN supplementation on respiratory 
function have not been investigated, but there is evidence that individual micronutrients are 
associated with later lung function and lung disease. Micronutrients may have a direct effect 
on lung function or act via improvements in birthweight and child anthropometry, changes in 
respiratory disease risk or alterations to the way in which the organism responds to 
environmental stresses. The effects of these on factors can be cyclical. For example, poor 
lung function can lead to increased risk of respiratory disease,156,157 which may itself lead to 
poorer lung function.158 
 
2.6.1 Airway development 
Knowledge of the early life determinants of lung development is important as it can 
determine lung growth and function later in childhood and adult life. Lung development 
depends on genetic, epigenetic and environmental factors, during both intra- and extra-uterine 
life. Airway development occurs predominantly in-utero,159 but infancy and childhood are 
also important for lung growth. Preterm delivery is a major cause of reduced lung function 
and later respiratory morbidity.160 
Lung embryology follows five stages: embryonic, pseudoglandular, canalicular, saccular and 
alveolar (Box 3). Approximately 100-150 million alveoli form by birth. Alveolar formation 
ceases in early childhood, but maximum lung capacity is only attained in early adulthood. The 
alveoli grow in size and the surface area for gas exchange increases by about 20 times from 
birth.161 Lung growth is controlled by a large number of growth and transcription factors, and 
lung development requires movements and fluid. Fetal lung movements, controlled by the 
phrenic nerve, are required for development. This has been shown in rabbit fetuses, where 
section of the cord at C1-C3 resulted in reduced lung weight.162 A number of factors are 
believed to increase (for example, hyperglycaemia and caffeine) or decrease (for example, 
hypoxia and maternal alcohol) fetal lung movements.163 Airway smooth muscle receives 
innervation  from  approximately  eight  weeks’  gestation  and  fetal  breathing  can  be  seen  from  
around ten weeks.161 
Lung fluid, made by epithelial cells in the distal airways, is also needed. If this fluid is 
drained, as happens during premature rupture of the membranes, this results in hypoplasia. 
The fetal movements combined with resistance in the upper airways help to maintain some 
fluid in the lungs.163 
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In people for whom lung development has been interrupted or environmental stresses increase 
to a destructive level, disease will result. In this sense the trajectory for lung function is set 
early in life. In the longer-term, micronutrient supplementation could also have an effect on 
chronic obstructive pulmonary disease (COPD) as this is in part related to lower peak lung 
function. In a follow-up of children born to mothers who were pregnant during the Dutch 
famine of 1944-45, Lopuhaä et al produced conflicting evidence of this. They showed that, 
compared with people conceived before or after the famine, those who were exposed to the 
famine in early to mid-gestation were more likely to suffer from COPD in adulthood, but their 
lung function did not differ significantly.164 Adults with poorer lung function also have 
increased risk for respiratory morbidity and also mortality from other diseases.165 
 
1. Embryonic, 0-7 weeks gestation. Lung tissue develops from the ventral foregut of the 
endoderm  at   approximately  24  days.  The   separate   lungs   can  be  seen  by   six  weeks’  
gestation.  
2. Pseudoglandular, 7-17 weeks gestation. Branching and elongation of the airways and 
blood vessels and formation of the terminal bronchiolus by 17 weeks. Epithelial 
multiplication is under the influence of hormones such as epidermal growth factor 
and insulin-like growth factor.  
3. Canalicular, 17-27 weeks gestation. Formation of the alveolar ducts and primitive 
alveoli. Vascularisation of the peripheral mesenchyme also occurs and thinning of the 
airway walls. The fetal lungs can be said to resemble adult lungs by 24 weeks. 
4. Saccular, 28-36 weeks gestation. Enlargement of the peripheral airways and 
formation of acini.  
5. Alveolar, >36 weeks to 2 years of age. Alveoli develop and increase in number. 
Box 3: Main embryological stages in the development of the lung 159,161,163 
 
2.6.2 Birthweight and lung function 
Research has shown that increased birthweight is associated with better lung function in later 
life.23,24  Being born with a low birthweight, particularly SGA, is a risk factor for pneumonia 
in childhood,166 and is associated with reduced airway function in early childhood, after 
adjusting for birthweight.167 
Despite their own study finding no association between birthweight and adult lung function, 
(10 ml per kilogram; 95% CI -20, 40 ml after adjusting for age, observer and height squared), 
Lawlor et al showed, in a meta-analysis of eight studies, a positive association of 24 ml (95% 
CI 13, 35 ml) increase in forced expiratory volume in the first second (FEV1) per 500 g 
increase in birthweight.24 One study included from a developing country by Stein et al (south 
India) found a 90 ml (95% CI 10, 160 ml) increase in FEV1 per 450 g increase in birthweight 
after adjusting for height and age. 23 A later study by Canoy et al, not included in the meta-
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analysis, found similar results: a 500 g increase in birthweight was associated with a 53 ml 
increase (95% CI 38, 68 ml) in FEV1 in 31-year-old adults after controlling for a number of 
adult and childhood confounders.168  
Turner et al looked in more detail at fetal anthropometry using ultrasound measures in-utero. 
They found positive associations between crown-rump length (CRL) in the first trimester and 
lung function at 5 years of age. Each 1 mm increase in CRL was associated with 5 ml 
increase in FEV1 and 6 ml in FVC, 169 and a 6% (95% CI 1, 11%) reduction in the risk of 
asthma in childhood.170 Maternal  α–tocopherol concentrations were associated with fetal size 
CRL (p=0.002), but no association was found between α–tocopherol and later lung 
function.169 
Overall, the epidemiological studies have found a positive association between birthweight 
and adult lung function after controlling for current size. Some degree of caution should be 
maintained, though, as all these studies have been observational and most retrospective and 
inadequate control of confounding cannot be ruled out. Differences may also be explained by 
differences in population, setting, disease morbidity and toxin exposure, amongst other things. 
The mechanisms by which fetal growth restriction may lead to impaired lung function are 
through reduced alveolar formation and development, potentially by a reduction in fetal 
elastin, leading to reduced surface area and lung weight. Gas exchange may also be affected 
by thickening of alveolar walls.171,172 IUGR can lead to alteration in methylation of specific, 
lung-related genes. An example of this is PPARγ, which is important for lung development. 
Joss-Moore et al showed in a rat model that IUGR led to increased methyl CpG binding 
protein 2 during alveolarisation. In addition, there were differences in male and female 
offspring. In males, there was a decrease in H3K9 methylation, while in females there was an 
increase. In normally grown rats, methylation was the same. 173 
 
2.6.3 Role of micronutrients 
Micronutrients may increase birthweight as described in section 2.5 and consequently 
improve lung function. Reductions in nutrients can also lead to structural changes in the fetal 
lung affecting alveolar size and number. Antenatal micronutrients may lead to changes in 
lung function by altering respiratory disease risk. A review of the effect of maternal and 
childhood diet by Devereux,174 for example, highlighted its importance in the development of 
asthma, a condition suffered by 300 million people.175 Here, I will outline the main 
micronutrients involved in determining lung function, not purely mediated by a change in 
birthweight. 
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Vitamin A 
The best evidence for long-term effects exists for vitamin A. Supplementation in both 
animals176 and humans177 has shown positive effects on lung function. Animal studies in 
lambs have shown that antenatal administration of vitamin A can improve lung function.176 
This process may in part be due to its role in the modulation of vascular endothelial growth 
factor, as shown by antenatal vitamin A supplementation in a mouse model.178 Vitamin A acts 
through its active metabolite, retinoic acid, binding to nuclear receptors (retinoic acid 
receptors, α,  β,  γ  and  retinoic  X  receptors  α,  β  and  γ),  which  in  turn  bind  to  promoter  regions  
of target genes, leading to a wide array of effects.179 Retinoic acid acts in the signalling of 
fibroblast-mediated alveolar septation.180 It affects gene transcription and inhibits formation 
of fibroblast growth factor 10, which is involved in a number of cell growth and morphogenic 
processes.161 It has also been linked with a reduction in bronchopulmonary disease and is 
recommended for use in extremely low birthweight infants. 181 
In the follow-up of a trial of vitamin A supplementation versus placebo and beta-carotene in 
Sarlahi, Nepal, Checkley et al showed that, after adjustment, antenatal vitamin A 
supplementation led to a greater FEV1 and forced vital capacity (FVC) in children at 9-13 
years of age. The magnitude of the difference was 46 ml in both cases, which corresponded to 
3% of the mean difference in the population.177 While this was the most similar study to ours, 
it differed  in  a  number  of  ways.  Firstly,  the  trial  design  was  different:  Checkley’s  study  was  a  
cluster randomised trial in which married women were given the supplements over 3.5 years, 
not just in the second and third trimesters.182 Secondly, the comparator group was placebo, 
while ours was iron and folate. Thirdly, there may have been a dose effect: they gave 7000 
µg/week of vitamin A, compared to 800 µg/day in our trial.  
Vitamin D 
A recent trial of antenatal vitamin D supplementation in the UK showed no effect on lung 
function or in symptoms of wheeze at three years of age. Goldring et al gave vitamin D 
supplements from 27 weeks gestation and measured lung function using impulse oscillometry 
(an alternative technique to spirometry useful in young children that measures respiratory 
impedance using short pulses of air pressure to test airway resistance). This trial does not rule 
out an effect of vitamin D as it was small and only 28% (n=51) produced acceptable results. 
The generalizability from the UK is also questionable.  183  
Maternal vitamin D depletion has been shown to alter lung structure and reduce lung volume 
in mice, independent of their somatic growth.184 In humans, the evidence for an effect on lung 
function and respiratory disease is mixed, with associations being seen in some cases,185,186 
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but not in others.187 There is evidence that deficiency in antenatal vitamin D has been 
associated with wheeze/asthma in offspring in developed countries.185,186,188 However, Pike et 
al did not find such an association between vitamin D levels at 34 weeks and wheeze, asthma 
or lung function in UK children at age 6.187 Similarly, a cohort study of 1200 children aged 4-
6 years from Spain by Morales et al found no association with wheeze or asthma with 
maternal 25-hydroxyvitamin D concentrations. There was a possible association with lower 
respiratory tract infections at one year.189 Exposure to air pollution may interact with 
nutritional deficits. One example is a reduction in conversion of vitamin D, as has been 
shown with an association between PM10 and reduced vitamin D levels in infants. 190 
Vitamin E  
A cohort study from the UK looked at the association between antenatal vitamin E intake, 
assessed by a food frequency questionnaire and respiratory outcomes. Comparing the highest 
tertile of vitamin E with the lowest, it found a difference in FEV1 of 77ml (95% CI 26, 128 
ml) at 5 years of age. There was a negative association with wheeze and asthma.191  
Selenium  
A cohort study of children from the UK showed a negative association between maternal 
selenium concentrations and wheeze (as defined by maternal recall using questions from the 
International Study of Asthma and Allergy in Childhood) in children aged 5: adjusted OR 
0.86 (95% CI 0.76, 0.97).192 
 
2.6.4 Air pollution 
Air pollution is amongst the most important environmental determinants of lung function and 
respiratory disease in children. Particle mass and other toxins such as nitrogen oxides can 
damage the developing lungs, leading to immediate effects in the child and long-term effects 
as adults.193,194 The main source of air pollution is indoor burning of biomass fuel, which was 
found to adversely affect lung function in adults in Nepal,52 and has been linked to respiratory 
infections in children.195 
 
2.6.4.1 Biomass 
Indoor air pollution is a major cause of ill-health in low-income countries. It is mostly due to 
the  burning  of  biomass  fuels  (also  referred  to  as  “solid  fuels”),  a  group  of  organic  materials  - 
particularly wood, dung, straw, and charcoal – used as a source of heat and light.196 
Incomplete combustion of biomass fuels in poorly ventilated houses produces domestic levels 
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of airborne particles hundreds of times higher than commonly encountered outdoors.197 It is 
estimated that between one-third  and  half  of  the  world’s  population  use  biomass  as  a  source  
of energy as it is readily available and usually cheap.198 Globally, solid fuel use is estimated to 
cause 3.5 million premature deaths per year, around one million of which are attributed to 
acute respiratory infections in young children.32,199 The deaths occur predominantly in poorly 
resourced settings where an increased susceptibility to illness coexists with reduced access to 
healthcare. As well as increased mortality, household cooking with solid fuels accounts for 
4.3% (95% CI 3.4, 5.3) of DALYs lost worldwide (6% for children under 5 years old), while 
ambient air pollution accounts for a further 3.1% (95% CI 2.7, 3.4). These figures make 
indoor air pollution the third leading contributor to global disease burden, and the highest in 
South Asia.32 There is limited information on indoor air pollution levels in Nepal, although 
one study showed a geometric mean 24-hour level of 455 µg/m3 in houses where biomass 
fuels were burnt.52 
 
2.6.4.2 Health effects 
Children experience adverse health effects from exposure to air pollution. Systematic reviews 
and meta-analyses show an increased odds of illness with solid fuel use, with odds ratios of 
2.80 (95% CI: 1.85 to 4.00) for chronic obstructive pulmonary disease,200 1.78 (95% CI 1.45, 
2.18) for pneumonia in children under 5,195 1.50  (95% CI 1.17, 1.94) for lung cancer,201 and 
1.30 (95% CI 1.04, 1.62) for tuberculosis.202 There is also weaker evidence for a link with low 
birthweight,203,204 anaemia and stunting.196,197,205 In a study of the association between biomass 
usage and respiratory infection in Nepal, Bates et al found an increased odds of infection 
related to not only biomass fuels, but also kerosene and gas usage in comparison with 
electricity.53 The incidence of respiratory infections plateaus with increasing particle mass 
over 1000-2000 µg/m3, suggesting that air pollution needs to be reduced to low levels to yield 
a health advantage.206 207  
Particle mass can directly damage the respiratory tract through oxidative stress.208 The smoke 
produced when biomass burns also contains a number of toxins, such as carbon monoxide, 
nitrogen oxides and sulphur dioxide.198 These affect both cell-mediated and humoral 
immunity.209 A study from the USA showed that particle mass was associated with airway 
damage using exhaled nitric oxide as a proxy. These were found to be independent of asthma 
status.210 
Exposure to air pollution antenatally can affect the lung function of the children later in life. 
A study from Poland by Jedrychowski et al measured PM2.5 (particles with median diameter 
less than 2.5 μm) levels over 48 hours in the second trimester and found an inverse 
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relationship between FEV1 or FVC and PM2.5.211 There is also some evidence for interaction 
between genes, for example those coding for anti-oxidants which act to reduce the 
inflammation produced by the air pollution.212 Similar to the epigenetic effects of in-utero 
nutrition, particle mass can lead to changes in DNA methylation. An example is a study of 
PM10, in which global methylation measured using two techniques (Alu and LINE-1) was 
inversely associated with long-term exposure to PM10 in multi-variable models. Interestingly, 
short-term (over three days) exposure did not elicit similar changes.213  
An important air pollution exposure in-utero is tobacco smoke. Independent of birthweight, 
there is evidence that smoking in pregnancy is associated with poorer lung function in the 
child.214 215 DNA methylation in eight genes in children was also associated with exposure to 
tobacco smoke in-utero.216 Bouzigon et al showed an increased risk of asthma associated with 
early exposure to tobacco smoke, related to the 17q21 region,217 and tobacco smoke is 
associated with hyper-methylation in studies of lung cancer.218 Smoking is not considered in 
great detail here because the prevalence during pregnancy amongst the women in the study 
was very low. 
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2.7 Blood pressure 
The previous follow-up at 2.5 years showed a 2.5 mmHg lower mean blood pressure in the 
MMN allocation group.8  Blood pressure varies according to age, sex, height and many other 
temporary factors such as anxiety levels or having just taken a meal. Early changes to the 
environment in-utero have been shown to be associated with renal disease and hypertension 
later in life,219 but the association with later blood pressure is complex (Figure 7). In addition 
to the role of the kidneys, which I will describe, offspring blood pressure is associated with 
placental size, maternal blood pressure, child growth, hormonal and nervous system 
regulation and the structure of the vasculature.220  
It is possible that the relationship between micronutrients and later blood pressure is mediated 
by change in birthweight or that birthweight and blood pressure may be the joint results of 
other processes such as hormonal responses. Birthweight is believed to be inversely 
correlated with blood pressure later in life, a 1 kg increase being associated with a fall in 
blood pressure of -2 to -3 mmHg.221 This is supported by a large meta-regression by Gamborg 
et al that included nearly 200 000 adults from the Nordic countries. It found a negative 
relationship with systolic blood pressure at 50 years of age, of -1.52 mmHg/kg (95% CI -2.27, 
-0.77) in men and -2.80 mmHg/kg (95% CI -3.85, -1.76) in women.222 Contradictory evidence 
in a meta-analysis by Huxley et al showed a smaller reduction of -0.6 to -0.4 mmHg, which 
they felt was accounted for by publication bias.223 A study of 1570 children from developing 
countries found negative associations of birthweight with systolic blood pressure in 
multivariable regression models using data from China, Guatemala and Chile, but not 
Nigeria.224 
Hypertension can also result from a combination of growth restriction in-utero and rapid 
growth in childhood.225 In a cohort study from Sweden, Leon et al showed that low 
birthweight and above average adult height were associated with the highest blood pressure. 
These men were considered to have not reached their full growth potential in-utero.226  
The mechanism by which birthweight relates to later blood pressure may be via its 
relationship with kidney size or, more specifically, nephron number, which is hypothesized to 
be related to essential hypertension.225 Nephrogenesis occurs in-utero from the 9th to the 36th 
week of gestation. Nephron number represents the difference between the number formed 
prior to birth and the number lost during life.227 In humans, birthweight is positively 
correlated with nephron number and intra-uterine growth restriction is associated with smaller 
kidneys relative to body size at birth, and also reduced kidney growth during early life.228 
Nephron number also varies by sex, age and ethnicity. In suboptimal in-utero conditions the 
fetus will preserve the brain and the heart at the expense of other organs such as the 
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kidneys.229 Konje et al showed a difference from 26 weeks gestation onwards between SGA 
and appropriate-for-gestational-age fetuses. The reduction occurred more in transverse and 
antero-posterior diameters than in length.230 As described by Brenner, the reduced number of 
nephrons may increase capillary pressure, leading to glomerular sclerosis which later results 
in hypertension.225 The relationship between nephron number and hypertension is, however, 
not straightforward as compensatory hyper-filtration can occur, maintaining a normal blood 
pressure.231 
The epidemiological studies show a similar magnitude of blood pressure reduction per 
kilogram to that found in the two-year follow-up of our cohort, but this was only associated 
with a 77 g increase in birthweight, i.e. a tenfold greater effect. This might suggest a 
mechanism other than one simply mediated by birthweight. In terms of micronutrient 
involvement, vitamin A and iron are thought to be the most important, and our trial showed 
improvements in maternal vitamin A (retinol) and a reduction in maternal anaemia.7 Retinoic 
acid regulates the c-Ret receptor for glial-derived neurotrophic factor, which is in turn 
involved in regulating nephron number.232 In rat studies, iron has also been implicated in 
changes in blood pressure and kidney size,233 but we would not expect to see this relationship 
in our study as both intervention and control groups received iron supplements (and assuming 
that the 30 mg of iron in the MMN is truly equivalent to the 60 mg in the control). 
 
 
 
Figure 7: Conceptual diagram for early origins of hypertension and renal disease 
Reused with permission for use in a dissertation from Luyckx et al, Lancet 2013.219 
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2.8 Control supplement 
The study was not able to investigate the effects of iron and folic acid as they were present in 
both MMN and control supplements. However, I will briefly consider them as they are both 
important micronutrients.  
 
2.8.1 Iron and folate together 
Pena-Rosas et al performed a Cochrane review of iron and folic acid supplementation in 
pregnancy in 2012. When comparing trials that used iron and folic acid with supplements that 
used  “the  same  supplements  without  iron  and  folic  acid”,  they  found  only  two  trials  and  one  
of them made up 97% of the total records. Meta-analysis showed a 57.7 g (95% CI 7.7, 107.8 
g) increase in birthweight and no effect on prematurity.234 
 
2.8.2 Folate 
The use of folic acid is common in pregnancy as it has been shown to reduce neural tube 
defects235 and mortality arising from them.236 Folic acid is recommended for women 
throughout the world and 53 countries have regulations for fortification. 237 There is evidence, 
particularly from animal and to some extent human studies, that folate can affect DNA 
methylation.238,239 It is an essential co-factor in the synthesis of purines and thymidylate and is 
a potent DNA methylator through the production of S-adenosyl-L-methionine (a co-factor in 
one-carbon metabolism). A mouse study found that the offspring of pregnant mice given a 
high folic acid diet showed greater airway responsiveness, in line with what would occur in 
asthma. The mechanism by which this occurs is thought to be via a change from a T helper 1 
phenotype to a T helper 2 phenotype, related to hypermethylation of the runt-related 
transcription factor-3 promoter region. Effects were transmitted to the F2 generation via 
males, indicating an effect on the germ cells. Hollingsworth et al found differential 
methylation at 82 loci. These effects were reversible when demethylating agents were used.240   
It is probable that antenatal folic acid alone increases birthweight. A meta-analysis of five 
trials by Lassi et al showed a non-significant increase of 105.0 g (95% CI -25.0, 235.4 g), but 
when one trial was removed due to suspected heterogeneity the difference increased to 135.8 
g (95% CI 47.9, 223.7g).241 Analysis of the association between antenatal folic acid intake 
(measured by food frequency questionnaires) and body composition from the ALSPAC 
cohort in the UK found no association at 9 years of age.242 
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Though the evidence is mixed, cohort studies in humans have suggested an association 
between antenatal folic acid consumption and wheeze in childhood. A large study of over 
3000 children by Haberg et al showed an increased relative risk for wheeze, defined as chest 
tightness/congestion and whistling/wheezing, of 1.06 (95% CI 1.03, 1.10) related to folate 
acid in the first trimester. It also found a positive association with respiratory tract infection, 
1.09 (95% CI 1.02, 1.15) in children aged 6 to 18 months, though this was less reliable as it 
was based on maternal recall. The study controlled for estimated intake of other 
micronutrients and the sample had a high prevalence of folic acid use amongst all 
participants.243 Similar increased risk of asthma was seen in Australian children aged <6 
years.244  Bekkers et al reported an association with wheeze in children at 1 year of age, but 
not later, in Dutch children.245 Contrary to this, a cohort of 1499 women and children in the 
United States did not find an association between folic acid supplementation and asthma at 
six years of age.246 There is also evidence that antenatal folic acid does not affect lung 
function.247  
 
2.8.3 Iron 
In their Cochrane review, Pena-Rosas et al also looked at iron supplementation alone. They 
found no effect on birthweight in a meta-analysis of nine trials (n=3953): 16.4 g (95% CI       
-37.3, 70.1 g). Sub-group analysis also showed no effect, but the effect size was larger when a 
30 mg supplement was used and when started in the first half of pregnancy.  
They then compared any iron-containing   supplement  with  “supplements  without   iron  or  no  
treatment/placebo”,  and  showed  an  increased  birthweight  of  30.8  g  (5.9, 55.7 g) in 14 trials. 
Sub-group analysis also showed a stronger effect if started in the first half of pregnancy: 38.6 
g (95% CI 3.3, 74.0 g). While not statistically significant, there was also a larger effect with 
the 30 mg supplement (52.9 g; 95% CI -11.5, 117.3 g) than the 60 mg supplement (27.6 g; 
95% CI 2.6, 52.3 g). The lack of statistical significance was likely to be due to the smaller 
sample size in the 30 mg trials. The presence of maternal anaemia and malarial settings made 
little difference to the results.234 A meta-analysis of antenatal multiple micronutrient 
supplementation also showed no effect on maternal anaemia. 248 
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2.9 Multiple micronutrients  
2.9.1 Janakpur trial 
The study was the second follow-up of the RCT in Dhanusha district, in which pregnant 
women received either daily multiple micronutrient supplements in the second and third 
trimesters or iron and folate supplements.7 I describe in detail the methods from the trial on 
which the follow-up was based, in section 3.1. The supplement used in the intervention group 
was the UNIMMAP multiple micronutrient supplement containing vitamin  A  800  μg,  vitamin  
C  70  mg,  vitamin  D  5  μg,  vitamin  E  10  mg,  vitamin  B1  1·4  mg,  vitamin B2 1·4 mg, niacin 18 
mg,   vitamin  B6   1·9  mg,   vitamin  B12   2·6   μg,   folic   acid   400   μg,   iron   30  mg,   zinc   15  mg,  
copper  2  mg,  selenium  65  μg,  and  iodine  150  μg.6 The control group received iron 60 mg and 
folic acid  400  μg.  The  micronutrients   in   the  supplement,  developed   from  US  and  Canadian  
recommendations (the National Research Council and the Institute of Medicine), were all at 
their recommended daily allowance. Only folic acid was given at a different dose that was 
designed to prevent neural tube defects. The formulation was approved by UNICEF, WHO 
and the United Nations University in 2000. Consideration was given to toxicity levels, side-
effects, potential interactions and deficiencies. In the MMN supplement the dose of iron was 
reduced to 30 mg. This was believed to be equivalent to the 60 mg dose in the control because 
the addition of vitamin C improves absorption of iron, resulting in the same bioavailability.  
The main outcomes of the trial were birthweight and gestation. The results for both trial and 
two-year follow-up are shown in Table 3.  Babies born in the MMN group were 77 g heavier 
(95% CI 24, 130 g) at birth, but there was no difference in head circumference or length. The 
proportion of babies with low birthweight (<2500 g) was correspondingly reduced (OR 0.69; 
95% CI 0.52, 0.93). There was no difference in gestation or proportion of preterm births, 
although gestation was 1.5 days longer in the intervention group. This equates to 
approximately 30 g, but does not fully explain the difference in weight. There was a 
suggestion of a increased neonatal mortality, but the study was not powered to detect it.   
The first follow-up, conducted at a mean of 2.5 years of age,8 found 917 children (85% of the 
number who might have potentially been found from the original trial), with similar numbers 
in both intervention and control groups. Children in the MMN group were 204 g (95% CI 27, 
381 g) heavier at 2.5 years, with larger head, chest, hip and mid-upper arm circumferences 
and 0.2 mm lower triceps skinfold thickness. Waist circumference was also close to a 
significant difference. Systolic blood pressure was 2.5 mmHg (95% CI 0.5, 4.6) lower. 
Similar to the birth findings, there was no difference in height. Control and intervention 
groups were very similar in terms of the confounding variables measured, but loss to follow-
up was associated with residence and occupation.  
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Table 3: Birth and two-year follow-up outcomes of the Janakpur trial 
 Intervention Mean 
(SD) 
Control  
Mean (SD) 
Difference (95% CI) 
Birth    
Birth weight (g) 2810 (453) 2733 (422) 77 (24, 130) 
Length (cm) 48.9 (2⋅9) 48.6 (3.2) 0.3 (-0⋅1, 0.6) 
Head circumference (cm) 33.8 (2⋅2) 33.6 (2.2) 0.2 (-0.1, 0.4) 
Gestation at birth (w) 39.4 (1⋅9) 39.2 (2.0) 0.2 (-0.1, 0.4) 
    
2 years    
Weight (kg) 10.900 (1.54) 10.697 (1.38) 0.204 (0.027, 0.381) 
Height (cm) 84.07 (4.83) 83.76 (4.68) 0.31 (-0.20, 0.82) 
Waist circumference (cm) 46.81 (2.84) 46.48 (2.75) 0.33 (-0.01, 0.68) 
Head circumference (cm) 46.64 (1.49) 46.40 (1.43) 0.24 (0.06, 0.43) 
Chest circumference (cm) 48.28 (2.45) 47.96 (2.26) 0.32 (0.04, 0.60) 
Hip circumference (cm) 46.34 (2.94) 45.95 (2.68) 0.40 (0.05, 0.74) 
MUAC (cm) 14.42 (1.07) 14.18 (0.99) 0.24 (0.11, 0.37) 
Triceps skinfold (mm) 7.15 (1.61) 6.95 (1.45) 0.20 (0.00, 0.40) 
Systolic blood pressure 
(mmHg) 
99.4 (13.68) 101.9 (17.54) 2.5 (0.47,  4.55) 
Bold results indicate p < 0.05.  
 
 
2.9.2 Meta-analyses 
The Janakpur trial was one of several coordinated trials of the UNIMMAP supplement in 
pregnancy. The UNIMMAP and similar trials are summarized in Table 4 and Table 5, 
respectively. The results have been combined in a number of meta-analyses that have looked 
at birth outcomes, summarized in Table 6. They vary in the trials included, but in general they 
show a small increase in birthweight with a corresponding reduction in SGA of 10-20%. No 
difference was found in other anthropometric outcomes or gestation. The largest and most 
recent was a Cochrane review by Haider and Bhutta which showed a reduction in SGA of 
13% (95% CI 0.81, 0.95).21 Kawai et al19 included the same trials, but also an earlier trial by 
Fawzi et al in HIV positive women.249 They showed a 44 g (95% CI 28, 60g) increase in 
birthweight and a reduction in relative risk for SGA to 0.85 (95% CI 0.78, 0.93) in the MMN 
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group. Ramakrishnan et al and Shah and Olhsson found increases of 53 g and 54 g, 
respectively.  
The meta-analysis by Fall et al17 showed a 22.4 g (95% CI 8.3, 36.4) increase in birthweight 
and a corresponding reduction in the OR for SGA of 0.90 (95% CI 0.82, 0.99). This meta-
analysis included the smallest number of trials which were also the most homogenous (the 
lowest I2 values). All were conducted in low- and middle-income countries. Nine used the 
UNIMMAP supplement and the other three used similar combinations and adjusted for 
cluster design, sex, maternal age and weight, parity and education. The analysts had access to 
the original data, enabling them to exclude outliers and create population specific reference 
ranges from which SGA cut-offs were calculated. The values used for the meta-analyses were 
therefore sometimes a little different from those in the original trial reports. 
The discrepancy in results between the meta-analyses may be due to the different trials 
included and also to the importance given to the trial by Zagre et al 15 from Niger. This trial 
reported a difference in birthweight of +48 g (95% CI 33, 62), but the meta-analysis by Fall et 
al used +53.98 g (95% CI –42.53, 150.50). While the difference in effect size was small, the 
widening of the confidence intervals reduced the weighting of the trial to 2.12%. If the 
original data from Zagre et al had been used, it would have had a 28.71% weighting in a 
random effects model, and would give an effect size of +29.9 g (95% CI 16.5, 43.3). The 
wider confidence intervals seem to make more sense, given the small sample size.  I 
contacted Professors Fall and Osmond, authors of the meta-analysis, who mentioned 
inconsistencies between the birthweight and gestation data. Ramakrishnan et al20 used the 
original number, giving the trial a 38% weighting. Shah et al18 and Kawai et al250 did not 
specify the weightings, but seem to have used the same figures as Zagre. Haider and Bhutta 
did not calculate the effect on birthweight.21 
 
2.9.2.1 Stratification 
Study design 
When separating into individually and cluster randomized trials, Shah et al found an effect in 
only the individually randomized trials.18 
BMI 
Haider and Bhutta indicated that the effects of the micronutrients were greater in mothers 
with higher BMI (≥20 mg/m2),21 and Fall et al found a 7.6 g increase in birthweight for every 
unit increase in maternal BMI. It may therefore be that a certain macronutrient status is 
needed for the micronutrients to be effective.   
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Timing of supplementation  and perinatal mortality 
Kawai et al found lower perinatal mortality in those who started supplementation in the 
second half of pregnancy.250 Their explanation was that longer supplementation would 
increase the weight of the fetus/infant, increasing complications in labour; it could alter 
metabolic regulation or might reduce death early in gestation, allowing the fetus to survive for 
longer, but still resulting in death. Similarly, the single trial powered to look at mortality, by 
Shankar et al in Indonesia,13 found lower mortality overall in the MMN supplemented group 
and a greater reduction in those in whom supplementation was started in the 3rd trimester. 
Ramakrishnan et al, however, found that supplementation after the first trimester was 
associated with higher neonatal mortality.20 They pointed out that studies with higher 
mortality were comparing 30 mg of iron in the multiple micronutrient supplement with 60 mg 
in the control group, and also that trials that started supplementation in the first trimester were 
considered to be of lower quality. Kawai et al have looked at perinatal mortality, including 
stillbirths and neonatal mortality, and may have found lower overall mortality than 
Ramakrishnan et al who looked at neonatal mortality only. 
The non-statistically significant increase in neonatal mortality seen in the Janakpur trial was 
similar to the results from the trial in Sarlahi.35 A pooled analysis of both these trials did 
suggest an increase in mortality in the neonatal period: RR 1.52 (95% CI 1.03, 2.25). It was 
proposed that this may have been due to an increased risk of asphyxia amongst the heavier 
infants, an effect on uterine sensitivity to oxytocin and to the survival of infants who may 
otherwise have died in-utero.251 A meta-analysis of these trials and other similar MMN trials 
did not find a difference in neonatal mortality. However, exclusion of the trial by Shankar et 
al, did show an increased early neonatal mortality: OR 1.40 (95% CI 1.08, 1.82).252 
 
2.9.2.2 Cumulative micronutrient intake 
Additional analysis by Roberfroid et al investigated cumulative micronutrient intake (CMI) in 
their trial from Burkina Faso. This was possible as supplement intake was directly observed. 
They divided CMI into tertiles and looked at the odds of SGA. SGA reduced by 21% (OR 
0.79; 95% CI 65, 95) per increase in tertile. There was also an interaction with gestation, with 
greater effects later in pregnancy, and maternal BMI. Interestingly, there was a similar 
association between CMI and birthweight for both MMN and the control (iron and folate) 
supplements.253 
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2.9.3 Additional meta-analyses 
I performed a search of antenatal MMN trials according to PRISMA guidelines.254,255 I 
searched   the   Medline,   Embase   and   Psychinfo   databases   for   “(micronutrient   or   multiple  
micronutrient or UNIMMAP) + (pregnancy or antenatal or prenatal)”  and  found  1486  records.  
I then removed the duplicates (n=650) and limited the search to humans, English language 
and randomised controlled trials, leaving 136 records. I searched these records and found 12 
relevant trials of MMN. To find follow-up studies, I searched by the first and last authors of 
the original trials, by country and by trial name if applicable. In addition, I thought it pertinent 
to summarize the trials that used a similar combination of micronutrients to the UNIMMAP 
trials. The numbers of studies considered are shown in Figure 8 and a description of the 
PRISMA search is given in Appendix 2.1.  
I redid the meta-analysis of birthweight with the trials that used the UNIMMAP supplement. 
Where necessary, confidence intervals were calculated using the following formula: 
µμ ± 1.96   × ඨ
σଵଶ
nଵ
+
σଶଶ
nଶ
 
where: µμ = mean value, σ = standard deviation, n = number in the trial groups 
Using the data used by Fall et al, the combined estimate of increase in birthweight changed by 
a very small amount to 24.0 g (95% CI 8.6, 39.4) when limited to the UNIMMAP trials 
(Figure 9). The proportion of SGA did not change. I also re-ran the meta-analysis with the 
original data from the trials with adjusted values where possible, which produced a difference 
in birthweight of +44.4 g (95% CI 32, 56g: Figure 10). Finally, I performed a meta-analysis 
of the nine UNIMMAP trials, plus trials testing similar MMN combinations, as summarized 
in Table 5, as an update of the previous meta-analyses. This resulted in a birthweight 
difference of +35.9 g (95% CI 22, 50 g: see Figure 11).  
In the trial from Bangladesh (MiniMat), women also had access to energy and protein 
supplements, given either earlier or later in pregnancy. Removing this trial from the meta-
analysis in Figure 11 made only a small difference to the outcome (+36.8 g; 95% CI 21.7, 
51.9 g).  
Meta-analyses provide a good overall picture of the effects of the micronutrients, and are 
generally considered the highest form of evidence. While there was a relatively small 
difference between all the trials, it is also useful to consider whether the differences between 
the studies played a part in the different effect sizes. I could find no obvious difference by 
region of the world or by study design (individually or cluster randomised). Other factors 
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such as the gestation at which supplementation was commenced and maternal BMI have been 
considered in the meta-analyses by others. It is useful in this respect to have studies from the 
same country, as is the case in Nepal and Indonesia. The Indonesian trials by Shankar et al13 
and Sunawang et al14 showed similar, non-statistically significant, results. The trial by 
Christian et al, from the adjoining district in the Terai region of Nepal, produced a quite 
different result of +7 g (95% CI 40.26, 54.26).35 The difference may be due to chance, but the 
lack of a clear explanation would point to the need for much more detailed analysis of the 
trial methods and participants (for example, knowledge of diet before and during pregnancy), 
much of which is not possible. 
 
 
 
Figure 8: Numbers of studies found at each stage of the search  
12 records 
identiﬁed through 
database searching  
12 records after duplicates removed
12 records screened 1 record removed (conference abstract)
9 studies identiﬁed 
through searches of 
other meta-analyses
11 full text articles assessed 
for eligibility
2 full text articles excluded 
(One was a non-randomised 
study, the other used a 
different control supplement)
9 articles included in the 
meta-analysis of birthweight
6 groups have conducted 
follow-up studies 1 assessed mortality only
3 performed 
cognitive follow-ups
4 performed 
anthropometry 
follow-ups
2 performed 
cardiovascular 
follow-ups
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2.9.3.1 Other trials not included in the meta-analysis 
A non-randomised, non-blinded   “side-by-side   effectiveness   trial”   in  Vietnam   by  Huy   et   al  
showed an increase of 166 g in the region that received antenatal UNIMMAP 
supplementation. While the effect size was larger than in most of the trials mentioned, the 
study design and the lack of adjustment for potential confounders raises uncertainty about the 
results. In this study, a third district provided gender training that was designed to improve 
maternal care practices. This district had similar results to the MMN district, so there 
appeared to be no additional advantage.256  
A large trial carried out by Liu et al compared the UNIMMAP supplement (n=6262) to folic 
acid alone (n=6261) and iron 30 mg and folic acid (n=6252). Participants were individually 
randomised, but stratified by geographical location. Comparison of the MMN with the iron 
and folic acid group showed no difference in birthweight (6.43 g; 95% CI -7.65, 20.51g), 
birth length or gestational age. There was a lower relative risk of neonatal, but not perinatal, 
mortality. This trial was not included in my meta-analyses because of the different control 
sample. If it is included in a meta-analysis of UNIMMAP trials (using original trial data, 
Figure 10), the effect size falls a little to 38.20 g (95% CI 20.09, 56.30). If included in the 
analysis of UNIMMAP plus similar trials (Figure 11), the effect size is 31.58 g (95% CI 
15.98, 47.18), I2 57.8%. Due to its large size, this trial had a 13.5% weighting in the meta-
analysis.  
The Antenatal Micronutrient Supplementation and Infant Survival (JiVitA-3) trial is currently 
ongoing in Bangladesh. At the time of writing, only a conference abstract of the findings had 
been published. The constituents of the supplement were the same as UNIMMAP, but the 
doses were a little different. Both the control and MMN supplement had slightly different iron 
(27 mg)   and   folate   (600   μg)   levels.   The   MMN   supplement   differed   in the following 
micronutrients:  vitamin  A  (770  μg),  vitamin  E   (15  mg),   riboflavin   (1.4  mg),  vitamin  C   (85  
mg),  zinc  (12  mg),  iodine  (220  μg),  copper  (1  mg),  selenium  (60  μg).  The  trial  was  a  cluster  
RCT involving 44 567 pregnant women. Supplementation was from the 1st trimester to 12 
weeks postpartum. MMN were associated with slightly fewer stillbirths (0.89; 95% CI 0.81, 
0.99) and preterm births (0.87; 95% CI 0.82, 0.92) and reduced prevalence of low birthweight 
(0.88; 95% CI 0.85, 0.91). There was no difference in SGA or overall mortality, though 
mortality was lower at 6 (0.87; 95% CI 0.74, 1.01) and 12 months (0.85; 0.73, 0.97) of age in 
girls, but not boys. The increase in birthweight (55 g), length (0.21 cm), and head 
circumference (0.21 cm) was attributed to a 0.3 week longer gestation.257 There were 
insufficient details in the abstract to be able to add this trial to my meta-analyses.   
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Figure 9: Meta-analysis of UNIMMAP trials only, using data from Fall et al, Food 
Nutrition Bulletin, 2009 17 
 
 
Figure 10: Meta-analysis of UNIMMAP trials only, using original data from the trials.  
NOTE: Weights are from random effects analysis
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Figure 11: Meta-analysis of UNIMMAP trials and five other similar multiple 
micronutrient trials, using original data from the trials.  
 
 
2.9.4 Long-term effects of antenatal multiple micronutrient supplementation  
Six groups who conducted UNIMMAP trials have carried out longer-term follow-ups. 
Andersen et al looked only at mortality, finding no difference in overall mortality up to two 
years of age.258 In addition to the Janakpur trial, three groups have done follow-up 
assessments of child growth: Roberfroid et al in Burkina Faso,259 Khan et al in 
Bangladesh,260,261 and Wang et al in China.262 Three groups have done cognitive follow-ups: 
Li et al in China,263 Tofail et al in Bangladesh,264 and Prado et al in Lombok, Indonesia.265 
Hawkesworth et al have looked at cardiovascular outcomes in Bangladesh.266 In addition to 
these, Ramakrishnan et al did an anthropometric follow-up,267 and Christian et al did follow-
ups of anthropometry, cardiovascular and cognitive outcomes.268-270 
 
2.9.4.1 Anthropometry 
In a factorial study design, Khan et al gave MMN, 30 mg of iron and folic acid and 60 mg of 
iron and folic acid to pregnant women in Bangladesh. Each of these three groups received 
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micronutrients early or later in pregnancy. They followed up the children until they were 54 
months of age. MMN supplementation resulted in lower linear growth compared to the 60 mg 
of iron and folic acid group, with a mean percentage of stunting of 36.1% (95% CI 33.3, 39.0) 
versus 31.8% (95% CI 28.8, 34.7). Compared to the 30 mg of iron and folic acid, there was 
no difference. Children of mothers who received early food supplementation in pregnancy 
were less likely to be stunted.260  
Wang et al found no difference in wasting, stunting and underweight between the MMN 
group and the controls of folic acid or iron and folic acid at 30 months of age in China.262 
Roberfroid et al showed small increases in length for age z-score (β = 0.13; 95% CI 0.02, 
0.24) and weight for age z-score (β  = 0.13; 95% CI 0.04, 0.23) at one year of age, but this 
difference had disappeared by 2.5 years.259  
In Sarlahi, Nepal, Stewart et al investigated the anthropometry of children at 6-8 years of age. 
They measured height, weight, mid-upper arm circumference, triceps and subscapular skin-
fold thickness and waist circumference. They found no difference between the MMN group 
and the control group. The folic acid, iron and zinc group, however, did show an increase in 
height of 0.64 cm (95% CI 0.04, 1.25) and small reductions in skinfold thicknesses.268  
Ramakrishnan et al investigated growth in children born in a MMN trial in Mexico. The 
children born in the original trial were subsequently randomised to receive postnatal 
micronutrients or iron supplements. Using intention to treat analysis they found no difference 
in height from the postnatal micronutrients. Though not explicitly analysed in their paper, 
there did not appear to be a difference between antenatal micronutrient and control groups in 
later height.267 
Overall, the follow-up studies do not show a difference in anthropometry in those born to 
mothers taking MMN antenatally.   
 
2.9.4.2 Cardiovascular outcomes 
Hawkesworth et al followed up children from the MINIMat trial in Bangladesh at 4.5 years of 
age. Compared to a control sample who received 30 mg iron and 400 μg folate, they found no 
difference in systolic blood pressure. For diastolic blood pressure, they used three models to 
adjust for potential confounders. The basic model (model 1) adjusted for maternal food 
intervention (this was a multi-arm trial that also tested food supplementation), another model 
adjusted for factors relating to the outcomes (model 2), and another for factors associated 
with the maternal interventions (model 3). Models 1 and 2 showed no effect. Model 3 showed 
a small increase in diastolic pressure of 0.87 mmHg (95% CI 0.18, 1.56). My feeling is that 
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model 3 was over-adjusted: there were three correlated measures of anthropometry (BMI, 
lean mass and height) and markers of child illness that should not be associated with the 
randomized interventions. Also, comparing 60 mg iron to 30 mg iron showed a small, non-
significant increase of 0.42 (95% CI -0.27, 1.11) in diastolic pressure, and I would assume 
that comparing with 60 mg iron would also produce a null effect. 
One explanation of the lower blood pressure results in the Janakpur follow-up was that the 
higher dose of iron in the control sample (60 mg) may have led to a higher blood pressure: the 
30 mg lower dose in the MMN had no advantageous or detrimental effects. This theory was 
contradicted by Hawkesworth et al, who showed no difference in systolic blood pressure 
when comparing the two doses of iron.266 
The team in Sarlahi also went on to investigate metabolic syndrome. They tested for a number 
of  outcomes:  “Blood  pressure,  BMI,  waist  circumference,  glycated  haemoglobin,  cholesterol,  
triglycerides,   glucose,   insulin   and   urinary   microalbumin:creatinine   ratio”.   They   found   no  
difference in any of these variables.269 
 
2.9.5 Summary 
A number of trials have tested the antenatal UNIMMAP supplement and many others have 
examined similar combinations of micronutrients. The meta-analyses overall have shown a 
small effect on birthweight, with a corresponding fall in the proportion with SGA. There does 
not appear to be an effect on other anthropometric measurements at birth. The follow-up 
studies have tended not to find a lasting effect of the antenatal MMN supplement in children. 
The Janakpur trial is unusual compared to the others in that there was a greater difference in 
birthweight, which was sustained until two years, and a difference in blood pressure was seen.  
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Table 4: Trials using the United Nations International Multiple Micronutrient Preparation (UNIMMAP) supplement 
Trial Trial details Main trial results* Long-term results 
Bhutta et al, 9 
Pakistan 
Cluster randomised. n=2378 
Enrolled in 2nd trimester 
Included nutrition education 
Supplementation till birth.  
70g heavier (95% CI -25, 115g) 
SGA: 0.73 (95% CI 0.39, 1.38) 
Nil  
Kaestel et al, 10 
Guinea Bissau  
Individually randomised. n=2100 
Enrolled <37 weeks 
Supplementation till birth 
Allocation was probably not 
concealed.  
47g heavier (95% CI -24, 119g) 
adjusted for gestation, malarial 
parasitaemia,  anaemia, sex, season. 
SGA: 0.74 (95% CI 0.42, 1.28) 
Andersen et 
al.258 
2 years 
There was no effect on under-2 mortality. However, 
when looking at the interaction of age and mortality, 
there was some evidence of a negative effect on late-
infant (92-365 days) RR 2.1 (95% CI 0.99 to 4.46). 
There was no effect in other age groups.  
Osrin et al. 7 
Dhanusha, 
Nepal 
Individually randomised. n=1200 
Enrolled in 2nd trimester 
Supplementation till birth 
 
77g heavier (95% CI 24, 130g)  
SGA: 0.75 (95% CI 0.49, 1.14) 
Vaidya et al, 8 
Age 2.5 years 
83% followed 
up. 
Growth 
Intervention group was 204g heavier (95% CI: 27-
381g) and systolic blood pressure was 2.5 mmHg (95% 
CI: 0.5-4.6) lower.  
Persson et al. 11 
Eneroth et al. 
271Bangladesh  
Individually randomised. n=4436 
Enrolled in first trimester 
Supplementation till birth 
 
Factorial design- MMN, 30mg of 
iron and folic acid and 60mg of 
iron and folic acid. Each of these 
three groups received 
micronutrients early or later in 
pregnancy.  
 
18g heavier (95% CI -40, 54g)  
SGA: 0.95 (95% CI 0.66, 1.22) 
Khan et al, 260 
54 months 
Growth 
MMN resulted in lower linear growth compared to the 
60mg of iron and folic acid group, with a mean 
percentage of stunting of 36.1% (95% CI: 33.3 to 39.0) 
versus 31.8% (95% CI: 28.8-34.7). Compared to the 
30mg of iron and folic acid there was no difference.  
Khan et al, 261 
54 months 
70% followed 
up 
Body composition  
Measured by leg-to-leg bioelectrical impedance.  
No difference between early or late prenatal 
supplementation and body composition, weight, height, 
MUAC, head circumference and skinfold thickness.  
Tofail et al, 264 
7 months of age 
Cognitive ability 
Assessed problem solving, motor development and 
behaviour. 
They stratified the groups into to whether the mother 
had a low BMI (<18.5kg/m2) or higher BMI. They 
showed that antenatal MMN was associated with 
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higher motor score and activity levels in both early and 
late food supplemented groups in mothers with a low 
BMI. No other differences were found in problem 
solving or behaviour.  
Eneroth et al, 271 
6 months 
Micronutrient status 
Blood was collected for haemoglobin, ferritin, zinc, 
retinol, vitamin B12 and folate.  
There was a higher B12 concentration in the MMN 
group in girls.  
 Hawkesworth et 
al, 266 
4.5 years 
Blood pressure, renal dimensions and kidney function 
(glomerular filtration rate).  
There was a small increase in diastolic blood pressure. 
0.87 mmHg (95% CI 0.18, 1.56) 
 
Roberfroid et 
al, 12 
Burkina Faso,  
Individually randomised. n=1426 
Enrolled <37 weeks 
Supplementation till 12 weeks 
after birth 
 
69g heavier (95% CI 23, 114g) after 
adjustment for maternal Hb, type of 
malaria prevention, maternal education, 
season and area. 
SGA: 0.89 (95% CI 0.62, 1.44) 
Possibly increased peri-natal mortality 
OR 1.78 (95% CI 0.95, 3.32) 
Roberfroid et 
al.259 
2.5 years 
Growth 
Greater length-for-age z score β  = 0.13 (95% CI 0.02, 
0.24) and weight-for-age β = 0.13 (95% CI 0.04, 0.23) 
after one year, but this difference had disappeared by 
2.5 years. 
 
No difference in mortality. 
Shankar et al, 
13 
Lombok, 
Indonesia, 
Cluster randomised. n=31 290 
Enrolled <37 weeks 
Supplementation till 12 weeks 
after birth 
 
21g heavier (95% CI -11, 53g) adjusted 
for clustering 
SGA: 0.97 (95% CI 0.83, 1.13) 
Reduced fetal and neonatal mortality in 
the MMN group RR 0.89 (95% CI 
0.81, 1.00) 
There was a greater reduction (28%) in 
those in whom supplementation was 
started in the 3rd trimester. 
Prado et al. 265 
42 months 
Cognition 
Tested a subgroup of 487 children.  
In children of undernourished mothers (MUAC 
<23.5cm), MMN improved motor ability β= 0.39 (95% 
CI 0.08, 0.70) and visual attention/ spatial ability β = 
0.37 (95% CI 0.11, 0.62) 
In children of anemic mothers (Hb <110 g/L) MMN 
improved visual attention/ spatial ability β= 0.24 (95% 
CI 0.02, 0.46) 
Sunawang et 
al,14 
Indra 
Cluster randomised. n=843 
Enrolled in 2nd trimester 
Supplementation till 4 weeks 
40.5g heavier (95% CI -22, 103g) 
SGA: 0.87 (95% CI 0.61, 1.24) 
Nil   
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after birth 
 
Zagre et al,15 
Niger 
Cluster randomised. n=2550 
Included nutrition education 
Enrolled in 1st trimester 
Supplementation till birth 
 
48g heavier (95% CI 33, 62g) 
adjusted for household size, education, 
diet morbidity during pregnancy, 
preventive measures against malaria 
and season 
SGA: 0.79 (95% CI 0.53, 1.18) 
Nil  
Zeng et al,16 
Zeng et al, 272 
China, 
Cluster randomised. n=5828 
Enrolled <28 weeks 
Supplementation till birth 
 
24g heavier (95% CI -8, 56g)  
SGA: 0.92 (95% CI 0.72, 1.18) 
 
Possibly a greater effect in the poorer 
households.  
Li et al, 263 
1 year 
Cognitive 
Assessed mental and psychomotor development, using 
age-appropriate Bayley Scales of Infant Development. 
The age-adjusted scores at one year were higher in the 
MMN group than the folic acid + iron or the folic acid 
groups for mental development. There was no 
difference at three months or six months and also no 
difference in the psychomotor scores.  
   Wang et al, 262 
2.5 years 
Growth 
No difference in wasting, stunting and underweight 
between the MMN group and the control of folic acid 
or iron and folic acid. 
 
*Birthweight and small for gestational age (SGA). SGA values taken from the meta-analysis by Fall et al 17,  who  defined  this  as  below  the  “within-population 10th centile”. 
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Table 5: Similar supplements to UNIMMAP  
Trial Number Supplement  Main trial results at 
birth 
Long-term 
results 
 
Christian et al, 
35 
Sarlahi, Nepal 
Cluster randomised 
Enrolled in 1st 
trimester 
Supplementation 
till 12 weeks after 
delivery 
n = 4926 
Folic acid 400 µg, iron 60 mg as 
ferrous fumerate, vit A, Zn 30 
mg, vit D 10 µg, vit E 10 mg, vit 
B1 1.6 mg, vit B2 1.8 mg, niacin 
20 mg, vit B6 2.2 mg, vit B12 2.6 
µg, vit C 100 mg, vit K 65 µg, 
copper 2 mg and Mg 100 mg. 
Control group had vitamin A as 
well.  
 
7g heavier (95% CI -
40, 54g) 
SGA: 1.05 (95% CI 
0.70, 1.57) 
Stewart et al, 268 
6-8 years 
Growth 
They measured height, weight, mid-upper arm 
circumference, triceps and subscapular skin-fold 
thickness and waist circumference.  
They found no difference between the MMN 
group and the control group.  
  Stewart et al, 269 
6-8 years 
Metabolic syndrome.  
They tested for blood pressure, BMI, waist 
circumference, glycated haemoglobin, cholesterol, 
triglycerides, glucose, insulin and urinary 
microalbumin:creatinine ratio.  
They found no difference in any of these 
outcomes.  
   Christian et al, 
270 
7-9 years 
Cognitive  
They used a number of tests:  
Intellectual functioning: Used the Universal 
Nonverbal Intelligence Test and tests of executive 
functioning.  
Motor: Movement Assessment Battery for 
Children and finger-tapping test. 
They did not find any find any difference between 
the MMN group and control groups.  
Friis et al,273 
Zimbabwe,  
Individually 
randomised 
HIV +ve and HIV –
ve women 
Enrolled in 2nd and 
3rd trimesters 
Supplementation 
till birth 
n = 1169 
Vit A 3000 µg, beta carotene 3.5 
mg, thiamine 1.5 mg, riboflavin 
1.6 mg, B6 2.2 mg, B12 4 µg, 
niacin 17 mg, C 80 mg, D 10 µg, 
E 10 mg, Zn 15 mg, Cu 1.2 µg, Se 
65 µg.  
Control = placebo 
No iodine, iron or folate- these 
part of the routine antenatal care 
26g heavier (95% CI 
-38, 91g) in HIV –ve 
women.  
101g heavier (95% 
CI -3, 205g) in HIV 
+ve women.  
 
SGA: 0.79 (95% CI 
0.47, 1.31) 
Nil  
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Gupta et al. 274, 
India 
Enrolled in 2nd and 
3rd trimesters 
Supplementation 
till birth 
n = 200 
 
BMI of women 
<18.5 and/or a 
haemoglobin of 7-9 
g/dL  
Vit A 1500 IU, B1 1 mg, B2 1.5 
mg, B6 1 mg, B12 1 µg, C 50 mg, 
D3 200 IU, E 7.5 mg, calcium 
pentothenate 5 mg, folic acid 0.15 
mg, nicotinamide 20 mg, biotin 
30 µg, Zn 15mg, potassium iodide 
0.15 mg, ferrous fumarate 10mg, 
magnesium oxide 100 mg, 
manganese sulfate 2.5 mg, copper 
2 mg, calcium 162 mg, 
phosphorus 125 mg, potassium 40 
mg, chloride 36.3 mg, chromium 
25 µg, molybdenum 25 µg, 
sodium selenate 30 µg, nickel 5 
µg, silicon dioxide 2 mg, 
vanadium 10 µg, boron 150 µg.  
Placebo consisted of calcium  
All subjects received iron and 
folic acid  
98 g heavier (95% CI 
−16,  213  g)  0.8  cm  
(95% CI 0.03, 1.57 
cm) longer  
0.2 cm (95% CI 0.04, 
0.36 cm) larger 
MUAC 
SGA RR = 0.45 (95% 
CI 0.21, 0.97)  
Adjusted for maternal 
age, family income, 
parity, pre-pregnancy 
weight, height, 
hemoglobin, sex and 
gestation. 
Early neonatal 
morbidity declined 
RR= 0.42 (95% CI 
0.19, 0.94)  
Nil  
Hanieh et 
al.,275 
Vietnam 
Cluster randomised 
Enrolled <16 weeks 
gestation 
Supplementation 
given twice weekly 
n = 833 
Fe 60 mg, folic acid 1.5mg, vit A 
1.6mg, vit D 400 IU, vit E 20mg, 
thiamin 2.8 mg, riboflavin 2.8 
mg, niacin 36 mg, vit B6 3.8mg, 
vit B12 5.2 µg, vit C 140 mg, Zn 
20 mg, iodine 300 µg, Cu 4mg, Se 
130  µg 
Control 60 mg Fe 
19.7g lighter (95% CI 
-70, 30g) adjusted for 
clustering, maternal 
age, parity, sex and 
gestation.  
Low birthweight 
(SGA not reported) 
1.53 (0.23, 10.1) 
Hanieh et al, 275 
6 months 
No difference in length-for-age z scores. Mean 
difference -0.04 (95% CI -0.2, 0.1). 
No  difference  in  any  parameter  of  “Bayley  scales  
of  infant  and  toddler  development”.276 
Ramakrishnan 
et al.,277 
Mexico 
Individually 
randomised 
Enrolled in 1st 
trimester 
Supplementation 
till birth  
n = 873 
Iron 60 mg as Fe SO4, folic acid 
215 µg, vit A 2150 IU, vit D3 309 
IU, vit E 5.73 IU, thiamin 0.93 
mg, riboflavin 1.87 mg, niacin 
15.5 mg, vit B6 1.94 mg, vit B12 
2.04 µg, vit C 66.5 mg, Zn 12.9 
mg, Mg 252 mg. 
Control 60 mg Fe SO4 
9g heavier (95% CI -
54, 73g) 
SGA: 0.82 (95% CI 
0.47, 1.41) 
Ramakrishnan 
et al. 267  
2 years 
25% loss to 
follow up 
The children born in the original trial were 
randomised to receive postnatal micronutrients or 
iron supplements. Using intention to treat analysis 
they found no difference in height from the 
postnatal micronutrients. Though not explicitly 
analysed in their paper, there does not appear to 
be a difference between antenatal micronutrient 
and control groups in later height.  
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Table 6: Meta-analyses of multiple micronutrient supplementation trials  (* developed countries) 
 Trials included Comments Results 
Fall et al 17 
2009 
Bhutta, Christian, Friis, Kaestel, 
Osrin, Ramakrishnan, Roberfroid, 
Shankar (SUMMIT), Sunawang, 
Tofail, Zagre, Zeng 
Contains trials that used the UNIMMAP 
supplement plus Christian, Friis and 
Ramakrishnan 
HIV-ve women only.  
I2 = 0%. Used the raw data from the 
trials rather than published results.  
Increase in birthweight of 22g (95% CI 8, 36g). Increase of 7.6g 
(95% CI 1.9, 13.3g) per unit increase in maternal BMI. There was a 
right shift in the entire birthweight distribution.  
Reduction in SGA OR = 0.90 (95% CI, 0.82, 0.99) 
Increase in large for gestational age OR= 1.13 (95% CI, 1.00, 1.28) 
No interaction with maternal height, parity or maternal age.  
Shah and Ohlsson 
18 2009 
Christian, Fawzi (1998), Fawzi 
(2007), Friis, Gupta, Hininger*, 
Kaestel, Osrin, Ramakrishnan, 
Roberfroid, Shankar (SUMMIT), 
Zagre, Zeng 
Fawzi 1998 was in an HIV +ve 
population.  
Control = iron and folate 
Excluded studies that included 
macronutrients. I2 = 55-64% 
Birthweight was 54g greater (95% CI 36, 72g) 
Greater effect in individually randomised rather than cluster 
randomised trials.  
Individual SGA = 0.82 (95% CI 0.73, 0.92) 
Cluster SGA = 0.98 (95% CI 0.84, 1.14) 
Kawai et al 21 
2011 
Bhutta, Christian, Fawzi (1998), 
Fawzi (2007), Friis, Gupta, Kaestel, 
Osrin, Ramakrishnan, Roberfroid, 
Shankar, Sunawang, Tofail, Zagre, 
Zeng 
Contains trials that used the UNIMMAP 
supplement plus Christian, Fawzi 
(1998), Fawzi (2007), Friis, Gupta  and 
Ramakrishnan 
I2 for SGA= 0% 
Increase in birthweight of 44g (95% CI 28, 60g) 
Reduction in SGA RR 0.85 (95% CI 0.78, 0.93) 
Micronutrient supplementation had no overall effect on perinatal 
mortality although subgroup analysis suggested a reduction when 
>50% of mothers had formal education (RR 0.93; 95% CI 0.82, 
1.06) or when supplementation was initiated after a mean of 20 
weeks gestation (RR 0.88; 95% CI 0.80, 0.97). 
Ramakrishnan et 
al 20 2012 
Bhutta, Christian, Fawzi (1998), 
Fawzi (2007), Friis, Gupta, 
Hininger*, Kaestel, Osrin, 
Ramakrishnan, Roberfroid, Shankar 
(SUMMIT), Sunawang, Tofail, 
Zagre, Zeng 
Contains trials from developing 
countries plus Hininger. Fawzi 1998 
was in an HIV +ve population. 
I2 = 46% for birthweight and 71% for 
SGA.  
 
Reduction in SGA RR 0.83 (95% CI 0.73, 0.95). The effect was 
greater in trials that used 60mg of iron. Increase in birthweight 53g 
(95% CI 43.2, 62.0g). There was no difference between starting 
supplements in the 1st trimester compared with later. 
Increased risk of neonatal death in trials that began after the first 
trimester RR 1.38 (95% CI 1.05, 1.81). Overall risk of neonatal 
death 0.97 (95% CI 0.87, 1.09).  
Haider and Bhutta 
21 2012  
Bhutta, Brough*, Christian, 
Diekmann*, Fawzi (2007), Friis, 
Gupta, Javenpaa*, Kaestel, Osrin, 
Ramakrishnan, Roberfroid, Rumiris, 
Shankar (SUMMIT), Sunawang, 
Tatala, Theobald*, Tofail, Vadillo-
Ortega, Zagre, Zeng 
Contains multiple micronutrient trials 
from both developing and developed 
countries. 
 
I2 = 57% for birthweight and 47% for 
SGA 
Reduction in SGA RR 0.87 (95% CI 0.81, 0.95).  
Maternal BMI <20 kg/m2 RR 0.90 (95% CI 0.83, 0.98). Maternal 
BMI ≥20 kg/m2 RR 0.85 (95% CI 0.80, 0.91). 
Maternal height <154.9 RR 0.91 (95% CI 0.85, 0.98). Maternal 
height ≥154.9 RR 0.82 (95% CI 0.76, 0.89).  
Supplementation started before 20 weeks RR 0.90 (95% CI 0.84, 
0.96). If started after 20 weeks RR 0.83 (95% CI 0.76, 0.91) 
Neonatal mortality RR 1.01 (95% CI 0.89, 1.15). 
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2.10 Causal diagrams 
 “felix  qui  potuit  rerum  cognoscere  causas” 
(fortunate is he who can understand the cause of things) - Virgil, Georgics 
Associations are common in epidemiology, but determining causation is difficult, some might 
say impossible. Identifying associations or predictors of an outcome are useful in their own 
right, but to effect change, particularly in public health contexts, causal inference is needed. 
Public health actions and policies are generally based on observational research (if any). 
Causal inference is therefore  assumed  at   this   later  stage  and  can  be  defined  as  “the   thought  
process  that  tests  whether  a  relation  of  cause  to  effect  exists”.  278 
 
2.10.1 What is causation? 
Causation has been discussed by philosophers and scientists for centuries. Aristotle for 
example   described   the   “four   causes”   model   (efficient,   final,   formal   and   material).   While  
flawed in many applications, his theory highlighted the multi-factorial nature of causation. 
David  Hume  defined  a  cause  as  “an object followed by another ... where, if the first object 
had   not   been,   the   second   never   had   existed.”   279 Historically, assumptions about causation 
were based on induction, as described by Francis Bacon in the 16th century. Induction is a 
process that involves making inferences about what will happen based on observation of 
previous events. Karl Popper instead proposed that experiments should be used to test or 
refute   hypotheses.   The   “truth”   can   change   and   is   falsifiable   by   a   single   experiment.   A  
scientific theory cannot be verified, i.e. proved undeniably true. In fact, falsifiability was 
Popper’s   main   criterion for a scientific theory itself. Scientists should test hypotheses 
attempting to refute their theories. Popper describes the assumption that all swans are white 
until the observation of a black swan that refutes this.  280 
Scientific truth is not just based on scientific facts, rather, as described by Thomas Kuhn in 
his 1962 book The Structure of Scientific Revolutions, it is defined by the scientific 
community and is therefore subjective. Kuhn said that science progresses non-linearly and is 
prone  to  revolutions,  also  referred  to  as  paradigm  shifts.  Famous  examples  may  be  Darwin’s  
theory of evolution or  Thomas  Bayes’  theorem  (though  neither  had  immediate  traction  within  
the scientific community). Kuhn defines three stages of science: pre-, normal and 
revolutionary. In pre-science an idea emerges which is then worked on in the normal science 
stage. At this stage results that may differ do not refute the hypothesis because they may be 
mistakes or special circumstances. Only when there is a critical mass of contradictory 
evidence would a theory change in the revolutionary phase.  
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Causal factors are often required to be both necessary and sufficient. A necessary factor is 
required for the effect to occur, but may require additional factors to act. A sufficient factor 
implies that the effect will occur if the factor is present. 278 281 The following criteria for 
causality were proposed by Austin Bradford-Hill in 1965.282 While not intended to be all-
encompassing, they have been widely adopted by epidemiologists and scientists. At the very 
least, they form an initial framework.  
1. Strength of the association. Stronger associations are more likely to be causal in nature, 
but this does not rule out a weak causal influence. This is particularly important in multi-
factorial diseases where each factor may only contribute a small effect. Strong causal 
assumptions assume that parameters take particular values. Weak assumptions allow a 
range of values to be taken. 283 
2. Consistency of findings in other settings. Other research in different places and 
populations should give similar results. This has been questioned because causal effects 
may be population-specific.   
3. Specificity of the association. A single cause and single effect. This criterion does not 
always hold as many effects may arise from a single cause or multiple causal factors may 
be needed for a single effect.  
4. Temporal sequence of association. The cause should precede the effect. This is said to 
be the only fundamental criterion.   
5. Biological gradient (dose-response). While generally true, there may be causes that 
require a threshold level to be reached before an effect is produced.  
6. Biological plausibility. By definition, this needs to be in line with current knowledge.  
7. Coherence with current knowledge. A similar criterion to biological plausibility. 
However, evidence may arise that is counter to current wisdom.  
8. Experiment. Can be proven by experiment. This is an ideal situation, but is not always 
possible. Some argue that causation can only be interpreted from interventional studies, 
such as trials. 284 
 
2.10.2 Counterfactual theory 
Causal  theory  is  based  on  the  idea  of  counterfactuals.  These  are  defined  as  “parameters that 
describe events under a  hypothetical  alternative  to  actual  conditions”.  285 These counterfactual 
outcomes do not occur, so are always assumed. The true counterfactual effect is therefore 
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always inferred. For example, if a person received a drug (exposure) and developed an 
allergic reaction (outcome), the counterfactual would be the outcome if he had not received 
the drug. The counterfactual is an assumption that is usually a substitute, an imperfect 
representation of the true counterfactual, such as a similar population or the same population 
at a different time. A quantitative counterfactual model was developed by Jerzy Neyman in 
1923 and was applied to observational studies by Donald Rubin in the potential outcomes 
model.285 Using counterfactual theory, causation is assumed when the counterfactual (or 
potential) outcomes differ, with the assumption that the exposures and individuals are 
independent.7 286 An association represents a different risk in separate subsets of a population 
using actual measured variables. Causation, using the counterfactual approach, represents a 
different risk in the same population with two exposures, the actual and the counterfactual.   
Glass et al argue that this framework is better suited to a public health context as it seeks to 
compare outcomes under different hypothetical interventions in complex networks of causal 
factors. It can also help to highlight where important (often distal) interventions may lie that 
may not lend themselves to straightforward study designs such as the randomised controlled 
trial. 287  
 
2.10.3 Causal inference in populations 
At its most basic, causation is straightforward, but identifying causal factors in populations is 
complicated and some, like RA Fisher, who famously argued that smoking was not a causal 
factor for lung cancer, 288 say it is impossible: we can only look at associations. Judea Pearl 
draws the distinction between associations and causation by defining an associational concept 
as  any  relationship  that  can  be  defined  in  terms  of  a  joint  distribution  of  observed  variables”.  
289 A causal relationship, however, is not just determined by the distribution alone and has 
directionality.  
At a population level non-determinism is a problem. This is where a treatment does not 
always   cause   an   outcome,   but   increases   its   probability.   An   “average   causal   effect”   in   a  
population is sought that is both population- and time-specific. Absence of an average causal 
effect does not mean the absence of an individual effect, though. 286 In the situation where 
there is no  average  causal  effect  and  no  effect  in  any  individual,  there  is  said  to  be  a  “sharp”  
null hypothesis. While Popperian falsification remains valid, the complexity of a population 
                                                     
7 In mathematical notation, on an individual level Oa=1≠Oa=0, and a population level E[Oa=1]≠E[Oa=0], 
where O is the outcome, Oa=1 and Oa=0 are potential outcomes and E is the average causal effect in the 
population. 
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and  system  render  the  single  “black  swan”  insufficient.  Falsification  therefore cannot apply in 
an absolute sense in epidemiology. This is not to say that research should not be designed to 
falsify current hypotheses. Using Bayesian language, it may change the probability of an 
outcome. 
A multi-causal model has been proposed in epidemiology. This theory held sway in the 
second half of the 20th century, particularly in relation to chronic diseases.278 Susser and 
Susser argue for a new multi-level epidemiological model of causation involving what they 
term eco-epidemiology.  The  new  “paradigm”  they  suggest  is  Chinese  boxes.  This  combines  a  
focus on both the small-scale individual molecular level and the wider societal level. 290 A 
model that was more applicable to chronic diseases was described by Rothman et al. In their 
component model, a number of components act together to produce an effect. For this, a 
number of sufficient causes that work together are needed, but each by itself may not be 
sufficient.291 Similar to this, Parascandola and Weed describe a probabilistic model of 
causation in which causes can exert degrees of influence on an effect. The cause may 
therefore not be necessary or sufficient, but this they feel may be more appropriate for a 
population, where determinism is difficult. This would be my preferred model of causation. 
281 
 
2.10.4 Causal diagrams 
Causal diagrams are networks of variables that form a subset of Bayesian networks and are 
akin to a graphical presentation of counterfactual theory. Causal diagram theory stemmed 
from the work of Sewall Wright in 1921 on path analysis, which later developed into 
structural equation models (SEM). The mathematical basis was defined by Judea Pearl using 
do-calculus. 289,292 While normally parametric in nature, it was extended into non-parametric 
forms.  According  to  Pearl,   these  require  us  to  “set  out  clearly  our  assumptions  about  causal  
relationships and they attempt to go further than normal epidemiological associations to 
describe  causality”.   289 They are considered to be less prone to error, especially in complex 
systems. 293 
Causal diagrams go beyond the normal depiction of exposure, outcome and confounders, to 
show   how   variables   are   related.   The   diagrams   are   constructed   using   the   author’s a priori 
knowledge of the relationships between variables which are connected together by edges 
(arrows or lines) that indicate a causal inference. These edges normally just denote the 
direction of causality rather than whether it is positive or negative or its strength. The 
diagrams tend to be hierarchical in nature, with parents and descendants. Variables are linked 
together to depict more than single relationships between them, enabling the mapping of 
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systems, depicting direct and indirect effects. 293 They also show what variables are not 
related in a system.  
Following the rules of causal diagrams provides a guide to analysis. They provide 
transparency in the analysis method, allowing others to critique and amend if necessary. 
Causal diagrams set out explicitly the assumptions and methods that follow them. They 
highlight backdoor pathways that need to be controlled for, and mediators that should not 
(unless the intention is to find a direct effect between two variables). A backdoor path is one 
that goes from one node to another against the direction of an arrow. I believe such 
transparency is crucial for research to advance as it sets out clearly what has been done and 
the justification for it.   
A criticism of causal diagrams is that they can constrain analysis and hypothesis generation. 
The counter-argument is that the approach does not preclude alternative hypotheses, but 
challenges researchers to set them out clearly. The diagrams help to avoid multiple analyses 
by specifying what analyses should be done. Another criticism of causal models, voiced by 
Philip  Dawid  amongst  others,   is   that   they  are     “just  an   ambitious   associational  model”   and 
questions whether the associations can equate with causal relationships. 294 The difference 
between the links in a SEM and a regression between two variables is that the former refers to 
a  causal  link,  while   the   latter  “represents   the  conditional  mean  of  a  dependent  variable  as  a  
function   of   explanatory   variables.”   295 Bollen and Pearl describe SEMs as “an   inference  
engine that takes in two inputs, qualitative causal assumptions and empirical data, and derives 
two logical consequences of these inputs: quantitative causal conclusions and statistical 
measures  of  fit.  Fitting  the  data  does  not  “prove”  the  causal  assumptions,  but  it  makes  them  
tentatively  more  plausible.”  283 SEMs cannot create causation from association. They rely on 
the prior knowledge and assumptions of the researcher, combined with data analysis. 284 
The most common form of causal diagram is the Directed Acyclic Graph (DAG), defined as 
“a   graph  whose   nodes   (vertices)   are   random  variables  with   directed   edges   (arrows)   and  no  
directed   cycles”.286 DAGs   use   the  Causal  Markov   assumption   that   “the   probability   of   each  
variable or node is independent of its non-descendants   conditional   on   its   parents”.   To  
construct a DAG, we start with the exposure and outcome and then add variables that are 
causes of both exposure and outcome. Common causes of any two variables in the model are 
then added, until there are no more variables to add. Unmeasured variables are normally also 
included. With the assumption that the model is correct, the causal effect can be found if there 
are no common causes (confounders) or the backdoor paths can be blocked from the exposure 
to  the  outcome.  In  this  scenario,  the  exposure  and  outcome  are  said  to  be  “D-separated”.296  
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2.10.5 Randomised controlled trials and observational studies  
In randomized controlled trials, association can equal causation. Appropriate randomization 
ensures   that   missing   counterfactual   values   occur   by   chance   and   that   “exchangeability”  
(defined  as  “independence  between  the  counterfactual  outcome  and  the  observed  treatment”)  
is present. 286 The outcome could equally have occurred in either counterfactual group. If two 
groups have the same treatment, the outcome would be the same in both, with the 
(independent) predictors equally distributed between both groups. Randomization does not 
guarantee exchangeability, but any departures are due to random variability rather than 
systematic bias: the missing counterfactual information is missing completely at random. A 
potential problem with RCTs is that there may be a difference between assigned treatment 
and received treatment. Blinding attempts to ensure that this does not happen, by preventing 
an independent effect of assigned treatment on outcome.  
Exchangeability does not exist in observational studies, but causal inference can be assumed 
if they are treated as conditionally randomized trials. This requires the three following 
criteria: 
1. Well defined interventions (or exposures). 
2. The conditional probability of receiving every value of treatment - depends only on the 
measured covariates. 
3. Positivity: the conditional probability of receiving every value of treatment is greater than 
zero. 286 
In some observational research a variable may be randomly assigned, for example studies 
looking at the effect of birth order. In observational studies, the distribution of outcome is 
conditional   on   another   factor   C.   The   assumption   is   that   the   exposure   was   “assigned”  
randomly in the groups of C. Standardization (or alternatively inverse probability weighting) 
can be applied in such a scenario to get the population effect. In this, the marginal 
counterfactual risk is the weighted average of the stratum-specific risks with weights equal to 
the proportion of individuals in the population with C = 0 and C = 1, respectively. 
Stratification would produce a conditional effect measure, rather than the marginal one, for 
the whole population. 286 
 
2.10.6 Bias and Confounding 
A  bias  is  “any association between treatment and outcome that does not arise from the causal 
effect  of  treatment  on  outcome”.  286 An example is confounding when exposure and outcome 
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share the same cause. The counterfactual definition of a confounder is a variable that can 
block the backdoor paths between exposure and outcome. This contrasts with the traditional 
definition of a confounder as a variable that is associated with the exposure and outcome 
(conditional on the treatment) and is not on the causal pathway between treatment and 
outcome. These two definitions normally coincide, but there can be situations when they do 
not (see Appendix 2.2). The counterfactual definition takes an absolutist stance that assumes 
confounding exists or does not, regardless of whether the variables are measured. The 
backdoor paths can be open, which allows confounding, or closed due to a collider (a node at 
which a causal path is blocked- see Appendix 2.2 for an example). Conditioning on a non-
collider closes the path, whereas conditioning on a collider opens up the pathway through it, 
thus allowing confounding. In this case unnecessary adjustment leads to confounding when it 
does not exist. 286 An alternative approach to using a causal diagram to control for 
confounding is to look for a change in the effect measure. This is not adequate as adjustment 
will usually change the effect measure and if done inappropriately can introduce bias as 
described.  Adjustment  for  confounding  requires  controlling  for  a  “sufficient  set”  of  variables  
(S) for exposure E and outcome O. This requires that: 
1.  “No  element  of  S  is  a  descendant  of  E,  (i.e.  not  on  a  causal  path  emanating  from  E) 
2.  The  elements  of  S  “block”  all  “back-door”  paths  from  E  to  O.”284 
 
2.10.7 Effect modification and interaction 
Effect modification occurs when the effect of the exposure on the outcome varies with levels 
of the effect modifier variable. The exposure variable is not affected by the effect modifier. 
Effect modification can be additive or multiplicative. It can be identified using stratification: 
exchangeability would exist within the different levels of the effect modifier.  
Interaction is similar to effect modification, but in contrast implies a causal effect of the 
interacting variable. The effect of exposure on outcome varies in levels of the interacting 
variable, due to a joint effect of exposure and interacting variables. Both variables work 
together to cause the outcome. Effect modification and interaction are independent of causal 
diagrams. 286 
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Chapter 3 Procedures  
 
 
“Eighty  percent  of  success  is  showing  up” 
Woody Allen 
 
 
This section summarises the methods used in the study. I begin with a detailed description of 
the previous trial methods and then the preliminary work prior to the start of data collection: 
the sample size calculations, piloting, training and the calibration of the equipment. I then 
describe the methods used in conducting the questionnaire, anthropometry, body composition, 
kidney dimensions, blood pressure, spirometry, isotope calibration study and air pollution 
measurements. Finally, I discuss some of the safety and ethical considerations within the 
study. 
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3.1 Method of original trial 
A detailed description of the original trial is provided by Osrin et al. 7 and described with the 
results in more detail in section 2.9.1. The trial was designed to test the effect of multiple 
micronutrient supplementation in the second and third trimesters of pregnancy. In total, 1985 
women attending the obstetric unit at Janakpur zonal hospital for antenatal care were screened 
for eligibility and 1200 were recruited. The trial was powered to detect a difference in 
birthweight of 100 g. At a power of 90%, with a two-sided significance level of 5%, allowing 
for 30% loss to follow-up, the sample size was 600 participants per arm.  
The eligibility criteria were: being within 12-20 weeks of gestation (measured by ultrasound), 
singleton pregnancy, no fetal abnormality on obstetric ultrasound (anencephaly, occipital 
meningocele, encephalocele, duodenal atresia and a grossly dilated pelvicalyceal system), no 
existing  maternal   illness   “of   a   severity   that   could   compromise   the   outcome   of   pregnancy”  
(cysticercosis, need for chlorpromazine or anticoagulant drugs with changing doses and 
symptomatic mitral stenosis or multivalvular heart disease) and residence within Dhanusha or 
the adjoining districts.  
Participants received the routine antenatal healthcare provided by the hospital, but were 
helped to access services if needed. They were randomized into either the MMN or the 
control groups. Participants were given identification (ID) numbers generated randomly by 
someone independent of the trial and allocated in blocks of 50. The supplements were placed 
in containers in Kathmandu and labeled with the ID numbers, again by someone not involved 
in the trial. Both MMN and the control supplements were manufactured by Danish 
Pharmaceutical Industries (Ballerup, Denmark) and were designed to look identical. Women 
were asked to take one tablet per day, preferably after food and at the same time. If other 
medications were needed, these were recommended by the study obstetrician. The MMN 
supplements were tested for their constituents. It was found that vitamin E levels were 25% 
higher and vitamin A (retinol), vitamin C and iron were approximately 10% lower than 
projected levels.   
The discrepancy estimate method was used to assess compliance. Supplements were given to 
participants in varying numbers. When new supplements were given, the remaining number 
was counted. Supplements were consumed for a median of 98% of days in the control and 
97% in the intervention group. 
Birthweight was measured with Seca 835 electronic scales (Hamburg, Germany) accurate to 
10 g, within 72 hours of birth, and infant length on a Kiddimetre board accurate to 1 mm 
(Raven Equipment, Castlemead, UK) or a Rollametre (Raven Equipment) if weather 
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conditions did not allow, and occipitofrontal head circumference with a plastic length tape 
accurate to 1 mm. Three measurements were taken and the median value chosen. Only the 
anthropometry of liveborn infants was assessed. 
Loss to follow-up was defined as failure to attend the antenatal clinic for 3 months and to 
meet the participant after three home visits.   Miscarriage   was   defined   as   “cessation   of  
confirmed   pregnancy   before   23   weeks’   gestation”   and   stillbirth   as   “delivery   of   an   infant  
showing  no  signs  of  life  after  23  weeks  gestation”.  Neonatal  deaths  were  categorized  as  early  
if within the first 7 days and late if 8-28 days. 
Maternal blood samples, taken from a subsample of participants, showed that retinol levels 
(vitamin A) and α  tocopherol (vitamin E) were significantly higher in the MMN group. The 
prevalence of anaemia (defined as haemoglobin <110 g/L) fell in both groups. An extra 60 
mg of iron and antihelminthic drugs were given if the woman had a haemoglobin level < 70 
g/L. If she had symptoms of night blindness, she was given 2000 μg   of   vitamin   A.  
Participants were followed up every two weeks either in their home or the clinic.  
1069 mothers and infants completed the trial and were seen at birth and one month of age. 
The intervention and control groups were comparable for all baseline measures, implying, at 
least for the variables measured, that the randomization process had been successful. Most 
women came from families in which the husband had a salaried income (43%) and the family 
owned land (94%). Approximately equal numbers of women had secondary or higher 
education as women who did not have any education. The sample was therefore not from the 
very poor group, although richer people were more likely to attend private clinics for their 
antenatal care.  
 
3.2 Sample size calculation  
The sample size available for follow-up was constrained to infants available from the initial 
trial, of whom there were 1064. From the 2-year follow-up we had contact details for 917, 
making this the likely maximum number. Members of the research team who performed the 
2-year follow-up estimated that we could find approximately 800 children. Power for the 
primary outcomes was calculated at this sample size. Statistical power is the likelihood of 
detecting an effect if one does exist. Greater power reduces the chance of a type II error. 
Figure 12 shows the relationship between sample size and power. Increasing sample size has 
diminishing returns in terms of power.  
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3.2.1 Weight  
The difference observed in weight at birth and at 2.5 years was 0.2 z scores. With an 
estimated sample size of 400 in each group, at 5% significance level, the study was powered 
at 81% to detect a difference of 0.2 z scores between the groups. This was calculated using 
Stata software (sampsi command). An approximation of the power can be calculated as 
shown in Appendix 3.1.  
 
3.2.2 Forced expiratory volume in 1 second (FEV1) 
Calculating the power for lung function was more complicated as reference ranges for 
Nepalese children do not exist. Power estimates were calculated using data from rural 
Nepalese teenagers and young adults after personal correspondence with Professor Graham 
Devereux297, and using US data for children (National Health and Nutrition Examination 
Survey III 298). With a sample size of 400 in each group, at 5% significance level, the study 
was powered at 80% to detect a difference between the groups of 0.2 z scores, equivalent to a 
4.0% difference in FEV1 using the Nepal adult data, or 2.6% using the US child data A similar 
study of antenatal vitamin A supplementation by Checkley et al found a 3% difference.177 
These calculations were made before the Global Lung Initiative equations described in 
Section 6.4 were produced. 26 
 
 
Figure 12: Power as a function of sample size  
Adapted from Stata commands produced by GJ Stoddard.299  
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3.3 Piloting and Training   
The pilot phase ran for four weeks prior to data collection. Piloting was done in two stages: 
after initial training, the instruments were piloted with adults and friends of the staff in the 
office; the instruments were then piloted in the field with families in areas where MIRA 
already worked. The instruments or methods were adapted at each stage. 
 
3.3.1 Questionnaire 
Piloting of the questionnaire ran from 25/8/11 to 14/9/11. The questionnaire was developed in 
English and translated into Maithili and Nepali. The final questionnaire was trilingual, with 
Nepali as the main language and English and Maithili translations. Translation was done by 
seven staff members of MIRA and UCL. Each question was back-translated to make sure the 
three versions were equivalent.  
The questionnaire was given to the field team for consideration. Each question was 
considered in detail, with an explanation of why it was being asked. It was piloted with other 
members of staff and friends. Each questionnaire was scrutinised in detail, with feedback 
provided individually to each member of staff conducting the interview. It was then piloted in 
field sites where MIRA had been working, both urban and rural. Each field team member 
conducted 12 interviews. The data entry officer was also involved in this process and did two 
field interviews to help make him aware of the questions being used. Modifications were 
made at each stage of the process. Mock interviews were conducted with the field team 
monthly to check their understanding and the consistency with which questions were asked. 
 
3.3.2 Anthropometry and spirometry 
The times at which each component of the project occurred during my PhD are shown in the 
Gantt chart in Appendix 3.2. Piloting of anthropometry and spirometry ran from 25th August 
to 20th September 2011. Anthropometry training was first done by measuring adult members 
of staff within the MIRA office, then with children 7-9 years old in two schools. A consent 
form was sent to parents (Appendix 3.3). In total, 53 children whose parents or guardians 
consented were assessed in the schools. A brief report detailing their measurements was given 
to parents along with a small gift for the child (an exercise book and pencil). A summary 
report was given to the school.  
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3.3.3 Air pollution 
During a pilot phase, the four field team members visited ten families each with children aged 
7-9 years to establish the main locations in which children spent their time. The parent or 
guardian  was  taken  through  an  “average”  school  day  and  asked  to  say  where the child would 
be for most of the time, in half-hour blocks over a 24-hour period. Children divided their time 
between five locations: bedroom/living room, kitchen, verandah, in school and outdoors. 
Periods in the kitchen were subdivided into time when cooking was taking place and time 
when it was not.  
The DustTrak II (TSI Inc, St Paul MN, USA) was used to take measures in kitchens of MIRA 
staff members to help determine the time needed between cooking and non-cooking samples. 
It was also used in schools to help decide where to place the instrument. It was noticed, for 
example, that very high exposure levels were recorded if the DustTrak was placed near a 
blackboard. 
 
3.4 Calibration 
Each  instrument  was  calibrated  according   to   the  manufacturer’s  instructions. Table 7 shows 
the method used to calibrate all the instruments used in the study and reported accuracies. 
Calibration was performed fortnightly unless stated otherwise. 
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Table 7: Accuracy and calibration method of all instruments used 
Device Calibration method Accuracy 
Air pollution   
Casella Apex pumps Calibrated before and after each use with a 
portable flow meter (Casella Rotameter) 
range 0.5 L/min to 5 L/min; calibrated in 
turn with a Bios Dry Cal DC-Lite Primary 
flow meter. 
0.1 L/min 
TSI DustTrak II 8530 
photometric device 
Photometric readings were calibrated against 
the Casella Apex. 
Gravimetric readings 
accurate to 0.00001 g 
Weighing balance for 
filter samples  
Professionally calibrated annually.  0.00001 g 
   
Anthropometry   
Harpenden callipers Callipers were zeroed before each use. They 
were calibrated against Vernier callipers, 
accurate to 0.05 mm. 
2 mm 
 
Leicester stadiometer Calibrated against a 50 cm metal calibration 
rod 
1 mm 
Seca 201 measuring tape Measuring tapes were inspected and 
calibrated against the 50 cm metal 
calibration rod daily. If the tape was found 
to be inaccurate, it was replaced.  
1 mm 
Tanita 418 bioelectrical 
impedance machine 
Body composition was calibrated against 
deuterium total body water.  
Weighing scales were calibrated with 
calibration weights of 5 kg, 10 kg, 15 kg and 
20 kg.  
0.1 kg 
   
Kidney measurements   
Aloka SDD-500 
ultrasound machine  
The machine was checked by a qualified 
ultrasound technician prior to the start of the 
study.  
Measurements accurate to 1 
mm. 
   
Blood pressure   
Omron M6 
Blood pressure monitor 
Instruments were calibrated before purchase. 
The manufacturer stated that they would last 
the course of the study without requiring 
recalibration.  
Measurement range: 
Pressure = 0 to 299 mmHg 
Accuracy: 
Pressure = +/- 3 mmHg 
   
GPS   
Garmin eTrex Summit Calibrated every time the batteries were 
changed,  as  per  the  manufacturer’s  
instructions.  
15 m 
The accuracy varies 
according to the number of 
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 satellites the instrument is 
able to pick up. It is 
reportedly accurate to the 
nearest 15 m, but this 
sometimes increased to 50 
m. 
   
Spirometry   
EasyOne spirometers Auto calibration FEV1 and FVC are accurate 
to 0.01 L 
 
3.4.1 Weighing scales 
We were unable to get accurate calibration weights until halfway through the project. The 
scales were subsequently calibrated fortnightly. The Tanita 418 was accurate for every 
calibration measurement throughout. 
 
3.4.2 Harpenden Callipers 
The callipers were calibrated against gold standard Vernier callipers using measurements of 
12 One Rupee coins (each measuring approximately 1.8 mm). The standard deviation of the 
measurements did not appear to vary with increasing distance. As shown in Figure 1, 
Appendix 3.4 neither of the Harpenden callipers showed a bias over time, implying that 
children at the end of the study could be compared with children at the start. The variability 
seen can be considered consistent with measurement error. While the overall difference was 
minimal (approximately 5-10%) and unlikely to affect the conclusions, in an attempt to 
maximise accuracy, I calibrated the results according to Equation As and Equation B. The 
difference between the Vernier and each Harpenden calliper was calculated, see Table 8. The 
mean difference for Calliper 1 was greater than for Calliper 2 and increased with increasing 
distance. The standard deviation did not increase. This is shown graphically in Figure 2, 
Appendix 3.4. Calliper 1 showed a gradient of 1.036 (95% CI 1.031, 1.040) and calliper 2 a 
gradient of 0.9893 (95% CI 0.985, 0.994).  
 
Equation A  
Calliper 1 y = 1.036x + 0.1451 
Equation B  
Calliper 2 y = 0.9893x + 0.1577 
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Table 8: Calibration of Harpenden callipers compared to the Vernier calliper 
 Calliper 1 Calliper 2 
Number of coins Mean difference from 
Vernier calliper (SD) (mm) 
Mean difference from 
Vernier calliper (SD) (mm) 
2 0.31 (0.08) 0.17 (0.08) 
4 0.37 (0.10) 0.06 (0.16) 
6 0.47 (0.11) -0.01 (0.11) 
8 0.64 (0.16) -0.01 (0.17) 
10 0.73 (0.14) -0.05 (0.11) 
12 0.95 (0.08) -0.03 (0.10) 
 
 
3.5 Consent 
Consent was obtained from parents or guardians in their homes in their native language. 
Children entered the study only after informed consent. The consent process is considered 
further in section 3.18.  
 
3.6 Questionnaire 
Children were identified through contact details obtained from the initial trial and previous 
follow-up. After obtaining informed consent, the questionnaire was administered at the 
respondent’s  home  in  their  native  language  by  our  local  staff.    The  questionnaire  can  be  seen  
in Appendix 3.5. 
I developed the questionnaire after extensive discussion with members of the MIRA and UCL 
research teams. It was based on the one used in the 2-year assessment, and was designed to 
contain similar information for longitudinal comparisons and new information to help answer 
the research questions. It had four sections: 
A: Demographic details 
B: Health status and “International   Study   of   Asthma   and   Allergies   in   Childhood”  
(ISAAC) questions on rhinitis and asthma. To assess the presence of asthma, we used 
the ISAAC  questionnaires  (our  study  was  not  part  of  the  “ISAAC  collaboration”),300 
which have been validated for use throughout the world. 301 The questionnaires were 
translated and back-translated into Nepali and the local language, Maithili. The main 
outcomes were wheeze, dry cough and runny nose in the last 12 months. We did not 
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use the ISAAC eczema questions as we felt they we would not be able to adequately 
distinguish eczema from other rashes. Two open questions about major and chronic 
illnesses were included. I went through each questionnaire with the data collectors 
and  coded  these  questions  into  “no  illness,  major,  chronic  or  major  and  chronic”. 
C:  Socioeconomic   level.  This  included  information  about  the  child’s  home  that  was  
used in relation to their exposure to air pollution. 
D: Food security. Food security was assessed using the Household Food Insecurity 
Access Scale (HFIAS),302 the Household Dietary Diversity Score (HDDS),303 and the 
Months of Adequate Household Food Provisioning (MAHFP)304 tools developed by 
the Food and Nutrition Technical Assistance Project. The questions were developed 
in the United States, but have been validated in other countries. The tools have been 
used successfully in other research carried out by MIRA in the district.305 The HFIAS 
and MAHFP indicate the degree of food insecurity perceived in a household over the 
last year, in terms of access to food and time without food. The HDDS was used to 
examine  the  breadth  of  the  child’s  diet  in  the  preceding  week. 
Questionnaires were checked daily for missing data or inconsistencies when the field team 
returned to the office. A further check was carried out by the data inputter before entering.  
A question on commencing puberty was included as it will affect growth and other changes in 
body dimensions. As it was unlikely that the children would have started puberty and this is a 
sensitive topic, the data collectors were asked not to press the parents. It was felt that the data 
collectors should not formally assess children to avoid the placing them or their parents in an 
uncomfortable position.  
 
3.7 Global Positioning System (GPS) recordings 
GPS  recordings  were  taken  at  each  person’s  house  using  the  Garmin  eTrex Summit Handheld 
GPS Navigator (Garmin ltd., USA). Waypoints were downloaded daily to MapSource 
software (Garmin ltd., USA). 
 
3.8 Anthropometry 
Anthropometry was conducted in accordance with guidelines produced by the UCL Institute 
of Child Health (based on an Anthropometric Standardization Reference Manual)306 – see 
Appendix 3.6 - and WHO.307 We attempted to minimise biological variation by taking 
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measurements at a similar time of day, but it was not possible to schedule appointments.  All 
measurements were recorded on a proforma (Appendix 3.7).  
 
Standing Height (trunk length) 
Height was measured  in  duplicate  with  a  Leicester  stadiometer.  The  child’s  shoes/sandals  and  
hair bands were removed. She was positioned with her head and back touching the 
stadiometer. Knees were extended and feet were placed together with their heels touching the 
base of the stadiometer. The head was placed in the Frankfort plane. The child was asked to 
take a breath in just prior to the reading. The observer read at the appropriate height to avoid 
parallax.  
Sitting Height 
Sitting height was measured with the child seated on a custom-made stool. The legs were 
supported so that the knees were bent at 90°. The measurement was taken in a fashion similar 
to standing height.  
Weight  
Weight was measured with a Tanita BC-418 scale (Tanita Corp, Japan). Children were given 
a standard set of clothes - underwear, vest and sarong - weighing 200 g. Before assessment, 
the child was asked to pass urine and wash her hands and feet. As a back-up, in case of 
damage to the Tanita BC-418, body weight was also measured with a Tanita Solar standing 
scale. The scales were zeroed and the child stepped on the predefined footmarks.  
Skinfold thickness 
Biceps, triceps, subscapular and supra-iliac skin fold thicknesses were measured in triplicate 
on the left side of the body. Two pairs of callipers were used and alternated fortnightly. 
Callipers were zeroed before each use. For all measurements an eyeliner pencil was used to 
mark the points to measure. Using the thumb and forefinger of the non-dominant hand, the 
observer pulled a fold of skin and subcutaneous fat about 1 cm from the pre-marked 
measurement point. The callipers were placed on the skinfold at 90° to the long axis 
approximately halfway up. The reading was taken when the dial almost stopped, after not 
more than four seconds. The callipers and skinfold were released. Observers positioned 
themselves to avoid errors due to parallax. 
The landmarks were identified as: 
Biceps: anterior aspect of the mid-upper arm. 
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Triceps: posterior aspect of the mid-upper arm. 
Subscapular: inferior angle of the lower margin of the scapula. The skinfold was 
grasped diagonally with the fold inclined infero-laterally at approximately 45°. 
Supra-iliac: a cross was marked above the top of the iliac crest along the mid-axillary 
line. An oblique skinfold was grasped 1 cm above the cross following the natural 
cleavage line of the skin at 45°. 
Body circumferences 
Body circumferences were measured in duplicate using Seca 201 measuring tapes, accurate to 
1 mm. Our intention was to alternate two measuring tapes fortnightly, but we needed to use 
nine tapes as they would tear easily. The tape was inspected and calibrated daily. For the 
measurements the child remained standing in the anatomical position while the observer took 
the readings. 
Head: if the child had long hair, it was lifted up and the measuring tape placed 
underneath. The head was positioned in the Frankfort plane. Maximum horizontal 
head circumference was measured around the forehead and occiput. 
Chest: chest circumference was measured with a vest on to avoid embarrassment. 
This was standardised across all children. The measurement was taken at the nipple 
line when the child was relaxed at the end of normal expiration. 
Waist: the child faced forward with her abdomen relaxed and arms hanging beside 
her. The child was asked to bend from one side to the other and the observer marked 
the point of flexure on both sides. The measuring tape was placed around the 
abdomen at these points, when the child was relaxed at the end of normal expiration. 
MUAC: the left arm was flexed to 90°. The observer marked the point mid-way 
between the olecranon process and the tip of the acromion. The arm was straightened 
and relaxed while the measurement was taken. 
Upper leg circumference: the observer marked the point mid-way between the greater 
trochanter and the lateral epicondyle of the femur, and measured the circumference at 
this point. 
Hip circumference: the measurement was made horizontally at the widest girth of the 
hips. 
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3.9 Bio-electrical impedance (BIA) 
Body composition was estimated using BIA with a population-specific calibration study using 
isotope dilution. BIA measures the electrical impedance of a person and uses calibration 
equations to convert impedance values to an estimate of total body water and then lean mass. 
The relative benefits of different methods of body composition estimation have been 
reviewed in detail.135 BIA measures the conductance of a small alternating current through the 
body. It works on the premise that different body tissues have different and consistent 
impedance to current. In simple terms, fat mass has high impedance (is a good insulator) 
while lean mass (LM), with its high water and electrolyte content, is a good conductor. The 
conductivity of tissues varies according to water content, and BIA assumes consistent 
hydration. The relationship between the resistance of an object and its dimensions is dictated 
by Ohm’s   law   - “a   volume   of   constant   section   is   proportional   to   the   square   of   the   length  
divided  by  the  resistance”  - so that there is a linear relationship between the height2/resistance 
(impedance index) and the LM. 308 309 Impedance is made up of two components: resistance 
and reactance. Reactance tends to be about 10% of resistance. The importance of reactance is 
poorly understood, but it is thought that it may relate to the intracellular to extracellular ratio. 
310 It is assumed that the reactance of the body is small, and that the only barrier to the flow of 
current is the resistance. These assumptions are not strictly true as the body does have some 
reactance and the limbs are not perfect cylinders.  
BIA was performed using the Tanita BC-418. This has 8 electrodes: two on each hand and 
foot plate. It passes an imperceptible alternating current (frequency 50-60 Hz) from one 
electrode to another, measuring impedance from arm-to-arm, arm-to-leg and leg-to-leg. 
Segmental impedance measures were not used in our study. This method assumes the body is 
made up of uniform cylinders that have uniform resistance. The reported age range is 7-99 
years old, but we were not able to get readings from some children because they were too 
small, with impedance values above the 1200 Ohm cut-off. Flexing the elbows to 90° lowered 
the impedance and enabled us to take measurements from these smaller children. Two 
recordings  were  taken,  one  with  the  child’s  arms  at  90°  and  one  with  elbows  straight  (at  180°).  
Initially, all measures were taken at 90°, and then later in the study measures were taken at 
both 90° and 180°. We tested this method to see if it would produce adequate results and to 
see if the error was acceptable.   
Children were given a standard set of clothes weighing 200 g. At the start of the assessment 
they were asked to pass urine and to wash their hands and feet. The standard male or female 
setting was used and a 200 g weight adjustment was applied. The child stood on the metal 
plates with legs apart and arms not touching the body. Measurements were conducted at a 
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similar time of the day, but it was not possible to conduct fasting measurements due to the 
logistical difficulties of getting children to the office.  
 
3.10 Ultrasound measurements of the kidney 
Ultrasound measurements of kidney size were taken by a local doctor trained in 
ultrasonography, using an Aloka SDD-500 machine with a 2-8 MHz convex probe (Aloka Co 
ltd, Japan). The maximum length and antero-posterior dimensions were found, making sure 
that sinus and parenchyma were visualised. Table 9 shows the landmarks used to identify the 
kidney. Due to time and logistic constraints no other organs were measured. 
 
Table 9: Landmarks used to identify the kidney 
 Right Left 
Superior medial Right adrenal gland Left adrenal gland 
Stomach 
Superior lateral Right lobe of the liver Spleen 
Medial Duodenum Pancreatic tail 
Inferior/Inferior lateral Hepatic flexure Splenic flexure 
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3.11 Blood pressure 
We used an Omron M6 (Omron Healthcare ltd, Japan) electronic blood pressure monitor with 
a paediatric cuff. This monitor has a dual check system that confirms the blood pressure by a 
second  sensor  and  “intellisense”  technology,  which  according  to  the  manufacturer  “assures  an  
accurate  and  comfortable  measurement”.  An  appropriate  cuff  size  was  used  for  children  aged  
7-9 years (17-22 cm cuff length). A larger cuff (22-32 cm) was available if required. While 
generally considered more accurate, ambulatory blood pressure measurements would not have 
been practical in this setting. Two identical monitors were used and alternated fortnightly.  
Measurements followed Great Ormond Street Hospital for children guidelines.311 Blood 
pressure was recorded after the child had been seated for at least one minute with her legs 
uncrossed. She was told to relax with her head back and right arm on the armrest at the level 
of  the  sternum.  The  brachial  artery  was  palpated  and  the  cuff  positioned  so  that  the  “artery”  
marker lay just superior. Data collection staff avoided standing over the child during 
recording. Two readings were taken - the cuff deflated fully and one minute between them - at 
the start and end of the assessment. The two lowest values were recorded.  
It was likely that a child coming to the office for measurements for the first time would 
experience  “white  coat  hypertension”.  This  is  a  brief  period  of  higher  blood  pressure  due  to  
anxiety. We tried to minimise this by doing the measurement later in the assessment. 
Occasionally, repeat measures were made when we suspected abnormally high readings due 
to anxiety.  
If the blood pressure was high, the paediatrician linked to the project was informed. The cut-
off for what was considered a high blood pressure was taken from the National Institute of 
Health 95% percentile cut off for a 7 year old girl of average height of >113 mmHg. 312 313  
The parents were reassured that, while the recording was high, a one-off reading did not 
imply a problem. In one case, the systolic pressure was 150-160 mmHg. This child had a 
long-standing renal disease, the history being consistent with nephritic syndrome. 
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3.12 Spirometry 
Lung function was measured using one of two EasyOne WorldSpirometers (NDD Zurich, 
Switzerland), alternated fortnightly. These spirometers were chosen because of their ease of 
use in similar environments and automatic calibration. Spirometry was done online, 
connected to a computer, to allow real-time assessment of each curve by the data collector. 
The criteria for the acceptability and repeatability of the spirometry curves were taken from 
“ATS/ERS  task  force:  standardisation  of  lung  function  testing”  by  Miller  et  al.  314 These were 
adapted slightly after discussion with the Portex respiratory physiology team to accept a 10% 
difference between spirograms in accordance with guidelines used by Kirkby et al in the 11-
year follow-up of children born in the Epicure study. 315 While still aiming for a 5% 
difference, this was done in recognition of the age of the child and the difficulties in 
performing the test. Bronchodilators were not used. Parents were requested only to bring their 
children for assessment when well.  
Three members of staff were trained to conduct spirometry. Most assessments were carried 
out by two investigators, with a third assisting if there was difficulty in achieving acceptable 
results. The success of spirometry, particularly in children, is very dependent on the 
communication skills of the investigator. A lot of time was spent discussing communication 
and trying to develop techniques to put the child at ease and to encourage a maximum blow.  
Prior to starting, the investigator explained and demonstrated the procedure to the child and 
their parent or guardian, who sat beside them to help. They initially practiced with the spirette 
by itself and with a balloon. The child was seated on a chair with her back straight, wearing a 
nose clip. Repeated blows were made until the criteria for acceptability and repeatability were 
met. If the child became tired, the test was stopped or postponed. If the child was unable to 
understand the instructions, another member of staff helped. A biological control (a member 
of staff) was tested every fortnight to monitor changes in spirometry readings over the year.  
All spirographs were assessed and interpreted by myself. One-in-ten were then over-read by 
Dr. Jane Kirkby, a respiratory physiologist from UCL, Institute of Child Health and Great 
Ormond  Street  Children’s  hospital,  UK.   
  
Chapter 3 
 115 
Individual  spirograms  are  ‘‘acceptable’’  if   
x They are free from artefacts 
o Cough during the first second of exhalation  
o Glottis closure that influences the measurement  
o Early termination or cut-off  
o Effort that is not maximal throughout  
o Leak  
o Obstructed mouthpiece 
x They have good starts  
x Back extrapolated volume 
o <5% of FVC 
x They show satisfactory exhalation  
o Duration of 3s for children or a plateau in the volume–time curve or if the 
subject cannot or should not continue to exhale 
 
Between-manoeuvre criteria 
x After three acceptable spirograms have been obtained. 
x The two largest values of FVC must be within 5% (or 10%) of each other 
x The two largest values of FEV1 must be within 5% (or 10%) of each other  
Box 4: Criteria for acceptability and repeatability of spirometry 314 
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3.13 Isotope calibration study 
An isotope calibration study was conducted to provide the calibration factor for the 
bioelectrical impedance measurements. It has been shown that population-specific calibration 
studies are needed to convert BIA impedance into an estimate of lean mass. Isotope 
calibration studies of BIA in children have been carried out in a number of low and middle-
income countries and have yielded different prediction equations. 316-319 
 
3.13.1 Participants 
The isotope calibration study was conducted over three weeks in month 4 of the project. At 
the time of the isotope calibration study, we had seen 200 children in the micronutrient trial 
follow-up. Based on the weights of these children (14 kg to 34 kg), we recruited children for 
the calibration study from both the trial cohort and other children in Janakpur. We began by 
contacting parents of children seen in our follow-up study as calibrating the BIA on the 
children in our cohort would be the ideal scenario. We then extended the sample by enrolling 
children from three local schools and neighbourhoods. To optimise the accuracy of the 
resulting prediction equation, we attempted to selectively sample 50 boys and 50 girls, with 
equal numbers in 2 kg weight bands. The children were all aged between seven and nine years 
and pre-pubertal. There was no difference between rural and urban children in mean weight or 
relative leg length in the first 200 children seen, and we did not stratify the sample on this 
basis.  
 
3.13.2 Isotope administration  
All children were invited to our office in the morning and time of entry was recorded. Each 
child was given a bracelet with her ID number and was monitored by a member of staff until 
she left the building. The first of two saliva samples was taken at least half an hour after entry. 
The child was advised to collect some saliva in her mouth and was given a salivette to roll in 
her mouth for approximately two minutes. She was asked not to chew the bud and to make it 
as wet as possible. When the salivette appeared wet enough, the child replaced it in the 
container and it was centrifuged immediately at 3000 rpm for at least three minutes. The 
process was repeated if more saliva was needed. The saliva was then pipetted into pre-
labelled 2 ml microtube bottles.  
The child was given a pre-prepared and pre-labelled drink of approximately 125 ml of bottled 
water with 1.2 ml of 99.8% sterility tested deuterium oxide (CK Gas Products Ltd, 
Hampshire). Deuterium (2H2O) was chosen because it is the mostly widely used isotope for 
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this purpose and is cheaper than the alternative 18O-labeled water. The drink was made to a 
concentration of 0.06 mg/kg, with the assumption that the average child weighed 20 kg. It 
was shaken for one minute and a sample taken for analysis of the dose concentration.  
The bottle with deuterium, straw and bag were pre-weighed before giving them to the child 
and post-weighed after the child had taken the drink, using an Ohaus Traveler TA152 
weighing balance (Ohaus Corp, USA) accurate to 0.01 g. In calibrating this balance we found 
that the weight drifted downwards up to 0.1 g over a 10 minute period. This drift was 
compensated for by zeroing the balance, nevertheless it was recalibrated every five minutes.  
The child was asked to drink the deuterated water through a straw and the bottle was kept in 
the bag to catch any droplets. Drinks were made in batches and stored no longer than one 
week in airtight bottles in sealed bags. The bottle, straw and bag were weighed after the 
procedure as before.  
After the measurements were taken, children were taken into a separate room where they 
were shown a film, given biscuits and a standard drink (totalling 230 ml). They were not 
allowed to take other food or drink from 3½ hours after the procedure until the second saliva 
sample, which was taken in a similar way to the first, four hours after isotope drink 
consumption. The saliva samples were stored in a freezer and transported frozen to the UK. 
The full protocol is provided in Appendix 3.8.  
To limit inter-observer variation, measurements were carried out by only two trained data 
collectors. Standing height, sitting height, weight and BIA were measured as in the rest of the 
study (see section 3.8 and 3.9).  
 
3.13.3 Total body water estimation (TBW) 
The samples were analysed by Iso-Analytical (Iso-Analytical ltd., Crewe, UK). Total body 
water was estimated using continuous flow isotope ratio mass spectrometry (Thermo-Fisher 
Gasbench-Delta XP system, Germany). The Hoffman method was used. This relies on the 
property that different isotopes have different degrees of deflection within a mass 
spectrometer. The samples were tested in duplicate using the equilibration technique. A 
sample was pipetted into Exetainer tubes containing 5% platinum on alumina. The tubes were 
sealed, filled with pure hydrogen and left to equilibrate for at least eight hours. The hydrogen 
gas enrichment would then be proportional to the water. The samples were measured against 
three reference standards, which were all prepared in the same manner.  
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3.14 Air pollution 
Despite its high prevalence and adverse health effects, most research takes fuel usage as a 
proxy for true exposure. In this study, we sampled the particle mass concentrations for 
children aged 7 to 9 years in the microenvironments in which they spent time. We performed 
size selective sampling to differentiate the particles that collect in the different regions of the 
respiratory system. We chose to measure the respirable fraction of particle mass (PM4), the 
reasons for which are described in Box 5. We also collected data on fuel usage, household 
characteristics and children’s   time-activity patterns, to produce a 24 hour time-weighted 
average (TWA) exposure. 
Particulate matter concentrations were measured in a subsample and the data were used to 
model the likely exposure for all children based on household fuel usage and time-activity 
information. A 24-hour TWA exposure estimate was created for each child in relation to 
respirable particulate (<4  μm  median  aerodynamic  diameter  PM4). Sampling was carried out 
from December 2011 to December 2012. Questionnaire data were collected for all children in 
the cohort. The only difference between the subsample and the rest of the children was that 
they could have been older. However, this was tested and found not to be the case.   
Due to the logistics of staff working hours and not being able to travel in the dark, we were 
not able to start the Apex at the time the child would normally sleep. One member of staff 
would start work early to go and pick up the Apex in the morning. 
 
We measured particles that have 50% penetration of the respirable fraction, with a mean 
aerodynamic  diameter   (defined  as  “a  unit  density  sphere   that  has   the  same  terminal  settling  
velocity  as   the  given  particle”320) of 4 µm in diameter (PM4). The European Committee for 
Standardization have defined the following four categories of particles, depending on where 
they reach in the respiratory tract: 
x “Inhalable  fraction  – mass fraction of total airborne particles which is inhaled through 
the nose and mouth.  
x Extrathoracic fraction – mass fraction of inhaled particles failing to penetrate beyond 
the larynx.  
x Thoracic fraction – mass fraction of inhaled particles penetrating beyond the larynx.  
x Respirable fraction – mass fraction of inhaled particles penetrating to the unciliated 
airways.”  321 
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The trend has been for PM10, or more recently PM2.5, to be used in studies of health, whereas 
PM4 has traditionally been the standard used to assess occupational exposures. The PM10  cut-
off was recommended as the particle size that penetrates the thoracic region by the American 
Conference of Governmental Industrial Hygienists.322 This cut-off was designed to be 
protective of workers, rather than to accurately define the fraction that passes to different 
parts of the respiratory system. PM2.5 was described by Miller et al320 as indicating particle 
mass that penetrates to the gas exchange region. The choice of PM4 was in part related to 
historic norms, in that the measurement of PM2.5 is less standardised and more expensive. In 
addition, we wanted to consider damage to the airways as well as impairment to the gas 
exchange area and there is also evidence that in children the particle size is a little greater. A 
50% cut-off of 4 µm was found to reach the tracheobronchial region compared to 3 µm in 
adults. 323 In reality there is probably not much difference as the fine particles created from 
combustion tend to be less than 1 micrometer, so the PM2.5 and PM4 are very similar.  
Additionally, simply by changing from nose to mouth breathing increases the particle size 
inhaled to the alveolar region to 5-10 µm. 320 
Box 5: Particle size choice 
 
3.14.1 Setting 
The measurements were carried out in Dhanusha district. Urban samples were taken in 
Janakpur, which houses about one-eighth of the district population. 40 Rural samples were 
taken from nearby villages. There are few asphalted roads, even in the city. Mechanized 
traffic consists mostly of motorbikes and small numbers of cars, tractors, trucks and buses.  
 
3.14.2 Sampling strategy 
We sampled air pollution concentrations in the six microenvironments in which the children 
resided: the bedroom, verandah, outdoors, the school and the kitchen when cooking was 
taking place and when it was not. The initial plan was to take repeat samples from 40 
bedrooms (5% of the expected total), eight verandah samples, eight schools, eight outdoor 
samples stratified by urban and rural, and eight kitchen samples stratified by biomass and 
non-biomass users (1% of the expected total). The bedroom is the location where children 
spend the most time during the day, so it was felt that it should make up the majority of the 
samples. We stratified the sample by urban or rural location as we thought the dust and traffic 
and the close proximity of air pollution from neighbours would make these locations different. 
We also stratified bedroom samples by ceiling type (cement, tiles and straw) as different roof 
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types were believed to allow different degrees of ventilation. We stratified kitchen samples by 
the type of fuel used: biomass and non-biomass. The initial sampling strategy can be seen in 
Appendix 3.9. We attempted to make the sample representative of all the children in our study. 
We chose houses to sample in by randomly ordering the first 100 children seen in the study, 
and proceeding down the list until the required number in each stratum was found. To take 
account of seasonal variation in air pollution levels, we repeated the measurements three 
times over a year during the winter season (December to March), the monsoon season (June 
to September), and the hotter spring and autumn seasons (April, May, October and 
November). After assessing the results from the first season, the sampling schedule was 
adapted. Due to the lack of variation by roof type, the number of bedroom samples was 
reduced and the number of outdoor and kitchen samples increased for the second and third 
seasons.  
Samples were taken at the following locations: 
Bedroom. A Casella Apex gravimetric sampler was placed in the room where the child slept, 
set to sample from late afternoon and collected first thing the following morning.  
Verandah. The TSI DustTrak monitor was placed in the verandah, approximately equidistant 
from the inside of the building and the outside. Sampling was done in the evening to coincide 
with the time that the child was normally on the verandah. The DustTrak was chosen because 
it can be programmed for a set time. Using this, we were able to do evening samples that 
would otherwise have been difficult to complete.  
Kitchen. An Apex sampler was placed in the kitchen about 1 m away from the stove for the 
period of cooking, and also when there was no cooking for a three-hour period (at least one 
hour after cooking had ceased). The DustTrak was also used to collect seven 12-hour samples 
to look at changes in air pollution concentration over time.  
School. Schools were chosen according to their accessibility and willingness to participate. 
An Apex sampler was placed in a classroom advised by the principal, during school hours, 
which varied from school to school and by season. Care was taken not to place it close to the 
door, windows, or blackboard. All classrooms were on the ground floor.  
Outdoors. Outdoor samples were taken by members of staff, close to their homes in eight 
rural and urban areas. An Apex sampler was kept in the garden or compound, as far as 
possible from the house or adjacent houses. 
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3.14.3 Time activity 
Time activity was recorded in the questionnaire. The data collector went through an average 
day with the parent or guardian, who said where the child was likely to be in every half-hour 
period. A table was created for each child, summarizing the amount of time in each of the pre-
determined locations. 
 
3.14.4 Gravimetric sampling 
Gravimetric sampling gives the average particle mass per hour that the children are breathing 
in, and is considered the gold standard. It was conducted in   accordance  with  “Methods   for  
Determination of Hazardous Substances (MDHS) no. 14/3 (Health and Safety Executive 
2000) guidelines”.  324 New glass fiber 37 mm filters (Casella, Bedford, UK) were weighed on 
a Sartorius balance (Sartorius Ltd, Epsom, UK) accurate to 0.00001g. The filters were pre-
weighed in the UK as close as possible to departure for Nepal. Post-sample weighing was 
done in four batches over a nine-month period, determined by the logistics of travel to the 
field site. Filters were kept in the laboratory overnight to acclimatize, and then weighed twice 
over two consecutive days and the average calculated. The weighing balance was zeroed and 
the filter was placed onto the weighing scales using a pair of flat-tipped tweezers. Care was 
taken not to keep electronic equipment, such as laptops, close to the balance when weighing 
as they may interfere with the reading. The filter was discarded if the two weights differed by 
more  than  100  µg.  Each  filter  was  placed  in  a  plastic  “filter  keeper”  (SKC  ltd.,  Dorset,  UK)  
and transported to Nepal in an airtight box.  
Air sampling was conducted using an Apex air pump (Casella, Bedford, UK) attached to a 
cyclone sampling head (Casella, Bedford, UK) to collect respirable sized particulate in 
accordance with MDHS guidelines. 324 The head and cassette were cleaned before every use 
and the filter inserted using flat-tipped tweezers. Flow rates were set to 2.2 L/min using a 
portable flow meter (Casella Ltd. Rotameter, range 0.5 to 5 L/min). The pump was allowed to 
run for one or two minutes to allow it to stabilise before calibrating.  
The time, volume, temperature and flow rate were recorded for each sample taken (see 
Appendix 3.10). The sampling head was placed at 1.1 m from the ground, attached to a 
portable Leicester stadiometer. This height was chosen because it was thought to be 
approximately   the   height   of   the   child’s   mouth   and   nose.   Time   was   recorded   from   data  
collectors’   mobile   phones,   synchronized   weekly.   The   sample   was   discarded   if   the   total  
sampling time differed by more than 5% from the time recorded on the Apex pump. After 
sampling, the Cyclone head was kept upright until the filter was removed. The Apex was re-
calibrated after use. If the flow rate of the pump had changed by more than 0.1 L/min, the 
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sample was discarded. Each filter was placed in the plastic filter keeper and airtight box, and 
taken to the United Kingdom where it was reweighed using the same balance and weighing 
protocol. Filters were examined and discarded if loss of material was thought to have 
occurred. One in ten filters were used as field blanks to correct for changes in filter weight. 
 
3.14.5 Photometric sampling 
A TSI DustTrak II 8530 monitor was used to measure particulate concentrations in the 
verandah and some of the kitchen microenvironments. This device provided 1-minute 
resolution of respirable dust concentrations. Sampling was performed at 1.7 L/min using a 
Dorr-Oliver cyclone attachment (TSI Inc, St Paul MN, USA). The DustTrak was zero 
calibrated, pre-programmed to run for the appropriate time, and placed in the location. Data 
were downloaded via TSI Trakpro software. 
 
 
3.15 Gesture of thanks 
All children who attended for anthropometry and spirometry were given a T-shirt and 
refreshments (tea, a packet of biscuits and fruit juice). Parents were compensated for the cost 
of transport to the MIRA office. They were also given a voucher to be seen by a local 
paediatrician (see Appendix 3.11). The local doctor was not part of the research and was paid 
at a local rate for all consultations and the costs of minor acute treatments.  
 
 
3.16 Safety  
The project was approved by UCL after a risk assessment. 
3.16.1 Safety of the children 
The research inconvenienced the participants in terms of time, but none of the procedures was 
invasive or potentially harmful. The only substance given to the children was deuterium, in a 
sub-sample of 109 children as part of the isotope calibration study. The protocol for isotope 
dilution is widely used in medical research in all age groups and has been approved by the 
International Atomic Energy Agency. Deuterium occurs naturally in the body and in all foods 
and fluids consumed at natural abundance levels. It is a stable isotope of water and is non-
toxic, non-radioactive  and  has  not  been  associated  with  any  risk   in  human  studies.  “Almost  
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half a century of stable isotope usage in human metabolic studies has occurred without 
documented  significant  adverse  effect”.  325   
The investigators performing the spirometry were trained to recognise wheezing and signs of 
respiratory distress and to inform a clinician immediately. If the child was suffering from 
acute respiratory distress, they were to contact a local paediatrician. A new salbutamol inhaler 
was kept on site, but no acute situations occurred. If necessary, referrals for further non-acute 
assessment were made to a local paediatrician.  
 
3.16.2 Infectious diseases 
Precautions were taken to prevent infection, including drinking clean water and using a bed-
net. Appropriate clothing and footwear were worn. Members of staff from the UK working 
long-term in Nepal were appropriately immunised prior to departure. These staff were 
covered by comprehensive health and travel medical insurance, which included cover for 
medical evacuation.  
 
3.16.3 Security  
The security of participants and staff was paramount. The project ran according to advice 
from our Nepalese partners, MIRA, under the guidance of the site manager. All operations 
were subject to his agreement and he was aware of all movements. Staff carried mobile 
phones with emergency contact numbers. Data collection staff were aware of the local culture 
and customs and were able to converse with the local population. Foreign staff were 
accompanied by Nepalese staff where appropriate. On days on which strikes occurred, the 
field staff went to other areas or remained in the office. 
 
3.16.4 Equipment 
The instruments and devices were new and were used according to their instructions only by 
those trained to do so. They were stored appropriately indoors. The instruments were serviced 
as recommended by the manufacturer. All electrical appliances were used according to their 
purpose with surge protectors. All staff were obliged to wear helmets when riding on 
motorbikes for work-related activities.  
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3.17 Challenges: strikes, festivals, and more strikes 
3.17.1 Finding the children 
The most difficult part of the project was finding the children. While we did have addresses 
from the previous follow-up, they were often quite vague: a name and village. We relied 
heavily on the local knowledge of our field staff. We were very lucky to have three members 
of staff who were involved in the trial and another person who took part in the last follow-up. 
It became progressively more difficult to find the children as the project went along.  
 
3.17.2 Strikes 
Strikes, known locally as bandas, happened often. The importance of the strike and its 
relevance to the study depended on who was striking and for what reason. An example was a 
strike called by medical students when one of their member was killed in a road traffic 
accident by a bus. While not particularly threatening for us, it did mean that all local public 
transport ceased, and that children could not come for anthropometry and spirometry 
measurements. Strikes leading to a ban on mechanised transport and stopping our field team 
from working were very common. In the middle of the project, all activities stopped for about 
a month after two bombs were set off close to the office. The first one exploded in a rally, 
killing five people. The second thankfully caused no harm. The rally was run by a separatist 
group from the Terai, who wanted Nepal to split into two countries, the hills and the plains. 
The group that planted the bomb was thought to be from a different separatist Terai group 
with similar but slightly different goals. Thankfully, these events did not lead to further 
violence. The tense nature of the strikes was often interspersed with holidays and festivals. 
While also calling a halt to our work, they were altogether more pleasant.  
 
3.17.3 Weather 
The weather was a constant source of problems. While normally very hot, the Central Terai 
does have cold and rainy seasons. This mainly caused transport problems for the participants 
and for us. The main problem was a spell of heavy rain for 24 hours that led to flooding of our 
office. Luckily, the water did not damage the equipment.  
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3.18 Ethics 
The research project was approved by both the University College London research ethics 
board (UCL Ethics Project ID 2744/001) and the Nepal Health Research Council (Reference 
number 51/2011; Appendix 3.12) A later amendment to conduct epigenetic analysis of DNA 
samples was approved by both boards.  
The research project was completed as planned. We did not perform an intervention and no 
adverse effects related to the children or staff were reported.  
 
3.18.1 Main study 
Informed consent from the parent or guardian of the child was taken at the start of the 
research when the family was first contacted. Participants were given a detailed information 
sheet describing the research project in their native language (information sheet and consent 
form in Appendix 3.13). In addition, the project was explained to them orally by a member of 
the research team. They were given an opportunity to discuss the project with the member of 
staff or to discuss it with other members of their family before deciding whether to participate. 
As part of the consent process, families were assured that they did not have to participate or 
could consent to part of the project and had the right to withdraw at any point. Parents or 
guardians were advised that the study was a follow-up of the one the mother and child were 
previously involved in. Families were fairly familiar with what we were planning to do and 
there did not seem to be major concerns. Oral and written consent (with thumbprints if unable 
to write) were obtained from the parent or guardian. 
Participants were advised that the information collected would be stored securely and treated 
confidentially and anonymously. In an example of different attitudes towards confidentiality 
to the UK setting, one guardian was concerned that the data would be kept confidential. He 
was reassured when told that it was for the benefit of his child rather than to hide something.  
Of the 852 children we found, one person refused to take any part in the research because of a 
long-standing issue she had with the organisation. Three others were happy to complete the 
questionnaire, but did not want their child to come in for the anthropometry and spirometry, 
mostly claiming a lack of time or benefit to them. 
3.18.1.1 Children with an illness or malnutrition 
During our assessment we found children with acute or chronic illnesses. This most 
commonly occurred because of high blood pressure, an abnormality on kidney ultrasound or 
if the child was found to be underweight. In the case of lung or kidney problems, these were 
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sometimes discovered for the first time by us. A formal letter of referral was made to the local 
paediatrician. Any further referral would be co-ordinated by him, but we provided help where 
possible. Occasionally, further ultrasound scans were needed and we covered their costs. In a 
small number of cases we tried to help organise further specialist care for the child. This 
medical care was within the government system, but we considered helping with 
transportation costs. The decisions were ultimately made by our partner organisation, MIRA.  
We regularly found children with malnutrition and referred them to the local malnutrition unit. 
A copy of the referral form can be seen in Appendix 3.14. No action was taken for children 
who were stunted as this is due to multiple causes over a long period and not obviously 
ameliorable to interventions. Children with low weight-for-age, on the other hand, may have 
been suffering from an acute episode that could be related to high morbidity and mortality, 
and potentially treatable. A decision was made to refer the child if their weight for height 
score was <-2 z scores in accordance with their referral guidelines (I believe adapted from 
Gorstein et al, 1994326). After discussion, we agreed that we would also refer children with 
BMI-for-age z score <-3. For children whose BMI-for-age z scores were -2 to -3, a referral 
was made to the local paediatrician who would refer on if needed.   
3.18.1.2 Time  
The assessments generally took a little longer than anticipated. On some occasions they 
would take a few hours due to difficulty in coordinating ultrasound measurements. We 
attempted to complete each assessment as quickly as possible and occasionally needed to 
reschedule. While not ideal, the participants did not seem overly concerned. 
 
3.18.2 Air pollution 
Approximately 80% of households in the follow-up used biomass fuels producing high levels 
of air pollution. Families and schoolteachers were sometimes concerned about the level of air 
pollution in their residences. When we reported the results back to them, our perception was 
that, while some appreciated that air pollution could be a problem to their health, others were 
not aware of it. In addition to the primary questionnaire, I supervised a medical student who 
conducted semi-structured interviews with some of the mothers in the study. In general, air 
pollution was thought to be detrimental, but understanding of its health risk was low. To 
explore these issues further, we ran a public engagement project with women from the 
families in which we were measuring air pollution levels. We did this by bringing together 
local women, our researchers and a well-known group of neighbouring artists from the 
Janakpur Women's Development Centre, to look at problems and potential solutions in a 
creative environment. More information on this is in Chapter 7.  
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3.18.3 Isotope calibration study 
Separate consent was taken for this part of the study (Appendix 3.13). A study such as this 
that  involved  giving  children  an  “isotope”  was  a  departure  from  the  type  of  work  we  had  done  
in this region and we were apprehensive about how it would be perceived. We were worried 
that it would cause concern to the participants and their families, be they children within our 
cohort or other children within the region.  
Despite it being safe, especially in locations such as ours where illiteracy rates are high, 
written information is less useful. To give the parents as much information as possible about 
what we were doing, a film detailing the project was created. The film explained the study in 
greater detail, showing what would happen, the purpose for doing it and some background 
information about our organisation. It did not replace other aspects of the consent process and 
parents or guardians were still able to discuss the issues. Our participants all chose to watch 
the film when it was offered to them and we received positive feedback on it. The film was 
produced by a medical student I was supervising and included the research team as a 
camerawoman and actors. We think that media such as this can be useful in low resource 
settings to help in the understanding of research. The main drawback of the film was the time 
and technical difficulty involved in producing it. To be fully effective, a film needs to be 
specific to the population and at the very least in the local language.  
 
3.18.4 Photographs 
The issue of how photographs of children were taken was considered at length. Within a 
research setting it is common for children to be photographed, either as a fundamental aspect 
of the research - for example, to portray the effectiveness of a nutrition intervention - or to set 
the scene. Photos are also commonly used to aid in teaching, advocacy and fundraising. In 
this sense, photographs can be valuable. 
In this study, written consent for the taking of photographs was specifically mentioned in the 
consent form. If a photo was to be taken, verbal consent, with an explanation of what the 
photo will be used for, was also taken. A separate consent process and form was completed 
for participants who were included in filming. 
To explore the issue of consent further, I conducted some qualitative research that considered 
the question of what ethical photography of children in low-resource settings is. 327 The 
research involved focus groups with UK doctors or researchers who have worked in low-
resource settings. The groups concentrated on medical as well as research settings. The 
discussions centred on the problem of what informed consent is and whether children, parents 
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or guardians really understand the extent to which a photograph may be shown. From this, we 
proposed  a  “ladder  of  dissemination”   that   links  how  widely   the  photograph   is  disseminated  
with how detailed the consent should be (http://www.biomedcentral.com/1472-6939/14/27).  
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4 Data management and analysis 
 
 
Chapter 4 describes the data collected in the study. It summarises how they were managed 
and cleaned, with a discussion of measurement error and bias. It then documents the global 
positioning system data and the analysis method for the isotope calibration study, with an 
investigation of methodological variations.    
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4.1 Data storage 
While work in Nepal does not fall officially under the UK Data Protection Act, we attempted 
to abide by it. All samples were anonymised and stored securely and no analyses or shared 
data included the names of participants. Questionnaires were stored in an office that was 
locked at all times when not in use. Outside normal working hours, the building was guarded 
by a security guard. All electronic data were stored in the research project computer. The 
computer was password protected and stored in a locked cupboard in the office. All data files 
were password protected and backed up daily on to two external hard drives. One was kept 
with the computer and the other in a locked cupboard in a separate location.  
 
4.2 Data cleaning 
4.2.1 Data management 
All questionnaires were checked by myself or the MIRA data manager daily when the field 
staff returned to the office. Data were entered as soon as possible, normally within one or two 
days, into an Open Office database. If there was a discrepancy, the data manager would alert 
the field staff member. If necessary, parents were called or visited again to clarify the data or 
complete the missing data point. The database containing information from the questionnaires 
was checked weekly basis by the data team manager. The data that were collected are shown 
in Table 10.  
Anthropometry, spirometry and air pollution data were entered into an Excel spreadsheet on 
the day in which the measurements were taken. All the data points in the spreadsheet were 
checked for accuracy against the original records. All spirometry curves were checked by 
myself. Any problems or queries were reported back to the respiratory team at Great Ormond 
Street hospital, who over-read one in ten spirograms.  
Data from the EasyOne (Easyware, ndd Zurich, Switzerland), GPS waypoints (Garmin Map 
Source programme, Garmin ltd., USA) and DustTrak II (Trakpro software, TSI Inc, St Paul 
MN, USA) were downloaded directly into their specialised software. Statistical analyses were 
carried out using Excel (version 14.3.2, Microsoft Corp, USA), Prism (version 6.0a, 
Graphpad Software Inc, USA) and Stata (version 12.1; Stata Corp, USA) software. 
 
  
Chapter 4 
 131 
Table 10: Data collected in the study  
Data type 
 
  Type of 
variable 
Description 
Questionnaire 
data 
 
Illness  History of recent or 
major illnesses 
Binary Illness questions 
that covered the 
last seven days 
and year  
  “International  Study  
of Asthma and 
Allergies in 
Childhood” 
Binary  
 Socio-economic 
status 
Multi-dimensional 
poverty index 
Binary 
questions 
combined into 
an ordered 
categorical 
MPI score 
10 pre-specified 
indicators 
 Air pollution Time activity Continuous 
(or more 
precisely, 
ordered 
categorical) 
Number of hours 
in six different 
locations. 
  Fuel usage Categorical  
  House characteristics  Ordered 
categorical 
Number of rooms, 
floor, windows, 
doors, roof, walls. 
 Food security HFIAS questions Binary Ten questions 
     
Anthropometry Weight 
 
Tanita 418 Continuous  
  Tanita Solar Continuous  
 Height Sitting height Continuous Duplicate 
  Standing height  Continuous Duplicate 
 Skinfold 
thickness 
Triceps Continuous Triplicate 
  Biceps Continuous Triplicate 
  Subscapular Continuous Triplicate 
  Suprailiac Continuous Triplicate 
 Body 
circumference 
Head Continuous Duplicate 
  Chest Continuous Duplicate 
  Waist Continuous Duplicate 
  Hip Continuous Duplicate 
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  Upper leg Continuous Duplicate 
  Mid-upper arm Continuous Duplicate 
 Body 
composition 
Bioelectrical 
impedance 
 
Continuous Whole body 
impedance values 
 Kidney 
dimensions 
Length Continuous Ultrasound 
measurements 
  Antero – Posterior 
distance 
 
Continuous 
 Blood pressure Systolic Continuous Lowest pressure 
recorded 
Lowest pressure 
recorded 
  Diastolic Continuous 
Spirometry 
 
 Forced expiratory 
volume in the first 
second  
 
Continuous Best value from 
acceptable curve 
  Forced vital capacity Continuous Best value from 
acceptable curve 
  Forced expiratory flow 
25%-75% 
Continuous Best value from 
acceptable curve 
     
Air pollution 
 
 Average respirable 
fraction particle mass  
Continuous Gravimetric PM4 
  Real-time readings  Continuous Photometric PM4 
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4.2.2 Assessment of outliers 
Bland-Altman plots were created for all repeat measures to look at reproducibility. 328 These 
plot the mean of two repeated measures against the difference between the measures. They 
are normally used to look at the correlation between two techniques or repeated 
measurements. In this example they are useful in identifying outliers, which were outside the 
95% confidence intervals. These data points were checked against the hard copies to look for 
data entry errors if considered beyond measurement error. For skinfold thickness, an 
erroneous data point did not make a difference because the median point was used rather than 
the mean.  
 
 
Figure 13: Bland-Altman plots for standing and sitting height  
 
 
 
 
 
Figure 14: Bland-Altman plots for systolic and diastolic blood pressure
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Figure 15: Bland-Altman plots for body circumferences 
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4.3 Missing data 
4.3.1 Main study 
Data were examined throughout the study to identify missing variables. Missing data are 
summarised in Table 11. With the exception of bioelectrical impedance (BIA), the number of 
missing data points was very small and unlikely to make a difference to our outcomes. The 
children who were missing for BIA were a little younger and lighter than those for whom we 
had measurements. Heights were the same. This difference may be partly explained by these 
children coming from families with a lower socioeconomic status (defined using principal 
components analysis- see Section 5.2). For bioelectrical impedance, measures for all children 
were present, but with different arm positions. This is discussed in greater detail in section 4.8. 
As described, arm position-specific calibration equations can be used. Importantly, there was 
no difference by trial group, so the main analysis of antenatal MMN would be unaffected. 
4.3.2 Birthweight 
From the initial trial only birthweights taken within 72 hours were used in analyses involving 
birthweight. This excluded 53 birthweights. Babies who were weighed after three days were a 
mean 82 g heavier than those weighed within 72 hrs. 
4.3.3 Child deaths 
Three children died between the ages of two and eight. Questionnaire data were collected 
from their parents. It is possible that they would have had lower values for their 
anthropometry and spirometry because these may have been related to their death (for 
example, chronic illness may lead to malnutrition and stunting), but as the number was so 
small it was unlikely to affect the main analyses. 
Table 11: Missing data 
Variable Number of missing 
data points 
Category of 
missing data 
Comments 
Bioelectrical 
impedance 
213 MNAR The children were 1 month younger 
(p=<0.001) and weighed 0.2 z scores 
less (p=0.02) than the other children.  
Spirometry 6 MNAR We could not get any data from 6 
children. Five had developmental delay 
and 1 child could not coordinate a blow. 
Suprailiac 
skinfold 
thickness 
1 MNAR One child refused.  
Renal 
ultrasound 
1 MCAR Ultrasound technician not available to 
do the measurement.  
MNAR = missing not at random, MCAR = missing completely at random 
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4.4 Error  
We made every effort to increase precision in data collection. The variation is made up of a 
combination of biological variation and measurement variation (error). By minimising 
measurement error, true biological variation between subjects can be identified, reducing the 
chance of a type II error.  
 
4.4.1 Measurement error 
Measurement error is made up of two components: accuracy and repeatability. Accuracy, or 
validity,   refers   to   how   close   the   value   is   to   the   “true”  measure.  To  maximise   accuracy  we  
used all instruments according to their instructions and conducted the measurements 
according to pre-defined approved standards, described previously. Instruments were 
calibrated and adjustments made accordingly. Repeatability, also referred to as reliability and 
precision, is how close repeat measures are to each other. 329,330 We attempted to reduce 
biological variation by taking measurements at a similar time of day, although this was not 
always possible. We could not account for other forms of biological variation, for example 
from season to season, but assumed these were balanced between the trial groups. Children 
were weighed post-micturition as a full bladder can contribute 250-300 g.331 Training was 
given prior to and during the data collection period on a regular basis. Only two data 
collection staff conducted the measurements and they remained blind to the original 
allocation. 
At the end of the piloting phase and periodically through the project, the technical error of 
measurement (TEM) was calculated for intra-332 and inter-observer 333 variability. TEM is the 
standard deviation of sets of repeated observations, with 2n as the denominator to account for 
two sets of observations. 334 It is a measure of error variability that has the same units as the 
variable, with 95% of the difference between two replicated measurements expected to lie 
wihin twice the TEM value.307,330 To allow a comparison between different variables, relative 
TEM (TEM%) was calculated. 335 The coefficient of reliability is also used in population 
studies.  It  gives  the  proportion  of  variation  that  is  “free  from  measurement  error”.  A  value  of  
0.95 means that 5% of the error is due to measurement error. TEM and coefficient of 
reliability were calculated for both observers conducting repeat measurements on a group of 
between five and ten children. 
We attempted to keep all coefficient of reliability values ≥0.95. 330 In the event of a lower 
value, further training was conducted, the tests were repeated on five different children and 
the process was repeated.  
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The following formulas were used, where necessary, simplified for two observers: 307,330,332,333 
Equation C 
Intra-observer variability =   
Where Mi1 and Mi2 are repeat measurements of the ith child and N is the number of children.  
Equation D 
Inter-observer variability =  
Where Y is the duplicate measurements from each observer j.  
Equation E 
TEM%=  
TEM
μ
  ×  100 
Equation F 
Coefficient  of  reliability  =  1−
൫்ாெ(ூ௡௧௘௥)൯మ
ఙమ  
Where μ = mean and σ = standard deviation.  
 
The data shown in Table 1, Appendix 4.1, show that intra-observer TEM was adequate 
throughout the project. With the exception of skinfold thicknesses, TEM% was <0.3%, with 
most values <0.1%. Skinfold thicknesses ranged up to 3.6%, but absolute TEM values were 
very small. Inter-observer TEM was generally good throughout, with R values >0.95. It was 
substantially less than 0.95 for chest and waist measurements in February 2012 (values of 
0.13 and 0.18, respectively). Head circumference TEM was also a little low on this occasion, 
at 0.82. After further training, R values rose to ≥0.90 and stayed high for the rest of the 
project. It is possible, however, that TEM values of 1-1.27 cm existed for these variables for 
the first five months of the project. This should not make a difference by trial group because 
the intra-observer TEM was still high, but means that a combined result could be unreliable. 
We can control for the effect of the observer when looking at the association between 
antenatal multiple micronutrient supplementation and waist and chest circumference. Table 
13 shows that adjustment for observer makes only a 0.0003 cm difference to head 
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circumference, a 0.003 cm difference to chest circumference and a 0.001 cm difference to 
waist circumference. This does not change the overall conclusions.  
The overall results for TEM values for each variable are shown in Table 12. For kidney 
dimensions, TEM values were calculated from a subsample of approximately 5% of the total. 
Kidney AP distance had the highest TEM% at around 5%. Skinfold thickness TEM% was 1-
2%, equating to ≤0.1 mm. The other anthropometry measurement TEMs were generally 
<0.1% with values ≤5mm. These were within the generally agreed norms for anthropometry 
of TEM <3 mm for height, <2 mm for body circumferences and TEM% <1% or <5% for 
skinfold thicknesses. 336,337 
TEM% values for the kidney were higher than for other anthropometric measurements. Our 
study was consistent with an assessment of error in renal measurements by Bakker et al. 
Using the standard deviation of the difference as a percentage (SDD%) of kidney length to 
measure intra-observer error, their observers reported SDD% of 5.1% and 6.1%. In our study 
the SDD% was up to 4.3% and 2.7% for the kidneys, making it consistent with the findings of 
radiologists assessed by Bakker et al. The AP diameter SSD% was a little higher at 7.5 and 
8.2%, but this was not assessed in the Bakker study. 338 
 
4.4.2 Biological variability 
Biological variability is a combination of total variability and measurement imprecision. It 
can be calculated with Equation G. 339 By removing imprecision, the confidence intervals 
should get smaller, the results of which are shown in Table 2, Appendix 4.1. The difference 
this made to anthropometry outcomes between intervention and control groups is shown in 
Table 12. Measurement error was very small, so confidence intervals changed by <0.0001 and 
the overall conclusions did not change. This difference is not important in a practical sense, 
but does highlight that we can be confident of our results and that any differences are unlikely 
to be the result of measurement error.  
 
Equation G  
Biological  variability=  ඥ(σTotal2-­  σMethods2) 
Where σ total is the total variability (standard deviation) and σ methods is the measurement 
imprecision, or TEM.   
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Table 12: Technical error of measurement for anthropometry variables 
  TEM TEM
% 
Difference 
in mean 
values 
95 % confidence 
intervals  
95% confidence 
intervals after 
adjustment for 
error 
Height 
(cm) 
Standing 0.06 0.05 0.00  -0.81, 0.81 -0.81, 0.81 
Sitting 0.05 0.05 0.02  -0.38, 0.41 -0.38, 0.41 
Skinfold 
thickness 
(mm) 
Triceps 0.08 1.08 -0.03 -0.37, 0.31 -0.36, 0.31 
Biceps 0.07 1.91 -0.01 -0.19, 0.18 -0.19, 0.18 
Sub-
scapular 
0.07 1.46 0.01  -0.18, 0.20 -0.18, 0.20 
Supra-iliac 0.08 1.44 -0.19  -0.52, 0.14 -0.52, 0.14 
Circum-
ferences 
(cm) 
Head 0.04 0.09 0.18 -0.02, 0.38 -0.02, 0.38 
Chest 0.05 0.09 0.15  -0.32, 0.63 -0.32, 0.63 
Waist 0.06 0.11 0.19  -0.33, 0.71 -0.33, 0.71 
Hip 0.05 0.09 0.07  -0.48, 0.61 -0.48, 0.61 
Upper leg 0.04 0.14 0.10 -0.23, 0.49 -0.23, 0.49 
Mid-upper 
arm 
0.04 0.25 0.04  -0.14, 0.23  -0.14, 0.23 
Kidney 
dimension 
(cm) 
Right 
length 
0.21 2.61 -0.01  -0.08, 0.07 -0.08, 0.06 
Right AP 0.14 4.73 0.02 -0.01, 0.06 -0.01, 0.05 
Left length 0.16 1.88 -0.03 -0.11, 0.05 -0.11, 0.05 
Left AP 0.19 5.66 0.02  -0.02, 0.06 -0.02, 0.06 
 
 
Table 13: Waist and chest circumference, by allocation, with adjustment for observer 
 Control mean Intervention 
mean 
Unadjusted 
difference (95% 
CI) 
Difference 
adjusting for 
observer (95% 
CI) 
Head 
circumference (cm)  
49.37 49.19 0.18 (-0.02, 0.38) 0.18 (-0.02, 0.38) 
Chest circumference 
(cm) 
55.59 55.74 0.15 (-0.33, 0.63) 0.15 (-0.32, 0.63) 
Waist circumference 
(cm) 
49.01 49.20 0.19 (-0.33, 0.71) 0.19 (-0.33, 0.71) 
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4.5 Bias 
4.5.1 Selection bias 
Selection bias should have been minimal for the follow-up as we attempted to assess all 
children born in the original randomised controlled trial. The analysis compared intervention 
and control groups, the initial allocation of the supplement was concealed and participants 
and data collection staff remained blind to allocation. The main bias was likely to be from 
differential loss to follow-up. If we wish to generalise from our cohort to Dhanusha district or 
further, we need to consider whether the sample was representative of the general population. 
It is possible that mothers who chose to participate differed systematically from those who did 
not; for example, in wealth or educational status. Using an absolute scale of poverty such as 
the Multi-dimensional Poverty Index could allow us to compare the sample with others in the 
region, country or other countries. This is discussed in section 5.2. 
4.5.2 Loss to follow-up  
Differential loss to follow-up may induce bias as it affects both the outcome and the 
likelihood of being followed up. We used the same definition of loss to follow-up as the 
previous   study   at   two   years   of   age:   “confirmed   information   that   a   participant had moved 
beyond  the  possibility  of  visiting.”  If  we  had  information  confirming  that  a  child  had  moved  
to a different location outside the region, we made all possible attempts to find them 
(questionnaires and measurements were conducted in Kathmandu and Hetauda). The trial 
profile can be seen in Figure 16. Table 14 shows the characteristics of the children found 
within the 8 year follow-up and those not found.  
Comparing those included with those lost to follow-up, there were differences in maternal 
education and residence. Children lost to follow-up were more likely to have mothers with 
some education and to be from an urban residence. Maternal education and residence were 
included in the multivariable model.340 Women lost to follow-up were also more likely to 
have had a preterm birth, but this was unreliable because data were missing for 61 individuals 
and the lost category included infants who had died. Two-by-two tables were created to show 
the numbers within the study and lost to follow-up (Table 15). Even though the appliance 
score was very similar, these results point to those lost to follow-up being more affluent.  
Comparing intervention and control groups, the intervention group were a little more likely to 
have delivered in hospital (Chi-square p value = 0.006), but were otherwise similar. This 
factor was not included in the adjusted analyses in section 6.3. As discussed by Assman et al, 
a significant difference in baseline characteristics does not necessarily mean that it should be 
adjusted for. More important is whether it is a strong predictor of the outcome. 341 
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Table 14: Characteristics of 841 children retained and 359 lost to follow-up 
 8 year follow-up Lost to follow-up 
 Control 
n=422 
Frequency (%) 
Intervention 
n=419 
Frequency (%) 
Before end of trial a 
n=69 
Frequency (%) 
After end of trial b 
n=290 
Frequency (%) 
Residence     
Urban 199 (47.2) 197 (47.0) 47 (68.1) 184 (63.5) 
Rural 223 (52.8) 222 (53.0) 22 (31.9) 106 (36.6) 
 
District 
    
Dhanusha 348 (82.5) 336 (80.2) 59 (85.5) 245 (84.5) 
Mahotari 74 (17.5) 79 (18.6) 10 (14.5) 43 (14.8) 
Siraha  2 (0.5) 0 1 (0.3) 
Sarlahi  2 (0.5) 0 1 (0.3) 
 
Mother’s  age  at  
enrolment 
    
<20 126 (29.9) 130 (31.0) 20 (29.0) 85 (29.3) 
20-29 273 (64.7) 272 (64.9) 44 (63.8) 196 (67.6) 
≥30 23 (5.5) 17 (4.1) 5 (7.3) 9 (3.1) 
 
Maternal education 
    
None 206 (48.8) 210 (50.1) 27 (39.1) 101 (34.8) 
Primary 37 (8.8) 33 (7.9) 16 (23.2) 37 (12.8) 
Secondary or higher 179 (42.4) 176 (42.0) 26 (37.7) 152 (52.4) 
     
Maternal Height 
mean (SD) 
151.0 (5.7) 150.4 (5.4) 150.4 (5.0) 151.0 (5.6) 
     
Ethnicity     
Terai Brahmin 55 (13.0) 50 (11.9) 10 (14.5) 45 (15.5) 
Terai Chhetri 7 (1.7) 15 (3.6) 3 (4.4) 17 (5.9) 
Terai Vaishya 296 (70.1) 276 (65.9) 38 (55.1) 176 (60.7) 
Terai Sudra 10 (2.4) 14 (3.3) 2 (2.9) 3 (1.0) 
Hill Brahmin 11 (2.6) 13 (3.1) 4 (5.8) 14 (4.8) 
Hill Chhetri 13 (3.1) 10 (2.4) 2 (2.9) 5 (1.7) 
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Muslim 23 (5.5) 29 (6.9) 8 (11.6) 17 (5.9) 
Newar 4 (1.0) 5 (1.2) 1 (1.5) 3 (1.0) 
Tibeto-Burman 3 (0.7) 6 (1.4) 1 (1.5) 9 (3.1) 
Other 0 1 (0.2) 0 1 (0.3) 
 
Main household 
livelihood 
    
No work 49 (11.6) 46 (11.0) 1 (1.5) 34 (11.7) 
Farming  72 (17.1) 72 (16.2) 7 (10.1) 34 (11.7) 
Salaried 153 (36.3) 178 (42.5) 34 (49.3) 148 (51.0) 
Small business 82 (19.4) 76 (18.1) 19 (27.5) 46 (15.9) 
Waged labour 53 (12.6) 43 (10.3) 5 (7.3) 18 (6.2) 
Student 7 (1.7) 3 (0.7) 3 (4.4) 4 (1.4) 
Out of country 6 (1.4) 5 (1.2) 0 6 (2.1) 
 
Land ownership 
    
0 47 (11.1) 44 (10.5) 8 (12.1) 30 (10.3) 
<30 dhur (~ 500 m2) 290 (68.7) 294 (70.2) 45 (65.2) 196 (67.6) 
>30 dhur 85 (20.5) 81 (19.3) 16 (23.2) 64 (22.0) 
 
Appliance score 
    
Motor vehicle, TV or 
refrigerator 
217 (51.4) 214 (51.1) 36 (52.9) c 146 (50.3) 
Sewing machine, 
cassette player, 
camera, fan, bullock 
cart, wall clock, radio, 
iron, bicycle 
147 (34.8) 138 (32.9) 21 (30.9) 95 (32.8) 
None of the above 58 (13.7) 67 (16.0) 11 (16.2) 49 (16.9) 
 
Parity 
    
0 185 (43.8) 182 (43.4) 33 (47.8) 140 (48.3) 
1-2 183 (43.4) 202 (48.2) 28 (40.6) 124 (42.8) 
≥3 54 (12.8) 35 (8.4) 8 (11.6) 26 (9.0) 
     
Preterm 29 (6.9) 28 (6.7)  41 (14.1) 
 
Delivery site 
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Hospital 218 (51.7) 252 (60.1)  176 (60.7) 
Home 194 (46.0) 165 (39.4)  100 (34.5) 
On the way 10 (2.4) 2 (0.5)  14 (4.8) 
 
Child sex 
    
Female 210 (49.8) 196 (46.8)  152 (53.5) c 
Male 212 (50.2) 223 (53.2)  132 (46.5) 
 
Birthweight (kg) 
 
2.74 (0.41) 
 
2.81 (0.43) 
  
2.75 (0.50) 
 
a 14 withdrew from trial, 1 dropped out with clinical problem, 19 moved beyond study area, 
28 untraceable, 7 miscarriages. 
b 4 refused to attend, 2 moved beyond study area, 2 not assessable within follow-up period, 
204 untraceable, 33 stillbirths, 29 neonatal deaths, 16 postneonatal deaths. 
c Original trial data incomplete. 
 
Table 15: Two-by-two tables showing the numbers included in the study and lost to 
follow-up, for maternal education, residence and preterm births 
Maternal education Study Lost Total 
No education 416 128 544 
Primary 70 53 123 
Secondary 355 178 533 
Total 841 359 1200 
Chi-square test for difference = <0.0001 
 
Residence Study Lost Total 
Urban 396 231 627 
Rural 445 128 579 
Total 841 359 1200 
Chi-square test for difference = <0.0001 
 
Preterm births Study Lost Total 
Normal gestation 784 254 1038 
Preterm 57 44 101 
Total 841 298 1139 
Chi-square test for difference = <0.0001 
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Figure 16: Trial profile 
  
1985 women screened for eligibility 
1200 randomised
785 did not meet inclusion criteria
600 allocated to control group 600 allocated to intervention group
24 lost to follow-up
   16 could not be found
    8 moved beyond study
12 discontinued trial
    5 lost to miscarriage
    7 withdrew from trial
564 delivered
   18 stillbirth
   12 neonatal death
23 lost to follow-up
   12 could not be found
   11 moved beyond study
10 discontinued trial
    2 lost to miscarriage
    7 withdrew from trial
    1 clinical problems
567 delivered
   15 stillbirth
   17 neonatal death
534 potential for follow-up 535 potential for follow-up
98 lost to follow-up
1 refused consent
8 post-neonatal deaths
     6 deaths at < 1 year
     2 deaths at 1-2.5 years
106 lost to follow-up
 5 post-neonatal deaths
     4 deaths < 1 year
     1 death 1-2.5 years
427 completed questionnaires 424 completed questionnaires
422 completed anthropometric 
measurements
419 completed anthropometric 
measurements
3 unable to come for 
anthropometric measurements
   1 moved to India
   1 could not come in time
   1 did not want to come
2 deaths >2.5 years
4 unable to come for 
anthropometric measurements
   1 moved to India
   1 could not come in time
   2 did not want to come
1 death >2.5 years
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4.5.3 Measurement bias 
In addition to measurement error, recall bias may have existed, particularly when asking 
questions about recent illness. It is possible that major illnesses were over-estimated and it 
was difficult to corroborate health information in this setting with medical records. It is 
expected that both the intervention and control groups would have a similar level of recall 
bias. 
Measurement bias may also occur with spirometry. Spirometry is more difficult to standardise 
because it depends very much on the communication between the observer and the child and 
the understanding of the child. We followed approved guidelines for the acceptability and 
repeatability of curves. Assessments were limited to three people, two of whom conducted the 
majority. All three received the same training.  
 
4.5.4 Air pollution sampling 
Due to logistic difficulties we were unable to measure each child continuously for long 
periods. We therefore had to model the data based on a subsample. This led to a 
generalisation  as  we  reduced  a  child’s  exposure  to  three  measurements  with  the  assumption  
that it was similar throughout life. This is inherently problematic, but a compromise is 
necessary as we were unable to do more sampling. This is discussed in more detail in section 
5.1.  
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4.6 Assessment of normality 
Histograms were created for the main outcomes variables (weight, height, blood pressure, 
FEV1 and FVC) to check for normality (Figures 17-19), with normal curves superimposed. 
The variables were deemed adequate for use in further analyses. Normality is required when 
testing an hypothesis using independent t tests, although they are robust to a degree of 
departure.  
 
 
Figure 17: Histograms showing distributions of weight, fat mass, lean mass and height 
variables 
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Figure 18: Histograms showing distributions of blood pressure and kidney dimensions 
 
 
Figure 19: Histograms showing distributions of lung function 
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4.7 Global positioning system (GPS) 
GPS waypoints were taken at the houses in which children lived, downloaded to MapSource 
software (Garmin ltd., USA) and maps were created using GPSVisualizer and Google Earth 
(Google Inc., USA). Examples of two of the maps are shown in Figure 20 and Figure 21 
using  Google’s  “terrain”  and  “hybrid”  backgrounds,  respectively.   
 
Figure 20: GPS map of Dhanusha district showing intervention (orange) and control 
group (blue) households 
 
Figure 21: GPS map of Janakpur city and surroundings showing intervention (orange) 
and control group (blue) households 
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4.8 Isotope calibration study  
The study set out to calibrate the Tanita BC-418 by measuring total body water using 
deuterium oxide, in a sample of children aged 7-9 in Nepal that was used to calculate body 
composition in a larger cohort. In addition, I investigated methodological variations, such as 
alteration of arm position to extend the range of the device and the effect of changes to the 
number needed for accurate prediction equations.  
 
4.8.1 Analysis 
4.8.1.1 Total body water estimation (TBW) and prediction equations 
TBW is proportional to the impedance index (height2/impedance). The derivation is shown in 
Equation H and Equation I. This assumes the body is a cylinder and that the conduction 
material is mostly water, so volume is equivalent to total body water: 
Equation H 
𝑎   =
𝑣
𝑙 =   𝑘   ×   
𝑙
𝑟 
therefore     𝑣   =   𝑘   ×   ௟
మ
௥  
 
where, a = cross-sectional area; v = volume; l = the length or height of the cylinder; k = 
conductance per unit length; and r = resistance 
 
TBW and lean mass (LM) were calculated with Equation I and Equation J respectively. Fat 
mass (FM) was calculated as the difference between LM and total mass. 
Equation I 
N=  
TA
a
  ×  
(Ed-­Et)
(Es-­Ep)
 
 
where N is the total body water, T is amount of tap water in which a is diluted =100 ml, A is 
the mass of drink given to the child, a is the portion of the dose diluted in T, and E values are 
isotope enrichments in delta (δ) units: Ed = dose, Ep = pre-dose, Es = post-dose, Et = tap 
water   
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Equation J 
lean  mass =  
ቌ
ቀ 𝑁1.044ቁ
1000 ቍ− 0.23
ℎ  
where 1.044 is the correction factor to account for hydrogen ion exchangeh,342-344 1000 is 
needed to covert the figure into litres, 0.23 is the amount of fluid drunk by the children in 
litres during the equilibration period, h = age and sex-specific hydration factors. The choice of 
hydration factors is described in Box 6.  
 
Based on the chemical analysis of cadavers, a hydration factor for LM of 0.773 is normally 
taken, 345,346 but age-specific hydration factors are needed in children. A normal healthy 
newborn baby, for example, has a much higher water content (80-83% of their LM) and this 
reduces to adult levels by 3 to 5 years.347 Hydration of LM can also change with the level of 
obesity. 348 The age and sex specific hydration factors used are: 0.761 for boys and 0.753 for 
girls aged 6 to 7.99 and 0.758 for boys and 0.752 for girls aged 8 to 9.99. 349 
Box 6: Choice of hydration  
 
 
 Prediction equations  
The calibration prediction equations for BIA were generated using stepwise multivariable 
linear regression models with lean mass (LM) as the dependent variable. While impedance 
index predicts LM, the coefficient of determination (R2) can be improved by adding other 
variables. Predictor variables were added to the model with assessment of goodness of fit.  
 
4.8.1.2 Comparison of our results with the Tanita system 
Agreement  of  our  results  with  the  Tanita  system’s  built-in equations was assessed using the 
Bland-Altman method.328  
 
                                                     
h The dilution volume is larger than the actual TBW volume obtained because the labelled hydrogen 
atoms exchange with hydrogen atoms associated with carboxyl, hydroxyl and amino groups. 
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4.8.1.3 Assessment of the effect of changing arm position 
Separate equations were created for the 180° and 90° arm positions and we assessed the 
difference these two methods made when applied to the whole cohort and also when limited 
to children <16 kg, in whom the 90° arm position may be useful. This is needed because the 
Tanita BC-418 software allows a maximum impedance of 1200 Ohms. Lighter children may 
have impedance values above this. To see if specific calibration equations for each arm 
position needed to be developed, I compared the effect of using the specific calibration 
equations against using the same 180° equation for both arms.  
 
4.8.1.4 Reduction of the sample.  
We attempted to find children in all weight categories in our larger cohort in order to optimise 
regression lines across the range of body weights. Finding extra children adds to the time and 
cost of conducting an isotope calibration study, and it would be useful to know how much of 
a reduction in the sample would be tolerable in practice. To explore the difference this would 
make, I looked at the effect a reduction in numbers would make to our equations and LM 
outcomes. I did this in two ways: 
i) Reduction of the weight range to 1.5, 1.25, 1 and 0.75 standard deviations from the mean 
weight.  
ii) Reduction of data points at the tails. I first identified data >1SD from the mean and 
assigned a number to each data point, from 1 to 34. I then used a random number generator to 
choose half of the numbers, which were removed (www.randomizer.org). The process was 
repeated four times to produce four datasets with 87 data points each.  
Prediction equations were then created for the new datasets, applied to our larger cohort of 
628 children, and summarized with Bland Altman plots.328 
 
4.8.2 Results  
One hundred and nine children participated in the isotope calibration study. In two cases we 
were unable to complete the study: one child had learning difficulties and was unable to 
provide a saliva sample; the other was found to be 10 years old after entering the study. Of the 
remaining 107 samples, 102 were sent for mass spectrometry analysis (five were removed 
when we had other children in their weight categories). We were unable to get a BIA reading 
in the 180° arm position in two cases. Both these children were light and their whole body 
impedance with arms at 90° was close to the Tanita BC-418’s  maximum  impedance.  Table 16 
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shows characteristics of the sample. Boys were heavier than girls (difference in mean weight 
2.2 kg; 95% CI 0.3, 4.2), but not different in height or BMI. The intra-observer TEM% was 
0.05% for both observers and the inter-observer coefficient of reliability was 0.97 for height. 
 
Table 16: Characteristics of the sample 
 Boys Girls 
Number 50 52 
Age (years) 8.7 (0.6) 8.6 (0.6) 
Weight (kg) 23.3 (5.4) 21.0 (4.7) 
Height (cm) 124.2 (9.4) 121.3 (8.9) 
Trunk height (cm) 111.8 (4.4) 110.1 (4.4) 
BMI (kg/m2) 14.9 (1.9) 14.4 (2.1) 
TBW (L) 13.9 (2.8) 12.5 (2.5) 
Lean mass (kg) 18.4 (3.7) 16.7 (3.3) 
Fat mass (kg) 4.9 (2.5) 4.3 (1.9) 
Fat mass % 20.4 (6.5) 20.1 (6.4) 
180° arms impedance (Ohms) 903.3 (96.5) 990.0 (100.8)  
180° arms impedance index 
(cm2/Ω) 
17.5 (3.7) 15.3 (3.2) 
90° arms impedance (Ohms) 844.1 (91.3) 934.7 (104.6) 
90° arms impedance index 
(cm2/Ω) 
18.7 (3.9) 16.1 (3.6) 
 
4.8.2.1 Prediction equations 
The prediction equations generated for TBW and LM (with height in cm and impedance in 
Ohms) with a 180° arm position were: 
Equation K 
TBW (arms 180°) = 0.715 + 1.596 ((height2/impedance) 
Root mean squared error = 0.78, R2 = 0.92 
Equation L 
LM (arms 180°) = 2.202 + 0.941 (height2/impedance) 
Root mean squared error = 1.05, R2 = 0.91 
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I added sex (coded 0 for females, 1 for males) and weight (in kg) to produce the final 
prediction equation, Equation M. Previous research has shown these to be the best predictors 
to add to the model (height and BMI tend to be collinear with weight).317  The R2 and root 
mean squared error results are shown in Table 17. Adding in weight and sex increased R2 
from 0.91 to 0.93 and reduced the root mean squared error from 1.05 to 0.95. Root mean 
squared error is a composite of the residuals and is a measure of model fit. The closer to 
zero, the better.  
Equation M 
LM (arms 180°) = 1.946 + (0.681× height2/impedance) + (0.211×weight) + (-0.363×sex) 
Root mean squared error = 0.95, R2 = 0.93 
 
Prediction Equation M and Equation P are shown in Figure 22 as scatterplots of impedance 
index against LM for the 180° and 90° arm positions. The graphs show the line of best fit 
with 95% confidence intervals (showing where the true line would be 95% of the time) and 
95% prediction lines (showing where future data points are likely to be 95% of the time. 
 
Table 17: Alternative models to predict lean mass  
 Arms 180° Arms 90° 
Predictors  R2 Root mean 
squared error 
R2 Root mean 
squared error 
Impedance index 0.91 1.053 0.92 1.044 
Impedance index, sex of child 0.92 1.025 0.92 1.014 
Impedance index, weight 0.93 0.960 0.93 0.954 
Impedance index, sex of child, 
weight 
0.93 0.949 0.93 0.942 
 
 
4.8.2.2 Comparison of our results with the Tanita system 
Figure 23 shows the level of agreement for derived TBW and LM obtained using the 
equipment’s   built-in equations and deuterium dilution. The built-in equations resulted in a 
mean error of 385 g (SD 1018 g) in lean mass, corresponding to a 2.2% error. The greatest 
error was 4.54 kg (25.8%). 
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4.8.2.3 Assessment of the effect of changing arm position 
The prediction equations generated for TBW and LM using the 90° arm position were: 
Equation N 
TBW (arms 90°) = 0.667 + 1.632 (height2/impedance) 
Root mean squared error = 0.78, R2 = 0.92 
Equation O 
LM (arms 90°) = 2.254 + 0.877 (height2/impedance) 
Root mean squared error = 1.04, R2 = 0.92 
Equation P 
LM (arms 90°) = 1.980 + (0.638×height2/impedance) + (0.208×weight) + (-0.378×sex) 
Root mean squared error = 0.94, R2 = 0.93 
 
The impedance values obtained with arms at 90° were a mean 63.9 Ω (95% CI 58.8, 68.9) 
lower for girls and 59.2 Ω (95% CI 54.0, 64.4) lower for boys than with arms at 180°. When 
using calibration Equation M and Equation P to calculate LM values in the larger cohort, the 
180° and 90° arm position gave a mean LM of 17.32 kg (SD: 2.5 kg) and 17.25 kg (SD: 2.4 
kg) respectively, with a difference of 70 g (95% CI 55, 86 g; p <0.00001). The largest 
difference was 321 g, equivalent to a 1.9% error in LM. When limiting this to children <16 kg 
(n=32), the mean difference was 19 g (95% CI -29, 67g; paired t test p 0.42).  
If BIA is conducted with arms at 90°, but calibrated with the standard 180° equation, the 
resulting error in LM is 694 g (95% CI 676, 711 g), with the largest difference being 1.55 kg 
(8.9% error). This is illustrated in Figure 24, in which the first graph shows the same standard 
180° calibration (Equation M) applied to both 180° and 90° data, producing an error that 
increases with mean LM value. When using a specific calibration, the error reduces and is 
consistent across LM values.  
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Figure 22: Scatter plots, with regression lines, 95% confidence intervals and 95% 
prediction lines for lean mass from isotope dilution and impedance index 
(height2/impedance)  
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Figure 23: Bland-Altman plots showing level of agreement between LM and TBW for 
isotope dilution and the Tanita system methods  
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Figure 24: Comparison of lean mass results using standard (180°) calibration versus 
specific calibration equations  
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4.8.2.4 Reduction of the sample 
Figure 25 shows the time required to find the target number of children. I looked at whether 
reducing the number of children included in the study made a difference to the prediction 
equations. In the first scenario the data range was limited, from all the data (n=100) to 0.75 
SD from the mean (n=50), see Table 18. The prediction equations were similar until the data 
were limited to <1SD. The error in LM increased from 0.7% to 1.3% as the numbers fell. In 
the second scenario, the central data remained, but data at the tails were reduced (half the data 
points >1SD from the mean; see Table 19). This produced an error effect on LM of 0.1 to 
0.7%. Bland-Altman plots, in Figure 26 and Figure 27, show the effect of reducing data at the 
tails of the distribution. In both scenarios the error increased at the tails of the distribution, 
particularly at greater weights. 
 
 
 
 
 
 
Figure 25: Time taken to complete the study 
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Table 18: Model fit and error in lean mass when collecting a smaller range of weights 
 Model 1  
All data 
Model 2 
<1.5 SD 
Model 3 
<1.25 SD 
Model 4 
<1SD 
Model 5 
<0.75 SD 
Number 100 89 76 66 50 
ht2/Z 0.681 0.641 0.639 0.592 0.618 
Weight 0.211 0.254 0.264 0.309 0.326 
Sex -0.363 -0.233 -0.311 -0.255 -0.297 
Constant 1.946 1.550 1.455 1.221 0.375 
      
R2 0.93 0.94 0.92 0.89 0.84 
Root MSE 0.95 0.79 0.78 0.81 0.87 
Residuals 86.53 53.32 43.74 40.56 34.63 
      
Mean 
(kg) 
17.32 17.21 17.24 17.17 17.09 
95% confidence 
intervals 
17.13 to 
17.51 
17.01 to 
17.41 
17.04 to 
17.44 
16.97 to 
17.37 
16.88 to 
17.30 
Standard 
deviation 
2.46 2.50 2.52 2.54 2.66 
Difference (g) 
from Model 1 
 113 82 149 231 
Percentage 
difference in 
mean 
 0.7 0.5 0.9 1.3 
 
 
Figure 26: Graphs showing impedance index against lean mass when smaller ranges of 
weights were tested. 
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Table 19: Halving the number >1 standard deviation from the mean 
 Model 1  
All data 
Model 2 
half data 
>1SD 
Model 3 
half data 
>1SD 
Model 4 
half data 
>1SD 
Model 5 
half data 
>1SD 
Number 100 83 83 83 83 
ht2/Z 0.681 0.636 0.731 0.656 0.681 
Weight 0.211 0.250 0.150 0.220 0.229 
Sex -0.363 -0.196 -0.397 -0.503 -0.341 
Constant 1.946 1.691 2.416 2.235 1.514 
      
R2 0.93 0.93 0.91 0.93 0.93 
Root MSE 0.95 0.85 0.93 0.87 0.93 
Residuals 86.53 57.48 68.53 59.33 58.38 
      
Mean 
(kg) 
17.32 17.21 17.39 17.33 17.28 
95% confidence 
intervals 
17.13 to 
17.51 
17.02 to 
17.40 
17.20 to 
17.58 
17.14 to 
17.52 
17.08 to 
17.48 
Standard 
deviation 
2.46 2.48 2.41 2.41 2.52 
Difference (g) 
from Model 1 
 112 66 10 40 
Percentage 
difference in 
mean 
 0.7 0.4 0.1 0.2 
 
 
Figure 27: Graphs showing impedance index against lean mass when smaller ranges of 
weights were tested. 
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4.8.3 Discussion 
The use of BIA is becoming increasingly popular, but body composition estimation is still 
under-researched in South Asia.317 I believe this study is the first to produce prediction 
equations for BIA for a Nepalese population. It is advantageous to be able to separate a 
person’s   body   weight   into   fat   and   lean   mass   with   a   simple   test   as   knowledge   of   body  
composition is important, both as a marker of health in children 135 and a predictor of chronic 
disease later in life. 130 An extension of BIA, bioelectrical impedance spectroscopy can also 
be used to estimate the intra- and extra-cellular compartments using tracers such as bromide 
and potassium isotopes.350 Using this method, BIA can estimate hydration in clinical settings, 
for example in dengue fever. 351,352  
In children, obesity is generally defined using BMI-for-age or weight-for-age, ideally using 
international growth charts. BMI is not a good predictor of adiposity in that it includes both 
FM and LM. Definitive confirmation of body composition is not possible without cadaveric 
examination, but it can be estimated via a number of methods. The more techniques that are 
used, the more components the body can be divided into. The three-component model also 
estimates fat-free dry tissue, while the four-component model divides this into protein and 
mineral. This would be the gold standard method for estimating body composition.  
It is rarely possible to use the most accurate methods, such as those using water or air 
displacement, for large-scale epidemiological studies as they are impractical or expensive. 
There are a number of alternatives to BIA, such as dual energy X-ray absorptiometry, 
densitometry and MRI, but few are as easy to use. Even skinfold thickness relies on a level of 
expertise to be able to get accurate results. Other simple methods such as waist circumference 
or waist:hip ratio are also advocated by some as predictors of disease.130,136,353  
 
4.8.3.1 Bioelectrical impedance 
BIA is a relatively simple, inexpensive and accurate method to assess body composition in 
healthy subjects and to assess fluid distribution and changes in both healthy subjects and 
those with disease. 308 Isotope calibration studies of BIA in children in different settings have 
produced different prediction equations. 316-319 The most likely reason for this is a difference 
in the phenotypes of different groups. Liu et at investigated the relationship between BIA and 
TBW in pre-pubertal children aged 8-10 years in five Asian countries. They noted the 
variability between the populations and recommended that ethnicity be included in all 
predictive equations. 354,355 Deurenberg et al also showed that body composition in the three 
main ethnic groups in Singapore- Chinese, Malays and Indians- varied by group. The 
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variation depended mostly on the distribution of body water and arm length relative to height. 
356  
Body composition also varies by age357 and the relative proportions of intracellular and 
extracellular water, as current does not completely penetrate the cell membrane. Extracellular 
fluid normally accounts for around 25% of body weight in the adult man and has a lower 
specific resistivity than intracellular water.356,358 This is corrected for by using age-specific 
hydration factors.  
The built-in equations of the Tanita BC-418 instrument were designed for Western European 
or North American phenotypes. This study has shown that they are inappropriate for children 
in Nepal, producing an error of approximately 0.3 kg, but up to 4.5 kg, with the instrument 
tending to underestimate LM and potentially overestimate FM. The  Tanita  system’s  equations  
are copyrighted and are not freely available for comparison.  
 
4.8.3.2 Methodological changes 
If care is taken in the selection of participants and in carrying out the procedures, a prediction 
equation with a low standard error can be produced, giving greater confidence in body 
composition estimates. We made some improvements to the standard method to improve 
feasibility and accuracy. First, we removed weight error due to clothing by standardising it. 
Second, we recorded and standardised the intake of fluids throughout the study. Third, we 
centrifuged saliva samples immediately so that we could get a further sample if necessary.  
I then examined the difference that arm position makes to lean mass estimates. The theory of 
segmental analysis divides the body into cylinders: the arms and legs, which are long and thin, 
with relatively high resistance, and the shorter, thicker trunk. Despite their low mass, the arms 
make up approximately 45% of whole body resistance.310 Even small changes to arm position 
can introduce bias. Achieving a 90° angle accurately is difficult and we found that even small 
changes to wrist position affected overall impedance values by about 15 Ohms. To enable us 
to get BIA results from smaller children, we adapted a standard technique of flexing the arms 
to 90°. This reduced the impedance by 50-60 Ohms and extended the range of the Tanita BC-
418 by approximately 5%, an important difference when dealing with undernourished or 
young children. The different arm position did result in a small difference in lean mass overall, 
but when limiting this to children who were less than 16 kg, in whom the technique would be 
most useful, the methods appear to be similar. Specific isotope calibration is required for each 
arm position.  
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To improve the feasibility of carrying out isotope calibration, I looked at the effects of a 
reduction in the number of participants needed. If time and resources permit, sampling across 
the weight range creates greater certainty in the regression line, highlighted by the narrow 
confidence intervals in our graphs. If we had sampled according to our population, in a 
normal distribution, there would have been few smaller and larger children, making the 
regression line less stable as the few data points at the extremities would have greater 
influence. I showed that a reduction in numbers did result in greater error. The difference in 
mean values was small, but the error became large at the extremities of the distribution. 
Limiting the number of individuals at the extremes of the data range could dramatically 
reduce time and resources needed to conduct the study, but - as shown in the hypothetical 
scenarios - does result in substantial error for heavier and lighter children.  
 
In summary, the isotope calibration study produced a population-specific equation for the 
children in the larger cohort. The importance of taking care of the position of the arms was 
highlighted, and if conducting the study with a different arm position, a specific calibration of 
this is required. A smaller sample reduces resource requirements substantially, but results in 
large errors at the tails of the weight distribution.  
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Chapter 5 Confounders 
 
 
Chapter 5 describes the analysis and results for the three main confounders considered in the 
study: air pollution, socioeconomic status and food security. The relationship of these 
variables with the outcomes is described in Chapter 6. The air pollution section describes the 
analysis of the gravimetric and photometric data and the creation of a 24-hour time-weighted 
average for each child. I have estimated socioeconomic status in two ways: the Multi-
dimensional Poverty Index (MPI) and an asset score based on a Principal Components 
Analysis (PCA) approach. The MPI was chosen to summarize the data and to be able to 
compare with other regions or countries. The asset score was used to compare within the 
group, and in further analyses such as in section 6.6. The food security section describes use 
of the Household Food Insecurity Access Scale, Household Dietary Diversity Score and 
Months of Adequate Household Food Provisioning tools with the creation of food security 
and dietary diversity scores.  
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5.1 Air pollution 
We sampled the respirable fraction of particle mass (PM4) for children aged 7 to 9 years in the 
microenvironments  in  which  they  spent  time.  Using  the  children’s  time-activity patterns from 
the questionnaire data, I produced a 24-hour time-weighted average (TWA) exposure. The 
results have been published in Environment International. 359 
 
5.1.1 Analysis 
Concentration was calculated using Equation Q. After reweighing the filters, the average 
pre-weight was subtracted from the average post-weight. This was then adjusted for the 
change in mass of the batch of field blanks. The sampling volume was calculated from the 
duration of sampling and the average of the start and end flow rates recorded. 
Equation Q 
Concentration  =  
(Average  post  weight  -­  Average  pre  weight)  ±  ∆  field  blank
Volume
 
 
The sampling schedule was based on the first 100 houses. There were no houses with metal 
roofs in this group, so these were not tested. Homes with metal roofs were given the average 
value for urban or rural houses. The lower limit of detection (LOD) was calculated using 3 
times the standard deviation of the weight change recorded in the field blanks (see Table 1, 
Appendix 4.2). Filters showing weight change below the limit of detection were assigned a 
value of one-half the LOD. Arithmetic and geometric means were calculated for each location 
in each season. These were then combined to produce an average for the year, by calculating 
a standardized mean, applying a weighting to each sample of 1/(n×3), where n = number of 
samples in that location in a season. The time-weighted average (TWA) was calculated using 
Equation R. The arithmetic mean concentration for each location was multiplied by the 
amount of time the child spent in it to produce the average exposure concentration over a 24 
hour period.  
 Equation R 
24-­hour  TWA=  
∑ bt1+  vt2+  ot3+  st4+  ct5+  kt6  
24
 
where: 
TWA = time weighted average; b = bedroom arithmetic mean; v = verandah arithmetic mean; 
o = outdoor arithmetic mean; s = school arithmetic mean; c = kitchen during cooking, 
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arithmetic mean; k = kitchen outside cooking hours, arithmetic mean; t = time spent in each 
location 
The average concentration was given on the DustTrak readout. A correction factor was 
required   as   the   DustTrak   is   calibrated   to   “Arizona   road   dust”,   and   would   differ   between  
aerosols and other factors such as relative humidity. The values recorded were converted to 
μg/m3 and a correction factor was applied, obtained from DustTrak-Apex side-by-side 
calibration: 0.43 for rural and 0.51 for urban samples (see Table 2, Appendix 4.2).  
 
5.1.2 Results 
5.1.2.1 Exposure data 
In total, 291 microenvironment measurements were collected from 55 households (6.6% of 
the cohort), 8 representative outdoor locations, and 8 schools. Fifty-eight were discarded: 14 
repeated weighing produced differences greater than 0.1 mg, 13 had damage to the filter, in 
15 cases there was equipment failure or inaccurate technique and in 16 cases there were 
mistakes in timing, labeling or location. Fifty-nine samples were below the limit of detection. 
In total, 110 days worth of air pollution data were gathered from across the various 
microenvironments, with a cumulative sampling duration of 2649 hours. Table 20 shows the 
average duration and total time at each location.  
Table 21 shows the concentration level by location in each season, and Table 22 average 
concentrations at each location over the year. In the bedroom, school and outdoors, 
concentration levels were highest in winter, followed by spring/autumn, and lowest in the 
monsoon season. The kitchen samples were lower in spring/autumn, possibly because more 
cooking is done outdoors and ventilation improves. In cold periods fires are useful for heat. 
Verandah sample concentrations were lowest in the monsoon season. The microenvironment 
measurements showed seasonal variation, with winter generally having higher concentration 
levels than spring/autumn, which were higher in turn than the monsoon season. 
Seven DustTrak samples were taken in kitchens to look at variation in respirable fraction 
concentration over time. The two non-biomass samples had adjusted average (peak) 
concentrations of 53 µg/m3 (425 µg/m3) and 166 µg/m3 (1080 µg/m3). The biomass samples 
tended to have both average and peak concentrations approximately ten times higher. Both 
the dung and wood samples produced similar concentrations. The highest peak concentration 
was just below 60 000 µg/m3. Both dung samples produced similar concentrations, but the 
wood samples varied from an average of 167 µg/m3 to 831 µg/m3. Depending on kitchen 
structure, levels could rapidly come down to the non-cooking level, even in biomass-using 
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houses. A summary of the DustTrak data is shown in Table 3, Appendix 4.2, and time-
concentration graphs from three kitchens are shown in Figure 28. 
Table 23 shows the average exposure levels for children at each location, calculated by 
extrapolating the particulates in the samples from 55 representative households to the overall 
sample. The 24-hour TWA was modeled for 429 boys and 405 girls. The mean 24-hour TWA 
was 168 µg/m3  (SD= 25.9), with no difference in exposure level between the sexes. The 
distribution of 24-hour TWA calculated for all children is shown in Figure 29 and the average 
contribution of each location to the total concentration in Table 23. The bedroom/living room 
made the largest contribution because of the large amount of time spent there. The verandah, 
bedroom and outdoors all made similar contributions. The kitchen contribution was low, due 
to the short amount of time, although a small increase in time spent in the kitchen made a big 
difference  to  a  child’s  exposure.   
 
5.1.2.2 Time activity 
Questionnaire data were collected on 851 children out of a possible 1053. Three children had 
died and the data for 14 children were removed because they lived outside the region where 
we did not have air pollution measurements. Time activity data are summarized in Table 23. 
Children spent most of their time indoors, amounting to about half the day on average. The 
amount of time at each location was similar for boys and girls. Two per cent of children did 
not go to school. 
 
5.1.2.3 Fuel use 
Households used a variety of cooking fuels (Table 24). A different fuel was often used at the 
start of cooking or to light the fire. For example, straw and kerosene were commonly used at 
the start of cooking, but not as the main cooking fuel. About one-third of households used 
wood, one-third animal dung, and one-third gas, as their main fuels. It was common for 
families to alternate between fuels, usually wood and dung. Animal dung cakes normally 
contained a small amount of wood or plant products to give them structure. The use of gas as 
a main fuel was more common in urban than rural settings (60.8% compared with 15.8%). 
The opposite was true for wood (27.2% compared with 41.7%) and dung (9.4% and 36.2%). 
Stoves were usually simple open fire designs of mud and clay with no chimney or hood. 
Cooking was done mainly indoors in the kitchen, and 786 (94%) households cooked indoors 
every day of the year. 
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5.1.2.4 House characteristics 
Forty-one percent of the sample lived in urban households. Houses had an average 3.6 rooms 
(range 1-15). Ninety-four households (11%) did not have a separate kitchen and 81 (10%) had 
only one room. Most house walls were made of cement and brick (63%), with the remainder 
mostly mud and wattle (branches or sticks woven into the wall to add structure) (34%). Roofs 
were made from cement (43%), tiles (54%), grass or straw (2%), or metal sheet (1%). Half of 
floors were cement or brick and the other half dirt.  
 
Table 20: Sampling times and duration 
Location Number of 
samples 
Average start 
time (range) 
Average end 
time (range) 
Average 
duration 
(minutes) 
Total 
sampling time 
(hours) 
Bedroom 96 15:49 (14:30 
to 17:38) 
09:35 (07:52 
to 15:25) 
1064 (854 to 
1397) 
1720 
Verandah 31 16:53 (15:43 
to 17:05) 
19:53 (18:42 
to 20:05) 
180 (179 to 
180) 
96 
Kitchen 
cooking 
31 07:48 (07:00 
to 08:50) 
10:38 (09:20 
to 11:59) 
163 (60 to 202) 85 
Kitchen no 
cooking 
29 11:43 (09:41 
to 15:04) 
14:18 (13:17 
to 18:04) 
184 (180 to 
229) 
92 
Kitchen 12 
hour samples 
7 07:24 (07:00 
to 08:00) 
19:24 (19:00 
to 20:00) 
720 (720 to 
720) 
96 
School 22 09:26 (06:55 
to 11:57) 
13:55 (11:15 
to 16:30) 
275 (120 to 
330) 
101 
Outdoors 38 07:11 (05:07 
to 10:30) 
19:02 (17:07 
to 20:24) 
725 (678 to 
796) 
459 
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Table 21: Respirable particle mass concentration by season in different locations 
 
Location   Winter  Spring & Autumn  Monsoon  
  Number of 
samples 
Arithmetic 
mean 
concentration 
(SD) (µg/m3) 
Geometric 
mean 
concentration 
(SD) (µg/m3) 
Number 
of 
samples 
Arithmetic 
mean 
concentration 
(SD) (µg/m3) 
Geometric 
mean 
concentration 
(SD) (µg/m3) 
Number of 
samples 
Arithmetic 
mean 
concentration 
(SD) (µg/m3) 
Geometric 
mean 
concentration 
(SD) (µg/m3) 
Bedroom Urban 
cement roof 
16 342 (185) 303 (1.64) 10 113 
(96.9) 
79.6 
(2.60) 
4 60.3 
(35.4) 
49.7 
(2.24) 
 Urban tiled 
roof 
4 384 (234) 311 
(2.33) 
4 112 
(50.8) 
102 
(1.73) 
4 204 
(182) 
  123 
(4.05) 
 Urban straw 
roof 
1 256 256 2 62.9 
(67.4) 
41.1 
(4.06) 
1 38.5 
 
38.5 
 Rural cement 
roof 
8 322 (109) 307 
(1.38) 
7 153 
(95.3) 
115 
(2.69) 
4 115 
(68.5) 
85.1 
(2.97) 
 Rural tiled 
roof 
16 398 
(216) 
352 
(1.65) 
4 173 
(201) 
111 
(2.78) 
2 66.4 
(71.3) 
43.1 
(4.09) 
 Rural straw 
roof 
2 217 
(1.80) 
217 
(1.01) 
4 374 
(304) 
285 
(2.39) 
3 160 
(249) 
48.8 
(6.83) 
           
Verandah Urban 8 410 
(221) 
347 
(1.98) 
2 850 
(460) 
786 
(1.77) 
5 58.0 
(28.2) 
50.3 
(1.95) 
 Rural 8 771 
(1060) 
455 
(2.72) 
2 469 
176 
452 
(1.47) 
6 95.0 
(63.2) 
78.5 
(1.99) 
           
School Urban 5 167 
(86.8) 
146 
(1.85) 
4 115 
(74.3) 
98.4 
(1.89) 
5 82.8 
(45.1) 
75.8 
(1.54) 
 Rural 2 161 
(143) 
126 
(2.83) 
4 63.1 
(8.93) 
62.6 
(1.16) 
2 71.8 
(3.30) 
71.8 
(1.05) 
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Outdoor Urban 7 305 
(216) 
259 
(1.79) 
7 105 
(67.1) 
85.0 
(2.15) 
5 24.3 
(0.32) 
24.4 
(1.01) 
 Rural 5 369 
(207) 
319 
(1.90) 
8 112 
(66.5) 
99.6 
(1.65) 
6 67.6 
(27.6) 
61.6 
(1.66) 
           
Kitchen 
cooking 
Biomass  7 1550 
(1050) 
1311 
(1.84) 
5 433 
 (368) 
318 
(2.46) 
9 933 
(499) 
835 
(1.63) 
Non-biomass 2 204 
(170) 
165 
(2.60) 
5 97.8 
(2.33) 
97.8 
(1.02) 
3 177 
(147) 
143 
(2.15) 
           
 
 
Dung 4 1410 (757) 1270 (1.70) 2 557 (649) 315 (5.23) 4 1140 (686) 982 
(1.89) 
 Wood 2 2270 (1740) 1910 (2.36) 2 244 (47.7) 242 (1.22) 4 775 (304) 730 (1.49) 
Kitchen no 
cooking 
Biomass 10 250 
(128) 
216 
(1.85) 
4 707 
(1220) 
216 
(5.17) 
7 96.0 
(2.63) 
95.9 
(1.03) 
Non-biomass 4 123 
(45.7) 
117 
(1.45) 
4 303 
(416) 
168 
(3.12) 
   
           
 Dung 4 260 (68.1) 251 (1.36) 3 95.2 
(2.92) 
95.2 
(1.03) 
2 92.9 (3.44) 92.8 (1.04) 
 Wood 6 234 (168) 183 (2.30) 1 2550 2550 4 97.1 (1.05) 97.1 (1.01) 
           
Total  106   76   66   
NB: Biomass samples are shown together and separated into those that used wood and dung only (the others used a mixture of the two) 
SD = standard deviation.  
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Table 22: Weighted average respirable particle mass over the year 
Location  Number of samples Standardized mean (µg/m3) (95% CI)* 
Bedroom Urban cement roof 30 116 (88, 144) 
 Urban tiled roof 12 233 (133, 333) 
 Urban straw roof 4 134 (109, 159) 
 Rural cement roof 19 175 (134, 217) 
 Rural tiled roof 22 125 (51, 199) 
 Rural straw roof 9 236 (120, 351) 
 Combined roof urban 47 166 (117, 215) 
 Combined roof rural 50 192 (135, 249) 
    
Verandah Urban 15 592 (281, 902) 
 Rural 16 445 (264, 627) 
    
School Urban 14 121 (82, 160) 
 Rural 8 123 (38, 209) 
    
Outdoors Urban 19 131 (81, 181) 
 Rural 19 202 (128, 276) 
    
Kitchen cooking Biomass  21 908 (614, 1203) 
Non-biomass 10 175 (63, 286) 
   
Kitchen no 
cooking 
Biomass 21 438 (-138, 1010) 
Non-biomass 8 213 (-16, 442) 
*Calculated by applying a weighting to each sample of 1/(n×3), where n = number of samples in that location in a season. 
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Table 23: Time activity and exposure level to respirable particulates by location, for girls and boys 
Location  Time activity Exposure*  
  Mean 
(hours) 
Standard 
deviation 
Minimum 
(hours) 
Maximum 
(hours) 
Mean 
(µg/m3) 
Standard 
deviation 
Minimum 
(µg/m3) 
Maximum 
(µg/m3) 
Proportion of total 
contribution (%) 
Bedroom/living 
room 
Boys 12.2 1.65 7.5 17 1750 530 936 3500 44 
Girls 12.3 1.77 8 18 1800 506 998 3730 44 
Verandah Boys 1.24 1.10 0 5.5 600 540 0 3250 15 
Girls 1.33 1.23 0 5.5 640 603 0 3250 16 
Kitchen during 
cooking 
Boys 0.04 0.23 0 2 20.2 147 0 1820 1 
Girls 0.03 0.19 0 2 19.7 136 0 1820 1 
Kitchen when 
there is no 
cooking 
Boys 0.21 0.53 0 4 66.7 180 0 1310 2 
Girls 0.21 0.49 0 3 71.0 170 0 875 2 
Outdoors Boys 5.07 1.64 1 12.5 915 369 196 2420 23 
Girls 4.83 1.56 0 12 884 355 196 2420 22 
School Boys 5.29 1.01 0 10 647 123 0 1210 16 
Girls 5.26 1.04 0 11 644 128 0 1330 16 
Total 
concentration in 
24 hours 
Boys     4000 607 2850 6120  
Girls     4060 636 2830 6440  
24 hour time-
weighted average 
Boys     167 25.3 119 255  
Girls     169 26.5 118 268  
* Exposure levels were calculated by multiplying average concentrations in each location by the time each child was in it.
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Table 24: Fuel usage. The number of households using a fuel to light the fire and during 
cooking  
 
Fuel type Fuel used to light the 
fire* 
Fuel used 
continuously* 
Main fuel used by a 
household (%) 
Wood 7 606 309 (37.1) 
Dung 0 392 231 (27.7) 
Straw 138 10 6 (0.7) 
Charcoal 2 3 4 (0.5) 
Other plant products 14 34 21 (2.5) 
Kerosene 230 6 3 (0.4) 
Gas 241 324 251 (30.0) 
Biogas 7 8 8 (1.0) 
Electricity 3 4 1 (0.1) 
Plastic 10 0 0 
Paper 4 NA NA 
Matches 9 NA NA 
* Multiple fuels may be used by the household. If more than one fuel was used, the main fuel 
used for cooking was also recorded.   
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Figure 28: 12-hour kitchen samples taken using the DustTrak II.  
The graph shows the concentration levels in a kitchen using non-biomass fuel, wood or dung 
as the main cooking fuel.  
 
 
 
 
Figure 29: 24-hour time-weighted average histogram, for all children
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5.1.3 Discussion 
5.1.3.1 Exposure data 
This  study  is  one  of  few  to  have  examined  children’s  exposure  levels  with  measurements  of  
air pollution concentrations in low resource rural settings, and adds valuable information on 
their time activity. Most estimates of household air pollution come from binary or categorical 
data on exposure to biomass fuels or the type of fuel used. This type of data is limited in its 
ability to differentiate exposure among members of the family. We found high exposure 
levels with substantial variability from season to season and by fuel type. The mean 24-hour 
TWA of 168  µg/m3, and mean exposure levels in all locations, were very high compared with 
the World Health Organisation recommendation of a maximum 24-hour mean of 25 μg/m3 for 
PM2.5 360 and the United States Environmental Protection   Agency   ‘National   Ambient   Air  
Quality  Standards’  recommendation  of  35  µg/m3. 361 The levels were also much higher than 
the national ambient air quality standards for Nepal recommendation of 120 µg/m3 PM10. 362  
While exposure levels were high, as shown by other research using comparable methods of 
exposure estimation, they were not unusual. Balakrishnan et al found higher 24-hour TWA 
mean  respirable  fraction  levels  of  227  μg/m3 for  boys  and  237  μg/m3 for girls aged 6 to 15 in 
solid fuel using households in southern India. 363 In studies of other particle fractions, 
Dasgupta et al found mean levels of 156-196 µg/m3 of PM10 in children in Bangladesh 364 and 
Dionisio et al found levels of 131-157 µg/m3 of PM2.5 exposure in children from the Gambia. 
365 Baumgartner et al found mean levels of 46-70 µg/m3 of PM2.5 in China, in which children 
carried the monitor with them where possible. 366 These samples were taken only in the 
summer- in adults exposure was approximately double in the winter. If this were to be 
maintained for children, these results would be comparable to ours. A similar study of 
microenvironment exposure of total suspended particles in the Himalaya region of northern 
India  found  similar  levels.  Saksena  et  al  showed  a  geometric  mean  level  of  4500  μg/m3 in the 
kitchen  during  cooking,  640  μg/m3 in the kitchen during non-cooking,  470  μg/m3 in the living 
room  and  190  μg/m3 outdoors during non-cooking times. 367 
There is limited information on indoor air pollution levels in Nepal. Kurmi et al found much 
higher 24-hour PM2.5 concentrations of 455 μg/m3 (95% CI 426, 485 μg/m3) in biomass-using 
homes, and 101 μg/m3 (95% CI 96,106 μg/m3) in gas-using homes in Nepal. 52 The study was 
carried out in the Hill region where the climate is colder and ventilation is minimal - our 
study area had high temperatures in summer and well ventilated rooms - and households used 
hard wood rather than the mixed biomass in our sample. 368 Our DustTrak:Apex calibration 
factors (Table 2, Appendix 4.2) were similar to those produced by Kurmi et al. 368 
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Kurmi et al showed an approximately ten-fold higher concentration in rural households, 
attributed to biomass fuel burning, whereas in our study the levels were similar. 368 These 
differences could be due to housing construction materials used in different climatic 
conditions and to the types of fuel used. In a study from Malawi, Fullerton et al also showed 
little difference between urban and rural samples (a significant difference was, however, seen 
when looking at the total inhalable dust levels). 369  
Most indoor exposure arises from burning of biomass fuels, as indicated by the very high 
levels during cooking. The high peak levels recorded during cooking are also in keeping with 
other studies that have shown very high air pollution levels during cooking in the South Asian 
context. 370 Children were only in the kitchen for short periods but, as the extended 12-hour 
photometric sampling showed, they were exposed to extremely high peak levels with a great 
deal of variability from minute to minute during cooking: particulate concentrations at times 
reached almost 60 000 µg/m3.  
We used microenvironment sampling, which I feel is superior to sentinel sampling in a few 
specific locations. We simplified the house to the kitchen, verandah and bedroom (or main 
room in the house). This does not capture more complex houses or the brief amount of time in 
other locations such as the bathroom or corridors. We assumed that the bedroom had the same 
exposure level as any other room except the kitchen. I chose to focus on the bedroom because, 
as the time activity data show, children spent most of their time in the bedroom and it 
accounted for two-fifths of total exposure. In most Nepalese households, rooms used for 
sleeping are also used for sitting in to do homework or watch television. Contrary to our 
initial assumption, there did not seem to be a large difference between different roof types. 
Percentage contribution was somewhat different to that of Balakrishnan et al, who showed 
about two-thirds of the exposure occurring in the living area. Their kitchen contribution was a 
little higher at 7-8% and outdoors was similar. This may be due to a difference in how the 
time activity was classified, in that we also included the verandah as a separate 
microenvironment. Together, the bedroom/living room and verandah amount to 60% of 
exposure in our study. 363 School, verandah and outdoor locations contributed similar 
proportions. To our surprise, concentration levels on the verandah were high in winter, spring 
and autumn seasons. The high exposure levels were likely to be from fires inside the house, 
outdoor fires and from other houses. The samples were taken in the early evening, which is 
the main cooking time. Dust may also be displaced from outdoors where levels were also 
fairly high, particularly in winter. Some of it may have been from fires, but most was 
probably displaced from fields and unsealed roads. Exhaust emissions would have made up a 
small proportion as mechanized traffic was relatively uncommon. Household air pollution is 
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thought to contribute to about 16% of ambient air pollution worldwide. 32 To a certain extent 
any source of particle mass is detrimental to health,371 and we are unable to quantify the 
source of particle mass without further work. The effects of air pollution on the respiratory 
system also depend on a number of individual factors aside from the level of exposure, such 
as the age of the person, respiratory rate and exercise level (particularly for outdoor air 
pollution) and predisposing disease. Marked seasonal variation was seen in non-kitchen 
samples, with winter concentrations being higher than summer, which were in turn higher 
than in the monsoon. As would be expected, rain and moisture in the air reduce airborne 
particle mass in the monsoon season. This pattern was described by Saksena et al 367 and 
Baumgartner et al, who showed an approximate doubling of the concentration in winter 
compared to summer.366 The kitchen samples were fewer and did not show an obvious pattern. 
Women are known to experience higher exposure levels due to their role in cooking and 
female children have been thought to spend more time in the kitchen helping with cooking 
364,367,372,373. This view was not supported by our data. We did not see a difference between 
boys and girls in time activity or exposure levels. It may be that the children in our study were 
a little too young to be helping with the cooking. The experience of our staff was that boys 
are more exposed when they in their first two years, while girls start to help their mothers 
with cooking at around 10-12 years and will be more exposed during their early teens.  
 
5.1.3.1 Time activity 
While pollution is likely to emanate from the kitchen where concentrations are high, its 
contribution to overall exposure was low because children spent little time there. This 
highlights  the  importance  of  time  activity  data.  Ezzati  and  Kammen  recommend  using  “time  
budgets”   for   this.373 We did not think self-completed diaries would be possible as our 
participants were children and levels of literacy were potentially low. Our questionnaire 
approach may have been prone to recall bias, but it is unclear in which direction it might 
occur. It may also be that the activity of children changes from one season to another, but we 
did not think that the recall method would be able to distinguish this accurately enough. Other 
methods include direct observation, often considered the gold standard, and the use of Global 
Positioning System (GPS) monitoring. Neither of these methods was considered appropriate. 
Apart from being logistically infeasible, following a child is intrusive and could affect her 
behaviour, and GPS was not accurate enough to distinguish which room she was in.  
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5.1.3.2 Fuel usage 
The data on fuel usage emphasize the importance of biomass fuels in the region. Of those 
commonly in use, animal dung is regarded as the least efficient and most polluting and is the 
bottom  rung  of  the  WHO  “energy  ladder”.  196 Nationally, about two thirds of households use 
wood as their source of fuel, while a fifth and a tenth use gas and dung, respectively. In 
Dhanusha the proportions are different, with 43% using wood, 44% using dung and 10% 
using gas. 40 The results from our study were quite different from national data, but were 
comparable with data from Dhanusha. The main difference was the approximately three times 
higher proportion of households using gas. 40 This may be due in part to our semi-urban 
sample proportion, but the figures are an oversimplification as most households used a 
mixture of fuels. Some used a more combustible and often more expensive fuel to start 
cooking, and then continued with a cheaper fuel. More expensive fuels like gas may be used 
for short cooking occasions like making tea and snacks, while biomass fuels are used for 
cooking main meals. Many households used two fuels together or alternately, particularly 
dung combined with firewood or agricultural residues. This is related to supply issues such as 
availability and demand issues such as family income. In a study of the association between 
biomass usage and respiratory infection in Nepal, Bates et al found an increased odds of 
infection related to not only biomass fuels, but also kerosene and gas usage, in comparison 
with electricity. This has important implications for our entire sample 53.  
 
5.1.3.3 House characteristics 
The make-up of the house is important. The location of the kitchen and ventilation can change 
air pollution levels greatly. Compared to the national figures in the census report, our data are 
very different for the percentage of houses with mud brick or stone walls (2.9% versus 62.8% 
nationally), but similar to the Dhanusha figure of 5%. The figure of 62.8% for cement and 
brick walls was higher in our sample than the national figure (28.7%) or the Dhanusha figure 
(30.5%). For roof type, the percentage with cement roofs was also higher at 43.2%, than the 
national (22.5%) or regional (19.9%) figures. 40 Cement roofs and brick walls, combined with 
the proportion using gas, point to a more affluent group in our sample. These tend to be the 
people who live in the town of Janakpur, but with increasing remittances from family 
members who migrate overseas, brick and cement houses are becoming more common in 
rural areas too. While those living in cement and brick houses are more likely to have a 
cleaner source of fuel, ventilation tends to be reduced, leading to greater containment of any 
smoke produced.  
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5.1.3.4 Limitations 
Although a large study of particle mass exposure in a low resource setting in children, our 
study has limitations. We assumed that the samples were representative of the true average 
concentration level. Sample variability was wide within one location and from one season to 
another. In a study with limited resources and time, we cannot be certain that we captured all 
the variability. Gravimetric sampling over short periods in microenvironments where 
particulate levels are low is problematic. Filter weight-gains will often be small and results 
below the limit of detection are of questionable utility. 374 While still advocating the use of 
gravimetric sampling in general, for future sampling I would also recommend greater use of 
photometric devices where concentration levels are thought to be low or for short samples. 
Given the exposure levels found from the other samples, I feel that the non-detect values are 
likely to be lower, leading to an under-estimate of mean concentration. I would, however, 
reinforce the need for calibration with gravimetric sampling when photometric methods are 
used.  
Another limitation was that we were unable to quantify the amount of time a child was next to 
a fire, and how far away from the fire she was during cooking. The photometric data suggest 
that peak levels can be very high. Barnes et al compared different methods of locating 
individuals and found that, while they were similar in terms of the time spent in a room, they 
differed in distance from a fire. 375 More detailed descriptions of housing construction 
materials and fuel use, combined with measurements and recordings, would be needed to take 
this further.  
 
In summary, the study found high concentrations of air pollution in all locations, with wide 
variation from season to season. The highest concentration was in the kitchen but the greatest 
contribution  to  a  child’s  exposure  was  the  bedroom.   
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5.2 Socioeconomic status 
5.2.1 Analysis 
5.2.1.1 Multi-dimensional Poverty Index 
The MPI is a measure of poverty reported by the United Nations Development Programme. 
Developed by the Oxford Poverty and Human Development Initiative, it aggregates 
individual level data from surveys such as the Demographic and Health Surveys and can be 
applied  at  country  and  regional  level.  The  score  is  a  combination  of  the  “incidence  of  poverty”  
(more strictly, this is the prevalence as it is the proportion of people who are deprived in at 
least one-third of the weighted indicators) and the     “average   intensity   of   poverty”   (the  
average number of deprivations people experience at the same time). The MPI is a composite 
of ten indicators, grouped into three domains, as shown in Figure 30: Education- years of 
schooling and school attendance; Health- child mortality and nutrition; and Living standards- 
cooking fuel, water, sanitation, electricity, floor and assets.376 377  
The questionnaire was designed in order to calculate the MPI, with the appropriate questions 
included (Table 25). I followed the instructions documented by Santos and Alkire for 
calculating the MPI.378  The questions were coded using Stata software to create the indicator 
variables. These were then weighted accordingly with the health and nutrition variables given 
a score of 1.667, and the standard of living variables a score of 0.556 if deprived. The 
proportion who were deprived was calculated and each dimension stratified into urban and 
rural and by allocation group. The variables were then added together to give a score for each 
dimension and a total MPI intensity score. If data were missing, as was the case for ten 
children in whom we did not have anthropometry results, we assumed they were not 
malnourished. The multidimensional headcount ratio, intensity of poverty and MPI score 
were calculated according to Equation S, Equation T and Equation U respectively.  
 
Equation S 
Multidimensional  Headcount  ratio  =  
Number  of  people  in  households  that  are  MPI  poor
Total  number  of  people
 
Equation T 
Intensity  of  poverty  =  
∑ (In  MPI  poor  households,  Deprivation  score  ×  Number  of  people  in  household)
Number  of  people  in  households  that  are  MPI  poor
 
Equation U 
MPI = multidimensional headcount ratio × average intensity across the poor 
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Figure 30: MPI indicators and dimensions 376 
 
 
5.2.1.2 Asset score 
The asset score was constructed from the questionnaire data using the methods described by 
Vyas and Kumaranayake.379 Variables for consideration in the PCA are shown in Table 26. 
To choose variables with a range of values over the population, they were included if the 
mean prevalence was >0.10 and <0.90. This left radio, TV, telephone, fridge, bicycle, 
motorcycle, biomass fuel, toilet, wall type and floor. Including these variables produced a 
bimodal kernel density plot. After removal of floor and toilet, the scree plot and kernel 
density graphs in Figure 31 were produced. This graph shows little truncation and has a fairly 
normal distribution. The first component was retained for the final PCA score. The second 
component also had an eigenvalue greater than one, but by convention the first factor is 
usually used. 379,380  
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Table 25: MPI dimensions and sources of information 381 
Dimension Indicators Definition of deprivation  Source of information  
Education Years of 
schooling 
Deprived if no household 
member has completed five 
years of schooling. 
Answer  “no”  to: 
Has any member of the household 
completed 5 years of schooling?  
School 
attendance 
Deprived if any school-
aged child is not attending 
school in years 1-8. 
Answer  “no”  to: 
Are all school-age children currently 
enrolled in school (Years 4-16)? 
Health Child 
mortality 
Deprived if any child in the 
family have died. 
Answer  “yes”  to: 
Have  any  of  the  child’s  siblings  died? 
OR 
Answer  “dead”  to  State of the child. 
Nutrition Deprived if any adult or 
child for whom there is 
nutritional information is 
malnourished.  
WHO BMI-for-age >2 SD below median 
Standard of 
living 
Electricity Deprived if household has 
no electricity 
Answer  “no”  to  electricity: 
What things do you have? 
Drinking 
water 
Deprived if household does 
not have access to clean 
drinking water or clean 
water is >30 minutes walk 
from home. 
Answer  “public  well”,  “traditional  well”,  
“river,  stream,  canal,  pond”  to: 
What is the main drinking water source for 
your household? 
OR 
Answer  “>30  minutes”  to: 
How far do you have to walk to get 
drinking water? 
Sanitation Deprived if household does 
not have an improved toilet 
or if toilet is shared. 
Answer  “yes”  to  anything  except  a  “flush  
toilet”:  What kind of toilet do your family 
members use? 
OR 
Answer  “no”  to:  Do you share your toilet 
with other households?                
Floor Deprived if household has 
dirt, sand or dung floor. 
Answer  “dirt”,  “sand”  or  “dung”  to: 
What is the floor mainly made of? 
Cooking 
fuel 
Deprived if household 
cooks with wood, charcoal 
or dung. 
Answer  “wood”,  “charcoal”,  “dung”,  
“straw”,  “other  plant  products”  or  “plastic”  
as a main fuel to: 
Which fuels do you usually use for 
cooking?    
Asset 
ownership 
Deprived if household does 
not own more than one of: 
radio, TV, telephone, 
fridge, bike or motorbike; 
and do not own a car or 
tractor.  
Excluding  “electricity”,  answer  “yes”  to  
less than two items and does not answer 
“yes”  to  “Bus/Truck/jeep/car/tempo”  or  
“tractor” to: 
What things do you have? 
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Table 26: Potential variables for inclusion in Principal Components Analysis 
 Variable Comment Mean (SD) Keep or Drop* 
Assets Electricity 1 if present, 0 if not 0.98 (0.15) Drop 
 Radio 0.47 (0.50) Keep 
 TV 0.77 (0.42) Keep 
 Telephone 0.11 (0.31) Keep 
 Mobile phone 0.93 (0.25) Drop 
 Fridge 0.12 (0.33) Keep 
 Bicycle 0.67 (0.47) Keep 
 Rickshaw 0.01 (0.08) Drop 
 Motorcycle 0.25 (0.43) Keep 
 Tractor 0.02 (0.14) Drop 
 Other asset 0.02 (0.12) Drop 
Fuel Biomass Use biomass as their main fuel 0.54 (0.50) Keep 
Water  1  if  tap,  own/neighbour’s  well,  deep  bore  
hole, hand-pump 
0 if they use a public well, traditional 
well, river, pond 
0.98 (0.14) Drop 
Toilet  1 if flush or pan toilet.  
0 if pit, open area or other 
0.65 (0.48) Keep 
House  Walls 1 if brick. 0 if stones or plant materials or 
wood 
0.66 (0.47) Keep 
Roof 1 if cement or tiles. 0 if metal or grass 0.97 (0.17) Drop 
Floor 1 if cement or brick. 0 if dirt or sand 0.50 (0.50) Keep 
 
 
Figure 31: Scree plot and kernel density graph from final factors chosen for asset score  
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5.2.2 Results 
5.2.2.1 MPI 
Table 27 shows the number of people who were deprived in each indicator and dimension 
with the results shown graphically in Figure 32. Table 28 stratifies the dimensions by place of 
residence and allocation group. The majority of households were considered poor for 
sanitation and cooking fuels used, while for school attendance, electricity and water the 
percentages were very low. 308 households (36.2%) had a MPI score of >3.3 and were 
regarded as being poor. Of these, 100 (11.8%) were considered to have severe poverty with a 
score >5. A further 184 (21.6%) were vulnerable to poverty.  
Figure 33 shows the distribution of MPI deprivation scores in the sample, with the 
distributions for each dimension shown in Appendix 5.1. The mean score used was 2.59 (SD 
1.60)  and  median  score  was  2.22  (IQR  1.11,  3.33).  The  mean  score  is  the  “average  intensity”  
for the whole sample when conducting the MPI, but as the data were skewed (and, strictly 
speaking, MPI is an ordered categorical variable), I have reported the median as well. 
Stratification by allocation group gave the same median deprivation score of 2.22 (IQR 1.11, 
3.33) in both groups.  
There were 5389 people in 851 households and the number of people in households that were 
MPI poor was 1980. This gave a Multidimensional Headcount ratio of 0.367. Intensity of 
poverty was 0.422 and MPI for the sample was 0.155. 
 
5.2.2.2 Asset score  
An asset score with a mean of 0 and a standard deviation of 1 was produced and divided into 
quintiles for use in further analyses. A comparison of the asset and MPI scores can be seen in 
Figure 34. This shows an inverse association and a correlation coefficient of 0.48. The dotted 
horizontal line represents the cut-off above which a household is considered MPI poor.   
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Table 27: Number and percentage of the sample who were considered deprived in each 
indicator  
Dimension Indicator Number of people 
who were deprived 
(Total number = 851) 
Percentage (%) 
 
Education Years of schooling 140 16.5 
School attendance 36 4.2 
Health Child mortality 172 20.2 
Nutrition 295 34.7 
Standard of living Electricity 20 2.4 
Drinking water 19 2.2 
Sanitation 840 98.7 
Floor 423 49.7 
Cooking fuel 643 75.6 
Asset ownership 95 11.2 
 
 
 
 
Table 28: Number and percentage of the sample considered deprived in each dimension  
 Whole sample Urban Rural Control Intervention 
Dimension* Number who 
are deprived 
(%) 
Number who 
are deprived 
(%) 
Number who 
are deprived 
(%) 
Number who 
are deprived 
(%) 
Number who 
are deprived 
(%) 
Education 157 (18.4) 56 (16.0) 101 (20.1) 74 (17.3) 83 (19.6) 
Health 406 (47.7) 158 (45.3) 248 (49.4) 210 (49.2) 196 (46.2) 
Standard of 
living 
841 (98.8) 340 (97.4) 501 (99.8) 425 (99.5) 416 (98.1) 
Total number 851 (100.0) 349 (100.0) 502 (100.0) 427 (100.0) 424 (100.0) 
*A household may be deprived in more than one dimension. 
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Figure 32: Distribution of proportion of deprived households in MPI indicators 
 
 
 
 
 
Figure 33: MPI deprivation score distribution across the sample 
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Figure 34: Scatterplot with line of best fit (95% confidence intervals) of asset score and 
MPI deprivation scores. Horizontal dotted line represents MPI score of 3.33. 
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5.2.3 Discussion 
Lower socioeconomic status is associated with poorer health outcomes in childhood,382 
decreased birth weight124,383 and child mortality.384,385 Socioeconomic status in early life is 
also associated with shorter adult height,27 lower educational achievement and reduced 
income,386 all of which help to perpetuate the cycle of intergenerational malnutrition and 
poverty. 5 387 People in less well-off groups tend to have a greater number of risk factors for 
illness combined with reduced access to ameliorative care.  
Socioeconomic status is a complex concept that incorporates social status (including social 
position, power and capital) as well as wealth.387 Poverty can be measured in a number of 
ways using either single or multiple indicators combined. As described by Howe et al, the 
approaches to measuring socioeconomic status fall into the following categories: asset based, 
consumption, income/wealth, education, occupation and subjective measures for which 
people rank themselves.380 Each has its strengths and limitations and none is perfect. Asset 
based indices are commonly used, for example in demographic and health surveys. A 
systematic review was performed to compare wealth indices. Twenty-two of the 33 datasets 
included showed weak agreement. Those with a higher number of participants and broader 
range of indicators tended to have better agreement, as did the datasets from richer countries. 
388 I did not think income would provide an accurate measure of socioeconomic status. Many 
people in the study region are subsistence farmers who do not have a regular income, but may 
have land and durable assets. We did not have the necessary information to be able to 
construct a measure of consumption and there is some evidence to say that asset scores 
perform as well as consumption indicators.389  
 
5.2.3.1 Multidimensional Poverty Index 
The MPI was chosen as a summary as it is an absolute score that can be used to compare our 
sample with other populations and can be broken down to show in which components people 
are poor. According to the most recent United Nations Development Programme report, 
Nepal has an MPI score of 0.217. This corresponds with an incidence of poverty of 44% for 
the year 2011, and with 25% living under $1.25 per day.390 Parts of Nepal have the highest 
MPI scores in the sub-continent: the Central Terai area that includes Dhanusha has an MPI of 
0.233. This is made up of an incidence of poverty of 46.2% and average intensity of 50.4%.376  
As with any summary tool, the MPI has limitations. For example, in our sample the majority 
of households had electricity and most children went to school. This does not express the 
reality  of  life  in  the  winter  as  “load  shedding”  leaves  a  house  without  electricity  for  up  to  18  
hours a day and the quality of schooling varies greatly. While this is a criticism of the MPI, 
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tools designed for comparison are bound to be simplifications of reality. There is inherently a 
trade-off between the complexity of a tool and its ease of use. The MPI can also be criticized 
for what it does not include; for example, security or empowerment indicators.  
There is also debate over whether a single  composite  score  can  ever  truly  represent  “poverty”.  
Ravallion argues that a composite score loses the valuable information of the individual 
indices and may be misleading. He goes further to question the validity of a scoring system in 
which child mortality  can  be  equated  with  the  “combined  deprivation  of  having  a dirt floor, 
cooking  with  wood,  and  not  having  a   radio,  TV,   telephone,  bike  or  car”.391 Intuitively, this 
would seem wrong, and I would give child mortality a higher weighting. The mortality 
indicator is a little different though from the others (possibly with the exception of asset 
ownership) in that it is an outcome in itself. The other indicators could be argued to be 
mediators or surrogate markers of a construct. For example, poor sanitation may be a 
mediator for childhood infection. In this respect, the other factors may contribute to child 
mortality.  
 
5.2.3.1 Asset score 
In contrast to the MPI, the asset score approach was used to provide a relative comparison 
within the group. PCA is a data reduction technique that is used to select variables highly 
predictive of a larger group of variables. This can be sub-divided to create categories with 
similar numbers of people, for example quintiles, that can be used in analyses such as in 
section 6.6. It is useful because it can stratify a population, allowing comparisons to be made, 
and is becoming an increasingly common way to combine assets.  
PCA-derived scores have been used in Nepal, for example in the Demographic and Health 
Survey. 49 They cannot be used directly to compare one group with another, unless the 
specific components are known. It is not clear, for example, how the asset score in the DHS 
was constructed. In addition, PCA does not allow for a predefined weighting of the 
importance of the indicators unless a greater number of variables on a particular topic are 
included.   
 
5.2.3.2 Comparison of PCA and MPI 
As shown in Figure 34, there was an inverse association between PCA and MPI deprivation 
scores meaning both tend to identify poorer and richer households the same. This shows some 
correlation between the scores, but there is quite a wide degree of variation, as indicated by 
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the correlation coefficient. For example, 62 (7.3%) of households were in the poorest quintile 
for asset score, but not considered poor for MPI. The assets used in constructing both scores 
were similar, but differed in the incorporation of health and education indicators in the MPI. 
If accurate, the sample could be said to be asset poor, but not multi-dimensionally poor. The 
MPI therefore has a broader range of indicators as it aims to document different types of 
poverty. Being deprived in assets alone will not classify a household as poor under the MPI. 
The method of construction is also different. The MPI uses predefined questions and 
weightings in a particular way. The PCA creates a score from the available data and is prone 
to biases in data collection. Neither technique provides information at a macro level, nor does 
it differentiate how resources are used within a household.  
 
5.2.3.3 Generalisability of results 
The MPI score found in our sample was lower than that found previously in Dhanusha, and 
on par with more affluent parts of the country. 376 The difference may be due to data quality 
issues (the MPI is often calculated from large routine datasets), but may also be due to biases 
in the selection of our sample. The sample was self-selected in that the women who 
participated in the original trial chose to enter the study and intended to have their delivery in 
the regional hospital. This was likely to lead to a lower MPI as it would select women who 
had the resources to go to the hospital. In addition, we selectively followed up the children 
who had survived past the age of two (the time of the previous follow-up). This would 
exclude the 40 women who had a miscarriage or stillbirth. It is possible that an indicator of 
poverty may have been underlying this death, for example under-nutrition in the mother 
leading to an inability to sustain the pregnancy. Another 42 children died before the second 
follow-up at two and a half years of age. By selecting those who did not die in early life, 
when  the  mortality  rate  is  the  highest  in  childhood,  the  “child  mortality”  indicator  would  be  
lower. Another source of bias is loss to follow-up, which may change the MPI score in either 
direction. Those who were unable to attend the hospital or take the micronutrients may have 
been more deprived. Alternatively, those who migrated from the area were probably less 
deprived.  
In summary, both the MPI and asset score can be used to measure SES. Neither method is a 
perfect measure and the correlation between them is not ideal. However, both can provide 
important information about the population in question, if interpreted in relation to the data 
used to create them. SES is a complex and often poorly defined concept, and multiple 
measures are helpful.  
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5.3 Food security 
Food security describes the availability to a household, region or country of enough food both 
currently and in the future. Food insecurity increases the risk of malnutrition and changes in 
anthropometry. It was therefore considered important to investigate levels of food security in 
the sample. The questionnaire included questions on access, availability of food over the year 
and dietary diversity.  
 
5.3.1 Analysis 
We assessed food security with the Household Food Insecurity Access Scale (HFIAS),302 
Household Dietary Diversity Score (HDDS)303 and Months of Adequate Household Food 
Provisioning (MAHFP)304. The analysis was carried out according to the instructions for 
questionnaire tools.  
HFIAS is made up of nine questions (Table 29). The questions can be divided into three 
“access-related  domains”:  anxiety,  quality  and  physical  consequences.  Anxiety  is  represented  
by  answering  “yes”  to  question  1;;  low  quality  food by answering  “yes”  to  questions  2,  3  or  4;;  
and physical   consequences   by   answering   “yes”   to   questions   5,   6,   7,   8   or   9.   The   HFIAS  
questions can then be categorized into levels of food security: food secure and mildly, 
moderately and severely food insecure, as shown in Appendix 5.2. 
The  HDDS  was   used   to   examine   the   breadth   of   a   child’s   diet   in   the   preceding  week.   The  
HDDS questions asked what food groups children had eaten in the last week. We modified 
the usual question about the last 24 hours to get a broader idea of what children were eating. 
The maximum score was 12, relating to a score of one for each of the following foods: cereal, 
roots and tubers, vegetables, fruits, meat, fish or shellfish, eggs, dairy, pulses, oils or fats, 
sugar or honey and other (spices, tea, coffee, etc.).  
The MAHFP indicates seasonality and duration of food insufficiency over the previous 12 
months. Months without adequate food supplies were recorded and summarized for each 
household. The food security indicators were then divided into the trial groups for comparison.  
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5.3.2 Results 
5.3.2.1 HFIAS 
The median HFIAS score was 0, with a range from zero to a maximum of 27. The prevalence 
of food insecurity was 8.6% (n=73). The proportion of households considered anxious was 
6.8% (n=58), as having low quality food was 16.0% (n=136) and as having physical 
consequences from food insecurity was 11.3% (n=96). The levels of food security are shown 
in Table 30, with the results from the Nepal DHS as a comparison. This shows that less than 
one in ten households were food insecure. There was no difference between rural and urban 
locations.  
5.3.2.2 HDDS 
Median HDDS was 9 (interquartile range 8, 10). Eating fruits and vegetables was very 
common and no different between trial groups. Meat or fish was only consumed by about half 
the children in the last week (see Table 31). 
5.3.2.3 MAHFP 
The median MAHFP score was the maximum score of 12, indicating that the household did 
not   lack   food  for  any  months   in   the  previous  year.  7.6%  of  households  had  some  difﬁculty  
obtaining   food   in   the   past   12   months,   with   3%   reporting   difﬁculty   obtaining   food   for   ≥3  
months. Though the numbers were small, in the post-monsoon season, rural households were 
more likely to have food insecurity (5.2% for rural, 1.7% for urban)- Table 32. 
5.3.2.4 Trial group 
The difference between the trial groups was less than 2% for all three indicators (Table 33).  
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Table 29: Household Food Insecurity Access Scale Score questionnaire results 
Question Total number 
answering yes 
(%) 
Of those who answered yes, what is the 
frequency of occurrence 
Rarely Sometimes Often 
1 Did you worry that your 
household would not have 
enough food?  
58 (6.8) 11 (19.0) 30 (51.7) 17 (29.3) 
2 Were you or any household 
member not able to eat the kinds 
of food you preferred because of 
lack of resources?   
58 (6.8) 12 (20.7) 36 (62.1) 10 (17.2) 
3 Did you or any household 
member just eat a few kinds of 
food day after day because of 
lack of resources?         
35 (4.1) 4 (11.4) 22 (62.9) 9 (25.7) 
4 Did you or any household 
member eat food that you did 
not want to eat because of a lack 
of resources to obtain other 
types of food?   
43 (5.1) 11 (25.6) 23 (53.5) 9 (20.9) 
5 Did you or any household 
member eat a smaller meal then 
you felt you needed because 
there was not enough food?      
27 (3.1) 7 (25.9) 14 (51.9) 6 (22.2) 
6 Did you or any other household 
member eat fewer meals 
because there was not enough 
food?   
26 (3.1) 3 (11.5) 18 (69.2) 5 (19.2) 
7 Was there ever no food at all in 
your household because there 
were no resources to get more? 
18 (2.1) 5 (27.8) 10 (55.6) 3 (16.7) 
8 Did you or any household 
member go to sleep hungry 
because there was not enough 
food? 
16 (1.9) 3 (18.8) 12 (75.0) 1 (6.2) 
9 Did you or any household 
member go a whole day without 
eating because there was not 
enough food? 
9 (1.1) 2 (22.2) 6 (66.7) 1 (11.1) 
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Table 30: Household Food Insecurity Access Prevalence 
 Number Percentage Food insecurity 
percentage for 
Nepal37 
1. Food Secure 778 91.4 49 
2. Mildly Food Insecure 
Access 
21 2.5 12 
3. Moderately Food 
Insecure Access 
29 3.4 23 
4. Severely Food Insecure 
Access 
23 2.7 16 
Total 851 100 100 
 
 
 
Table 31: Household Dietary Diversity Score (HDDS) 
 Number Percentage 
Cereal 848 100 
Roots and tubers 823 97.1 
Vegetables 729 86.0 
Fruits 604 71.2 
Meat 463 54.6 
Fish or shellfish 366 43.2 
Eggs 232 27.4 
Dairy 683 80.5 
Pulses 837 98.7 
Oils or fats 835 98.5 
Sugar or honey 800 94.3 
Other (spices, tea, coffee, etc.) 660 77.8 
NB. Three children died, so the total number is 848.  
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Table 32: Months of Adequate Household Food Provisioning (MAHFP) by Nepali 
month and season 
Season Winter (Push-
Phagun) 
Spring/Summer 
(Chait-Jyesth) 
Monsoon 
(Ashadh-Bhadau) 
Post-monsoon 
(Asoj-Mangsir) 
Number households 
without enough food 
2 36 40 32 
Month 
Push 
(Dec-
Jan) 
Magh 
(Jan– 
Feb)    
Phagun 
(Feb– 
Mar)                       
Chait 
(May– 
Apr)  
 Baisakh 
(Apr– 
May)   
Jyesth 
(May 
- Jun) 
Ashadh 
(Jun– 
Jul) 
Shrawan 
(Jul– 
Aug) 
Bhadau 
(Aug – 
Sep) 
Asoj 
(Sep-
Oct) 
Kartik 
(Oct–
Nov) 
Mangsir 
(Nov– 
Dec)    
1 2 0 7  9 30 26 28 24 25 24 4 
 
 
Table 33: Food security prevalence by allocation group  
* Limited to children who were able to come for anthropometry measurements. 
 
5.3.3 Discussion 
Food security was defined  by  the  World  Food  Summit  1996  as  existing  “when  all  people  at  
all  times  have  access  to  sufficient,  safe,  nutritious  food  to  maintain  a  healthy  and  active  life”.  
Other aspects of food security include the affordability of food, its quality and safety. The 
WHO  categorizes  “three  pillars”  of  food  security: 
x “Food  availability:  sufficient  quantities  of  food  available  on  a  consistent  basis. 
x Food access: having sufficient resources to obtain appropriate foods for a nutritious 
diet. 
x Food use: appropriate use based on knowledge of basic nutrition and care, as well as 
adequate  water  and  sanitation.” 
In the Declaration of Rome, countries pledged to halve the number of undernourished people 
by 2015. The Nepal government reiterated this pledge in 2006 when the interim constitution 
stated that food security was a fundamental human right for all its citizens. The government 
 Control Intervention 
 Number* 
(%) 
Number* 
(%) 
Households that are food insecure 39 (9.2) 35 (8.4) 
Households with not enough food for the whole year 29 (6.9) 35 (8.4) 
Median HDDS  9 9 
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announced a Three Year Interim Plan (2010-2013) to reduce food insecurity. It plans to 
identify and target groups who are vulnerable to food insecurity, especially in remote areas, 
with specific programmes (although it does not specify what these will be). 37 A country or 
region’s  food  security  can  be  affected  by  a number of factors. In Dhanusha district most food 
is grown locally. Many people live off their own land as subsistence farmers. Food 
availability therefore varies by the time of the year and the region is particularly dependent on 
the weather.  
The tools used in the study were designed to capture as much of this information as possible 
and to be similar with those used by the Nepal DHS. They were developed in conjunction 
with a review of 11 studies of food security by Coates et al, which confirmed the importance 
of food access and dietary diversity. The review also showed a number of common concerns 
across different settings, such as worry about adequate quantity of food. 392 
The results from all three food security questionnaires indicated that food insecurity was rare 
in the sample and that children had diverse diets. Food insecurity was also uncommon at all 
points in the year and, although the numbers were low, rural residents were a little more 
vulnerable than urban residents in the post-monsoon period.  
Comparing our data with the Nepal DHS (2011) for the Central Terai region, we found a 
greater proportion of food secure households (50.1 vs 92.2%, p<0.001). The DHS would have 
sampled the population to be representative of the region and should be a more accurate 
descriptor of the level of food security. However, the number of households sampled 
(n=1975) was not much greater than our sample. The DHS also used the same questionnaire 
tools, but modified from a one-month  period  to  12  months  to  “allow  for  seasonal  variations”. 
37 This could account for the difference, as families are more likely to experience aspects of 
food insecurity over a longer period. The use of a 12-month period does make it difficult to 
compare the Nepal DHS to others that have used the same questionnaires.  
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Chapter 6 Main analysis and results 
 
 
 
 
In this section I describe the main findings from the study. I start by considering the mortality 
with reference to the previous trial and follow-up. I then consider the growth of all the 
children together, before dividing them by allocation. I examine anthropometry, blood 
pressure and respiratory results. I perform univariable and multivariable regressions based on 
a pre-specified conceptual model and explore potential effect modification. This is followed 
by a summary of the health outcomes and two further analyses investigating the effect of air 
pollution on asthma symptoms and socioeconomic status on growth.  
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6.1 Mortality 
A discussion about mortality at birth has been presented in detail elsewhere. 7,251 There was a 
non-significant excess neonatal mortality in the original Janakpur trial in the MMN group. 
The meta-analysis of this and similar trials by Ronsmans et al did not find a statistically 
significant difference in neonatal mortality, but as described in section 2.9.2, when the large 
trial from Lombok, Indonesia was removed, the OR rose to 1.40 (95% CI 1.08, 1.82). 252  
After the high mortality in early life, rates drop in mid-childhood, so mortality was unlikely to 
be an important factor to consider in this follow-up. Nevertheless, considering the previous 
debates on this issue, I updated the profile to show the number of children who died. 
Mortality rates were calculated as in Appendix 6.1.  
Overall, a similar number of children had died in both allocation groups. At the two-year 
follow-up (including stillbirths but not miscarriages), one more child had died in the 
intervention group. Three further children died between the two-year and eight-year follow-
ups. Two of these were from the control group and the third from the intervention group. The 
number of miscarriages, stillbirths and postnatal deaths is shown in Figure 35. With the 
caveat that no time period showed a statistically significant difference at the 95% level 
between intervention and control groups, my impression is that the MMN supplement might 
change the time at which deaths occur, but does not contribute to a difference overall. If this 
is true, it is not clear to me whether it is good or bad. It does seem safe to say that MMN 
supplementation does not reduce mortality as was initially hypothesised. 
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Figure 35: Mortality in control (blue) and intervention (intervention) groups  
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6.2 Growth of the whole cohort 
6.2.1 Analysis 
6.2.1.1 Application of WHO reference ranges 
The anthropometry data were normalised using the WHO Child Growth Standard reference 
ranges to create z scores for weight-for-age (WAZ), height-for-age (HAZ) and BMI-for-age 
(BAZ) for children aged 5-19. 25 Most reference ranges have been created for children under 
five, but the WHO recently developed ranges for school children and adolescents: the 2007 
WHO Reference Curves. To create these reference ranges, they initially examined 34 datasets 
from 22 countries, but found a great deal of heterogeneity. They then re-examined the 
National Center for Health Statistics/WHO international growth reference data and created 
new reference ranges from them using the Box-Cox power exponential method. This uses 
curve smoothing by cubic splines and can cope with skewed and kurtotic data. 25  
 
6.2.1.2 Regression to the mean 
The statistical phenomenon of regression to the mean may occur when categorisations are 
applied to the data. An example would be when children who are stunted at one time point 
move closer to the mean value over time, i.e. show greater catch-up growth. As described by 
Cameron et al, regression to the mean can be accounted for by calculating the difference 
between the second height and the product of first height and the correlation between the 
heights. 393   
 
6.2.1.3 Exclusion of children with illness 
As illness may adversely affect growth, it was decided that we would also restrict the analysis 
to children who were well. Major and chronic illnesses were coded as described in section 3.6.  
 
6.2.1.4 Body composition 
Fat mass (FM) was calculated as the difference between lean mass (LM) and total mass and 
BMI as body weight (kg) divided by height (m) squared. Both LM and FM can be divided by 
height squared, to give the lean mass index (LMI) and the fat mass index (FMI). Such a 
model allows independent evaluation of both LM and FM relative to body size. 394 395 
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6.2.2 Results 
6.2.2.1 Anthropometric status of the children 
The anthropometry results for the whole cohort are shown in Table 1, Appendix 6.2. and a  
summary of the main results at 8.5 years, adjusted for age and sex, is presented in Table 34. 
Girls were a little shorter and lighter than boys.  
The distributions of WAZ, HAZ and BAZ for age are shown in Figure 36. The graphs show 
normal distributions at all time points, but shifted to the left: the children in our sample were 
both lighter and shorter than the global standard applied. Figure 37 shows scatter plots for 
HAZ, WAZ and BAZ from birth to eight years. For height, there was a reduction of 1.15 z 
scores over the period. For weight, the reduction was a little less at 0.87 z scores, but the 
infants were relatively lighter to begin with. For HAZ, there appeared to be some recovery 
from 2.5 to 8.5 years, whereas WAZ showed a steady decline. BAZ showed recovery at 2.5 
years, but this was due to greater reduction in HAZ, leaving children with an appropriate 
weight for height. The standard deviation for WAZ was similar over the three time points, but 
for HAZ reduced from 1.26 to 0.94. 
Table 35 shows the proportion of children underweight, stunted and with low BMI, at the 
three time points. At 8.5 years of age, just over half the children had low weight-for-age, and 
approximately one-third had stunting and low BMI. For children who were stunted (limited to 
complete data), WAZ scores reduced progressively: the changes from birth-to-2.5 years and 
2.5-to-8.5 years were -0.53 and -0.33, respectively. However, there appeared to be some 
catch-up growth in HAZ in childhood: the changes from birth-to-2.5 years and 2.5-to-8.5 
years were –1.91 and 0.80, respectively. The proportion stunted at 8.5 years fell by 30% from 
that at 2.5 years. However, accounting for regression to the mean caused this positive change 
in mean score to disappear (-0.56 z scores). 
Only 1.4% of the children were overweight (defined as BAZ >1 SD). For girls the figure was 
0.5% and for boys 2.3%. 
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Table 34: Main anthropometry results for the whole cohort at 8.5 years, stratified by sex 
  Number Mean Standard 
deviation 
Range 
Weight-for-age Girls 406 -2.09 0.97 -4.6 to 1.4 
 Boys 435 -2.03 1.09 -4.8 to 2.7 
      
Height-for-age Girls 406 -1.54 0.92 -5.7 to 1.1 
 Boys 435 -1.45 0.95  -4.0 to 1.4 
      
BMI-for-age Girls 406 -1.66 0.92 -4.2 to 1.7 
 Boys 435 -1.64 1.01 -4.5 to 3.3 
 
 
 
 
 
Figure 36: Frequency distributions of weight-for-age, height-for-age, and body mass 
index for age, at birth, 2.5-years, and 8.5 years  
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Figure 37: Change in z scores. Black bars denote mean ± 1 standard deviation 
 
 
 
Table 35: Proportion of infants/children underweight, stunted and wasted  
 Underweight (weight-for-age 
<-2 z) 
Stunted (height-for-age 
<-2 z) 
Low BMI (BMI-for-age 
<-2 z) 
 Number 
(%) 
Mean for 
children 
underweight 
Number 
(%) 
Mean for 
children 
stunted 
Number 
(%) 
Mean for 
children 
wasted 
Birth 186 (17.9) -2.7 91 (9.0) -2.7 348 (34.8) -2.9 
2.5 years 340 (37.2) -2.7 537 (58.8) -3.0 54 (5.9) -2.5 
8.5 years 444 (52.8) -2.8 242 (28.8) -2.6 293 (34.8) -2.6 
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6.2.2.2 Exclusion of children with illness 
The anthropometry results for the whole cohort, stratified into well children and children with 
a history of major or chronic illness (n=34) are shown in Table 2, Appendix 6.2. The list of 
illnesses included achondroplasia, congenital heart disease, developmental delay of unknown 
cause, leishmaniasis, prolonged diarrhoea, renal conditions (hydronephrosis, nephritic 
syndrome), rheumatic fever, and tuberculosis. Children with a history of illness tended to be a 
little shorter and lighter, but as the numbers were small we cannot draw definitive conclusions.  
 
6.2.2.3 Body composition 
The mean fat mass proportion was 14.5%  (girls 15.2%, boys 13.7%). The distribution of fat 
mass was normal, but with a few much heavier children (Figure 38). Figure 39 shows 
scatterplots of lean and fat mass. There was a positive association between lean and fat mass 
(β   coefficient 0.28; 95% CI 0.24, 0.33). This association was no longer present when 
controlling for height (squared) using LMI and FMI, i.e. their association was explained by 
each correlating with height.  
 
 
 
 
Figure 38: Distribution of fat percentage in the whole cohort  
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Figure 39: Scatterplots of fat mass against lean mass and fat mass index against lean 
mass index 
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6.2.3 Discussion 
Levels of malnutrition were high. Estimates for the Terai from the 2011 Nepal Demographic 
and Health Survey suggested that 37% of children under five were stunted, 11% were wasted, 
and 30% underweight. Boys fared slightly worse than girls in all categories, and estimates for 
rural populations were higher than urban figures.49 We found a similar proportion of stunting, 
but a 23% higher estimate of low BMI as an index of underweight. The fact that our children 
were older raises concerns about further deterioration in nutritional status beyond the age of 
five years. 
The results show that the children started off life small and then continued to get smaller. 
Most research tends to focus on the first year or five years of life, but we have shown that 
even after two years of age there was a reduction in weight z score. While growth failure was 
greatest in early life, there appeared to be some scope for catch-up. Contrary to the idea that 
height trajectory is set early,396 the children in our study did show some catch-up growth. The 
proportion who were stunted fell by 30% from 2.5 to 8.5 years, but this catch-up in the 
smallest children is potentially explained by regression to the mean. As recommended by 
Cameron et al, analysis of groups that have been categorised should include correction for 
regression to the mean. 393   
The levels of obesity found in our study, as defined by BMI, were very low, but the 
percentage of fat was relatively high. This compares to an estimate of mean fat percentage 
(using bioelectrical impedance) in UK 8 year olds of 21% in girls and 17% in boys. 397 The 
relatively high fat percentage is   in  keeping  with   the   idea  of   the  “thin-fat”  phenotype   that  is  
common in the Indian subcontinent, in which there is a relatively greater amount of fat for the 
size of the person. It may be due to inadequate nutrition at critical periods and may possibly 
confer a survival advantage.398,399  
As described in section 4.4, we can be confident of the findings as TEM and TEM% values 
were below consensual norms of 3 mm for height, 2 mm for body circumferences, and 1% or 
5% for skinfold thicknesses. 336 337 The standard deviation of HAZ reduced over the three 
time points, which may be a true phenomenon or potentially due to a selection bias. For 
example, we may have found less children in the tails of the distribution. This is possible, but 
unlikely, as there was little indication of it when considering children lost to follow-up. The 
difference may also be due to measurement error. Length/height measurement in newborns 
and at two years is much more difficult to perform than at eight years. Similar data on 
measurement error are not available for comparison. While potentially leading to a wider 
standard deviation, it would not necessarily lead to a change in the mean value as the error 
could occur in both directions.   
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A potential limitation was that the references used to calculate anthropometric z scores 
differed from those for children under five years used in the trial and previous follow-up.25 
This might have led to inconsistencies, but the references for older children are based on 
statistical extrapolation from the younger ranges and were designed for compatibility. In 
addition the ranking of children should stay the same.   
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6.3 MN Anthropometry and blood pressure  
6.3.1 Analysis 
6.3.1.1 Primary analysis: unadjusted comparison of allocation groups 
The primary analysis compared allocation groups with t tests and univariable regression 
models by intention-to-treat. 
 
6.3.1.2 Secondary analysis 
A. Multivariable regression 
Although allocation was balanced, I adjusted for potential confounders to increase precision. 
To choose possible confounders, I built a causal diagram and used the rules set out in section 
2.10 to identify variables to include in multivariable models. In the main analysis, controlling 
for confounding was not essential as the antenatal MMN were randomised (with balanced 
allocation) and appropriately blinded. The intervention and control groups appeared to be 
similar for most of the information we collected, but adding in covariates using the causal 
diagram can help to improve precision in linear models (and potentially efficiency in non-
linear models). 400 Adjustment would also act to increase the statistical power.401 
The causal diagram is only an approximation and at times a gross simplification of reality. It 
can, however, play a useful role in determining the relationship between variables and 
suggestions for which factors should be controlled for. Importantly, it also helps to prevent 
over-adjustment by controlling for things that are unnecessary or are mediating factors. The 
structure of the causal diagram was based on a priori knowledge. I created it using the data 
from the previous trial and follow-up and my reading of the subject matter. The diagram was 
based on the hierarchical models produced by Victora et al402 and, more recently, Fenske et 
al403. My model is similar to these, but goes further in showing the actual relationships 
between the factors, albeit mostly limited to the data available. Fenske et al undertook 
reviews of the literature to identify the factors to include in their conceptual model of stunting. 
They divided the factors into underlying, intermediate and immediate determinants, broadly 
similar to the hierarchical levels described by Victora et al.  
o Underlying - maternal, household and regional characteristics 
o Intermediate – household food competition, water, sanitation, hygiene, indoor 
air pollution, healthcare and infections (both chronic and recurrent), nutrition 
(breastfeeding, complementary feeding, micronutrient deficiency) 
o Immediate - IUGR, inadequate caloric nutrient intake and uptake 
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They then estimated the effects of each of the components through a complex statistical 
approach involving quantile regression and boosting (a statistical inference method for 
complex models), using data from the Indian National Family Health Survey 2005/2006. 
They confirmed sex and age as being important non-modifiable factors. Both were 
incorporated in the analyses by conversion of the data to z-scores. They also identified wealth, 
maternal education and maternal BMI.403 Wealth was included as an asset score. Maternal 
BMI was considered a possible effect modifier in the meta-analyses by Fall17 and Haider21. 
Other   factors   such   as   religion,   partner’s   occupation,   sex   of   household   head,   urban/rural  
location, number of household members, drinking water, meal frequency by age, and iron 
supplementation were not found to be important determinants of stunting. 403  
The diagram was passed to all involved in the design and analysis of the study and to 
independent researchers at the Institute for Global Health for corrections, refinements and 
comments. The final diagram is shown in Figure 40. A number of directed acyclic graphs 
were produced from it for specific outcomes, as described in the individual analyses. I 
discussed each of the diagrams with Dr Rhian Daniel, the statistician who advised on the 
choice of confounders. The diagrams were not used for choosing effect modifiers. 
This conceptual model was used as the basis for the multivariable regression analyses in this 
research. It was designed primarily around the information collected in the study, but also 
included a few other important variables.  Multivariable linear regression models based on the 
diagram included covariates describing air pollution (24 hr-TWA), dietary diversity (HDDS 
score), food security (HFIAS score), maternal education (no education, primary or secondary 
and above), maternal height, household asset score and residence (urban or rural). Adjustment 
for maternal height was not considered essential, but was included in the model to augment 
information on diet and socioeconomic status. Maternal BMI was not included as it was not 
measured at an optimal time (rather than pre-pregnancy, BMI was measured during 
pregnancy and at the two-year follow-up) and would go into the same box as parental height. 
I included covariates for maternal education and residence to offset the potential effects of 
differential loss to follow-up.340 
Figure 40 was designed specifically for this study. It should be used with caution in other 
research as the a priori assumptions on which the model is based may not be universally 
applicable. Some of the arrows are likely to be appropriate in any setting - for example, 
anthropometry of boys and girls would be different everywhere - but other arrows are 
context-specific. An example is the arrow from SES to maternal education. In some settings 
maternal education would lead to a change in SES and is sometimes considered part of the 
same construct. I assume here that, primarily due to the lack of social mobility, SES of the 
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family or household is a more important factor in determining the level of education the 
female members of the family receive. The model would be the same or similar in other parts 
of the Terai, but would be different if the population in question were from the capital city, 
Kathmandu. While not directly generarisable to other contexts, the diagram in Figure 40, 
could be used as a starting point upon which similar models are constructed.   
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Figure 40: Conceptual model  
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Assumptions in linear regression 
Multivariable linear regression models were created for the outcome variables and the 
inherent assumptions were tested for linearity, normality, homoscedasticity, leverage and 
multi-collinearity.404 
Linearity 
The association between predictor variables and outcome variables should be linear when 
using linear prediction models. This was tested by plotting the residuals against each 
covariate separately, which should create a random scatter around the zero value. An example 
of graphs from the multivariable regression for weight-for-age z scores is shown in Figure 41.  
Normality 
A normal distribution of the variables is required for hypothesis testing, but not for regression 
analysis. Unbiased coefficients can still be obtained with non-normal data. Rather, the 
residuals, or errors, should be identically and independently distributed. This was checked by 
looking at a kernel density plot of residuals, an example of which is shown in Figure 42. As 
linear regression is quite robust to non-normality, the decision was made to not transform the 
data. 
Homoscedasticity 
Linear regression assumes homogeneity of the variance of residuals, i.e. a constant error of 
variance. If a pattern exists, it is said to be heteroscedastic. This can be shown graphically 
using the rvfplot command in Stata, which plots residuals against predicted values. An 
example from the multivariable regression for WAZ is shown in Figure 43. Homoscedasticity 
can also be tested with the Breusch-Pagan test of the null hypothesis that there is homogeneity 
of residuals. Heteroscedasticity was thought to exist for most outcomes, so robust standard 
errors were used.405 Robust standard errors produce wider confidence intervals and are 
therefore more conservative.  
Leverage 
Data points that differ greatly from the mean value may have a large influence on a regression. 
The influence of a data point is also a product of the degree to which it is an outlier, i.e. how 
large the residual values are. Other than removing children with chronic diseases as discussed 
previously, even if a data point had high leverage, it did not seem justified to remove it from 
the analyses. 
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Multi-collinearity 
Collinearity occurs when predictor variables have a near-perfect linear association. This 
makes the regression model unstable, increasing the standard errors. Multi-collinearity of the 
multiple regression models was checked by calculating the variance inflation factor (vif). Vif 
scores of greater than ten may indicate multi-collinearity. Tests of all models showed scores 
of <2, indicating that multi-collinearity was unlikely to exist.  
Independence 
We assumed that individuals were independent.  
 
 
Figure 41: Tests for linearity: plots of each covariate against residuals from the multi-
variable regression of weight-for-age 
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Figure 42: Kernel density plot of residuals for multivariable regression for weight-for 
age z scores 
 
 
 
Figure 43: Scatterplot of residuals against fitted values for multivariable regression for 
weight-for-age z scores  
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B. Secondary analysis: Exclusion of children with illness 
Prior illness may affect childhood growth, and children with major or chronic illness were 
excluded as described in section 6.2.   
 
C. Secondary analysis: adjusted for birth size 
The direct effects of antenatal multiple micronutrient supplementation, not mediated by birth 
size, were investigated for the main outcomes. By removing the effect of birth size, the 
independent effect of MMN on anthropometry at 8.5 years can be seen. Based on the causal 
diagram in Figure 40, this was done by adding birth anthropometry indices to the multi-
variable regression models (including maternal height, air pollution, food security and dietary 
diversity) and comparing them with models that did not include birth indices.  
 
D. Secondary analysis: conditional growth 
Conditional growth was calculated for two time points - 2.5 years and 8.5 years - to examine 
the difference between actual and expected growth based on previous measurements. A 
positive value represented growth faster than expected. I regressed current size on previous 
measures using the method described by Adair et al.406 Conditional relative height takes into 
account previous height and weight measures, while conditional weight accounts for previous 
height and weight, and also current height. Standardised residuals were used as the outcomes 
in univariable and multivariable linear regression models. 
 
E. Effect modification 
Sex 
I stratified the results by sex to look for a different magnitude of effect in girls and boys as a 
difference was seen at birth.  
 
Maternal BMI  
Maternal BMI was considered a possible effect modifier on birth outcomes in the meta-
analyses by Fall et al17 and Haider and Bhutta21.  
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6.3.2 Results 
6.3.2.1 Primary analyses 
The main trial profile is shown in Figure 16. Figure 44 shows the number of children included 
in each aspect of the analysis. Not shown are the missing data for particular outcomes, as 
described in Section 4.3: 213 BIA measurements (104 control and 109 intervention), one 
kidney ultrasound (intervention) and one skinfold thickness (intervention). 
The primary unadjusted analyses showed no difference between children whose mothers 
received antenatal MMN or the control of iron and folate. Unadjusted differences 
(intervention minus control) with p-values from independent t tests were 0.047 z scores (95% 
CI -0.093, 0.186; p 0.51) for WAZ, 0.023 z scores (95% CI -0.104, 0.150; p 0.72) for HAZ 
and 0.043 z scores (95% CI -0.088, 0.175; p 0.52) for BAZ. There was no difference in 
systolic (0.017 mmHg; -1.016, 1.051; p 0.97) or diastolic blood pressure (0.128 mmHg; -
0.932, 1.187; p 0.81). Table 36 shows a comparison with the birth and 2.5 year data.  
 
 
Figure 44: Flow chart for anthropometry analysis 
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Table 36: Anthropometric indices at birth, 2.5 and 8.5 years, by allocation 
    Control Intervention 
  Sample Frequency <-2 SD 
(%)  
Mean (95% CI) Mean (95% CI) 
Birth*  WAZ 1044 186 (17.9) -1.28 (-1.35, -1.19) -1.08 (-1.17, -1.00) 
HAZ 1016 91 (9.0) -0.41 (-0.52, -0.30) -0.34 (-0.45, -0.24) 
BAZ 1002 348 (34.8) -1.63 (-1.74, -1.52) -1.42 (-1.53, -1.31) 
2.5 
years 
WAZ 915 340 (37.2) -1.76 (-1.85, -1.67) -1.62 (-1.72, -1.53) 
HAZ 915 537 (58.8) -2.29 (-2.39, -2.19) -2.20 (-2.31, -2.10) 
BAZ 915 54 (5.9) -0.40 (-0.50, -0.30) -0.29 (-0.39,-0.18) 
8.5 
years 
WAZ 841 444 (52.8) -2.08 (-2.18, -1.98) -2.03 (-2.13, -1.93) 
HAZ 841 242 (28.8) -1.51 (-1.59, -1.42) -1.48 (-1.57, -1.39) 
BAZ 841 293 (34.8) -1.67 (-1.76, -1.58) -1.63 (-1.72, -1.53) 
BMI: body mass index; WAZ: weight-for–age; HAZ: height-for-age; BAZ: BMI-for-age       
*Excluding birth data <-4.5 and >3 z scores 
 
6.3.2.2 Secondary analyses 
A. Multivariable regression 
Multivariable regression models tended to increase the effect size, but the results did not 
reach statistical significance. The only outcome that did was head circumference, at 0.19 cm 
difference (95% CI 0.02, 0.37). The results are shown in Table 37. Adjusting for current size 
(in the form of WAZ, HAZ, BAZ, lean mass or fat mass) for blood pressure did not make an 
important difference to the results.  
 
B. Exclusion of children with illness 
Contrary to our initial assumption, excluding children with prior history of major or chronic 
illness tended to reduce the effect size slightly. The difference was small and the number of 
children excluded was only 34.  
 
C. Adjustment for birth size 
There was no difference between allocation groups due to the direct effects of antenatal 
multiple micronutrient supplementation, not mediated by birth-size, on z score: 0.044 (95% 
CI -0.083, 0.171) for WAZ, 0.056 (95% CI -0.060, 0.171) for HAZ, and 0.054 (95% CI -
0.075, 0.183) on BAZ.  
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Table 37: Child anthropometric indices by allocation, showing mean values, unadjusted, and adjusted differences  
 
 
 
 
 
 Control  
Mean (SD) 
Intervention  
Mean (SD) 
Unadjusted difference  
(95% CI) 
Adjusted difference *  
(95% CI) 
Adjusted difference 
restricted to children 
without major or chronic 
illness (95% CI) 
Weight (kg) Weight  20.04 (3.31) 20.14 (3.35) 0.10 (-0.35, 0.55) 0.30 (-0.08, 0.67) 0.25 (-0.12, 0.63) 
Lean mass 17.34 (2.44) 17.30 (2.49) -0.05 (-0.43, 0.34) 0.10 (-0.23, 0.43) 0.08 (-0.25, 0.42) 
Fat mass 3.01 (1.6) 2.94 (1.58) -0.07 (-0.32, 0.18) 0.02 (-0.21, 0.25) 0.05 (-0.18, 0.27) 
       
Height (cm) Standing 120.72 (5.91) 120.73 (6.06) 0.00 (-0.81, 0.81) 0.35 (-0.31, 1.01) 0.27 (-0.38, 0.93) 
Trunk length 64.14 (2.94) 64.16 (2.96) 0.02 (-0.38, 0.42) 0.14 (-0.20, 0.48) 0.07 (-0.28, 0.41) 
       
z score Weight-for-age -2.08 (1.01) -2.03 (1.06) 0.05 (-0.09, 0.19) 0.09 (-0.03, 0.22) 0.07 (-0.06, 0.19) 
Height-for-age -1.51 (0.92) -1.48 (0.96) 0.02 (-0.10, 0.15) 0.06 (-0.05, 0.17) 0.05 (-0.06, 0.16) 
BMI-for-age -1.67 (0.96) -1.63 (0.98) 0.04 (-0.09, 0.18) 0.07 (-0.06, 0.20) 0.05 (-0.08, 0.17) 
       
Skinfold 
thickness (mm) 
Triceps  7.39 (2.56) 7.36 (2.41) -0.03 (-0.37, 0.31) 0.07 (-0.24, 0.38) 0.10 (-0.20, 0.37) 
Biceps  3.95 (1.34) 3.95 (1.40) -0.01 (-0.19, 0.12) 0.06 (-0.11, 0.23) 0.08 (-0.10, 0.25) 
Subscapular  4.91 (1.29) 4.93 (1.51) 0.01 (-0.18, 0.20) 0.06 (-0.12, 0.24) 0.07 (-0.11, 0.26) 
Supra-iliac 5.76 (2.54) 5.57 (2.35) -0.19 (-0.52, 0.14) -0.11 (-0.42, 0.21) -0.06 (-0.36, 0.25) 
       
Body 
circumference 
(cm) 
Head  49.19 (1.48) 49.37 (1.47) 0.18 (-0.02, 0.38) 0.19 (0.02, 0.37) 0.15 (-0.02, 0.32) 
Chest  55.59 (3.39) 55.74 (3.64) 0.15 (-0.33, 0.63) 0.28 (-0.14, 0.71) 0.27 (-0.16, 0.70) 
Waist 49.01 (3.76) 49.20 (3.96) 0.19 (-0.33, 0.71) 0.29 (-0.19, 0.77) 0.23 (-0.25, 0.71) 
Hip 57.30 (4.00) 57.36 (4.11) 0.07 (-0.48, 0.61) 0.33 (-0.14, 0.81) 0.26 (-0.22, 0.73) 
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*Multivariable regression models included variables describing air pollution, dietary diversity, food security, maternal education and height, household asset score, and 
residence, using robust standard errors. Age and sex were included if not intrinsic to z score. 
Upper leg 31.11 (2.91) 31.21 (2.91) 0.10 (-0.30, 0.49) 0.26 (-0.09, 0.61) 0.21 (-0.14, 0.56) 
Mid-upper arm 15.94 (1.40) 15.99 (1.38) 0.04 (-0.15, 0.23) 0.11 (-0.06, 0.27) 0.10 (-0.07, 0.26) 
       
Renal 
dimension (cm) 
Right length  7.90 (0.55) 7.89 (0.57) -0.01 (-0.08, 0.07) 0.00 (-0.07, 0.07) -0.01 (-0.08, 0.06) 
Right antero–posterior 
distance 
2.98 (0.26) 3.00 (0.28) 0.02 (-0.01, 0.06)  0.02 (-0.01, 0.06) 0.02 (-0.02, 0.06) 
Left length  8.25 (0.57) 8.22 (0.58) -0.03 (-0.11, 0.05) -0.03 (-0.10, 0.05) -0.05 (-0.12, 0.03) 
Left antero–posterior 
distance 
3.29 (0.32) 3.30 (0.32) 0.02 (-0.03, 0.06) 0.02 (-0.03, 0.06) 0.01 (-0.03, 0.06) 
       
Blood pressure 
(mmHg) 
Systolic  98.06 (7.14) 98.08 (8.10) 0.02 (-1.02, 1.05) -0.06 (-1.10, 0.98) -0.20 (-1.23, 0.83) 
Diastolic  61.16 (7.36) 61.29 (8.27) 0.13 (-0.93, 1.19) 0.19 (-0.87, 1.25)  0.15 (-0.92, 1.22) 
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D. Conditional growth results 
In general, there was a tendency for positive effect sizes up to 2.5 years and negative effect 
sizes up to 8.5 years on both WAZ and HAZ, but these did not reach statistical significance. 
 
Table 38: Conditional growth: effect of antenatal multiple micronutrient supplements 
on growth at different time points 
 2.5 years 8.5 years 
 Unadjusted 
difference 
(95% CI) 
Multivariable 
regression * (95% 
CI) 
Unadjusted 
difference 
(95% CI) 
Multivariable 
regression * (95% 
CI) 
WAZ 0.08 (-0.06, 0.22) 0.09 (-0.05, 0.24) -0.06 (-0.20, 0.08) -0.04 (-0.18, 0.09) 
HAZ 0.05 (-0.10, 0.18) 0.08 (-0.04, 0.21) -0.10 (-0.24, 0.04) -0·09 (-0.12, 0.04) 
 
* Multivariable regression models included variables describing air pollution, dietary diversity, food 
security, maternal education and height, household asset score and residence, using robust standard 
errors.  
 
  
Chapter 6 
 224 
E. Effect modification 
Sex 
Table 39 shows stratification by sex, with birth and 2.5 year data for weight shown for 
comparison in Appendix 6.3. In boys, there was no difference in anthropometry outcomes. 
While there were no statistically significant differences, in girls there was a tendency towards 
increased weight. There was a 0.17 (95% CI -0.01, 0.35) z score difference in WAZ, 
equivalent to approximately 500 g. When formally tested, there was no evidence of 
interaction (p=0.24). 
Maternal BMI  
No difference was seen due to effect modification by maternal BMI (categorised as <18.5 and 
>18.5 kg/m2). For mothers with BMI<18.5, WAZ was 0.15 (95% CI -0.06, 0.37), while for 
mothers with BMI>18.5, WAZ was 0.06 (95% CI -0.09, 0.21).  
Table 39: Child anthropometry by allocation group, by child sex 
  Control 
Mean 
(SD) 
Intervention 
Mean (SD) 
Unadjusted 
difference 
(95% CI) 
Multivariable 
regression * 
(95% CI) 
Multivariable 
regression 
restricted to 
children 
without major 
or chronic 
illness 
(95%CI) 
Weight Girls 19.55 
(2.96) 
19.71 (3.15) 0.16 (-0.44, 
0.75) 
0.51 (-0.03, 
1.04) 
0.51 (-0.03, 
1.06) 
 Boys 20.53 
(3.57) 
20.53 (3.49) -0.00 (-0.67, 
0.66) 
0.101 (-0.43, 
0.63) 
0.01 (-0.51, 
0.53) 
Height Girls 120.40 
(5.92) 
119.98 (5.93) -0.42 (-1.57, 
0.74) 
0.33 (-0.65, 
1.32) 
0.44 (-0.51, 
1.39) 
 Boys 121.05 
(5.89) 
121.38 (6.12) 0.33 (-0.80, 
1.47) 
0.36 (-0.55, 
1.27) 
0.14 (-0.78, 
1.06) 
       
WAZ Girls -2.14 
(0.92) 
-2.02 (1.02) 0.12 (-0.07, 
0.31) 
0.17 (-0.01, 
0.35) 
0.17 (-0.01, 
0.35) 
 Boys -2.02 
(1.09) 
-2.04 (1.09) -0.02 (-0.23, 
0.18) 
0.03 (-0.15, 
0.21) 
-0.02 (-0.19, 
0.16) 
HAZ Girls -1.55 
(0.91) 
-1.53 (0.93) 0.02 (-0.16, 
0.20) 
0.06 (-0.11, 
0.23) 
0.08 (-0.08, 
0.24) 
 Boys -1.47 
(0.93) 
-1.44 (0.98) 0.03 (-0.15, 
0.21) 
0.06 (-0.10, 
0.22) 
0.02 (-0.14, 
0.18) 
BAZ Girls -1.73 
(0.87) 
-1.58 (0.97) 0.15 (-0.03, 
0.33) 
0.18 (0.00, 
0.36) 
0.16 (-0.02, 
0.34) 
 Boys -1.61 
(1.04) 
-1.67 (0.99) -0.06 (-0.25, 
0.13) 
-0.02 (-0.20, 
0.16) 
-0.05 (-0.23, 
0.13) 
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6.3.3 Discussion 
6.3.3.1 Main results 
At follow-up at 8.5 years, we saw no differences in anthropometric outcomes (with or without 
adjustment for birth size), conditional relative growth, or blood pressure between groups 
whose mothers were allocated antenatally to either multiple micronutrient or iron and folic 
acid supplements. In addition, we found no difference in body composition measured by BIA 
and skinfold thickness, suggesting neither a global difference in lean or fat mass nor a 
difference in their distribution. 
Because of balanced allocation, the primary analysis was unadjusted. We developed adjusted 
models from a conceptual diagram whose assumptions are uncertain in view of the 
complexity of childhood growth as an outcome. We used causal diagram analysis to make 
them explicit, and attempted to adjust for important variables, without over-adjustment. 
Overall, the similar follow-up studies have not shown a lasting difference in anthropometry in 
children born to mothers taking antenatal multiple micronutrient supplements. In Burkina 
Faso, Roberfroid et al showed increased length-for-age and weight-for-age z scores after one 
year, but the difference had disappeared by 2.5 years.259 In China, Wang et al found no 
difference in wasting, stunting and underweight at 30 months of age.262 In Bangladesh, Khan 
et al found no difference in weight or body composition at 54 months of age, but reported 
lower linear growth than in the iron and folic acid control group.260,261  
The only outcome that showed a difference between allocation groups was head 
circumference in multivariable analysis. Is the difference in head circumference a true result? 
One could argue not: I would be cautious in over-interpreting one outcome amongst the many 
tested, the difference was only 2 mm (very close to our detection limit), the univariable 
regression results did not show a statistical difference and other body circumferences showed 
no difference. On the other hand, one might say that it is important in that we are confident in 
anthropometry measurements as highlighted by the low error values, multivariable regression 
may be more likely to produce an accurate answer by reducing the effect of confounding and 
the difference was very similar in absolute terms to that found at 2.5 years (potentially 
indicating canalisation of this trait). If we were to apply a correction for multiple testing, the 
result would become insignificant. Whether or not to do this is a point of debate amongst 
statisticians. Researchers, deliberately or not, search for interesting (usually positive) results 
that are more likely to be published, and multiple testing could lead to false positive results. 
Contrary to this, having an a priori hypothesis, to which we attach importance by making it 
our primary outcome, is somewhat arbitrary and to not use the data to their full extent seems 
wasteful. In this case I consider most of the outcomes to be measuring the same thing - body 
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size and composition (the only one that may be different is blood pressure as this also comes 
under hormonal and nervous control) - and in this analysis it is a moot point as the results 
were null: applying a Bonferroni correction simply increased the p value. My personal view is 
that correction for multiple testing is over-cautious, but I would recommend that the results of 
each analysis conducted should be shown so that the reader can put them into context.  
We assume that the previous follow-up showed a true difference between intervention and 
control groups in early life: the trial was of high quality and the results in keeping with 
similar trials. There are therefore two interpretations of the current results: (1) the difference 
had disappeared by mid-childhood, or (2) any differences were not manifest in our indicators 
(we were unable to find them). If (1) is correct and there were no lasting effects of antenatal 
MMN, it may be that their effects were transient, for example through reversible epigenetic 
changes. Methylation early in life tends to be irreversible, but it may be that any changes 
happened too late to modify growth trajectory or are, in fact, reversible. Any beneficial 
biological consequences of the supplement may have been vitiated by the detrimental effects 
of the environment. The second possibility is that long-term physiological effects were 
present but undetected. Our follow-up rates were high and measurement error was low so, 
other than by chance, it would seem unlikely that there was a large effect that we were unable 
to find. It is conceivable that the difference in anthropometry was still present, but had 
diminished over time.  
Anthropometric differences may emerge at subsequent follow-up as the current ages of 
cohorts across all the trials may be insufficient to see effect. At seven-to-nine years of age, 
children are in their lowest growth rate period and the groups may diverge again in 
adolescence. There is some evidence for this from a study in baboons, in which an effect of 
changing weaning diet was manifest in females only in adolescence.407 
 
6.3.3.2 Mediation and conditional relative growth 
The results seem to show no direct effects of antenatal MMN after removing the effect on 
birth size. Looking at the conditional growth changes, the weight- and height-for-age 
outcomes did not show a statistical difference, but the 2.5 year data tended to show positive 
effect measures, while at 8.5 year findings were negative. Presumably the MMN had a 
positive effect on growth in-utero (to produce a difference in weight at birth), which 
diminished over the first two years and then became negative in later childhood, allowing the 
control group to catch-up in size. 
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6.3.3.3 Blood pressure 
At 2.5 years, there was a 2.5 mmHg (95% CI: 0.5, 4.6) lower blood pressure in the MMN 
group, but in this follow-up we did not find a difference in systolic or diastolic blood pressure 
or in kidney dimensions. The mechanism by which birthweight relates to later blood pressure 
may be via its relationship with kidney size or, more specifically, nephron number, which is 
hypothesized to be related to essential hypertension.225 Presumably, as we found no difference 
in kidney size and body composition, blood pressure should also be the same. However, the 
relationship between nephron number and hypertension is not straightforward as 
compensatory hyperfiltration can occur, maintaining a lower pressure when there is a lower 
nephron number. 231  
We cannot say whether the two-year results were a true effect or one that occurred by chance. 
The practicalities of measuring blood pressure in two-year-olds in a field setting make it 
likely that there was a higher degree of error. The mean blood pressure was higher than the 
8.5 year measurements and the standard deviation was approximately two-and-a-half times as 
large. This should, however, have been the same for both trial groups.  
 
6.3.3.4 Effect modification 
Though not statistically significant, when stratifying by sex, there was a tendency for a larger 
effect of MMN in girls. This was seen at birth in the secondary analysis: girls +108 g (95% CI 
36, 179 g) and boys +49 g (95% CI -33, 122 g). A different effect might be biologically 
plausible, for example through sex-specific DNA methylation from alterations in maternal 
diet,408-410 smoking,411 or through differential fetal mortality. However, the test for interaction 
was negative and the study was not powered to find a difference in sex, so I would be 
cautious in the interpreting it. Other trials have been inconclusive. Friis et al showed a 
"marginally significant" interaction with length,273 Stewart et al showed a non-significant 
difference in height-for-age z scores, with boys being taller,268 and Roberfroid et al showed no 
interaction.253 
Maternal BMI also showed no difference, but the effect size was a little larger for mothers 
with BMI <18.5. This analysis was exploratory in that it was not powered to find an 
interaction and the maternal BMI variable may not have been accurate. An interaction cannot, 
therefore, be ruled out.  Stratification reduces the sample size in each group, leading to wider 
confidence intervals and to find an interaction the sample size needs to be approximately four 
times larger. A further limitation was that we did not have pre-pregnancy maternal BMI, but 
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used maternal BMI from the 2-year follow-up, assuming that maternal BMI would not have 
changed dramatically within the time frame. 
 
6.3.3.5 Generalisability 
Generalisation of the findings may be limited by non-representative recruitment to the 
original trial or differential loss to follow-up. It is possible that women who chose to 
participate differed systematically from those who did not. Although we adjusted internally 
for socioeconomic status, rural participants may have been from more affluent groups who 
could afford to travel to the urban hospital for antenatal care. 
 
In summary, the anthropometric findings showed that the difference in weight, present at 
birth and at two years, was not evident at eight years of age. These results do not rule out a 
future difference in anthropometry emerging, nor do they rule out health benefits, but they do 
suggest no lasting effects of antenatal multiple micronutrient supplementation on weight in 
mid-childhood.  
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6.4 Respiratory results 
On the basis of a similar trial of antenatal vitamin A supplementation in humans,177 and of 
animal studies,176,184 I hypothesised that children who had received antenatal MMN 
supplementation would have better spirometric lung function at 8 years of age than control 
children. 
 
6.4.1 Analysis 
Where possible, we did not perform spirometry if the child was unwell. Six children were 
unable to perform spirometry: five had developmental delay and one poor co-ordination. 
Spirometry data from a further 42 (5.0 %) children were excluded because of poor technique, 
representing an overall failure rate of 5.7%. I examined all spirometry curves and chose FEV1, 
FVC and FEF25-75 values as described in section 3.12. To confirm that any low results were 
not due to poor technique, I re-examined all 119 results where the values were <1 litre. The 
trial profile for the respiratory analysis including exclusions is shown in Figure 45. 
 
For the restricted analysis, children were excluded due to illness: 
1. Acute illness or symptoms during spirometry: n=8. 
2. Chronic or major illness (asthma, congenital heart disease, hydronephrosis, nephritic 
syndrome, recurrent pneumonia, rheumatic fever, single kidney and tuberculosis), 
including an ISAAC asthma diagnosis or wheezing/whistling in the past year: n=51. 
3. History of pneumonia requiring hospital treatment (2 possible bronchiolitis, 2 
neonatal pneumonia and 47 pneumonia classified as major illness): n=51. 
In total, 95 children were excluded (some children had multiple illnesses).   
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Figure 45: Flow chart for respiratory analysis 
 
6.4.1.1 Primary analysis 
Lung function varies with age, sex, height and ethnic group. Lung function data were 
therefore adjusted for sex, age and height at time of testing using the Global Lung Function 
Initiative (GLI-2012) multi-ethnic,   ‘all-age’   reference   ranges, based on equations produced 
recently because lung function is known to differ by ethnic group. 26 These cover Caucasians, 
African-Americans, East-Asians  (‘North’  and  ‘South  East  Asia’).  An  ‘Other/Mixed’  category  
was also created from a composite of the four equations. As specific reference ranges do not 
yet exist for South Asia, the data were applied to each of the reference range equations using 
data   from   ‘healthy’   children   to   ascertain   best   fit,   based   on   the   fact   that   mean   (standard  
deviation) spirometry z-scores in a healthy population should approximate 0 (1).  Figure 46 
shows the results graphically and the data can be seen in Table 1, Appendix 6.4. A poster 
describing this work was presented at the European Respiratory Society annual conference 
2013.  
None of the reference ranges were perfect. The African-American GLI equation provided the 
best fit for FEV1
 
(mean (SD) 0.09 (0.86) z scores) and the SE Asia equation was slightly 
better   for   FVC   (Figure   1).   The   ‘NE   Asia’   and   ‘Other’   equations   were   found   to   be  
inappropriate. FEV1/FVC was interpreted appropriately using all the equations except the 
equation for SE Asia. After consultation with Professor Janet Stocks, who advised on the 
Control
427 completed questionnaires
Intervention
424 completed questionnaires
422 completed anthropometric 
measurements
419 completed anthropometric 
measurements
3 unable to come for 
anthropometric measurements
   1 moved to India
   1 could not come in time
   1 did not want to come
2 deaths >2.5 years
4 unable to come for 
anthropometric measurements
   1 moved to India
   1 could not come in time
   2 did not want to come
1 death >2.5 years
393 acceptable results
350 acceptable results in a 
healthy population
400 acceptable results
357 acceptable results in a 
healthy population
29 poor technique 19 poor technique
43 acute or prior illness that 
may affect lung function
43 acute or prior illness that 
may affect lung function
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respiratory aspect of the project, it was decided that, in the absence of South Asian equations, 
the Caucasian ones should be used for group comparisons as these are based on the largest 
amount of data and may be considered a normative standard.  
Primary analysis was based on all children with technically acceptable spirometry results. The 
association between birthweight and child lung function was first investigated. Data were 
examined by allocation group, the distribution of the variables was assessed for normality, 
and allocation groups were compared with two-tailed t tests.  
 
6.4.4.2 Secondary analysis  
The secondary analysis excluded children with acute or chronic illness or prior pneumonia 
requiring hospitalisation, adjusted for potential confounders and looked at effect modification 
by sex. A directed acyclic graph was created showing our a priori assumptions about the 
causal relationship between the variables in the study (Figure 47). It was used to decide which 
variables to control for in the multivariable regression to increase the precision of the result. I 
developed multivariable linear regression models adjusting for air pollution, food access and 
diversity, maternal education and height, household asset score, residence and maternal height 
(the latter to augment information on diet and socioeconomic status). I also included 
covariates for maternal education and residence to offset the potential effects of differential 
loss to follow-up340, and a term identifying the spirometer used. 
The model assumptions were tested as in section 6.2. Since distribution of FEV1/FVC was 
heteroscedastic, robust standard errors were applied to the regression models for this outcome. 
All analyses were conducted as intention to treat. 
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Figure 46: Comparison of data from Nepalese children according to ethnic-specific GLI 
equations. Solid horizontal lines = mean (SD) 
 
 
 
Figure 47: Directed acyclic graph showing association between variables measured.  
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6.4.2 Results 
841 children attempted spirometry. There were no differences between observers for FEV1 or 
FVC, nor within the biological control over time. A small difference in FVC was observed 
between the two spirometers (mean 0.15; 95% CI 0.03, 0.26 z-scores), and this was therefore 
included in the multivariable model.  
 
6.4.2.1 Exclusions 
Although the prevalence of asthma was extremely low (< 2%, see section 6.6), 95 (11.3%) 
children had evidence of acute or chronic illness that might have affected lung function, some 
of whom had multiple diagnoses; nine out of 95 (9.5%) also had poor technique. Although 
lung function was somewhat lower in children who were excluded on health grounds, 
excluding them had relatively little impact on summary results from either trial group (Table 
40). There were no anthropometric or sex differences between children excluded on health 
grounds and the remaining children. 
 
6.4.2.2 Lung function of entire cohort 
When expressed in relation to predicted values for Caucasian children, mean (SD) z-scores 
for   the   entire   group   of   ‘healthy’   Nepalese   children  with   acceptable   spirometry   were   -1.15 
(0.8) for FEV1 and -1.05 (0.8) for FVC, corresponding to reductions of 13.7% and 12.4%, 
respectively, when compared with healthy Caucasian children (Figure 48). 26 The proportional 
reductions in both these outcomes meant that the FEV1/FVC z-score was, however, close to 
that predicted for Caucasian children (within 1.5%). Data for the whole cohort stratified by 
sex are shown in Table 2, Appendix 6.4.  
 
6.4.2.3 Birthweight and lung function 
Though a great deal of variability existed, there was a positive association between 
birthweight and childhood lung function. A one z-score increase in birthweight was 
associated with an increase of 0.10 z scores (95 % CI 0.04, 0.15) in FEV1 and 0.11 z scores 
(95% CI 0.06, 0.18) in FVC. Multivariable regression for the effect of birthweight on lung 
function, controlling for air pollution, dietary diversity, food security, maternal education and 
height, household asset score and residence, produced similar results. Scatterplots of 
birthweight against lung function can be seen in Figure 49.  
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6.4.2.4 Effect of antenatal micronutrients 
Anthropometry and lung function results stratified by trial group in those with technically 
acceptable spirometry, along with those excluded due to illness, are shown in Table 40. The 
full spirometry results showing exclusion categories by allocation group are shown in Table 3, 
Appendix 6.4.  
Table 41 shows the difference in lung function values between the allocation groups in 
univariable and multivariable regression analyses. There were no significant differences in 
lung function between the control and intervention groups. The multivariable regression 
results in z scores (intervention – control) were -0.08 (95% CI -0.19 to 0.04) for FEV1, -0.05 (95% 
CI -0.17 to 0.06) for FVC, -0.04 (95% CI -0.15 to 0.07) for FEV1/FVC and -0.06 (95% CI -0.20 to 
0.09) for FEF25-75%. Adjustment for confounders and exclusion of children on health grounds 
made little difference to the results. When analysed according to sex, girls in the intervention 
group had slightly worse FEV1 than those in the control group, on univariable analysis  (-0.18 
95% CI -0.34, -0.02. Table 42), but not in the multivariable model. The effect on lung 
function independent of birthweight in girls was -0.21 (95% CI -0.37, -0.05) in univariable 
regression. In boys there was no difference (-0.05; 95% CI -0.22, 0.12). 
 
 
 
Figure 48: Frequency distributions for spirometry indices.  
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Figure 49: Scatterplots and linear fit for birthweight against FEV1 and FVC z scores 
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Table 40: Lung function and anthropometry by allocation group in those with 
acceptable spirometry 
Entire cohort Control n=393 
Mean (SD) 
Intervention n=400 
Mean (SD) 
Age (years) 8.5 (0.4) 8.4 (0.4) 
Weight z-score a -2.1 (1.0) -2.0 (1.0) 
Height z-score a -1.5 (0.9) -1.5 (0.9) 
BMI z-score a -1.7 (0.9) -1.6 (1.0) 
FEV1 b -1.11 (0.8) -1.18 (0.8) 
FVC b -1.02 (0.8) -1.07 (0.8) 
FEV1/FVC b -0.20 (0.8) -0.24 (0.8) 
FEF25%-75% b -0.48 (1.0) -0.53 (1.0) 
   
Children without evidence of prior significant 
disease 
Control n=350 Intervention n=357 
Age (years) 8.5 (0.4) 8.5 (0.4) 
Weight z-score a -2.1 (0.9) -2.0 (1.1) 
Height z-score a -1.5 (0.9) -1.5 (0.9) 
BMI z-score a -1.7 (0.9) -1.6 (1.0) 
FEV1 b -1.07 (0.8) -1.16 (0.8) 
FVC b -1.01 (0.8) -1.05 (0.8) 
FEV1/FVC b -0.15 (0.7) -0.22 (0.7) 
FEF25%-75% b -0.42 (1.0) -0.50 (1.0) 
   
Lung function results in children with 
technically acceptable data but who had 
evidence of acute or chronic illness or had been 
hospitalised for pneumonia  
Control n=43 Intervention n=43 
Age (years) 8.5 8.4 
Weight z-score a -2.1 (1.3) -2.0 (0.9) 
Height z-score a -1.5 (1.1) -1.5 (1.2) 
BMI z-score a -1.8 (1.2) -1.6 (0.8) 
FEV1 b -1.44 (1.0) -1.41 (0.9) 
FVC b -1.16 (0.9) -1.22 (0.8) 
FEV1/FVC b -0.57 (0.9) -0.34 (1.0) 
FEF 25%-75% b -0.92 (1.3) -0.77 (1.2) 
 
a  Anthropometry z-scores calculated according to WHO reference ranges.25 
b Spirometry z-scores calculated according to the Quanjer GLI-2012 spirometry equations 
based on Caucasian subjects.26 
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Table 41: Comparison of lung function (expressed as z-scores) in children, by allocation 
group 
 
 
 
Control 
n=393 
Mean (SD) 
Intervention 
n=400 
Mean (SD) 
t test 
p for 
difference 
Unadjusted 
difference  
(95% CI) 
Multivariable 
regression *  
(95% CI) 
Multivariable 
regression 
restricted to 
children 
without 
illness (95% 
CI) n= 707 
FEV1  -1.11 (0.84) -1.18 (0.79) 0.41 -0.08 (-0.19, 
0.04) 
-0.06 (-0.18, 
0.05) 
-0.07 (-0.19, 
0.05) 
FVC  -1.02 (0.83) -1.07 (0.81) 0.63 -0.05 (-0.17, 
0.06) 
-0.04 (-0.15, 
0.08) 
-0.03 (-0.15, 
0.09) 
FEV1/ 
FVC 
-0.20 (0.75) -0.24 (0.77) 0.60 -0.04 (-0.15, 
0.07) 
-0.04 (-0.15, 
0.07) 
-0.08 (-0.19, 
0.03) 
FEF25-75%  -0.48 (1.02) -0.53 (1.02) 0.56 -0.06 (-0.20, 
0.09) 
-0.05 (-0.20, 
0.10) 
-0.08 (-0.22, 
0.07) 
*Multivariable regression includes variables describing air pollution, dietary diversity, food 
security, maternal education and height, household asset score and residence, using robust 
standard errors. Analysis restricted to those with technically satisfactory results.  
 
Table 42: Lung function by allocation group, stratified by sex 
  Control  
Mean (SD)  
Intervention  
Mean (SD) 
Unadjusted 
difference  
(95% CI) 
Multivariable 
regression * 
(95% CI) 
Multivariable 
regression 
restricted to 
children 
without illness 
(95%CI) 
FEV1 Girls -1.18 (0.81) -1.36 (0.72) -0.18 (-0.34, -
0.02) 
-0.15 (-0.31, 
0.02) 
-0.15 (-0.32, 
0.02) 
 Boys -1.04 (0.86) -1.04 (0.82) 0.00 (-0.16, 
0.16)  
-0.02 (-0.19, 
0.14) 
-0.05 (-0.22, 
0.12) 
FVC  Girls -1.13 (0.84) -1.26 (0.82) -0.14 (-0.30, 
0.03) 
-0.10 (-0.28, 
0.07) 
-0.10 (-0.29, 
0.08) 
 Boys -0.92 (0.80) -0.91 (0.76) 0.01 (-0.14, 
0.16) 
-0.00 (-0.16, 
0.15) 
-0.00 (-0.17, 
0.16) 
FEV1/
FVC 
Girls -0.15 (0.74) -0.23 (0.80) -0.08 (-0.23, 
0.08) 
-0.06 (-0.23, 
0.10) 
-0.08 (-0.25, 
0.09) 
 Boys -0.24 (0.76) -0.24 (0.76) -0.00 (-0.15, 
0.14) 
-0.03 (-0.18, 
0.12) 
-0.08 (-0.24, 
0.07) 
FEF 
25%-75%  
Girls -0.57 (0.96) -0.69 (0.95) -0.12 (-0.32, 
0.07) 
-0.07 (-0.27, 
0.14) 
-0.08 (-0.29, 
0.12) 
 Boys -0.39 (1.07) -0.40 (1.07) -0.01 (-0.22, 
0.19) 
-0.06 (-0.27, 
0.15) 
-0.10 (-0.31, 
0.11) 
*Multivariable regression includes variables describing air pollution, dietary diversity, food 
security, maternal education and height, household asset score and residence, using robust 
standard errors. Analysis limited to those with acceptable spirometry data. 
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6.4.3 Discussion 
6.4.3.1 Main results  
Contrary to our initial hypothesis, there was no evidence of an effect of antenatal multiple 
micronutrient supplementation on lung function in Nepalese children at 8 years of age. 
Despite undertaking the study under somewhat challenging field conditions, we performed 
spirometry on 80% of the children available for follow-up between the ages of 7-9 years, with 
technically satisfactory results achieved in 94.3% of subjects. After excluding children with a 
significant prior medical history, and adjusting for height, age and sex, FEV1 and FVC in 
‘healthy’   Nepalese   children   were   approximately   13%   lower than expected for Caucasian 
children.  
As described in section 2.6, previous animal and human evidence has suggested potential 
long-term effects of antenatal micronutrient exposure. The best evidence exists for vitamin 
A.178,412 Supplementation in both animals176 and humans177 has shown positive effects on lung 
function. In a follow-up at 9-13 years of age of an antenatal vitamin A supplementation trial 
from the adjoining district of Sarlahi, the intervention group had greater mean adjusted FEV1 
and FVC, of 46 ml in both cases. The differences in trial design (cluster versus individually 
randomised trials), comparator group (placebo) and dosage (longer period of supplementation 
with a 20% higher dose), as described in section 2.6, may account for the differing results of 
our study and that of Checkley et al. 177,182 The difference in the control group may be 
important. Though not a clear association, antenatal folate, a potent DNA methylator, has 
been implicated in respiratory disease in children. 243-245  
Since no specific reference range currently exists for the South Asian population, we chose to 
use the GLI Caucasian equations 26 to adjust for age, sex and height before investigating the 
potential effect of antenatal MMN supplementation. As expected, FEV1 and FVC values were 
lower than would be expected for Caucasian children, and were slightly lower than those 
observed in children from South Asia whether living in the UK 413 or in India.414 Ethnic 
differences may be due to differences in anthropometry or body composition. While the 
Caucasian equations were not a perfect fit, they were chosen for comparison as they have 
been produced with the greatest amount of evidence and could be considered a normative 
standard. The larger population on which the Caucasian equations are based would give 
greater precision, but may be less accurate. 415 
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6.4.3.2 Birthweight 
The difference in FEV1 of 0.02 z scores was equivalent to 43 ml per 500 g increase in 
birthweight. This is comparable to the studies looking at the association between birthweight 
and adult lung function, which showed an approximately 50 ml FEV1 increase per 500 g 
birthweight.  168,416 
 
6.4.3.3 Effect modification 
In a secondary analysis I looked at the effect in boys and girls separately. While generally not 
reaching statistical significance, there was a tendency for antenatal MMN to have a 
detrimental effect on FEV1 and FVC in girls, but not in boys. The effect was similar for both 
indices, so there was no difference in the ratio and also no difference in FEF 25-75. While not 
statistically significant, there was also a tendency for girls to be a little heavier than boys, but 
not taller. Overall, the difference was small and may well have occurred by chance.  
 
6.4.3.4 Strengths and limitations 
The sample size for the study was large, with an excellent follow-up rate, no evidence of bias 
in those lost to follow-up and few exclusions due to poor spirometry technique. The trial 
groups were well-balanced and potential confounding factors were documented and 
controlled for. It is possible that any effect of MMN supplementation could have been 
masked by unadjusted confounding. While we controlled for air pollution in the regression 
models, an antenatal nutritional intervention may have no effect at such high levels. Our air 
pollution estimates were directly measured, but were only based on a subsample. It is, 
however, unlikely that there would have been marked differences in results had it been 
possible to undertake personal exposure estimates in all individuals.  
 
In summary, we found lower average spirometry values compared to Caucasian children, but 
no long-term difference in lung function or respiratory disease resulting from antenatal 
multiple micronutrient supplementation.  
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6.5 Health questions 
6.5.1 Results 
The questionnaire asked about illness in the last seven days and in the last year. The results 
for the whole cohort are shown in Table 43. Fever was very common, experienced by 
approximately 5% in the last week and 80% in the last year. Other illnesses were rare. The 
results by allocation group are shown in Table 44. No difference in the occurrence of illness 
was apparent between the groups, so no statistical analyses were done.  
 
Table 43: Health results for the whole cohort 
 In the last 7 days In the last 12 months 
 Number of children (%) Number of 
children (%) 
Median 
number of 
episodes 
Range 
Fever 46 (5.4) 687 (81.0) 2 1 to 12 
Diarrhoea 4 (0.5) 6* (0.7) 1 1 to 5 
Blood in stools 3 (0.4) 30 (3.5) 2 1 to 12 
Pneumonia 2 (0.2) 19 (2.2) 1.5 1 to 12 
Fast breathing 4 (0.5) 16 (1.9) 2 1 to 12 
Chest indrawing 3 (0.4) 15 (1.8) 2 1 to 12 
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Table 44: Self-reported illness over the last week and last year and food security by 
allocation group. Data presented as number (%) unless otherwise specified.  
 Control (n = 422) Intervention (n= 419) 
Illness in the last 7 days   
x Fever 23 (5.5) 22 (5.3) 
x Pneumonia 0 (0.0) 2 (0.5) 
x Fast breathing 1 (0.2) 3 (0.7) 
x Chest indrawing 0 (0.0) 3 (0.7) 
   
Illness in the last 12 months   
x Fever 346 (82.0) 336 (80.2) 
x Persistent diarrhoea* 2 (0.5) 4 (1.0) 
x Blood in the stools 11 (2.6) 19 (4.5) 
x Pneumonia 9 (2.1) 10 (2.4) 
x Fast breathing 7 (1.7) 9 (2.2) 
x Chest indrawing 8 (1.9) 7 (1.7) 
x Doctor diagnosis of asthma 4 (0.9) 9 (2.1) 
x Wheeze 7 (1.7) 9 (2.1) 
x Dry cough 91 (21.6) 107 (25.5) 
*Persistent diarrhoea lasting for >13 days.  
 
 
6.5.2 Discussion 
Reported morbidity was high, as indicated by how common fever was, but the occurrence of 
specific symptoms was rare. The questions were chosen to represent conditions that would 
affect growth and respiratory outcomes, particularly pneumonia and persistent diarrhoea. As 
discussed in section 6.6, the prevalence of asthma, based on questionnaire or clinical, 
diagnosis, was low.  
It is difficult to corroborate illness reports without reliable medical records. Hospital or clinic 
records are often not kept and only represent a proportion of children seen in hospital. 
Children from poorer households may not be taken to see health providers when unwell, 
particularly those who have to travel large distances. Anecdotally, it seemed that it was 
common for parents to take their children to a medical practitioner of some sort - a medical 
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assistant or pharmacist, for example - but records of these interactions are not kept. We relied 
on parental recall, which is potentially prone to bias. This may act to increase the recall of 
major illness, but to forget less common ones. We would, however, expect recall bias to be 
similar in both trial groups.  
In summary, while fever was common, recall of specific illness was rare. There was no 
obvious difference between the trial groups.  
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6.6 Asthma and air pollution 
Using the ISAAC questions, in this analysis I sought to estimate the prevalence of asthma in 
children aged between seven and nine years, and then to investigate the association between 
air pollution and the risk of wheeze and rhinitis. Exposure to indoor air pollution at an 
individual level is generally high due to the use of biomass fuels for cooking by about 75% of 
households,40 and has been considered before for children in Nepal,417 but this study went 
further by using personal exposure estimates of air pollution both indoors and outdoors for 
each child.  
 
6.6.1 Analysis 
A directed acyclic graph based on a priori knowledge was constructed, from which potential 
confounding factors were selected for inclusion in multivariable logistic regression models 
for boys and girls separately (Figure 50). I controlled for socioeconomic status, maternal 
education and urban or rural residence. In a similar method to that described in section 5.2, a 
socioeconomic score variable was created using principal components analysis, including 
household assets and house structure, divided into quintiles. Biomass fuel use was not 
included as a potential component as it was the exposure variable in this analysis.379 To 
explore the association between air pollution and dry cough, the exposure variable was 
divided into tertiles (the numbers were too small to investigate wheeze and sneezing in this 
way).  
 
6.6.2 Results 
Questionnaire data were obtained from 848 children. Fourteen were excluded from the 
analysis as they were from outside the region (where we did not have air pollution estimates). 
While 14.7% of children had ever had wheezing or whistling, there was a very low reported 
prevalence of wheeze of 1.9% in the last 12 months (see Table 45). A further six children not 
detected by the ISAAC questionnaire had a clinical diagnosis of asthma from their doctor. In 
contrast, dry cough at night was very common, reported by approximately a quarter in the last 
year. Approximately one-in-ten children had nasal symptoms and these were slightly more 
common in the winter season. 
The air pollution exposure results are described in section 5.1. The results for association of 
air pollution with wheeze, dry cough and sneezing, runny or blocked nose are shown in Table 
46. In girls, there was no association between air pollution and any of the outcomes 
investigated in univariable or multivariable regression models. In boys, there was an 
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association with dry cough at night: odds ratio (OR) 1.15 (95% CI 1.05, 1.26) for a 10 µg/m3 
increase in air pollution. There was no association with sneezing, runny or blocked nose. In 
comparison with the lowest tertile of air pollution, the OR in boys for dry cough at night was 
1.66 (95% CI 0.94, 2.91) for the middle tertile and 2.37 (95% CI 1.35, 4.17) for the upper. 
 
 
 
Figure 50: Directed acyclic graph showing the relationship between air pollution and 
wheeze 
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Table 45: Responses to the ISAAC questions, for 834 children in southern Nepal, 2012 
  Number who answered yes (%) 
Asthma  Girls Boys 
Has your child ever had wheezing or 
whistling in the chest at any time in 
the past? 
 52 (12.8) 70 (16.3) 
Has your child had wheezing or 
whistling in the chest in the past 12 
months?   
 9 (2.2) 7 (1.6) 
How many attacks of wheezing has 
your child had in the past 12 months? 
1-3 6 6 
4-12 3 1 
In the past 12 months, how often, on 
average,   has   your   child’s   sleep  been  
disturbed due to wheezing? 
Never woken with 
wheezing 
3 2 
Less than one night/week 3 4 
One or more nights/week 3 1 
In the past 12 months, has wheezing 
ever been severe enough to limit 
your   child’s   speech   to   only   one   or  
two words at a time between breaths? 
 4 2 
Has your child ever had asthma?     3 (0.7) 6 (1.4) 
In the past 12 months, has your child 
had a dry cough at night, apart from 
a cough associated with a cold or 
chest infection? 
 90 (22.2) 108 (25.2) 
    
Rhinitis    
Has your child ever had a problem 
with sneezing, or a runny, or blocked 
nose when he/she DID NOT have a 
cold or the flu? 
 49 (12.1) 55 (12.8) 
In the past 12 months, has your child 
had a problem with sneezing, or a 
runny, or blocked nose when he/she 
DID NOT have a cold or the flu? 
 42 (10.4) 44 (10.3) 
In the past 12 months, has this nose 
problem been accompanied by itchy-
watery eyes? 
 5 (1.2) 5 (1.2) 
In which of the past 12 months did 
this nose problem occur? 
Monsoon 10 8 
Post-monsoon 23 13 
Winter 21 31 
Spring/summer 13 13 
In the past 12 months, how much did 
this nose problem interfere with your 
child’s  daily  activities? 
Not at all 37 38 
A little 2 4 
A moderate amount 3 0 
A lot 0 2 
Has your child ever had hay fever?      8 (2.0) 12 (2.8) 
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Table 46: Associations between air pollution and ISAAC outcomes, for 834 children in 
southern Nepal, 2012 
  Univariable regression Multivariable regression* 
  Odds 
ratio** 
95% CI 
 
p Odds 
ratio** 
95% CI 
 
p 
Wheeze in 
the last 12 
months  
Girls 0.93 0.69, 1.25 0.620 1.10 0.80, 1.51 0.574 
Boys 1.41 0.96, 2.08 0.078 1.47 0.96, 2.25 0.074 
Dry cough at 
night in the 
last 12 
months 
Girls 0.99 0.91, 1.08 0.864 1.01 0.92, 1.10 0.906 
Boys 1.16 1.06,1.27 0.001 1.15 1.05, 1.26 0.002 
Sneezing/ 
runny, or 
blocked nose 
in last 12 
months 
Girls 0.96 0.69, 1.35 0.830 1.04 0.71, 1.53 0.847 
Boys 1.02 0.99, 1.05 0.235 1.02 0.99, 1.05 0.291 
*Adjusted for socioeconomic circumstances, maternal education, presence of a smoker within 
the household and urban or rural residence.  
** Odds ratios are for a 10 µg/m3 increase in PM4 (24-hour time-weighted average) 
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6.6.3 Discussion 
The findings showed a low prevalence of wheeze overall and severe symptoms were rare. 
Asthma is common in children worldwide, but its prevalence varies greatly by location. 
Estimates  of  “wheeze   in   the   last   12  months”   can   range   from  around  one-in-fifty to one-in-
three children. There is a positive association with gross national income and it is generally a 
little less common in girls than boys.418-420 While the prevalence was low compared with 
worldwide figures, it was in keeping with a review of studies from India that found a median 
prevalence of 4.75%, with some studies reporting <1%.421 A  study  from  Nepal’s  Kathmandu  
Valley that used a definition of wheeze or cough showed a prevalence of 6%. 417 
Dry cough was very common, reported in the last year by approximately a quarter of the 
sample. This may be a true phenomenon as the region is very dusty outside of the rainy 
season and air pollution levels are high, but it may also in part be a function of how the 
question was interpreted. A previous study from the Terai found slightly higher figures for 
wheeze in children aged 9-13 years, but the prevalence of cough was much lower at 3-4%.422 
As discussed previously, the main limitation of our study for assessing prevalence was that 
the sample may not have been fully representative of children from the region. The initial trial 
recruited women who chose to have antenatal care at a public hospital, and may have 
excluded both the poorest and the wealthiest. 
Exposure to air pollution is known to be associated with exacerbations of asthma on a day-to-
day basis, but the evidence for it playing a role in primary causation of asthma is mixed and is 
based mostly on data from high-income countries.423 There is evidence of increased 
prevalence of asthma in biomass-using households,424 and a case-control study from the 
Kathmandu Valley showed an increased odds of asthma associated with secondhand tobacco 
smoke (OR 1.9; 95% CI 1.0, 3.9) and biomass fuels (2.2; 95% CI 1, 4.5). 417 A non-ISAAC 
study by Shrestha and Shrestha looked at respiratory symptoms in adults and found an 
increased odds of both wheeze and cough of 4.75 (95% CI 1.4, 16.7) and 3.37 (95% CI 1.3, 
8.7), respectively, for people who used unprocessed fuels.425 Similarly, a trial of chimney-
stoves in Guatemala showed a reduction in wheeze in adult women of 58% (95% CI 0.25, 
0.70), but there was no difference in lung function. 426 Worldwide estimates have shown no 
association between PM10 and current wheeze,427 and a large multi-centre comparison of 
asthma prevalence showed an inverse association overall, but the results were inconsistent. 423 
Overall, we did not find an association between respirable particle mass and symptoms of 
asthma or rhinitis, except for dry cough in the last 12 months among boys. At this age, 
exposure to air pollution was similar in boys and girls as the children were generally not 
involved in cooking. It is possible that the gender difference in association with cough was 
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related to boys having a narrower airway calibre before puberty. 428 The lack of association 
with most outcomes may be a true phenomenon or potentially due to a plateau effect that has 
been described for respiratory illness.207 All the children were exposed to a high average 
concentration of air pollution and we had no individuals with lower exposure to compare with. 
It is possible that air pollution is associated with asthma prevalence at the much lower levels 
common in high-income countries. In keeping with our results, a review of the evidence 
showed an association of air pollution with cough alone. 429 
This study could not rule out alternative explanations due to its cross-sectional design. We 
can only make assumptions about causal associations. Air pollution, for example was 
measured at the same time as the outcome. We assume that the exposure to air pollution was 
similar to that experienced by the child previously. Other confounding factors may not have 
been included in our model: we limited our measurements to particle mass, but specific toxic 
components in the air may also be important.  
In summary, participants described a low prevalence of asthma and rhinitis symptoms 
consistent with other studies from South Asia. Air pollution levels were high in general, but a 
specific association was seen only with cough at night in boys. 
 
  
Chapter 6 
 249 
6.7 The effect of socioeconomic status on growth 
Socioeconomic status (SES) is associated with nutritional status in children in low- and 
middle-income countries,386,430-432 but how it affects the growth of different tissues in different 
periods is less well understood. Evidence is emerging of the importance of growth in different 
periods during childhood, not only on immediate health, but also on longer-term health and 
education. 406 A greater understanding of how and when SES may affect growth is important 
in countries in which levels of poverty are high and under-nutrition is common. I looked at 
the effect of SES on growth in two different periods in childhood: early in life at 0-2.5 years, 
and in mid-childhood at 2.5-8 years.  
 
6.7.1 Analysis 
I defined SES on the basis of owning a set of predefined household assets, using 
questionnaire data collected at birth. Asset score at birth was included as an ordered 
categorical variable as described previously. The questions included an asset rank used by the 
World Health Organization that stratified households into four categories, with more 
expensive items like a motor vehicle or a refrigerator given the highest ranking and having 
none of the items as the lowest rank. The two middle categories were collapsed due to low 
numbers.433  
I was not able to use the measures of SES as described in Section 5.2, because they were 
taken at 8 years, i.e. after the outcome. Only individuals for whom we had complete data at 
all three time points were included in the analysis.  
HAZ and WAZ25 at the three time points (birth, 2.5 and 8.5 years) were summarized. 
Variables representing stunting (HAZ <-2 z scores) and underweight (WAZ <-2 z scores) 
were created and used as dependent variables in logistic regression models. Linear regression 
was used to look at the relationship between asset score and lean and fat mass at 8.5 years.  
I then examined the association between SES and conditional height (CH) and conditional 
relative weight (CRW) in the two periods. Conditional relative growth at 0-2.5 years and 2.5-
8.5 years was estimated using the method described by Adair et al.406 Conditional height takes 
into account previous weight and height, while conditional relative weight accounts for 
previous weight and height, and also current height. Height can be considered a marker of 
skeletal growth and weight a marker of soft tissue growth. The inclusion of birth data in the 
8.5 year relative growth analysis had no effect on the model. Standardized residuals from 
linear regression models, using asset score as an ordered categorical variable were used as the 
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outcome. I constructed a causal diagram based on a priori assumptions (Figure 1, Appendix 
6.5). No confounding variables were thought to be present.  
 
6.7.2 Results  
Complete anthropometry data were available for 793 children (48.3% girls). Approximately 
half the families were in the wealthiest asset group. Our data showed a high prevalence of 
under-nutrition. At 8.5 years of age, just over half the children were underweight and 
approximately one third were stunted.  
HAZ and WAZ scores by SES are shown in Table 47. They suggest an inverse relationship 
for both indices, as confirmed by the reduction in odds of being stunted and underweight for 
each increase in rank of asset score. From level 1 to 2, there tended to be a non-significant 
reduction in odds, while a significant effect was seen when moving to level 3 in all cases 
except HAZ at birth. Similarly there was a no association between moving from level 1 to 2 
on lean mass (0.46 kg; -0.15, 1.07 kg) and fat mass (0.05 kg; -0.35, 0.46 kg). A significant 
association was seen when moving to level 3 on lean mass (1.34 kg; 0.77, 1.92 kg) and fat 
mass (0.59 kg; 0.22, 0.97 kg). 
The regression analysis showed a positive association between asset score and conditional 
height, with the exception of weight from 0-2.5 years (Table 48). Moving from asset level 1 
to 2 showed non-significant changes, while moving to asset level 3 had significant 
associations. The largest effect was on CH in the younger period. At 2.5-8.5 years, there was 
a similar effect for both CH and CRW.  
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Table 47: Mean weight- and height-for age z score at 0, 2.5 and 8.5 years in three asset 
score categories.  
  Asset score Odds of stunting and underweight  
(95% CI)* 
  1 (poorest) 2 3 (least poor) OR asset level 2 OR asset level 3 
Birth HAZ -0.42 -0.37 -0.30 0.97 (0.53, 1.78) 0.78 (0.44, 1.40) 
 WAZ -1.46 -1.15 -1.11 0.63 (0.41, 0.97) 0.54 (0.36, 0.82) 
       
2.5 
years 
HAZ  -2.63 -2.42 -2.03 0.75 (0.53, 1.07) 0.49 (0.35, 0.68) 
 WAZ -2.00 -1.83 -1.52 0.91 (0.63, 1.31) 0.60 (0.42, 0.85) 
       
8.5 
years 
HAZ -1.84 -1.66 -1.28 0.88 (0.60, 1.32) 0.49 (0.33, 0.72) 
 WAZ -2.45 -2.25 -1.82 0.88 (0.62, 1.25) 0.52 (0.37, 0.73) 
*Comparator group is asset level 1. The odds ratios for stunting (<-2 z scores) and 
underweight (<-2 z scores) are shown in the right hand columns. 
 
 
Table 48: Conditional relative growth, showing standardised residuals for height and 
weight in the two periods considered 
 Height Weight 
 0-2.5 years 
Standardised 
residuals (95% 
CI) 
2.5-8.5 years 
Standardised 
residuals (95% 
CI) 
0-2.5 years 
Standardised 
residuals (95% 
CI) 
2.5-8.5 years 
Standardised 
residuals (95% 
CI) 
Asset level 2 0.117 (-0.083, 
0.318) 
0.166 (-0.048, 
0.380) 
-0.009 (-0.214, 
0.195) 
0.060 (-0.154, 
0.275) 
Asset level 3 0.473 (0.285, 
0.661) 
0.320 (0.119, 
0.522) 
0.106 (-0.086, 
0.297) 
0.221 (0.190, 
0.423) 
*Comparator group is asset level 1.  
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6.7.3 Discussion 
The results confirm the finding of other research that SES is an important factor determining 
the anthropometric status of children. I have gone on to show that it may affect the growth of 
skeletal tissue, represented by conditional growth in height in both early and later childhood, 
and soft tissue, represented by conditional relative growth in weight in mid-childhood only.  
There was a consistent inverse relationship between SES and both HAZ and WAZ. In 
addition, the higher the household SES, the lower the risk of stunting or underweight in 
childhood and underweight at birth. A significant effect was seen when moving from level 1 
to level 3 in the asset score, i.e. the more expensive assets. SES was not associated with being 
short at birth,  
We defined growth as the residual of the regression model, conditional on previous 
anthropometry measures. It was therefore not just a change in height or weight, but a 
deviation from expected values. Similar to the results for stunting and wasting, moving from 
asset level 1 to 2 tended to have positive, but non-significant associations, while moving to 
asset level 3 had significant associations. The effect of SES was stronger on growth in height 
than weight, particularly in early life. This was supported by the greater effect on lean mass 
than fat mass at 8.5 years. Of interest was the lack of effect on soft tissue growth in early 
childhood. One possible contributing factor may be the high prevalence of breastfeeding 
across all socioeconomic levels in the region, such that - at least in early life - infants were all 
likely to have access to similar nutrition and this might mitigate some of the detrimental 
effects of low SES. At 2.5-8.5 years, there was a similar effect for growth in both height and 
weight.  
SES is a proximal  factor  that  does  not  directly  affect  a  child’s  ability  to  grow,  but  acts  through  
a number of complex pathways. An example is its association with illness. Low SES may 
increase the risk of contracting an illness, perhaps related to poor sanitation and inappropriate 
health  behaviours,  and  also  the  ability  to  treat  it  through  the  family’s  capacity  to  access  and  
afford healthcare. These factors act to influence the risk and severity of illness, which in turn 
increases the metabolic demands on a growing child and reduces their ability to absorb 
nutrients and, if severe, halts growth. Cross-sectional studies in low- and middle-income 
countries show that SES is positively associated with anthropometry and growth in children. 
Four longitudinal studies, all from Brazil, have confirmed these findings.430,434-436 Lourenço et 
al considered children of a similar age to ours and showed a positive association between 
wealth and height up to 10 years of age.434 The only study to look at a change in 
anthropometry was by Gigante et al,435 who showed that, while income was associated with 
height at 4 and 18 years, it was not associated with a change in height between the two time 
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points. They concluded that SES is important for early, but not for later, growth. They also 
suggest that in the lower social classes, social mobility is unable to significantly change the 
trajectory of height attainment.435 430 
A potential limitation of the study was the use of an asset score as an index of SES, as is 
commonly done with DHS data and was recommended by WHO at the time at the initiation 
of the study. SES is a complex concept to define and that there are many alternative methods 
and ideally other measures would have been used in addition to this, but they were not 
available.380 Accurate measures of consumption were not present and I felt that income would 
be unreliable as in this setting it is often seasonal and may be non-monetary. 
 
In summary, SES affects the growth of children when the family own more expensive assets. 
The greatest influence is on skeletal growth in early life.  
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7 Public engagement and dissemination 
 
“We  don't  see  things  as  they  are,  we  see  them  as  we  are.” 
Anais Nin 
 
 
As part of the research process we felt it was important to report the results to the participants 
and community. The public engagement aspect of this project involved dissemination of the 
main research findings to the participants and local community and an art project focusing on 
air pollution. In addition to this some of the results have been published and presented at 
scientific conferences. When conducting the air pollution measurements, it became evident 
that our participants did not fully understand the results and their implications. To help with 
this and also to develop further understanding ourselves, we ran a project with local artists 
exploring the use of biomass fuels for cooking.  
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7.1 Public engagement – main project 
There are a number of definitions of public engagement, the one I find most useful being from 
the National Co-ordinating Centre for Public Engagement: 
“Public  engagement  describes  the  many  ways  in  which  higher  education institutions and their 
staff and students can connect and share their work with the public. Done well, it generates 
mutual benefit, with all parties learning from each other through sharing knowledge, expertise 
and skills. In the process, it can build trust, understanding and collaboration, and increase the 
sector's  relevance  to,  and  impact  on,  civil  society.”  http://www.publicengagement.ac.uk/what 
 
7.1.1 Participants and local community 
We held two identical public engagement events over consecutive days in Janakpur, to which 
we invited the participants, the head teachers of the schools in which we did air pollution 
measurements and local government and NGO leaders. Approximately 150 people attended 
these events. During the events, senior MIRA staff summarised the results prior to the study, 
described the current project and mentioned the main results. Attendees were given written 
information about the project to take with them.  
We then presented the public engagement art project and showed replicas of the pictures the 
artists produced. Finally, we showed the main project and Smokescreen films that were 
created. The main project film was shot and produced by Sebastian Roberts, a medical student 
who did his elective with me. This film can be seen through the following link: 
http://youtu.be/nFkLOI9UHyw  
In addition, I spoke to a journalist from a local newspaper about the results of the project.  
 
7.1.2 Scientific community 
Summary of the results to the scientific community took the form of posters and presentations 
at scientific conferences and meetings and the publication of papers.  
Posters 
x Kular D, Devakumar D, Manandhar DS, Shrestha BP, Saville N, Osrin D. Food security 
status in southern Nepal: application of the Household Food Insecurity Access Scale 
questions”.  Nutrition Society Sustainable Diet and Food Security conference, Lille, 
France 28-29th May 2013 
x Devakumar D, Kirkby J, Manandhar DS, Osrin D, Shrestha B, Chaube SS, Stocks J. 
Applicability of the Global Lung Function Initiative (GLI) reference ranges to 
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spirometry data from children in Nepal. European Respiratory Society Annual Congress 
2013. 7-11th September 2013 
x D Devakumar, JCK Wells, SS Chaube, NM Saville, DS Manandhar, A Costello, JA 
Ayres, J Stocks, D Osrin. The long-term effects of antenatal multiple micronutrient 
supplementation in Nepal. 8th World Congress on Developmental Origins of Health and 
Disease, Singapore. 17th Nov 2013  
x Bartington SE, Bakolis I, Gulliver J, Devakumar D, Kurmi O, Osrin D, Ayres JG, 
Saville N, Costello A, Manandhar DS, Hansell AL. Domestic exposure to Carbon 
Monoxide and PM2.5 in biomass fuel households in Janakpur, Nepal. UK and Ireland 
Exposure Science Meeting. Manchester, UK. 4th March 2014 
 
Presentations 
x Devakumar  D.  “Antenatal  multiple  micronutrient  supplementation  in  Nepal”.  School  of  
Public Health, University of Saõ Paulo.  
x Devakumar  D.  “The  long-term effects of antenatal multiple micronutrient 
supplementation  in  Nepal”.  Wellcome  Trust  Bloomsbury  group  conference,  Kings  
College London, 1-3rd July 2013. 
x Devakumar  D.  “Antenatal  multiple  micronutrient  supplementation  in  Nepal”.  Body  
composition group, Institute of Child Health, UCL, 8th July 2013. 
x Presented by my MIRA colleague Mr Sushil Yadav at the Perinatal Society of Nepal 
conference: 
Devakumar D, JCK Wells, SS Chaube, Yadav SK, NM Saville, DS Manandhar, A 
Costello, JA Ayres, J Stocks, D Osrin.  “Follow-up of antenatal multiple micronutrient 
trial in Dhanusha  district,  Nepal”,  PESON  conference,  Kathmandu,  Nepal  28th 
November 
x Devakumar D, JCK Wells, SS Chaube, NM Saville, DS Manandhar, A Costello, JA 
Ayres,  J  Stocks,  D  Osrin.    “The  long-term effects of antenatal multiple micronutrient 
supplementation in Nepal”.  Commonwealth Association of Gastroenterology and 
Nutrition 13th scientific congress, Colombo, Sri Lanka, 6th Dec 2013 
x Devakumar  D.  “Longitudinal follow-ups. An example from antenatal multiple 
micronutrients in Nepal”.  Faculty of medicine, University of Colombo, 9th Dec 2013. 
 
Scientific papers published  
x Devakumar D, Semple S, Osrin D, Yadav SK, Kurmi OP, Saville NM, Shrestha BP, 
Manandhar DS, Costello A, Ayres JG. Biomass fuel use and the exposure of children to 
particulate air pollution in southern Nepal. Environment International. 2014 Feb 14; 
66C: 79-87. http://www.sciencedirect.com/science/article/pii/S0160412014000166  
 
Papers prepared  
x Devakumar D, Grijvala C, Roberts S, Chaube SS, Saville NM, Manandhar DS, Costello 
A, Osrin D, Wells JCK. Isotope calibration of the Tanita BC-418 bioelectrical 
impedance machine in children in Nepal.  
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x Devakumar D, Ayres JG, Bartington S, Stocks J, Chaube SS, Saville NM, Manandhar 
DS, Costello A, Osrin D. Cross sectional study of asthma and rhinitis in the context of 
exposure to air pollution in Nepal.  
x Devakumar D, Chaube SS, Wells JCK, Saville NM, Ayres JG, Manandhar DS, Costello 
A, Osrin D. The effects of antenatal multiple micronutrient supplementation on 
anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-
blind randomized controlled trial 
x Devakumar D, Stocks J, Ayres JG, Kirkby J, Yadav SK, Saville NM, Devereux G, 
Wells JCK, Manandhar DS, Costello A, Osrin D. Effects of antenatal multiple 
micronutrient supplementation on lung function in mid-childhood: follow-up of a 
double-blind randomised controlled trial in Nepal 
x Devakumar D, Kular D, Daniel R, Osrin D, Shrestha BP, Wells JCK, Manandhar DS, 
Costello A, Saville NM. The effect of socioeconomic status on the growth of children 
in Nepal 
 
Abstract published 
x Kular D, Devakumar D, Manandhar DS, Shrestha BP, Saville N, Osrin D. Food 
security status in southern Nepal: application of the Household Food Insecurity 
Access Scale questions. Proc Nutr Soc. 2013, 72 (OCE5), E314  
http://journals.cambridge.org/download.php?file=%2FPNS%2FPNS72_OCE5%2FS0029665
113003480a.pdf&code=377e2f0b8e813fa7e051a6bcc1b17fc3  
 
 
7.2 Smokescreen 
Following the main data collection, we ran a public engagement project focusing on air 
pollution. The project used art to explore the issues around indoor air pollution from cooking. 
Air pollution in the region is mostly caused by the indoor burning of biomass fuels and is 
disproportionately experienced by the women of the household who do the cooking. When 
performing the air pollution testing, a number of the participants asked us for more 
information about what we were doing and the problems with air pollution. While 
quantification of the level of air pollution is important, I felt that more could be done to 
identify the problems they face and come up with potential solutions. Our target audience was 
the women within our current micronutrient follow-up project in whose houses we obtained 
air pollution measurements. To help both them and us gain further understanding of the 
research, we designed a public engagement project to follow on, but the direction of the 
project was determined by the participants involved. I sought and obtained additional funding 
through a UCL Beacon public engagement award.  
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The main aims of the project were: 
1. Through the use of art, to get the people affected by indoor air pollution to help us 
understand the issues they face and the obstacles to change. 
2. To find potential solutions to the problem of indoor air pollution to inform future 
research. 
3. To involve some of the participants in our current follow-up, providing something 
tangible.  
4. To provide junior members of UCL and MIRA experience in public engagement. 
 
7.2.1 Art project summary 
The project ran over a period of four months: a month of set-up, two months of primary 
activities, and a month for the evaluation and final event. We brought together local women 
who had participated in previous projects and artists from the Janakpur Women's 
Development Centre (JWDC), to look at problems and think about potential solutions in a 
creative environment. The JWDC is a co-operative of female artists from poor local 
communities who produce Maithili art. As well as helping to preserve their artistic heritage, 
the centre works as a functioning business that helps to empower women. In addition to 
having experience of painting on walls, they have also worked on other health promotion 
pictures and have created a picture for our micronutrient follow-up project. 
In the initial phase, 50 women were identified and asked to take part. Of these, 34 attended 
focus group discussions. After starting the project one group ceased due to illness and time 
commitments, leaving a total of 29 participants who completed the project. Initially we had 
hoped to involve some men from the households as well, possibly in a separate group. This 
would have been important as the head of the household (and decision maker) is often a man. 
Unfortunately, it was not possible because of a combination of a lack of male volunteers and, 
on our part, not searching hard enough to find men.  
We held four focus groups at the start of the project, in which the women came together with 
an artist and a facilitator. They discussed the issues around air pollution such as the fuels they 
use and why they use them, the health effects of air pollution and possible ways to mitigate 
the effects. 
Women chose to meet regularly to design pictures that would describe the health effects of air 
pollution and ways to reduce it. The groups met approximately weekly with an artist and the 
MIRA facilitator. The original intention of the project was that small pictures would be 
produced in the kitchens of the participants. However, the participants chose to produce large 
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pictures that would be painted directly on walls and metal boards around the city. In total, 11 
pictures were made. A community meeting with local officials was held at which decisions 
were taken about where to display the pictures, after which negotiations took place with local 
officials.   As   well   as   in   locations   close   to   the   participant’s   home,   the   pictures  were   placed  
around the city; for example, in the main public hospital, the railway station and in a school. 
The pictures were also shown at our public engagement events. Examples of some the 
pictures produced are shown in Figure 51.  
To evaluate the project six semi-structured interviews (four with participants and two with 
artists) and a final focus group discussion with representatives of all the groups were 
performed. The main findings from these were: 
 
1. Issues and obstacles related to air pollution. While individual understanding of the 
problems was limited, collectively, and with the help of the facilitator, the women mentioned 
most of the detrimental effects of air pollution. One aim of the project was for the participants 
to teach us about the problems they face. Through the focus group discussions, interviews and 
artwork they helped to deepen our understanding. Choice of fuels, for example, is about more 
than just availability and cost. Issues such as the taste of the food and cooking traditions are 
also important.  
2. Solutions. The participants came up with some solutions that were portrayed in the artwork, 
such as improving kitchen ventilation and keeping children away when cooking. The project 
also drew attention to the subject of indoor smoke in the community. The women could see 
that air pollution is an important issue and were able to highlight the problem to others 
through their large pictures. In terms of change, they described changes they had made to 
their cooking practices, such as cooking in better ventilated areas. One woman made a 
structural change to her house. She knocked down a wall and had a new one built to allow the 
smoke to escape.  
3. Involvement of participants. The most pleasing aspect of the project was the enthusiasm of 
the participants, who all reported back positively. Twenty-nine of the 50 people asked 
completed the project, committing their time for four months. Even though the women could 
meet as often as they liked, or not at all, they chose to do so weekly. They had long, detailed 
discussions about the subject and really seemed to enjoy the art work. As a testament to this, 
the   facilitator   said   that   normally  when   she   runs  women’s   groups once a month she has to 
contact the women to persuade them to come. In this project, the participants were calling her 
weekly to ask her when she was coming.  
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This was the first experience of public engagement for myself and the MIRA staff member 
who ran the project. There were also two interns who helped with the project, both of whom 
were contributing to a public engagement project for the first time. As shown in the staff 
evaluation, all junior members enjoyed the project and learnt a great deal from it, both in 
terms of the public engagement process and about the subject matter. One member 
commented   that   it   was   a   “thrilling,   eye-opening   experience”.  Another   said   how   happy   she  
was  to  have  this  opportunity:  she  learnt  how  to  “think  for  myself”  and  “computer skills and 
English”.  On  the  negative  side,  language  limited  the  degree  to  which  the  two  British  interns  
could contribute.  
 
7.2.2 Film 
A film documenting the project process was made by Dinesh Deokota, a Nepalese filmmaker 
I hired. He visited the site a number of times, filming the groups and the artists to tell the 
story of the project. The full version of the film in English can be seen at 
http://youtu.be/dHvlzrVBLOY. The original version in Nepali shown at the event can be seen 
at http://youtu.be/Xa-5eEY57MI. 
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Figure 51: Photos from the Smokescreen project showing the creation and some of the 
final pictures 
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8 General discussion 
 
“When  my  information changes,  I  alter  my  conclusions.  What  do  you  do,  sir?” 
John Maynard Keynes 
 
 
The PhD set out to investigate the lasting effects of multiple micronutrient supplementation in 
pregnancy, with a focus on growth and lung function. In addition to this, I considered a 
number of other factors: air pollution exposure, measures of food security and socioeconomic 
status, and public engagement. The findings of each have been discussed up to this point. In 
this chapter, I begin by discussing the main objectives of the study in terms of the long-term 
effects of antenatal multiple micronutrients on growth and lung function of children. I 
describe possible explanations for the results and questions arising from them. In the second 
half of the chapter I consider whether multiple micronutrients should be given to pregnant 
women in low- and middle-income countries and the policy options related to nutrition 
supplementation. 
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8.1 Multiple micronutrient supplementation in pregnancy 
In this section I consider whether the findings from the study are correct and possible 
explanations for why an effect was not seen. I then discuss whether a health advantage might 
emerge in the future and whether the results could be generalizable. 
The results showed that MMN supplementation did not lead to apparent differences in 
phenotype at eight years of age. Our results were similar to those of the other follow-up 
studies described in Section 2.9, which found no difference in long-term outcomes. The only 
outcome that may have been different was head circumference, but this could have been a 
chance finding. Efficacy trials also tend to show more positive findings than in a real-life 
setting, so any effects are likely to be further attenuated. It is important to remember, though, 
that the comparator group was not placebo. The results suggest that MMN – at least at one 
recommended daily allowance (RDA) and over the second and third trimesters - had no 
additional benefits over iron and folic acid, rather than having no effect at all.  
Explanations for the results are either that there was truly no difference at eight years or that 
we were unable to detect a difference. If there were no lasting effects of antenatal MMN, it 
may be that their effects were transient, perhaps through reversible epigenetic changes. 
Methylation early in life tends to be irreversible, but it may be that any changes happened too 
late to modify growth trajectory or are, in fact, reversible. Neither transgenerational nor 
current environmental influences are likely to be redressed over the course of two trimesters 
of micronutrient supplementation. Any beneficial effect may be dwarfed by the detrimental 
effects of the environment.  
The second possibility is that long-term physiological effects were present but undetected. 
We can have confidence in our results. Our follow-up rates were high, with little evidence of 
differential loss to follow-up, and measurement error was low so, other than by chance, it 
would seem unlikely that there was a large effect that we were unable to find. In addition, we 
assumed that, if not measured and included in the multivariable regression, alternative causes 
of growth were balanced across the intervention and control groups as a result of 
randomisation. It is therefore unlikely that a type II error occurred. It is conceivable that the 
difference in anthropometry was still present, but had diminished over time. Multivariable 
models showed a difference in mean weight of 295 g, similar to the difference at 2.5 years of 
age, but a much smaller proportion of the weight of an 8-year-old. It may be that the 
intervention only had an effect in early childhood, and this difference was maintained in 
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absolute terms. To be able to detect a difference of this magnitude would require a sample 
approximately ten times as large.9  
If nutritional interventions in-utero do lead to phenotypic differences in childhood, as 
predicted by the DOHaD theory, potential reasons for a lack of effect are that the dose or 
timing of the micronutrients were incorrect or that a threshold effect exists.  
Dose - despite being given at one RDA, the dose was potentially suboptimal. Calls have been 
made for an increased dose of micronutrients.22 Levels were tested in a subsample and 
vitamin A and iron were  about  10%  lower  than  expected.  It  may  also  be  that  a  “one-size fits 
all”   approach   is   not   appropriate   and   more   tailored   supplements   are   needed   relating   to   the  
likely micronutrient, and possibly also macronutrient status, of pregnant women. 
Timing - At 12  weeks’  gestation,  MMN  given  in  pregnancy  may  have  been  too  late  to  effect  
changes  in  the  woman’s  phenotype  and  energy  stores.  It  is  also  probably  too  late  to  improve  
micronutrient stores sufficiently. In-utero weight gain happens mostly in the third trimester, 
but DNA methylation occurs mainly around the time of implantation. By 12 weeks, the fetus 
is mostly formed and the scope for change is limited.  
Threshold - While diets were likely to be balanced, it may be that a threshold rather than a 
dose-response effect exists. Potentially, a deficiency leads to a deficit in lung function, but 
once adequate levels are reached there is no further benefit. An important micronutrient to 
consider here is vitamin A because supplementation programmes for children under five years 
of age have existed in Nepal since 1993. The 2011 Nepal Demographic Health Survey 
showed that 79% of children in the Terai aged 6-59 months received vitamin A supplements 
in the last six months. 43 Lung development continues into childhood161 and supplementation 
may correct any deficit in both trial groups, resulting in similar lung function in childhood. 
The degree to which the childhood supplementation programme had an effect would 
presumably depend on vitamin A sufficiency in a child, when exactly they receive the 
supplement and the level of maturity the lungs have reached.  
 
In addition to the main findings, the effect of antenatal MMN may have been a little different 
in boys and girls. Girls were slightly heavier and had a lower FEV1 (approximately 0.2 z 
scores for each), while there was no effect in boys. Head circumference was also a little larger 
                                                     
9 A difference of 0.2 z scores is approximately 740 g (700 g in boys and 780 g in girls) in an eight-
year-old. Based on the number of children found, the power to detect a 200 g (approximately 0.06 z 
scores) difference would be 14%. To find a difference of 200 g would require a sample of 8700 
children. 
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in girls (0.27 cm; 95% CI -0.00, 0.54), compared to boys (0.09 cm; 95% CI -0.14, 0.32) and 
the data from birth showed that girls were heavier. 7 The differences were not statistically 
significant and no interaction was found, so we should be cautious in the interpretation, but 
the findings are potentially consistent with biological mechanisms described previously and 
do raise an interesting question of whether a trade-off in tissues has occurred. The expensive-
tissue hypothesis describes how the body reduces the size of one organ to preserve energy for 
another, as implicated in the thrifty phenotype hypothesis. 437 Such trade-offs have been seen 
in studies comparing brain mass and gut mass in fish438 and pectoral muscle mass (used for 
flight) in birds.439 Research in mammals has generally found evidence against this hypothesis, 
but the results did indicate that lung tissue mass may be negatively correlated with adipose 
tissue. 10 440  
 
Later effects 
While the findings at 8 years were null, we cannot rule out the re-emergence of a difference 
between the trial groups later and it is still possible that the birthweight advantage may have 
longer-term health effects. While they seemingly lose the advantage they had, the slower 
relative growth of children of greater birthweights may be linked with physiologic differences, 
as it is believed that being born small and having catch-up growth is detrimental to health in 
terms of later non-communicable disease.406 As seen in animal studies where rats were 
malnourished over many consecutive generations, it may also take multiple generations to 
return   to   a   “normal”   phenotype.   441,442 The difference in birthweight in girls, if real, could 
have important implications for the next generation. Research from the USA showed that the 
strongest predictor of offspring birthweight is maternal birthweight. 443 Evidence from cohort 
studies in Brazil also shows that maternal weight at birth and 20 months is associated with 
offspring birthweight. 126 It can also affect outcomes later in life. Barker et al showed that the 
birthweight of a woman was associated with the birthweight of her children and their blood 
pressure as adults. There was a 2.4 mmHg (95% CI 0.1, 4.7 mmHg) reduction in systolic 
blood pressure per one pound (454 g) increase in birthweight. 444  
 
                                                     
10 The authors did not specifically test the correlation between lung mass and adipose tissue, but did 
see a positive correlation between lung and digestive tract tissue and a negative correlation between 
digestive tract and adipose tissue. 
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Generalisability of findings 
The main findings should be generalisable to other women and children in similar settings in 
low- and middle-income countries (LMICs). A potential bias is that the women recruited to 
the trial were not from the richest or poorest demographics, as they were from a group who 
chose to give birth at Janakpur Zonal hospital. Recent data show that 32% of women in the 
Terai deliver in an institution, 43 this despite deliveries in government hospitals being free of 
charge. The figure is likely to be higher for people living in Janakpur as transport to the 
hospital is easier. I am uncertain as to whether this would have made a difference to the 
outcomes. The effect might have been greater in poorer, undernourished mothers, but no 
difference was seen when stratifying by maternal BMI. While not the poorest, compared to 
other countries, the women within the study were not well-off.  
 
Further questions arising from this study 
Follow-up of current cohort 
x Does an effect of antenatal MMN or of changing growth trajectories alter disease risk 
later in life, for example cardiovascular disease rates in middle-age? 
x Is there a difference in other organ systems between the groups, such as the nervous 
system?  
x Will MMN supplementation lead to a difference in the offspring of the children born 
in the study?  
Alternative studies 
x Would the outcomes be different if supplementation was started at a different time: in 
the first trimester or pre-conceptually? 
x Would a different combination, either of micronutrients or dosages, lead to a different 
outcome?  
x Other than sampling variation, what accounts for the differences between populations 
or the same population in different locations that have been shown in systematic 
reviews and follow-up studies? In studies that have examined antenatal MNN is there 
a sex-specific difference in outcomes? 
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8.1.2 Anthropometry and lung function of Nepalese children 
A striking finding was the low anthropometry (mean WAZ = -2.1, HAZ = -1.5) and 
spirometry (mean FEV1 = -1.2, FVC = -1.1) values for the children in our sample in relation 
to international standards. Approximately half the children were underweight, a third stunted 
and they had spirometry values >10% lower than Caucasian children. 26 The relatively lower 
percentage  of  lean  mass  (and  higher  fat  percentage)  is  in  keeping  with  the  idea  of  the  “thin-fat”  
phenotype described in India, 445 and has implications for studies of anthropometry in children 
as reporting BMI may not be reliable. 
The children started off life small and continued to get relatively smaller. This is supported by 
analysis of the 2011 Nepal Demographic and Health Survey, which showed that children <12 
months of age were significantly less likely to be underweight than those between 12 and 60 
months. 43 Victora et al, who looked at growth up to the age of five in 54 LMICs, showed a 
reduction in anthropometry scores up to two years of age, but normal growth thereafter.446 
Contrary to this, we saw a reduction in weight-for-age (but not height-for-age) from two years 
onward, as well as earlier.  
The growth patterns seen may be a consequence of using worldwide growth reference ranges 
that do not account for different growth patterns in a particular population of children. The 
WHO growth curves were designed to provide normative standards for child growth, i.e. 
“how  children   should   grow”.   447 While population-specific reference ranges could be more 
appropriate, they may not be able to predict full growth potential, for example if all children 
are exposed to a particular risk factor.  
Aside from issues of classification, the reasons for growth deficiencies in children in our 
sample involve a complex web of genetic and environmental factors. Of interest was that our 
findings were in a context of low disease burden in mid-childhood, in a sample who were a 
little better off than some and in whom food security and dietary diversity were generally 
good. Alternative explanations include environmental stressors such as air-pollution and 
environmental enteropathy. As discussed in detail in Section 5.1, all children in our sample 
were exposed to much higher levels of air pollution than both national and internationally 
recommended upper limits, mostly due to the indoor burning of biomass fuels, but also to 
high outdoor levels most likely from displaced dust. Environmental enteropathy occurs when 
there is breakdown of the gut intestinal barrier resulting in flattened gut villi and 
inflammatory infiltrates. This leads to microbial translocation across the gut wall, resulting in 
a chronic inflammatory process and poor weight gain. Despite being very common, the 
causes are poorly understood, but are related to unhygienic conditions. 448 We were unable to 
test for this, but it does provide one explanation for the continued poor growth of all children. 
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Further questions arising from this study 
x Are the findings of continued poor growth of children in mid-childhood mirrored in 
other populations in LMICs?  
x Does growth in mid-childhood (and differences in lean and fat mass) have long-term 
implications in terms of adult anthropometry and health? 
Air pollution 
x Would repeat measures of air pollution taken over longer time periods produce 
similar results?  
x Would behaviour change interventions at the household level work to reduce air 
pollution exposure?  
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8.3 Policy implications 
Policies pertaining to nutrition are important for improving mortality and morbidity of women 
and children in LMICs. The concept of developmental origins of health and disease is gaining 
evidence and could have an important role to play in public health nutrition policy, by 
highlighting windows in which interventions can have maximal effect. Pregnancy is believed 
to be a time in which a woman can be motivated to change her behaviour for lasting benefit to 
herself and her offspring. The short-term goals within pregnancy can make health promotion 
activities more achievable; for example, smoking cessation to improve the growth of the fetus, 
rather than to reduce risk of cancer decades later. In addition to the immediate effects and the 
reduction in the burden of long-term chronic disease, such policies also touch on ideas of 
intergenerational equity or justice. The underlying factor for most, if not all, the outcomes 
investigated in this project is the socioeconomic status of the child and their family. 
Restructuring the social and economic hierarchy of a society is complicated and will take 
decades, possibly generations, but is likely to provide the most sustainable improvements. 
Several policies exist regarding food production and other factors relating to child growth and 
health. Shrimpton describes two categories of policy: normative or rights-based and needs-
based. MMN are primarily needs-based in terms of correcting maternal micronutrient 
deficiency, but also applies the normative standards of growth charts. 449 Designing policies 
that may be effective is a complicated process that only in part relies on the evidence. 
Potentially more important is the political will of the government and other international 
bodies. Walt and Gilson for example, describe the importance of context, process and actors, 
as well as the content of a policy in their description of the Health Policy Triangle. 450 The 
post-2015  “sustainable  development  goals”,  may  provide  an  opportunity  in  which  the  context  
is appropriate and relevant actors are willing to listen.  
The policy choices that pertain to the field of nutrition, at a user level, are supplementation 
programmes, food fortification or monetary policies. Fortification, recommended by WHO,451 
can occur at a universal level or be targeted at a specific group. Fortification of all foods has 
the advantage that everyone gets the micronutrient. It may be appropriate for certain 
micronutrients that would not cause toxicity in high doses, but not for many micronutrients 
combined. Targeted supplementation with MMN can be used if certain foods can be 
identified for the relevant group. This would be difficult to do in this setting. 452 The extent to 
which fiscal policies would work in low resource, particularly subsistence farming, settings is 
questionable. They may help to make undesirable foods prohibitively expensive and a tax 
credit scheme could work in some populations, but I do not think it would be appropriate for 
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rural Nepal. The rest of this chapter will consider supplementation, specifically in relation to 
the UNIMMAP supplement in pregnancy.  
 
 
8.3.1 Should multiple micronutrient supplements be given to pregnant women from low 
and middle-income countries?  
Despite the relatively good evidence base for antenatal MMN, it is true that more research is 
needed and clear answers may only be available in the next generation. While we do not have 
a definitive answer to whether antenatal micronutrients are beneficial, the question remains 
and policy recommendations need to be made in the light of imperfect evidence.  
Supplementation has the advantage of being able to deliver the appropriate dose in a reliable 
form. In our study, the tablets were well accepted with very high compliance rates in both 
trial groups. As described by Shrimpton, delivery, rather than compliance, is the most 
important aspect.449 Delivering the micronutrients to pregnant women would be complicated 
but can be achieved, as shown by the example of immunisations. For energy and protein, 
community based programmes are probably best, but for micronutrients it is difficult to 
provide the right dosage. Supplementation has a clear causal mechanism and a relatively good 
evidence base. The argument against supplementation is that these programmes are not 
sustainable. It is a top-down approach decided by governments and often international bodies 
and may not have the support of the people affected. Taking a pill would create reliance on 
others and would not be as appealing as food. Supplementation does not solve the specific 
problems that individuals or populations may have.  
The main benefit of antenatal UNIMMAP supplementation is a small increase in birthweight 
and the corresponding reduction in the percentage of babies who are born with low 
birthweight or SGA. Birthweight has been shown in many instances to be positively 
associated with long-term health (excluding large babies). In this respect, MMN 
supplementation has been recommended by many. 22,452 Bhutta and colleagues (from The 
Lancet Nutrition Interventions Review Group and the Maternal and Child Nutrition Study 
Group) recommend the use of MMN supplementation instead of iron and folate. They 
calculate that 43 715 deaths would be averted by giving MMN in pregnancy at 90% coverage 
in the 34 countries most in need. Along with nine other nutrition interventions, their models 
suggest it would reduce deaths by 15% in children under 5 years of age and reduce stunting 
by 20%. 452  
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Cost 
Changing from the recommended alternative of iron and folic acid would be more expensive, 
but most of the costs are in the delivery of the supplement to pregnant women. The 
supplement itself would be <20% more than iron and folic acid in terms of production costs, 
though the price would vary with economies of scale. 453 Analyses by Bhutta et al suggest that 
the additional cost of MMN in pregnancy (at 90% coverage) in the 34 LMICs in which it 
would be most useful would be (International)$472 million ($244 million for consumables, 
$70 million for personnel and $157 million for other costs). The package of all ten nutrition 
interventions they recommend would cost (International)$9.6 billion. The other interventions 
they consider in pregnancy are calcium supplementation to mothers at risk of low intake and 
energy protein supplements as needed. 452 Using these figures and assuming a 20% higher 
cost of MMN than iron and folic acid and the same delivery costs, MMN would cost an 
additional (International)$50 million.  In global terms this is small.  
An   additional   “cost”   to   consider   is   the   opportunity   cost.   This   is   the   next   best   alternative  
forgone.  If (International)$472 is spent on MMN, what interventions would not be spent on? 
This is more difficult to gauge, but it is likely that supplementation beginning earlier or with 
macronutrients, or interventions to tackle upstream factors would be more effective. 
Opportunity cost would be context  specific  depending  on  a  country’s  budget  and  needs. 
 
8.3.2 Supplementation policy options 
Within supplementation programmes, there are four main options for policies: single 
micronutrients, multiple micronutrients, food or a combination of these. 
8.3.2.1 Single 
Single micronutrient supplementation is common worldwide. An evidence base, including 
mechanism of action and dosage, can be established relatively easily and the supplements can 
be targeted to the most useful time period (for example, folate periconceptually) or can be 
population specific (for example, iodine). It is also easier to convey why they are necessary: 
folate, for example, will reduce neural tube defects. The disadvantage, especially in 
populations with multiple nutritional deficits, is that women rarely require supplementation 
with only one micronutrient. Taking many separate tablets is complicated, confusing and 
likely to lead to reduced adherence. 
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8.3.2.1 Food 
Dietary changes are thought to be the best options as they can  be  incorporated  into  a  person’s  
lifestyle. Meta-analyses have shown that balanced protein/energy supplements probably lead 
to an increase in birthweight. Imdad and Bhutta found an increase in birthweight of 59.9 g 
(95% CI 33, 87 g) and a reduction of SGA of 0.69 (95% CI 0.56 to 0.85) due to the 
supplements.454  Ota et al found a similar increase in birthweight of 41.0 g (95% CI 4.6, 77.3 
g), corresponding to a reduction in SGA of 0.79 (95% CI 0.69 to 0.90) and increase in birth 
length of 0.16 cm (95% CI 0.01, 0.31 cm). The effect was a little larger in undernourished 
women (67.0 g; 95% CI 13.1, 120.8 g), while no effect was seen in adequately nourished 
women. The effects did not appear to last into childhood. 455 
The foods used need to be culturally appropriate and adaptable enough to be prepared in a 
variety of doses. When giving energy supplements, care should be taken not to increase the 
caloric intake to a level that would lead to obesity and gestational diabetes, as this can be 
detrimental to both fetus and mother. Food supplements are the most likely to be consumed 
and sustainable, but are more difficult to deliver safely with the right constituents and variety.  
 
8.3.2.1 Multiple micronutrients with other constituents 
The composition of the micronutrient supplements can be debated. The UNIMMAP 
supplement contains most micronutrients that would be useful, but some are missing. An 
example of one that might be useful is calcium, which has been shown to increase birthweight 
(by 85 g; 95% CI 38, 134 g) and may also reduce preterm birth (0.76; 95% CI 0.60, 0.97).154 
Due to the potential interaction with iron absorption, the addition of calcium may require a 
change in the iron dose, or it may need to be given as a separate supplement. 456 
 
8.3.2.1 Food and multiple micronutrients 
Intuition would suggest that the most useful supplement would be a combination of 
micronutrients and macronutrients to provide all the requirements for pregnant women. 
Huybregts et al looked specifically at whether food supplements with MMN are beneficial. 
They showed no effect on birthweight, but did find a difference in birth length of 4.6 mm 
(95% CI 1.8, 7.3) in the adjusted analysis. 457 The Bangladesh MiniMat trial compared MMN 
to iron and folic acid in two groups that either received protein-energy supplementation early 
(as soon as pregnancy was identified: usually first trimester) or at the usual time (their own 
choice: usually second trimester). MMN plus early food supplementation (2696 g; 95% CI 
2663, 2729g) had a slightly lower birthweight than later food supplementation (2710 g; 95% 
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CI 2657, 2745g), but this was not a significant difference. They found no difference in birth 
length. 11,271 
An example of this approach is described in Box 7 with  two  new  “ready  to  use”  products  for  
pregnant women by Nutriset: Enov'Mum and Plumpy'Mum. These products provide an 
appropriate combination of nutrition, but have all the problems of sustainability. In my 
opinion, this would seem most useful for countries or regions suffering from an acute 
problem, for example a natural disaster, rather than being a long-term solution. 
 
Enov'Mum  
A lipid-based supplement designed for non-emergency or chronic emergency contexts, 
though based on the guidance the WHO, World Food Program and UNICEF for populations 
affected by emergency.458  The supplement is very similar to UNIMMAP (with slightly 
different doses) but also contains calcium, phosphorus, potassium and magnesium, protein 
and  lipids.  The  cost  is  2.90  €/kg.   
 
Plumpy'Mum 
This is for women with BMI <18.5. The micronutrient content is similar, but it contains 
approximately three times the lipid and five times the protein content. The cost is 
approximately three times higher than  Enov’Mum. 
Box 7: Examples of nutrition supplements containing both macronutrients and 
micronutrients  
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8.4 My recommendation  
The wider goal of this project and other similar research is to provide evidence for public 
health policy. Health policies for low-income countries such as Nepal need to be a 
combination of factors that lead to short-term improvements in health and remediation of 
suffering, and longer-term prevention of the underlying causes of illness. Supplementation 
was designed to be an example of the former, but this research set out to investigate whether 
it could also relate to longer-term benefits. The meta-analyses showed an increase in 
birthweight which, as described in Chapter 2, is associated with improvements in health. The 
study by Bhutta et al, based predictions of mortality and morbidity on this difference in 
birthweight. The authors argue that this difference is sufficient to warrant nutritional policies 
with a resulting predicted fall in child mortality. 452 
Based on the evidence in my research, I would not advise a shift in nutrition policy from the 
current recommendation of antenatal iron and folic acid supplements. As described in Section 
2.8, the evidence base for these micronutrients can also be questioned, but they have been 
used for many decades and are considered safe.  
Both the positive and negative aspects of antenatal MMN supplementation need to be 
balanced when deciding whether to recommend the UNIMMAP supplement for pregnant 
women. While others may arise in the future, the main advantage of MMN supplementation 
at the moment is the small increase in birthweight. The main negative effects are the potential 
increase in neonatal mortality and the cost. I do not think antenatal MMN supplementation 
does increase mortality (at least, overall mortality) and the cost, while large, is relatively 
small for a global supplementation programme.  
I think supplementation can be a useful policy. In itself it does not make a difference to the 
root causes of nutrition problems, but can help to make a population healthier while other 
upstream policies are implemented. My reservation in recommending the UNIMMAP 
supplement is that the health benefits are based on the difference in birthweight and the actual 
evidence for improvements in mortality and long-term health is absent or limited. Birthweight 
is a composite of many processes that occur in-utero and the role of antenatal MNN in this is 
unclear. On balance, therefore, I would not recommend MMN.  
The null findings from the study do not definitively rule out future benefits later in life or in 
the next generation. If a difference in weight does truly exist in girls, as described by Prentice 
and Moore in Figure 4,86 and by Wells,459 improvements in maternal size may lead to 
improvements in birthweight in future generations. We therefore may not be able to assess the 
importance of MMN for many years to come, and the policy implications should be 
reassessed as new evidence accrues. 
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If not a change to antenatal multiple micronutrient supplementation, what should be done? 
Bhutta et al recommend calcium supplements, protein-energy supplements and iodine where 
required.452 Though not possible to assume from my research, it is likely that policies 
designed to improve the macronutrient intake of girls and women, in conjunction with 
micronutrients, would produce the best results in a population in southern Nepal. The results 
of previous meta-analyses indicate the need for pre-existing macronutrient status, 17 although 
the trials in Burkina Faso457 and Bangladesh11 did not find a difference.   
Understanding of causation can help us advise on the most productive policies and 
interventions. The conceptual diagram in Figure 40 shows the complex nature of child growth, 
with many interrelated factors. MMN supplementation makes up only a small part of this. 
Focusing on factors that have multiple connections and that are central to the causal pathways 
is likely to have the best chance of improving health. An example is maternal education. 
Based on our assumptions, improving maternal education will result in changes to child 
illness, breastfeeding and caring practices, air pollution exposure and healthcare seeking 
behaviour. In addition to improvements in the education system, improvements in gender 
equality would help to achieve this. The diagram does not, however, show the relative 
importances of these factors and further work would be required to elucidate it. The model 
also highlights the limitations of potential interventions in that a number of factors cannot be 
controlled for; for example, birth order and gestation. Understanding causation cannot 
influence the many other aspects involved in policy formation, such as the financial and 
political implications. 
In addition to nutrition policy, this research has provided evidence that can help to shape 
policy on air pollution exposure mitigation. Air pollution concentrations we found were very 
high. Policy has tended to encourage improved stoves and chimney ventilation based on the 
only trial in this subject area, the results of which were mixed.426,460 This work shows that 
exposure levels can potentially be altered by behaviour change (for example, avoiding areas 
of high air pollution concentration during certain times of the day). Further research into this 
topic area would be required as this study only points to a potential intervention and is not 
strong enough to warrant policy change.  
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8.5 Conclusions and summary 
Overall, my research has shown that MMN supplementation in pregnancy does not have 
lasting effects at 7-9 years of age. In addition to the main outcomes, I have documented the 
growth and respiratory status of children in southern Nepal and the degree of air pollution that 
they are exposed to. The study has shown that children in Nepal are both underweight and 
stunted and have lower lung function than international standards, and are exposed to very 
high levels of air pollution.  
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Appendix 1 
Appendix 1.1 Funding letter 
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Appendix 2  
Appendix 2.1 PRISMA guidelines 
  
Structured 
summary 
 
Objectives: to summarise the birthweight and SGA outcomes from trials using 
the UNIMMAP supplement in pregnancy and then to look at the long-term 
outcomes of these trials in childhood.  
Data sources: Medline, Embase and Psychinfo databases 
Study eligibility criteria:  
Intervention group uses UNIMMAP supplement in pregnancy  
Control group uses iron 30 mg and folic acid  
Participants: Pregnant women from low- and middle-income countries 
Interventions: UNIMMAP supplement 
Results: Birthweight and proportion of SGA 
Long-term outcomes: anthropometry, cognitive and cardiovascular 
Rationale The review was designed to look for any new trials of the UNIMMAP 
supplement, look at the combined effect of the UNIMMAP supplements in 
isolation and to look for long-term effects of these supplements. 
Objectives To summarise the birthweight and SGA outcomes from trials using the 
UNIMMAP supplement in pregnancy 
to look at the long-term outcomes of these trials in childhood.  
Protocol and 
registration 
NA 
Eligibility 
criteria 
All trials that have tested the UNIMMAP supplement in pregnancy in low- and 
middle-income countries. 
All studies that have followed up children from these trials.  
Trials reported in English 
Information 
source 
Databases: Medline 
No date restrictions.  
Search Present full electronic search strategy for at least one database, including any 
limits used, such that it could be repeated. 
Study selection Trials that use the UNIMMAP combination in pregnancy 
Data collection 
process 
 
Data were not confirmed with the authors.  
Though, the data from the original trials were compared with previous meta-
analyses. Where there was a discrepancy with one trial, the authors of the 
meta-analysis were contacted.  
Data items 
 
Birthweight and SGA proportion 
Any follow-up outcomes 
Risk of bias in 
individual 
studies 
No specific methods were used to assess bias in the original trials.  
In the follow-up studies, differential loss to follow-up was recorded.  
Summary 
measures 
Principal summary measures birthweight and proportion of SGA.  
Follow-up outcomes depended on the outcome.  
Synthesis of 
results 
Random effects meta-analysis was used to combine results of birthweight. This 
was done using adjusted data from the original trials and data from the meta-
analysis by Fall et al (Food Nutr Bull 2009; 30(4): S533-46), who had access 
to the original data. I2 were reported for each meta-­‐ analysis. 
Risk of bias 
across studies 
The trials have a low risk of bias. All were double blind randomized controlled 
trials.  
Additional An additional meta-analysis was performed with the addition of five of similar 
Appendices 
316 
 
analyses multiple micronutrient supplements. 
Study selection See section 2.9.3 
Study 
characteristics 
See section 2.9.3 
 
Risk of bias 
within studies 
Results of 
individual 
studies 
Synthesis of 
results 
Meta-analysis of UNIMMAP trials only using the data from Fall et al (Food 
Nutr Bull 2009; 30(4): S533-46): birthweight +24.01 g (95% CI 8.60, 39.41 g), 
I2 = 0% 
 
Meta-analysis of UNIMMAP trials only using original the data from the trials: 
birthweight +44.26 g (95% CI 32.41, 56.10 g), I2 = 6.5% 
Risk of bias 
across studies 
Additional 
analyses 
Meta-analysis of UNIMMAP and similar trials: birthweight +35.90 g (95% CI 
21.54, 50.25 g), I2 = 32% 
Summary of 
evidence 
 
Using either the original data or that from the Fall et al meta-analysis showed a 
small increase in birthweight (24 to 44 g), with corresponding reduction in 
SGA. These differences were in keeping with the previous meta-analyses 
conducted. Adding the six similar micronutrient trials produced a result 
between these two estimates.  
With the exception of the Janakpur trial, the follow-up studies generally did 
not show long-term changes in anthropometry or cardiovascular symptoms. 
Some differences were seen in cognitive tests, but may tests were conducted in 
these studies.  
 
Table 1: Profile for Systematic review of UNIMMAP trials describing birthweight (with 
meta-analysis) and SGA and long-term outcomes using the PRISMA guidelines (Liberati A, 
et al. PLoS Med 2009; 6(7): e1000100) 
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Appendix 2.2 Example of when the traditional theory of confounding and the 
counterfactual theory differ 
 
As described by Hernan and Robins (Causal Inference, Chapman & Hall/CRC; 2012), there 
can be examples of when the traditional theory of confounding introduces bias by creating 
confounding where it did not exist. Take this example, where C is associated with exposure E 
and outcome O. C is not on the causal path from E to O, so would be adjusted for using the 
traditional method. Using the counterfactual definition however, you would not condition on 
C because C is a collider. By conditioning on the variable C, it opens up the backdoor path 
from E to O, introducing confounding.  
 
 
 
Figure 1: Model showing no confounding, but where it can be induced through 
inappropriate adjustment  
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Appendix 3 
 
Appendix 3.1 Power calculation 
Assuming the same sample size in each group, the statistical power for a difference in means 
can be calculated as follows: 
 
𝑛 =   
σ2(Power  ×  α)2
difference2
 
400=  
12(Power  ×  0.05)2
0.22
 
Power=  
ට400×0.04
1
0.05
 
 
 
Where 
n = sample size 
α=  significance  level 
σ  =  standard  deviation 
difference = expected difference in mean 
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Appendix 3.2 Gantt Chart 
 
Year 1, 2011 1 2 3 4 5 6 7 8 9 10 11 12 
Training:  
body composition & 
spirometry 
            
Formulation of 
questionnaire 
                         
Advertising and 
employing staff  
            
Training of data 
collection staff 
                     
Identifying and locating 
children 
                        
Piloting questionnaire 
and data collection  
                        
Data collection                         
Advisory group meeting                         
  
Year 2, 2012 1 2 3 4 5 6 7 8 9 10 11 12 
Data collection                         
Data analysis                         
Advisory group meeting                         
   
Year 3, 2013 1 2 3 4 5 6 7 8 9 10 11 12 
Writing up of thesis                         
Dissemination of results             
Public engagement art 
project 
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Appendix 3.3 Consent form (piloting)  
 
Informed Consent Form for Parents or Guardians  
                                                                       
Piloting of body measurements  
This  project  will  involve  measuring  your  child’s  body  size,  blood  pressure  and  respiration.  None  of  these  measurements  will  harm 
your child. This is being done to help train our staff in data collection. The information we collect will be anonymised and used only 
to  look  at  the  data  collector’s  technique.  A  report  will  be  provided  for  you  and  a  small  gift  for  your  child.   
If you are happy for your child to be involved please sign and return the form. Thank you for your help.  
Signed:    
    
 Date:       
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Appendix 3.4 Calliper calibration 
 
 
Figure 1: Harpenden calliper calibration repeated measures over time. 
 
 
 
Figure 2: Graphs to show the change in difference (mean and standard deviation) from 
the Vernier calliper over increasing distance 
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Appendix 3.5 Questionnaire 
MIRA Dhanusha 
Micronutrient follow up programme 
 9 Year Follow up form 
 
Nepali date   
अÛतरवाता[  ͧलएको  ͧमǓत  (साल  मǑहना  र  गत)े  
20FF  FF  FF 
Time 
अÛतरवाता[शुǾ   गरेको   समय     
FF:FF am/pm 
Data   collector’s   initials   or   ID  
number 
अÛतरवाता[कारको  आई  डी  नं    
 FF 
GPS waypoint number:  FFF Telephone number of parent: 
 
बÍचाको  अवèथा                          िजͪवत  Alive c           मतृ  Dead d 
State of the child   बÍचाके  अवèथा 
यदȣ   बÍचाको   म×ृय ु  भएको   भए   बÍचाको   म×ृय ु  भएको   साल   मǑहना   र   गत े  लेÉनहुोस।                   
20FF  FF  FF  
If dead, what was the date of death?   यदȣ  बÍचाके  म×ृय ु भईल  अǓछ  त  बÍचाके  म×ृय ु भईल  साल, मǑहना  आ  गते ͧलख ु. 
 
बÍचाको  म×ृय ु हुनकुो  कारण  बारेमा  èपçट  ǽपमा  लेÉनहुोस  । 
What was the cause of death?     बÍचाके  म×ृय ु होईके  कारणबारेमे  Ĥçट  ǽपस  ͧलख ु । 
………………………………………………………………………………..……………
……………… 
…………………………………………………..…………………………………………
……………... 
यǑद  बÍचाको  म×ृय ु भएमा A,C,D सोÚनहुोस। 
Section A – Demographics 
A1: आमाको  नाम……………….                                                        ID  number  आई  डी  न.ं FFFF 
        Mother’s  name  माईके  नाम 
यǑद  आमा  उ×तरदाता  नभएमा उ×तर  Ǒदने  åयिÈतको  सàबÛध  लेÉनहुोस।……………………. 
Name & relationship to child if not the mother 
यǑद  माई  उ×तरदाता  नई  अǓछ  त  उ×तर  देवेवाला  åयिÈतके  सàबÛध  ͧलखु  । 
A2: आमा Ǒददȣ, दाई, बǑहनी, भाई   मÚये  कुन  हो  लेÉनुहोस ्   FF जàमा  भाई, बǑहनी सÉंया  लेÉनहुोस ् FF   -  
म×ृय ु भएको  भाई, बǑहनी, दाईको  बारेमा  पǓन  सोÚनहुोस _         
          Birth order of mother?  (please ask if mother's siblings died) 
          भाइ[  Ǒददȣ  भाई  मÚये  कोन  Ǔछ  ͧलख ु .    -  म×ृय ु  भेल भाइ[  Ǒददȣ  भाई  के  बारे  मे  सेहो  पछुु _ 
बासèथान  Location  
A3:    िजãला:    धनषुा Dhanusha c     महोतरȣ  Mahottari d    सला[हȣ  Sarlahi    e     ͧसराहा  Siraha f       अÛय  
Otherg  ...........       
          नगरपाͧलका        Municipality c                    गा  ǒब  स    VDC d 
          नगरपाͧलका / गा  ǒब  स  को  नाम  Municipality /VDC name......................................   
         वडा  न ं Ward.....................................      टोल    Tole.......................................... 
 A4:   घर  कहा ँ छ? 
Where is the house?    घर  कत  अईछ  ? 
Janakpur City जनकपुर  सहर c        Town with large market (e.g. Mahendranagar) बजार d              Village गाँउ e 
A5:  घर  सग  सगं ै Þयèत  सडक  छ? 
Is the house beside a busy road?        घरके  आसपास  बेसी  गाडीघोडा  चलवाला  रोड  अइछ  ? 
Yes - Tarmac main highway  कालो  पğ े मÉुय  सडक   c            Tarmac other road कालो  पğ े सानो  सडक  d 
             Dirt road  धुले  सडक e                                                                     No छैन f 
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A6:     कǓत  बष[  देͨख  तपाईको  बÍचा  èकुलमा  छ?     FF 
            Number of years child has completed at school?     
         कते  वष[  सँ  अहाँके  बÍचा  èकुलमे  छई  । 
A7:     जàमा  पǐरवार  सदèय  सÉंया 
            Number of people in the household  जàमा  पǐरवार  संÉया  
 
 
FF 
बÍचा   सगं  
पǐरवारका 
सदèयहǽको  
सàवÛध 
Relationship to child 
बष[  
Age (years) 
 
धुĨपान   गनȶ  
गनु[हुÛछ? 
Smoker 
के  ͪपउन ु हुÛछ? 
Smokes what? 
Cigarettes ͧसगरेट = 1  
Beedi ǒबडी = 2 
Chillum ͬचͧलम = 3  
Hooka  हुका = 4 
Ǒदनमा   कǓत  
वटा   सàम  
ͪपउने   गनु[  
हुÛछ? 
How many per day? 
Ĥाय  गरेर  कुन  ठाउँमा  
धुĨपान   गनȶ   गनु[  
हुÛछ? 
Where do you mostly 
smoke? 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
 
FF 
Yes छ c 
No   छैन d 
 
FF 
Indoors घर  ͧभğ c 
Outdoors घर  बाǑहर d 
Section B- Child’s  health 
 
B1:    गएको  दईु  हÜता  ͧभğ  बÍचालाई  कुन ै ͩकͧसमको  ǒबमारȣ  भएको  छ?    छ Yes c        छैन  No d 
          Has the child been unwell in the last 2 weeks?   
          ǒबतल  दईु  हÜता  ͧभतरमे  बÍचाके  कोनो  ͩकͧसमके  ǒबमारȣ  भेल  छल? 
B1.1: यदȣ  बÍचा  ǒबरामी  भएको  भए  कुन  Ĥकारको  ǒबमारȣ  हो  èपçट  ǽपमा  लेÉनहुोस? 
              If yes, what illness?   यदȣ  बÍचा  ǒबमारȣ  भेल  छल  त  कोन  ǒबमारȣ  भेल  छल  Ĥçट  ǽपसँ  ͧलख?ु 
              ...……………………………………………………………….. 
          .......................................................................................... 
(यदȣ  बÍचा  अǑहले  ǒबरामी  अवèथामा  छ  भने  ǒबरामी  Ǔनको  भएपǓछ  माğ  èपाईरोͧमटरको  लागी  ãयाउन  सãलाह  Ǒदनहुोस) 
(If currently unwell, please delay the spirometer until better)  
(यदȣ  बÍचा  अखन  ǒबमारȣ  छै  त  ǒबमारȣ  Ǔनक  भेलाके  बाद  माğे  èपाईरोͧमटरके  लेल  लैबाक  सãलाह  Ǒदयɋ) 
B2:       तपाईको  बÍचालाई  कुन ै ͩकͧसमको  Ǒदघ[  रोग  छ  ।?                           Yes छ  c                No  छैन  d 
                Does your child have a chronic illness?   अहाँके  बÍचाके  कोनो  ͩकͧसमके  दȣघ[  रोग  अ  ैछ  ? 
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B2.1:   यदȣ  छ  भने  कèतो  खालको  Ǒदघ[  रोग  छ  èपçट  ǽपमा  लेÉनहुोस 
                  If yes, what illness?  अगर  छई  त  केहन  ͩकͧसमके  Ǒदघ[  ǒबमारȣ  छई  èपçट  ǽपमे  ͧलखु  । 
              .............................................................................................. 
              ........................................................................................... 
B3:        ǒबगतमा  बÍचालाई  कुन ै ͩकͧसमको  ठूलो  खालको  ǒबमारȣ  भएको  ͬथयो?                 Yes छ c        No  छैन  
d 
                Has the child had any major illnesses in the past?  ǒबतल  Ǒदनमे  बÍचाके  कोनो  ͩकͧसमके  बढका  ǒबमारȣ  भेल  छल  ? 
B3.1:   यदȣ  छ  भने  कèतो  खालको  समèया  भएको  हो  èपçट  ǽपमा  लेÉनुहोस ्  
                If yes, what illness?  अगर  भेल  छल  त  केहन  ͩकͧसमके  समèया  भेल  छल, Ĥçट  ǽपसँ  ͧलख ु । 
            ....................................................................................................................... 
           ........................................................................................................................ 
B4:      गएको  १२  मǑहनामा  बÍचालाई  तलका  मÚये  कुन ै लêण  देͨखएको  ͬथयो? 
   Has your child had any of the following symptoms in the last 12 months?          ǒबतल  १२  मǑहनामे  बÍचाके  Ǔनचच्के  कोनो  लêण  देÉने  छेͧल  ?           
 
  
If yes, how many episodes? 
Ïवरो       Fever Yes  छ c      No  छैन  d FF 
१३  Ǒदन  भÛदा  बढȣ  लगातार  पखालालागेको  
Persistent diarrhoea (episodes lasting for >13 days)?   
Yes  छ c      No  छैन  d FF 
Ǒदसामा  रगत  देͨखन े     Blood in stool?   Yes  छ c      No  छैन  d FF 
ǓनमोǓनया     Pneumonia? Yes  छ c      No  छैन  d FF 
छȤटो  Ǔछटो  सास  फेनȶ    Fast Breathing? Yes  छ c      No  छैन  d FF 
कोखा  हाÛने       Chest Indrawing? Yes  छ c      No  छैन  d FF 
B5:   गएको  ७  Ǒदनमा  बÍचालाई  तलका  मÚये  कुन ै लêण  देͨखएको  ͬथयो?  
            Has your child had any of the following symptoms in the last 7 days?           ǒबतल  ७  Ǒदनमे  बÍचाके  Ǔनचच्के  कोनो  लêण  देÉने  छेͧल  ? 
Ïवरो  Fever Yes  छ c      No  छैन  d 
पखाला  लागेको diarrhoea?   Yes  छ c      No  छैन  d 
Ǒदसामा  रगत  देͨखन े  Blood in stool?   Yes  छ c      No  छैन  d 
ǓनमोǓनया   Pneumonia? Yes  छ c      No  छैन  d 
छȤटो  Ǔछटो  सास  फेनȶ   Fast Breathing? Yes  छ c      No  छैन  d 
कोखा  हाÛने       Chest Indrawing? Yes  छ c      No  छैन  d 
B6:    उमेर   अनसुार   बÍचाको   शǐररमा  आउने   पǐरवत[न   सगं ै  बÍचाको   वृͪ ƨ   र   ͪवकास   Ǔछटो   Ǔछटो   हुÛछ   ।  
×यसकारण   हामी   तपाईको   बÍचामा   शǽु   भएको   पǐरवत[न   बारेमा   जाÛन   चाहÛछौ   ।      केटामा   Ĥायः   गरेर  
अÖडकोषको  वƨृी  हुन  थाãछ, र  केटȣमा  èतनको  ͪवकास  हुन  थाãछ  । 
When puberty starts children grow quickly, so we want to know whether your child started puberty?  In boys usually starts with an increase 
in the size of the testes and in girls it is breast development. 
बÍचामे   होईवाला   शारȣǐरक   पǐरवत[नसँ   बÍचाके   वृͪ ƨ   ͪवकास   जãदȣ   होईछई   ।   तईसँ   हमसब  आँहाके   बÍचामे   सुǽ   भइल   पǐरवत[नके   बारेमे   जाने   चाहइǓछ   । बेटामे   Ĥायः  
अÖडकोषके  वृͪ ƨ  होइछई  आ  बेटȣमे  छाती  के  ͪवकास  होइछइ  । 
 
तपाईको  छोरामा गÜुताɨगमा  रौ  आएको  महससु  गनु[  भएको  छ ?  Yes  छc         No छैन d      Don't know  थाहा  
छैनe 
Boys: have you noticed any pubic hair growth?  आहाके  बेटामे  गुÜताडमे  केश  आइल  से  महसुस  कइनेǓछ  । 
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 तपाईको  छोरȣमा  èतनको  ǒबकास  भएको  पाउन ु भएको  छ  ?              Yes  छ  c           No छैन d          Don't know  
थाहा  छैन e 
  Girls: have you noticed any breast development in your daughter?  आहाके  बेटȣमे  छातीके  ͪवकास  भेल  छई  से  महसुस  करैǓछ  । 
B7: ISAAC questions for asthma 
1. ͪवगतमा  कुन ै पǓन  समयमा  तपाईको  बÍचालाई  Ëयार–Ëयार  (छाǓतमा  ससेुले  जèतो  आवाज  आउने)  भएको   
      ͬथयो  ?                              Yes  छ  c          No छैन d         
        Has your child ever had wheezing or whistling in the chest at any time in the past?                               
        ǒबतलाहा  कोनो  समयमे  आहाके  बÍचाके  Ëयार–Ëयार  (छाǓतमे  सुसकारȣ  जेहन  आवाज  आइल  छल)  भेल  छल  ? 
यदȣ  छैन  भÛने  उ×तर  आएमा  Ĥæन  न.ं  ६  मा  जानहुोस  ।   IF  YOU  HAVE  ANSWERED  “NO”  PLEASE  SKIP  TO  QUESTION  6 
2.  गएको  १२  मǑहनामा  तपाईको  बÍचालाई  Ëयार  Ëयार  (छातीमा  ससेुले  जèतो  आवाज  आउने)  भएको  ͬथयो?   
   Yes छ  c         No  छैन d               
      Has your child had wheezing or whistling in the chest in the past 12 months?                                  
      ǒबतलाहा  १२  मǑहनामे  आहाके  बÍचाके  Ëयार  Ëयार  (छाǓतमे  ससुकारȣ  जेहन  आवाज  आइल  छल)  भेल  छल  ? 
यदȣ  छैन  भÛने  उ×तर  आएमा  Ĥæन  न.ं  ६  मा  जानहुोस ् ।         IF  YOU  HAVE  ANSWERED  “NO”  PLEASE  SKIP  TO  QUESTION  6 
3.  गएको  १२  मǑहनामा  कǓत  पटक  तपाईको  बÍचालाई  ससेुले  जèतो  आवाज  आउने  भएको  ͬथयो? 
How many attacks of wheezing has your child had in the past 12 months? 
ǒबतलाहा  १२  मǑहनामे  कतेवेर  आहाके  बÍचाके  Ëयार  Ëयार  (छाǓतमे  ससुकारȣ  जेहन  आवाज  आइल  छल)  भेल  छल? 
      None भएन  c           1 to 3 एक  पटकदेͨख  ३  पटकसàम d          4 to 12    ४  पटकदेͨख  १२  पटकसàम  e   
      More than 12 १२  पटक    भÛदा  बढȣ  f 
4.  गएको  १२  मǑहनामा  कǓतको  माğामा  (सरदर)  तपाईको  बÍचालाई  Ëयार  Ëयार  भएर  स×ुन  गाıो  भएको  ͬथयो? 
       In  the  past  12  months,  how  often,  on  average,  has  your  child’s  sleep  been  disturbed  due  to  wheezing? 
      ǒबतलाहा  १२  मǑहनामे  कतेदेरतक  आहाके  बÍचाके  Ëयार  Ëयार  भक  सुतमे  ǑदÈकत  भेल  छल  ? 
        Never woken with wheezing   कǑहãयै  पǓन  नǒबउͨझएको c 
        Less than one night per week एक  हÜतामा  एक  रात  भÛदा  कम d 
        One or more nights per week हÜतामा  एक  वा  एक  भÛदा  बढȣ  रात  सàम e 
5.     गएको  १२  मǑहनामा  कडा  Ëयार  Ëयारको  कारण  बÍचाले  एउटा  वा  दईूवटा  माğ  शÞद  एक  पटक  सास  फेदा[  बोãन  
सÈने  भएको  ͬथयो?           Yes छ  c        No छैन d                                                                                                   
            In  the  past  12  months,  has  wheezing  ever  been  severe  enough  to  limit  your  child’s  speech  to  only one or two words at a time between breaths? 
           ǒबतलाहा  १२  मǑहनामे  बहुत  Ëयार  Ëयारके  कारण  सँ  एकटा  आ  दटुा  माğे  शÞद  एकवेर  सास  फेरकाल  बोलै  छलै  ?         
6.    तपाईको  बÍचालाई  कǑहãय ै दम  भएको  ͬथयो?                            Yes छ  c         No छैन d                                                                                                   
 Has your child ever had asthma?   आहाके  बÍचाको  कǑहयो  दमा  भेल  छल  ? 
7.     गएको  १२  मǑहनामा  तपाईको  बÍचालाई  रातीमा  सुÉखा  कफ  आउने  भएको  ͬथयो?      Yes छ  c      No छैन d 
           In the past 12 months, has your child had a dry cough at night, apart from a cough associated with a cold or chest infection? 
   गेलहा  १२  मǑहनामे  आहाके  बÍचाके  राईतमे  सुÉखल  कफ  अव ै छल?ै                                                                                                                                             
B8: ISAAC questions for rhinitis 
1.    तपाईको  बÍचालाई  कǑहãय ै ǽघा  नलागेको  बेलामा  पǓन  Ǔछक  आउने  वा  ͧसगान  बÊने  वा  नाक  बÛद  हुने  
भएको  छ? 
          Has your child ever had a problem with sneezing, or a runny, or blocked nose when he/she DID NOT have a cold or the flu? 
          आहाके  बÍचाके  कǑहयो  सǑद[  नई  भेल  समयमे  Ǔछकै  छल ै या  नाक  सँ  पानी  या  नाक  बÛद  होइछल?ै 
       Yes छ c                No छैन d 
      यदȣ   छैन  भÛने  उ×तर  आएमा  Ĥæन  न.ं  ६  मा  जानहुोस  ।   IF   YOU   HAVE   ANSWERED   “NO”   PLEASE   SKIP   TO  
QUESTION 6 
2.   गएको  १२  मǑहनामा  तपाईको  बÍचालाई  ǽघा  नलागेको  बेलामा  पǓन  Ǔछक  आउने  वा  नाक  बÛद  हुने  भएको  
छ? 
        In the past 12 months, has your child had a problem with sneezing, or a runny, or blocked nose when he/she DID NOT have a cold or 
the flu? 
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गेलहा  १२  मǑहनामे  आहाके  बÍचाके  सǑद[  नई  भेल  समयमे  Ǔछकै  छलै  या  नाक  सँ  पानी  या  नाक  बÛद  होइछलै  ? 
      Yes छ c                 No  छैन d 
      यदȣ  छैन  भÛने  उ×तर  आएमा  Ĥæन  न.ं  ६  मा  जानहुोस  ।    IF   YOU   HAVE   ANSWERED   “NO”   PLEASE   SKIP   TO  
QUESTION 6 
3.    गएको  १२  मǑहनामा  नाक  सàवÛधी  समèयाको  कारणले  आखा  ͬचलाउने  र  आसु  झनȶ  भएको  छ? 
        In the past 12 months, has this nose problem been accompanied by itchy-watery eyes? 
        गेलहा  १२  मǑहनामे  नाकके  समèया  सँ  आखँ  हउवाई  छेल ै या  आखँ  से  पानी  खसैछेल?ै 
      Yes छ  c               No छैन d                                                                                                   
 
4.   गएको  १२  मǑहनामा  कुन  मǑहनामा  नाक  सàवÛधी  समèया  देͨखयो? कुन  मǑहनामा  भयो  ͬचÛह  लगाउनुहोस  । 
In which of the past 12 months did this nose problem occur? (Please circle any which apply) 
गेलहा  १२  मǑहनामे  कोन  मǑहनामे  नाकके  समèया  भेल  छल  ? कोन  मǑहनामे  भेल  छल  ͬचÛह  लगाउ  । 
 
[A] बशैाख Baisakh 
(Apr – May)     
[B] जेçठ Jyesth 
(May - Jun)   
[C]  असाढ Ashadh 
(Jun – Jul)   
[D] Įावण 
Shrawan (Jul – 
Aug)   
[E] भाġ Bhadau 
(Aug – Sep)   
 [F] असोज Asoj 
(Sep – Oct)   
[G] काǓत [क Kartik 
(Oct – Nov)   
[H] मंͧ सर Mangsir 
(Nov – Dec)    
[I] पौष Push 
 (Dec – Jan) 
[J] माघ Magh  
(Jan – Feb)    
[K] फाãगणु  
Phagun (Feb – Mar)                       
[L] चैğ Chait  
(Mar – Apr)  
 
5.   गएको  १२  मǑहनामा  नाक  सàवÛधी  समèयाले  बÍचाले  गनȶ   दैǓनक  कृयाकलापमा  कǓतको  माğामा  असर  
पायȾ? 
In  the  past  12  months,  how  much  did  this  nose  problem  interfere  with  your  child’s  daily  activities? 
गेलहा  १२  मǑहनामे  नाकके  समèया  सँ  बÍचाके  Ǒदनभरके  कामकाजमे  कते  ǑदÈकत  भेल  छल  ? 
Not at all                    c  असर  गरेन 
A little                        d  थोरै  माğामा  असर  गयȾ] 
A moderate amount        e   केǑहमाğामा  असर  गयȾ 
A lot                          f  धेरै  माğामा  असर  गयȾ 
6.   तपाईको   बÍचालाई  कǑहãय ै ǒबǽवाको   एलजȸको  कारणले  आखँा   र  नाकबाट   पानी  आउनाको  साथै  आँखा  
ͬचलाउन े भएको  छ?                 Yes छ  c        No छैन d                                                                                         
Has your child ever had hay fever?    आहाके  बÍचाके  कǑहयो  एलजȸके  कारण  आइँख  या  नाकसँ  पानी  आबकेै  साथ े आईँख  हउवाई  छेल?ै 
 
Section C: Socioeconomic status 
 
ͧश¢ा  Education 
C1: तपाईको  पǐरवारको  कुन ै सदèयले  ५ वष[  सàम èकुलमा  पɭनभुएको  छ?              Yes छ  c        No छैन d 
Has any member of the household completed 5 years of schooling?  
आहाके  पǐरवारके  कोनो  सदèय  ५  वष[  èकुलमे  पढने  छई  ?                                                                                             
C2: èकुल  जाने  उमेरका  सब ै बÍचाहǽ  हालसाल ै èकुलमा  भना[  भएका  छन?्(४  वष[  देͨख  १६  वष[  सàमका)   Yes छ  c    
No छैन d 
Are all school-age children currently enrolled in school (Years 4-16)?  
èकुल  जाईवाला  उमेरके  सब  बÍचासब  भरखर  èकुलमे  भना[  भेलछईर   (४  वष[  से  १६  वष[  तकके) 
èवाèØय  Health 
C3: बÍचाको  कुन ै भाई  बǑहनी वा  दाई  Ǒददȣ  को  म×ृय ु भएको  छ?         Yes छ  c        No छैन d                                                                                                   
Have  any  of  the  child’s  siblings  died?      बÍचाके  कोनो  भाई  बǑहन  या  भैया  Ǒददȣके  म×ृय ु भेल  छई ? 
Standard of Living 
C4: तपाईको  घरको  लाͬग  खानेपानीको  मÉुय  Įोत  के  हो? 
  What is the main drinking water source for your household?   आहाके  घरके  लेल  ͪपयवाला  पानीके  मुख  Įोत  ͩक  छई  ? 
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(1) घरैमा  ãयाइएको   Ǔनजी  धारा  Piped drinking water in 
residence   
(7) बोǐरङग  Deep bore hole 
(2) साव[जǓनक  धारा   Public water tap   (8) आÝनो  चापाकल  Own (private) handpump in courtyard 
(3) Ǔनजी  इनार   Own (private) well   (9) Ǔछमेकȧको  चापाकल   Neighbour’s  handpump  
(4)  साव[जǓनक  इनार Public well   (10) साव[जǓनक  चापाकल   Public handpump 
(5) Ǔछमेकȧको  इनार  Neighbour’s  well   (11) नदȣ,  खोला,  नहर,  पोखरȣ  River,  stream,  canal,  pond 
(6) पारàपǐरक  साव[जǓनक  इनार  Traditional public well   
 
C5: खान े पानी  ãयाउनको  लागी  तपाईलाई  कǓत  टाढा  सàम  Ǒहɬनु  पछ[?     ३०  ͧमनेट  भÛदा  कम <30 minutes c       
                                                                                                                                        ३०  ͧमनेट  भÛदा  बढȣ >30 minutes d 
How far do you have to walk to get drinking water? 
ͪपयवाला  पानी  लावके  लेल  आहा  सबके  कते  दरु  चल  परइय  । 
C6: तपाईको  पǐरवारका  सदèयले  कèतो  Ĥकारको  शौचालयको  Ĥयोग  गनु[  हुÛछ?   
What kind of toilet do your family members use? 
आहाके  घरके  सदèय  केहन  Ĥकारके  पखैाना  टटȣ  Ĥयोग  करैइय  ? 
[A] Flush toilet   Ýलस                                         [B] Pan toilet    Üयान                        [C] Pit toilet  खाãड े चपȸ     
[D] Bushes / stream / open areas      खुãला  ठाँउ           [E] Other's toilet  अǾको  चपȸ  
C7: तपाईको  चपȸ  अकȾ  घरका  सदèयले  पǓन  Ĥयोग  गनु[  हुÛछ?  Yes छ  c        No छैन d                                                                                                   
Do you share your toilet with other households?                
आहाके  पखैाना  टटȣ  दोसरा  घरके  आदमी  सेहो  Ĥयोग  करैइय  ? 
C8: तपाई  बèने  घरमा  कुन  कुन  बèतुहǽ  छन?् 
What things do you have? 
आहा  रहेवाला  घरमे  कोन  कोन  समानसब  अइछ  ? 
[A] ǒबजुलȣ Electricity  [B] रेͫडयो Radio [C] टेͧलͧभजन  TV   [D] टेͧलफोन Telephone  
[E] मोबाइल Mobilephone   [F] ĥȧज Fridge [G] साइकल Bicycle [H] ǐरÈसा Rickshaw   
[I] मोटरसाइकल Motorcycle [J] ɪयाÈटर 
Tractor 
[K] बस,ɪक,  िजप, कार,  टेàपो  Bus/Truck/jeep/car/tempo   
 
C9: घर  के  ले  बनेको  छ?  (पखा[ल) 
What are the walls of the house mainly made of?    घर  कͬथ  सँ  बनल  अ  ैछ  ? (ͧभ×ता) 
c Cement and bricks ͧसमेÛट  र  इँटा d Mud and bricks  माटो  र  इ͠ा e Mud and Stone  माटो  र  ढुɨगा 
f Planks of wood   काठको  पटाहा g Grass / Straw Thatch  खर  पराल h Metal sheets  Řकट  पाता 
i Mud and woven stems or bamboo (tat)   टाट j Other  अÛय  ............................. 
 
C10: घरको  छानो  के  ले  बनेको  छ? 
What is the roof mainly made of?    घरके  चार  कͬथ  सँ  बनल  अइछ  ? 
c Cement  ͧसमेÛट d Traditional tiles (Khapadaa)   खपडा   e Tiles टायल 
f Metal sheets जèताको  छाना g Grass / straw thatch   फुसको  छाना h Other  अÛय  ............................. 
 
C11: भईु  के  ले  बनेको  छ? 
What is the floor mainly made of?    भुईया  कͬथ  के  अइछ  ? 
Dirt    माटो  c Dung    गोबर  d Sand    बालुवा  e Cement  ͧसमेÛटf Other     अÛय  
g ................... 
 
C12: तपाई  Ĥायः  गरेर  बèने  घरमा  जàमा  कǓत  वटा  कोठा  छन?्    FF 
How many rooms are there in total in the house you usually live in? 
आहा  Ĥायः  रहेवाला  घरमे  जàमा  काई  हÛना  अइछ  ?  
C13:  कुन  कोठामा  तपाईको  बÍचा  स×ुने  गछ[? 
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In which room does your child sleep?  आहा  के  बÍचा  कोन  हÛनामे  सतु ै अइछ  ? 
Room where food is cooked   खाना  पकाउन े कोठा  c 
Bedroom  छुटै  स×ुने  कोठा  d 
Room where people sit   माÛछे  आएर  बèने  कोठा  e 
C14:  तपाईको  बÍचा  स×ुने  कोठामा  : 
In the room where your child sleeps:  आहाके  बÍचा  सुतवाला  कोठͧलमे    : 
तपाईको  बÍचा  स×ुने  कोठामा  ͧससा  भएको  Ðयाल  कǓत  वटा  छन ् ?  
How many windows are there with glass? आहाके  बÍचा  सतुवाला  हÛनामे  ͧससावाला  काइटा  ͨखडकȧ  अइछ  ? 
FF 
तपाईको  बÍचा  स×ुने  कोठामा  ͧससा  नभएको  Ðयाल  कǓत  वटा  छन ् ?   
How many windows are there without glass? आहाके  बÍचा  सतुवाला  हÛनामे  ͧससा  नइभेल  कइटा  ͨखडकȧ  अइछ  ?   FF 
तपाईको  बÍचा  स×ुने  कोठामा  ढोका  कǓत  वटा  छन ् ? 
How many doors are there? आहाके  बÍचा  सुतवाला  हÛनामे  काइटा  केवारȣ  अइछ  ? 
FF 
तपाईको  बÍचा  स×ुने  कोठामा  कǓत  वटा  बाǑहर  Ǔनèकने  ठाउँहǽ  छन ढोका  नभएको]  ?   
How many seperate doorways without door are there? आहाके  बÍचा  सुतवाला  हÛनामे  काइटा  बाहर  Ǔनकलवाला  जगह  अइछ  ?   FF 
 
C15: खाना  पकाउनकोलागी  तपाईको  घरमा  धेरैजसो  कुन  इÛधन  Ĥयोग  गनु[  हुÛछ? 
Which fuels do you usually use for cooking?   खाना  पकावकेलेल  आहाके  घरमे  सबसे  बेसी  कुन  ͬचज  सँ  पकवई  Ǔछ   
 आगो   बाãनको   लागी    
Ĥयोग  गनȶ  ईÛधन  
Fuel used for lighting the 
fire 
(please tick all that apply) 
 
खना   पकाउनको   लागी  
ǓनरÛतर  Ĥयोग  गनȶ  इÛधन 
Fuel used continuously for cooking 
(please tick all that apply) 
एक  भÛदा  बढȣ  इÛधन  Ĥयोग  
गरेको  भए  मÉूय  ǽपमा  Ĥयोग  
गरेको  ईÛधनमा  Ǒटक  
लगाउनहुोस 
If more than 1 fuel is used, which is the 
main fuel 
(please tick one fuel) 
Firewood  दाउरा [A] [A] [1] 
Dried cow dung (goitha) 
गइुठा 
[B] [B] 
[2] 
Straw पराल [C] [C] [3] 
Charcoal  कोईला [D] [D] [4] 
Other plant products 
झारपात 
[E] [E] 
[5] 
Kerosene मǑ͠तले [F] [F] [6] 
Gas Êयास [G] [G] [7] 
Biogas (gober gas) 
गेवर  Êयास 
[H] [H] 
[8] 
Electricity ǒबधुत [I] [I] [9] 
Plastic Üलाçटȣक [J] [J] [10] 
Other  (please state) 
अÛय   भए   èपçट   ǽपमा  
लेÉनुहोस 
 
[K] 
 
…………………… 
[K] 
 
…………………… 
[11] 
 
…………………… 
 
 
C16: के  तपाइ[सग छु͠ै भाÛसा  कोठा  छ?                                   Yes छ c         No छैन  d 
             Do you have a separate kitchen?       आहा  लग  छुटे  भÛसा  कोठा  छइ  ? 
C17:  घर  ͧभğ  खाना  पकाउने  चलन  कǓतको  छ?     months/yr बष[मा  कǓत  मǑहना            days/wk  हÜतामा  कǓत  
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Ǒदन       
What is the custom of cooking indoors?    घरͧभतरमे  खाना  बनाबके  चलन  केतेके  छई ?  
C18:  तपाईको  घर  पǐरवार  ͧभğबाट  कोहȣ  सदèय  बैदेͧशक  रोजगारमा  जानुभएको  छ  अथवा  गइरहनु  हुÛछ?   Yes छ c      
No छैन d 
Has any member of your family (household) migrated overseas or outside the district for work? Or does anyone go regularly?  
आहाके  घरपǐरवार  ͧभतरसे  कोनो  सदèय  वदेैͧशक  रोजगार  मे  गेलछई  या  जाइवाला  छई  ? 
यǑद  छ  भने  कहाँ? 
[A] India भारत )  [B] Arab   countries अरब  
मलुकुहǽ 
[C] Malaysia मलेͧसया [D] Other countries specify अÛय  देश  (उãलखे  
गनु[होस)्............................ 
 
 
Section D Food security and vulnerability 
 
अब  म  तपाईलाई   केǑह  Ĥæन  तपाई  बसेको  घरको  खाना  वा  खाधाÛनको  पहंुचको  बारेमा  सोÚन  लागेको   छु   ।  
कृपया  गएको  ३०  Ǒदनको  बारेमा  माğ  जवाफ  Ǒदनहुोला  र  तपाई  वा  तपाई  बसेको  घरको  पǐरवार  सदèयको  बारेमा  
भÛन ु होला।  Įोत  भÛनाल े पसैा  वा  खाधाÛन  जनाउने  छ  । 
I am now going to ask you some questions about food and food access in the house where you stay. Please answer about the last 30 days 
only and please answer for yourself and your household. By 'resources' we mean money or food. 
आब  हम  आहाके ͩकछ  बात  आहा  रहैǓछ  से  घरके  खाना  आ  खाइवाला  ͬचजके  पगेुके  सàबÛधमे  पछुब  ।  कृपया  ǒबतलाहा  ३०  Ǒदनके  बारेमे  माğे  जवाफ  
देवेपरत  आ  आहा  और  आहा  रहैǓछ  से  घरके  पǐरवार  सभके  बारेमे  माğ  कहब  ।  Įोत  के  मतबल  पसैा  या  खाइवाला  ͬचज  बझुपरत  । 
D1 तपाईको  घरमा  खाना  नपÊुला  भनेर  ͬचÛता  भएको  ͬथयो?    Yes I worried ͬचÛता  ͬथयो c          No I did not worry  
ͬचÛता  ͬथएन d 
Did you worry that your household would not have enough food?  
आहाके  घरमे  खाना  नई  पगुत  तईके  लाͬग  ͬचÛता  भेल  छल  ? 
(यǑद  ͬथएन  भने  Ĥæन  न.ं  D2  मा  जानुहोस)्       If no go to question D2 
D1.1 यǑद  खान  नपÊुने  ͬचÛता  ͬथयो  भने  कǑहले  कǑहले?   
If you worried that you would not have enough food how often?  
अगर  खाना  नपगुत  तईके  ͬचÛता  भेलछल  त  कǑहया  कǑहया  ?   
        Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D2 Įोत  को  अभावल े गदा[  कुन ै मनपनȶ  खानेकुरा  खान  नसकेको  ͬथयो?   
Were you or any household member not able to eat the kinds of food you preferred because of lack of resources?   
पसैाके  अभावके  कारण  कǑहयो  मन  परेवाला  खाईवाला  खाना  नई  खाइसकͧल  ?    
          Yes we were not able to eat  खान  नसकेको  ͬथयो  c            No ͬथएन  d 
(यǑद  ͬथएन  भने  Ĥæन  न.ं  D3  मा  जानहुोस)्  If no go to question D3. 
D2.1 मनपनȶ  खानेकुरा  खान  नसकेको  ͬथयो  भने  कǑहले  कǑहले? 
        If you were not able to eat foods you preferred how often?  
मनपरेवाला  खाना  नपगुल  त  कǑहया  कǑहया  ? 
        Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D3 Įोतको  अभावल े गदा[  Ǒदन  Ǒदन ै एकै  Ĥकारको  खानेकुरा  खान ु परेको  ͬथयो?   
Did you or any household member just eat a few kinds of food day after day because of lack of resources?         
पसैाके  अभावसँ  Ǒदन  Ǒदने  एके  रंगके  खाना  खाई  परल  छल  ? 
Yes   ͬथयो  c No  ͬथएन  d 
(यǑद  ͬथएन  भने  Ĥæन  न.ं  D4  मा  जानहुोस)्  If no go to question D4 
D3.1 यǑद  ͬथयो  भने  कǑहल े कǑहले? 
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If yes how often?   अगर  छेल  त  कǑहया  कǑहया?    
Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D4 Įोतको  अभावल े गदा[  अÛय  खानेकुरा  पाउन  नसकेको  कारणले  मन  नपनȶ  खानेकुराहǽ  खान ु परेको  ͬथयो?   
      Did you or any household member eat food that you did not want to eat because of a lack of resources to obtain other types of food?   
Įोतके  अभावसँ  कोनो  दोसर  खाईवाला  ͬचज  नई  भेटल  त  मन  नई  परल  खाईवाला  ͬचज  खाई  परल  ? 
Yes ͬथयो  c       No  ͬथएन  d 
(यǑद  ͬथएन  भने  Ĥæन  न.ं  D5  मा  जानहुोस)्  If no go to question D5 
D4.1 यǑद  ͬथयो  भने  कǑहल े कǑहले?    
If yes how often?     अगर  छल  त  कǑहया  कǑहया  ? 
        Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D5.  खानेकुराको  अभावल े छाकमा  चाहना  भÛदा  कम  खाना  खान ु भएको  ͬथयो?        Yes ͬथयो  c      No  ͬथएन  
d 
Did you or any household member eat a smaller meal then you felt you needed because there was not enough food?      
खाईवाला  ͬचजके  अभावसँ  छाकमे  चाहैसे  कम  खाना  खाइ  परल  छल  ? 
         (यǑद  ͬथएन  भने  Ĥæन  न.ं  D6  मा  जानहुोस)्  If no go to question D6 
D5.1 यǑद  ͬथयो  भने  कǑहल े कǑहले?    
If yes how often? अगर  छल  त  कǑहया  कǑहया? 
        Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D6 खानाको  अभावल े गदा[  खानाको  छाक  घटाउनु  परेको  ͬथयो?       Yes ͬथयो  c         No  ͬथएन  d 
Did you or any other household member eat fewer meals because there was not enough food?   
खाईके  अभाव  सँ  खानाके  छाक  घटावे  परल  छल  ? 
(यǑद  ͬथएन  भने  Ĥæन  न.ं  D7  मा  जानहुोस)्  If no go to question D7 
D6.1 यǑद  ͬथयो  भने  कǑहल े कǑहले?    
If yes how often?  अगर  छल  त  कǑहया  कǑहया  ? 
        Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाहँȣ  d                Often  Ĥायः  जसो  
e 
D7 Įोतको  अभावल े खाना  पटÈकै  वा  क×ती  पǓन  नभएको  अवèथा  ͬथयो?  
Was there ever no food at all in your household because there were no resources to get more?    
पैसाके  अभाव  स ँ खाना  साफे  या  कमो  नई  भेल  अवèथा  छल  ? 
Yes ͬथयो  c        No  ͬथएन  d 
(यǑद  ͬथएन  भने  Ĥæन  न.ं  D8  मा  जानहुोस)्  If no go to question D8 
D7.1 यǑद  ͬथयो  भने  कǑहल े कǑहले?    
If yes how often?  
अगर  छल  त  कǑहया  कǑहया  ? 
        Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D8   खानाको  अभावल े गदा[  भोकै  स×ुन ु परेको  ͬथयो  ?     
Did you or any household member go to sleep hungry because there was not enough food?     
          खानाके  अभावसँ  भखुले  सतेु  परल  छल  ? 
Yes ͬथयो  c        No  ͬथएन  d 
       (यǑद  ͬथएन  भने  Ĥæन  न.ं  D9  मा  जानहुोस)्  If no go to question D9 
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D8.1 यǑद  ͬथयो  भने  कǑहल े कǑहले?    
If yes how often?     अगर  छल  त  कǑहया  कǑहया  ? 
        Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D9 खानाको  अभावल े गदा[  Ǒदनभरȣ  भोकै  बèन ु परेको  ͬथयो?   
Did you or any household member go a whole day without eating because there was not enough food?    
खानाके  अभाव  सँ  Ǒदनभैर  भुखले  रहल    परल  छल  ? 
Yes ͬथयो  c          No  ͬथएन  d 
 (यǑद  ͬथएन  भने  Ĥæन  न.ं  D10  मा  जानहुोस)्  If no go to question D10 
D9.1 यǑद  ͬथयो  भने  कǑहल े कǑहले?    
If yes how often?       अगर  छल  त  कǑहया  कǑहया? 
         Rarely (very little)  आÈकल  झÈुकल  (एÈदम  कम)  c                  Sometimes कǑहलेकाँहȣ  d                Often  Ĥायः  
जसो  e 
D10 गएको  १२  मǑहनामा  कुन ै मǑहना  तपाईको  पǐरवारको  आवæयकता  अनसुार  खाना  नपÊुने  अवèथा  ͬथयो?  
Over  the  last  12  months,  were  there  any  months  in  which  you  did  not  have  enough  food  to  meet  your  family’s  needs?                          
ǒबतलाहा  १२  मǑहनामे  कोनो  मǑहना  आहाके  पǐरवारमे  चाहल  जते  खाना  नई  पगुल  अवèथा  भेल  छल  ? 
 Yes ͬथयो  c          No  ͬथएन  d 
(यǑद  ͬथएन  भने  Ĥæन  न.ं  D11  मा  जानहुोस)्  If no go to question D11 
D10.1 यǑद  ͬथयो  भने  कुन  मǑहनामा?  
If yes which months? अगर  छल  त  कǑहया  कǑहया  ?  
 
[A] बशैाख Baisakh (Apr – May)     [B] जेçठ Jyesth (May - Jun) [C]  असाढ Ashadh (Jun – Jul) [D] Įावण Shrawan (Jul – Aug) 
[E] भाġ Bhadau (Aug – Sep) [F] असोज Asoj (Sep – Oct)  [G] काǓत [क Kartik (Oct – Nov) [H] मंͧ सर Mangsir (Nov – Dec)    
[I] पौष Push (Dec – Jan) [J] माघ Magh (Jan – Feb)    [K] फाãगणु   Phagun (Feb – 
Mar)                       
[L] चैğ Chait (Mar – Apr) 
 
D11 गएको  ७  Ǒदन  ͧभğमा  तपाइको  बÍचाले  तलका  मÚये  कुन  कुन  (घरम ै बनाएको)  खानेकुरा  खानभुयो? 
In the last 7 days which of the following foods did your child eat (i.e. foods that were made at home)? 
ǒबतलाहा  ७  Ǒदन  ͧभतरमे  आहाके  बÍचासभ  Ǔय  Ǔनचका  सबमे  से  कͬथ  कͬथ  (घरमे  बनाउँल)  खाईवाला  खैलक  ? 
[A] Cereals e.g. rice, wheat, maize, millet,  अÛन  जèत ै   चामल, गहँु, मकै, कोदो  
[B]  Root   tubers  e.g.  potatoes,  yams,  sweet  potatoes,   taro,  elephant’s   foot  etc  जरामा  हुने  जèत ै :आल,ु तǽल, सखरखÖड, ͪपडाल,ु 
ओल  आǑद  
Vegetablesतरकारȣहǽ:   [C] yellow colour like pumpkin & carrots   पहɅलो  तरकारȣहǽ  जèत ै फसȸ, गाँजर  आǑद        
                                         [D] green leavesहǐरयो  सागपातहǽ 
Fruits  फलफुलहǽ    [E] yellow like mango and papaya पहɅलो  जèत ै आँप  तथा  मेवा    [F] other non-yellow fruit  अÛय  फलफुलहǾ    
Meatमास:ु         [G] goat खसी      [H] chicken कुखुरा       [I] duck हाँस         [J] buffalo रागा ं     [K] pig बगंरु                                                      
[L] mouse/rat मसुा         [M] cow/bull  गाई/गोǽ  
Fish/shell fish  माछा/घɉगी:   [N] small fish सानो  माछा      [O] large fish  ठुलो  माछा           [P] snails घɉगी             [Q] crabs  गँगटा  
[R] Eggs अÖडा                   [S] Dairy  दधू  पदाथ[हǽ  
[T] Pulses & nuts दाल :गेडागडुी /बदाम                [U] Oil / fats तले :ͬचãलो  पदाथ[हǽ                 [V] Sugar / honey ͬचनी :मह/ͧमठा 
[W] Other e.g. spices, tea, coffee  अÛय  जèत:ै  मसला, ͬचया, कफȧ               
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Where is your child during an average day? 
01:00 02:00 03:00 04:00 05:00 06:00 
      
07:00 08:00 09:00 10:00 11:00 12:00 
      
13:00 14:00 15:00 16:00 17:00 18:00 
      
19:00 20:00 21:00 22:00 23:00 24:00 
      
IB=Indoor bedroom  IK= Indoor kitchen IKC= Indoor kitchen when 
cooking  
O=Outdoors V=Veranda S=School  Please state if other 
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Appendix 3.6 Anthropometry: Childhood nutrition research centre, standard operating 
procedure 
 
Weight (digital scales) 
1. Operator checks that scales are on level floor, away from any objects and tared to zero. 
2. Subject wears underwear or swimsuit 
3. Subject stands on centre of scales, keeping still, facing forwards and hands at sides. 
4. Operator records measurement once read-out is stable. 
5. The measurement is recorded to the nearest 0.01 kg 
 
The measurement is repeated and recorded twice after excluding any erroneous values. 
 
 
Height (wall-mounted stadiometer) 
1. Remove shoes and any hair ornaments that will interfere with the measurement 
2. Subject stands straight with  
  (a) feet flat on floor,  
(b) back, shoulders, head, buttocks (and calves if backboard reaches) against back-board of 
stadiometer,  
  (c) heels against heel plate and  
(d) head in horizontal Frankfurt (orbito-meatal) plane passing through upper margins of the 
external acoustic meatuses and the lower margin of the left orbit. 
3. Subject takes a breath in and on expiration the headboard is moved down gently onto the 
head compressing the hair and the measurement recorded. 
4. The measurement is recorded to the nearest 0.1 cm 
 
The measurement is repeated and recorded twice after excluding any erroneous values. 
NB If it is not possible to have all the back, buttocks and calves in contact with the backboard make 
sure the subject is standing with a upright spine.  
 
 
Circumferences  
Use appropriate insertion tape depending on size of circumference to be measured.   
Measurement of circumferences should not be over clothing unless it is light and close fitting such 
as a swimming costume. 
 
Head circumference 
1. Remove hair ornaments so that hair can be compressed close to the skull. 
2. Subject stands straight with head in Frankfurt plane. 
3. Operator places insertion tape horizontally around widest point of occipital bones and 
forehead perpendicular to the long axis of the face.   
4. Operator records measurement at point on tape indicated after compressing hair by pulling 
tape tight. 
5. The measurement is recorded to the nearest 0.1 cm 
 
The measurement is repeated and recorded twice after excluding any erroneous values. 
           
Mid-upper arm circumference (MUAC, left side) 
1. Subject stands straight with left arm at side and elbow bent at an angle of 90o. 
2. Operator finds the depression at the end of the acromion process and locates the lateral tip 
of the acromion process. 
3. Operator finds the point of the olecranon process (elbow).  
4. Operator measures the distance between acromion tip and point of elbow. 
5. Operator marks a point halfway between these anatomical landmarks.       
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6.  Subject lets arm hang loosely at the side.  If also measuring bicep and tricep skinfolds, 
extend this line horizontally to the anterior and posterior of the upper arm. 
7. The operator measures, and records, mid-upper arm circumference at this point, with the 
tape perpendicular to the long axis of the arm and pulled tight so that it is in contact with 
the skin without compression. 
8. The measurement is recorded to the nearest 0.1 cm 
 
N.B Ensure that the arm is relaxed and hanging at the side whist taking the measurement. 
The measurement is repeated and recorded twice after excluding any erroneous values. 
 
Waist circumference (WHO/ Lohman method) 
1. Subject stands straight with abdomen relaxed and arms hanging at the sides and feet 
together. 
2. Operator faces the subject and finds the narrowest girth as seen from the front.  If this 
proves to be difficult then the subject may be asked to bend to the side and the operator 
then identifies the point at which the trunk folds, and uses this as the landmark.  For obese 
subjects the smallest horizontal circumference at a point between the lowest rib and top of 
iliac crest is measured. 
3. At the end of normal expiration, measure and record the waist circumference at this point 
with the tape horizontal and in contact with the skin without compressing the waist. 
4. The measurement is recorded to the nearest 0.1 cm 
 
The measurement is repeated and recorded twice after excluding any erroneous values 
 
Hip circumference 
1. Subject stands straight with arms at the sides and feet together. 
2. Whilst squatting at the side of the subject the operator finds the widest girth of the hips, 
usually around the greater trochanters of the femur, but may vary according to the shape of 
the subject.   
3. The tape is passed around the widest point and the operator checks this is horizontal and in 
close contact without compression. 
4. The measurement is recorded to the nearest 0.1 cm 
The measurement is repeated and recorded twice after excluding any erroneous values. 
 
 
Skinfold thickness measurements 
General technique: 
1. Always check the dial of the calipers start at zero and adjust if necessary.  
2. Use an eyeliner pencil to mark the points to measure. 
3. Assuming the operator is right handed, then once the site has been located and marked the 
thumb and forefinger of the left hand are used to elevate a fold of skin and subcutaneous fat 
about 1cm away from the measurement point.  If necessary the skin can be lifted using both 
hands and then held by the left hand whilst measuring with the right. 
4. The thumb and finger must be far enough away from the point of measurement so that the 
fingers are not compressing the point of measurement and the skinfold is pulled away from 
the musculature in order to form a fold with almost parallel skin surfaces.  It may not be 
possible to achieve parallel sides when the skinfold is large.  Care must be taken to only 
grasp skin and subcutaneous fat. 
5. The right hand is used to open the calipers and place them over the skinfold perpendicular 
to the long axis of the fold  approximately half way between the crest of the fold and the 
body surface.   
6. The calipers are released whist continuing to hold the skinfold with the left hand.   
7. A reading is taken once the dial first slows to almost a stop.  This should be around 3 secs 
but never more than 4 secs because if the calipers are left in position too long, particularly 
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in obese subjects, they will start to compress the skinfold and give an inaccurate 
measurement.   
8. Once a reading is taken release the calipers FIRST before releasing the fold held by the left 
hand.  In young children there is a danger that they may suddenly pull away and there is a 
risk of damage to the skin.  The operator should be aware and release the calipers quickly. 
9. Whilst  taking  a  reading  the  operator’s  head  should  be  positioned  so  as  to  avoid errors due 
to parallax. 
10. A measurement is recorded to the nearest 0.2 cm. 
11. The measurement is repeated and recorded three times after excluding any erroneous 
values 
 
 
Biceps (on left) 
1. Subject stands straight with arm held loosely at the side.  
2. Operator finds the level of the mid-upper arm circumference measurement (see MUAC above) 
and locates the point on the anterior aspect of the arm.  Using the previous mark for MUAC, a line 
is drawn perpendicular to that line and directly over the humerus.  
3.The skinfold measurement is taken by the operator gently pinching the skin and adipose 
tissue immediately above this site and pulling it away from the underlying muscle.  
4. The caliper is then used for the measurement at the exact level on the mid-upper arm plane. 
The measurement is repeated and recorded three times after excluding any erroneous values 
 
Triceps (on left): 
1. Subject stands straight with arm held loosely at the side.  
2. The operator finds the level of the mid-upper arm circumference measurement (see MUAC 
above) and locates the point on the posterior aspect of the arm.  Using the previous mark for 
MUAC, a line is drawn perpendicular to that line and directly over the humerus.  
3. The skinfold measurement is taken by the operator gently pinching the skin and adipose 
tissue immediately above this site and pulling it away from the underlying muscle.  
4. The caliper is then placed at the exact level on the mid-upper arm plane. 
The measurement is repeated and recorded three times after excluding any erroneous values 
 
Subscapular (on left) 
1. Subject stands straight with arms held loosely at the side. 
2. The operator finds the inferior angle at the lower margin of the scapula.  If this is difficult 
to locate then gently take the left forearm and place behind the back, mark the scapular angle 
and then release the arm. 
3. The skinfold is grasped diagonally so that the point of measurement is just inferior to this point 
and the fold is inclined infero-laterally at approximately 45 0 to the horizontal and in the natural 
cleavage line of the skin. 
4. The caliper is placed approximately 1 cm from the fingers of the left hand, perpendicular to the 
long axis of the skinfold.  
The measurement is repeated and recorded three times after excluding any erroneous values 
 
Suprailiac (on left) 
1. Subject stands straight with arms held slightly abducted to aid access to the measurement site.  
2. The operator palpates the top of the iliac crest and marks a cross aligned with the mid-axillar.  
3. An oblique skinfold is grasped just above the centre of the marked cross (see 2 above) and 
following the natural cleavage line of the skin so that the fold is approximately 1cm above the iliac 
crest at the mid-axillary point. It should be aligned inferomedially at approximately 45 0 to the 
horizontal.  Two hands may be used to grasp the skinfold initially and then the right hand removed 
to use the caliper.  
4. The caliper is placed on the fold at the mid-axillar point. 
The measurement is repeated and recorded three times after excluding any erroneous values 
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Appendix 3.7 Anthropometry data collection form
ID    
    
Data collector initials for anthropometry 
 
 
English date  
      
Time 
:        
Weight  Tanita 418 =    Kg  Tanita Solar =              Kg 
 
Height     
Standing height =   cm  Standing height =   cm  
Sitting height     =   cm  Sitting height     =   cm 
 
Skinfold thicknesses:     Caliper  1 F 2 F 
 First (mm) Second (mm) Third (mm) 
Triceps    
Bicep    
Subscapular    
Suprailiac     
 
Circumferences  Tape 1 F 2 F 3 F 
 First (cm) Second (cm) 
Head   
Chest    
Waist    
Hip   
Upper leg    
Mid-upper arm    
 
Blood pressure:  Monitor 1 F Monitor 2 F 
1.    /     mmHg    2.      /         mmHg  
 
Ultrasound kidney size:    Right    length  cm,  A/P            cm 
    Left       length  cm,  A/P   cm 
 
Spirometry:    1 F  or  2 F 
 
Data  collector’s  initials: 
FEV1 =  
FVC  =  
MEF 25-75 =  
 
Hair sample Yes   No  
Nail sample Yes   No  
 
Bioelectrical impedance (Please staple)  
Add 0.2kg for clothes 
Whole body =  Ω 
 
Right leg =  Ω 
 
Left leg =  Ω 
 
Right arm =  Ω 
 
Left arm =  Ω
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Appendix 3.8 Janakpur Deuterium Calibration Protocol 
Summary of proceedings 
1. Gain Consent 
2. Check that child hasn't drunk water in last 30mins  
3. Explain saliva sample technique and deal with questions 
4. Collect pre-dose samples 
5. Administer dose, recording time & planning the post-dose interval 
6. Perform bioelectrical impedance (BIA), weight, standing height and sitting height 
measurements 
7. Monitor child during 4 hour waiting period & give standard meal & drinks 
8. Collect post-dose saliva sample at the 4 hour mark Thank participants and give 
participation gifts.  
9. Spin down all samples and freeze ready for analysis.  
10. Enter all participant data.  
 
Explanation For Consent 
Read the following information to participants 
We would like to do a test to measure the total amount of water in your body. This can give 
us information of about your body composition, which means information about the basic 
constituents of your body (e.g. muscle, bone, fat and water). This gives us lots of information 
about your general health. We will use this data to help us in a larger study, which we are also 
conducting in Dhanusha. None of the tests we are performing today are harmful or painful. 
The testing will take between about 5 hours, 4 hours of which is waiting time.  
 
The testing involves 2 stages.  
PART 1: Before the test begins we need to make sure that you have not eaten or drunk for 30 
minutes. The first stage involves you giving one saliva sample and then drinking a "special" 
water drink. The saliva test involves wetting a cotton wool bud in your mouth. The "special 
drink" is drunk through a straw from a small plastic bottle. At this stage we will also do other 
measurements of your height and weight and will ask you to stand on a machine called a 
"bioelectrical impedance machine". 
The special water drink is a substance called deuterium - also known as heavy water. 
Deuterium is entirely harmless - it is simply a different form of water. It is normally present 
in low quantities in the human body. We give you a concentrated amount of the substance 
enabling us to measure it in your body from the saliva samples that you give us during the test. 
From this we can measure the amount of water in your body. The Bioelectrical impedance 
test involves you standing on this machine (SHOW THEM THE MACHINE) and holding the 
handles. The machine sends a tiny electrical current that you cannot feel through your body 
and measures the resistance through different parts of your body. From this we can calculate 
percentages of water, fat, muscle and bone in your body.  
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We will then measure your height and weight using scales and measures. Combing the results 
from the deuterium, the bioelectrical impedance and other tests enables us to measure your 
body composition accurately. Some of these tests take time to calculate the result so 
unfortunately some, but not all, of the information will be available today. After you have 
done the first saliva sample and the other tests, the first stage is complete.  
 
PART 2: The second part of the test involves waiting before performing the second saliva 
sample. We need total of four hours for the deuterium drink to distribute evenly through your 
body. During this waiting time we will give you food and drinks. You must not drink 
anything other than what we give you as this will affect the test. In the final 30 mintues we 
will ask you not to eat or drink anything. After this time you will perform the final saliva 
sample, also using a cotton bud in the mouth.  
Once this done, the test is complete.  
If you have any questions please free to ask them now, or at any stage during the test.  
 
Protocol for researchers 
Preparation for the test - 30minutes  
The first priority is to make sure that a valid period of nil by mouth is obtained. On arrival 
participants and their guardians should be told that the study cannot start until we have waited 
30 mins without the children eating or drinking (including chewing gum). During the period 
of the study, the children must not eat or drink anything without instruction from the 
researchers. Once this has been explained and the time recorded the consent can be gained.  
Gaining Consent 
Explain about 30 min nil-by-mouth period before starting the test 
Deliver explanation/watch film 
Discuss project with parent/guardian and answer any questions 
Obtain signature of parent/guardian  
This period is unlikely to take the full 30 mins so this time should be spent with resolving any 
questions and demonstrating the technique of saliva sample collection.  
 
Saliva Collection  
In order to obtain an adequate sample, the following technique should be explained clearly to 
the child. Approximately 2ml of saliva is needed to run the total body water test. The cotton 
wool buds need to be made VERY wet to give an adequate sample. Below 1ml of saliva the 
test risks becoming unusable. Observing expansion of the cotton bud to 150-200% of its "dry" 
size is a means of assessing adequacy of the sample. Inadequately wet sample will show 
minimal expansion of the cotton bud. This is more reliable that assessing adequacy on how 
"wet" the sample looks.  
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Demonstrate the following to the child:  
1. The various components of the test: the salivette, the drink and the sample container. 
Focusing on the salivette show the cotton wool bud and the container itself, where the saliva 
collects after centrifugation. 
2. The technique for getting a good sample.  
Build up lots of saliva in mouth.  
Put cotton wool in mouth. 
Roll it around mouth with your tongue. DO NOT chew it.  
Do this for 1-2 mins and make the cotton wool bud as wet as possible.    
Remove with fingers and replace into receptacle. Do NOT drop on the floor! 
If there is time prior to performing the pre-dose sample, check the child's understanding and 
repeat explanation as required. 
Steps for Collecting Pre-dose sample 
Explain clearly how to get an adequate sample, checking understanding 
Encourage the child to build up saliva in the mouth 
Don disposable gloves and snap the cap off the salivette 
Remove the cotton bud from the container and place the cotton bud in child's open mouth 
Encourage the child to move the cotton bud round the mouth. Remind them not to chew the 
bud. Wait at least 1.5 minutes.  
Ask the child to present the bud at the front of the mouth and check for adequacy 
If adequate, reholster in salivette. 
Shake the salivette. It should  “thud”  and  stick  when  shaking.   
Store sample safely ready for centrifugation. 
 
Deuterium drink  
The accuracy of the total body water test relies on knowing the precise amount of deuterium 
that has been consumed. Spillage of the prepared drink should be avoided at all costs. 
Explanation to the child in a clear fashion will increase success of avoiding error. In the event 
of a spillage, if it is only small droplets these can be approximated to 0.1 ml per beaded 
droplet. Larger losses which are not possible to quantify accurately will invalidate the test.  
Shake the drink before giving to the child. 
Say   the   following:   “The   drink   needs   to   be   drunk   very   carefully   with   the   straw   to   avoid  
spilling  any  of  the  drink.”   
The drink needs to be kept in the bag, so that if any does spill we can catch the drops.  
Try to drink the whole drink & when you are finished give the drink back to me.  
Appendices 
340 
 
Explain that they are about to drink the special "heavy water" drink and discuss the proper 
technique to avoid spilling. 
Steps for administering deuterium dose 
Open sealed prepared deuterium drink, undo lid and insert straw. 
Give the drink, within the bag, to the child. Ask them to take the drink with both hands. 
Instruct to drink all drink using the straw. 
When finished take empty container, bend straw into bottle and seal with lid. Next seal bag 
around container.  
Record the time the dose was given. 
Calculate the time to perform "post-dose", four hours later.  
 
Waiting Period  
As soon as the deuterium drink has been drunk the time must be recorded, correct to the 
nearest minute. The post-dose sample must be conducted at 4 hours following, making sure 
that the participant has not drunk or eaten for 30 minutes prior to this.  
During this period children will be given standardised drink (fizzy drink or water filled up to 
demarcation on plastic cups), administered at set times. Additional tests are performed at this 
stage. 
During this period the pre-dose samples should be centrifuged. The samples should be spun 
for a minimum of 3000 rpm for 3 minutes. In exceptionally low yield samples try running for 
another couple of minutes - harvest after this point is minimal however.  
 
Weight, Height and BIA 
Height: Height was measured with a Leicester stadiometer, accurate to 0.1cm. The 
stadiometer was calibrated with a 50cm calibration rod.  
Position:  The  child’s  feet  should  be  placed  together  with  their  heels  touching  the  stadiometer.  
Their knees were kept extended and their head was placed in the Frankfort position. The child 
is asked to take a breath in just before the reading is taken. The measurement should be taken 
with the observer reading at the appropriate height to avoid parallax. 
The sitting height measurements are taken with the child seated on a custom-made stool. 
Their legs should be supported so that the knees were bent at 90°.  
Weight: Prior to weighing and BIA the child should empty their bladder. Body weight was 
measured with a Tanita Solar stand on scale accurate to 0.1 kg. The children are weighed 
wearing only their underwear, a vest and a sarong that together weigh 200g. The weighing 
scales are calibrated fortnightly with calibration weights. 
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BIA: The children stood on the metal plates with their legs apart and their arms not touching 
their  body.  Two  recordings  were   taken,  one  with   the  child’s  arms  at  90°  and  one  with  their  
arms at 180°. The weight of clothes used was 200g.  
 
Second saliva sample 
The second saliva sample must be performed at least 4 hours following consumption of the 
deuterium dose but only if there has been a clear period of 30 minutes of nil-by-mouth prior 
to performing the sample. The test saliva sample must not be collected earlier than this. If the 
child eats or drinks anything during this period of nil-by-mouth, the test must be delayed 30 
minutes after the last drink or foodstuff consumed.  
Steps for collecting post-dose sample are the same as above (page 339)  
Avoid lapses in concentration and technique from both researcher and child  
Ensure adequacy of sample.  
Once the sample has been successfully collected the test is complete 
After the test: Once the final saliva sample has been given this test is complete. To complete 
the testing the following tasks are required.  
Re-weigh dose bottle and straw 
Storage 
Data Entry 
 
Centrifugation and sample storage 
Spin down samples, colour code label and freeze 
Pipette into sample freezing tubes - expel air from pipette (squeeze it fully), introduce the 
bottom of the receptacle and then release allow the pipette to fill. 
Discharge pipette into the freezing tube close to the top - avoid forming bubbles 
Repeat process until freezing tube is 90% full 
Seal tube, check label and then place in freezer box and into freezer.  
 
Making up the dose 
A standard dose of 1.2g of deuterium is used in this study representing 0.06g of deuterium x 
average weight of children in this study (20kg) 
Labelling 
Colour Label all components before starting using indelible marker pens. Label participant ID 
and nature of the sample in question on all parts. Thus: lid and bottles for dosing and freezer 
tubes and body and cap for salivettes.  
Colour coding: 
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Dose and dosing bottles (GREEN) 
Pre-dose salivettes and tubes (RED) 
Post-dose salivettes and tubes (BLUE) 
List of Components per Test: 
Salivettes x3, Freezer tubes x3, Dosing bottle, Straw, Re-sealable plastic bags, Fresh Cold 
Water - 100ml, Deuterium 1.2g, Pipettes x3, Generic components, Marker pens Red, Green, 
Blue, Bottles still water. Freezer box for receptacles, Bottle of deuterium, Filter (one per day), 
5ml Syringes (one per day) 
 
Calibrating scales 
To ensure accuracy scales need to be calibrated each day and prior to use.  
 
Method 
Turn scales on with held press of "On/zero/Off/Yes" button 
Wait 1 minute before performing calibration 
Press and hold "Print/Cal" until "CAL" appears on display 
Wait for flashing "-C-" to disappear and flashing "100g" to appear 
Place 100g calibration weight on scale 
Press " On/zero/Off/Yes" Button 
Wait for "DONE" to show on display 
 
Steps to make up dose 
Wash hands. 
Take off lid of dose bottle, place the empty bottle on the scales and wait till weight reading is 
stable.  
Zero scales 
Measure out 1.2ml of deuterium using syringe delivered through filter. Go slowly, allowing 
for measurement lag and observe weight increase using the scales.  
Once done - pump one empty (air filled) full syringe slowly through the filter - returning any 
unused deuterium to the container (normally about 2 drops). Be careful not to push off the 
filter. 
Fill the bottle up 75% with bottled water. 
Seal both deuterium container and dosing bottle 
Agitate dosing bottle for one minute- (fix elbow and shoulder and rotate wrist prone and 
supine in full 180 degree motion for this time - rather than simply shaking)  
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Immediately place down - remove lid and shake off/dry any loose drops externally and those 
on lid and bottle rims which would otherwise evaporate. 
Take clean, fresh pipette and withdraw 2ml of fluid from the centre of the bottle and place in 
pre-marked (GREEN DOSE) freezer tube. 
Seal both bottle and freezer tube. Double check bottle for spilled external drops and dry if 
found. One violent shake WITH top sealed can dislodge difficult droplets wedged between lid 
and bottle. Repeat drying process on final time.  
Place bottle into plastic bag with straw.  
Weigh bottle making sure all aspects of plastic bag are resting on the scale are part of this 
amount, ensuring no overhang. 
Seal bottle bag and leave aside ready for testing. 
 
Sebastian Roberts, Final year medical student, UCL 
Dr Delan Devakumar, Wellcome Trust Research Training Fellow, UCL 
29/1/12 
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Appendix 3.9 Air pollution sampling strategy 
 
 
Figure 1: Air pollution sampling profile used for the first season of sampling 
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Appendix 3.10 Air pollution data collection form 
 
Air Pollution 
 
 
 
Child’s  ID School Data collector ID 
FFFF   
 
 
 
Apex 
number 
Nepali date Filter 
number 
Time 
start 
Volume 
start 
(L or m3) 
Temp 
start 
(oC) 
Time 
end 
Volume 
end 
(L or m3) 
Temp 
end 
(oC) 
Calibration 
end (L) 
F 20FF FF FF FFF _ _:_ _ 
 
 
FF _ _:_ _ 
 
 
FF  
          
F 20FF FF FF FFF _ _:_ _ 
 
 
FF _ _:_ _ 
 
 
FF  
          
F 20FF FF FF FFF _ _:_ _ 
 
 
FF _ _:_ _ 
 
 
FF  
          
F 20FF FF FF FFF _ _:_ _ 
 
 
FF _ _:_ _ 
 
 
FF  
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Appendix  3.11  Doctor’s  voucher 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Doctor's Voucher 
 
Dr. SN Yadav                                                               Date: _ _ _ _ / _ _ / _ _ 
 
ID N..........        
  
Child Name: ...........................................    Age........... Sex............. 
   
This voucher can be used to cover the cost of essential, acute medications up to a 
value of Rs 200. It can be redeemed up to the end of the research project in 
December 2012.  
 
This voucher can be used for the following medications: 
Oral antibiotics: amoxycillin, ciprofloxacillin, norfloxacillin, cefixime, 
    metronidazole  
Oral aciclovir 
Anti-malarials: chloroquine and sulfadoxine 
Albendazole 
Skin treatment for scabies 
Salbutamol inhaler  
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Appendix 3.12 Ethic approval letters 
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Appendix 3.13 Information sheets and consent form 
Information Sheet for Parents or Guardians  
                                                            
 
You will be given a copy of this information sheet. If you decide to take part you will be asked to sign a 
consent form.  
Title of Project: The effects of antenatal micronutrient supplementation and current 
air pollution on growth and lung function in 8-10 year old children   
This study has been approved by the UCL Research Ethics Committee (Project ID Number): 2744/001 
Name Dr D Devakumar 
Work Address MIRA Dhanusha office, Ramanand Chowk, Janakpur 
Contact Details  
 
041523371 
We would like to invite            to participate in this research project.             
x Details of Study:  
 
This study is the follow-up of the children born in the previous study in which mothers were given a vitamin 
and mineral supplement in pregnancy. We want to see all the children (up to 1064 children) to find out the 
long term effects of this supplement. We would like to know if the supplement makes your child bigger and 
improves their breathing. This will help to decide whether such supplements should be used in the future.  
If   you   are   happy   to   participate,   we  would   like   to   ask   you   some   questions   about   your   child’s   health,   your  
family, where you live and what you eat. We will then ask you to come to the Mother and Infant Research 
Activities (MIRA) office when convenient, where we will take some measurements of your child: their height 
and weight, percentage of body fat, body measurements, and skinfolds (by pressing the fat gently on the arm, 
shoulder and abdomen). They will not be asked to undress completely. We will then check their blood 
pressure, perform some breathing tests by asking them to blow into a small machine, and look at the size of 
their kidney with an ultrasound  machine.  We  will  take  some  samples  of  your  child’s  hair  and  toenails  to  find  
out the level of minerals. A sample of saliva will also be requested to investigate their hereditary make-up 
(genetic markers related their growth and lung function). As in the previous study, we will use identification 
numbers  and  will  not  mention  your  child’s  name  on  any  of  the  samples.   
The whole assessment will take approximately 45 minutes and none of the measurements will harm your 
child.   
We would also like to measure the quality of the air your child is breathing in. This would involve sampling 
the  air  with  small  machines  in  your  home  and  in  your  child’s  school.     
We may ask if we can take a photograph of your child during the project. This will only happen with your 
consent  at  the  time.  The  photographs  may  be  used  to  help  summarise  the  work  done  by  MIRA.  Your  child’s  
name and contact details will not be included with them.  
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You may decide to personally withdraw or withdraw your data from the research project at any time. This will 
not affect you in any way.  
We will cover the costs of transport to the MIRA office (using public transport). We will also provide a 
consultation with a doctor in Janakpur to check over your child and cover the costs of essential, acute 
medications up to a value of NRs 200. We will also provide refreshments and a small gift for your child to say 
thank you.  
All   the   information   we   collect   will   not   show   your   child’s   name   and   will   be   stored   securely.   Only   the  
researchers will have access to it. The scientific findings may be published in the scientific media or presented 
at scientific meetings, but your name or identifiable information will not appear anywhere.   
  
 
 
Please discuss the information above with others if you wish or ask us if there is anything that is not clear or if 
you would like more information.  
 
It is up to you to decide whether to take part or not; choosing not to take part will not disadvantage you in any 
way. If you do decide to take part you are still free to withdraw at any time and without giving a reason.   
 
All data will be collected and stored in accordance with the Data Protection Act 1998. 
 
 
Information Sheet for Parents or Guardians  
                                                            
 
You will be given a copy of this information sheet. If you decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form. 
Title of Project: The effects of antenatal micronutrient supplementation and current 
air pollution on growth and lung function in 8-10 year old children – calibration study 
This study has been approved by the UCL Research Ethics Committee (Project ID Number): 2744/001 
Name Dr D Devakumar 
Work Address MIRA Dhanusha office, Ramanand Chowk, Janakpur 
Contact Details  041523371 
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We would like to invite            to participate in this research project.             
x Details of Study:  
 
This study is designed to measure the body composition of Nepalese children in this region. We will try to 
measure   the   total  amount  of  water   in  your  child’s  body  and  from  this,  estimate   the  amount  of  body  fat  and  
muscle and bone. This information will be useful for other research looking at the size and make-up of 
children in Nepal.  
If you are happy to participate, we would like your child to drink special water drink is a substance called 
deuterium - more commonly knows as heavy water. This drink is entirely harmless and is simply a different 
form of water. It occurs naturally in all of us. Before and 4 hours after the drink they will be asked to provide 
a saliva sample using an absorbent cotton wool swab. The saliva samples will be given a unique identification 
number, stored in a secure location in the Mother and Infant Research Activities (MIRA) office and 
transported to London where it will be tested.  
The study will be done while your child is at school and it will not disrupt their lessons.  
We may ask if we can take a photograph of your child during the project. This will only happen with your 
consent  at  the  time.  The  images  may  be  used  to  help  summarise  the  work  done  by  MIRA.  Your  child’s  name  
and contact details will not be included with the images.  
You may decide to personally withdraw or withdraw your data from the research project at any time. You 
would just need to inform the research assistant if so.   
All the information we collect will be anonymised and stored securely. Only the researchers will have access 
to the data that is collected. The information may be published in the scientific media or presented at scientific 
meetings, but your name or identifiable information will not appear anywhere.   
 
Please discuss the information above with others if you wish or ask us if there is anything that is not clear or if 
you would like more information.  
 
It is up to you to decide whether to take part or not; choosing not to take part will not disadvantage you in any 
way. If you do decide to take part you are still free to withdraw at any time and without giving a reason.   
 
All data will be collected and stored in accordance with the Data Protection Act 1998. 
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Informed Consent Form for Parents or Guardians  
                                                                          
Please complete this form after you have read the Information Sheet and/or listened to an explanation 
about the research.  
Title of Project: The effects of antenatal micronutrient supplementation and current air pollution on 
growth and lung function in 8-10 year old children     
This study has been approved by the UCL Research Ethics Committee (Project ID Number): 2744/001 
 
Thank you for your interest in taking part in this research. Before you agree to take part, the person organising 
the research must explain the project to you. 
If you have any questions arising from the Information Sheet or explanation already given to you, please ask 
the researcher before you to decide whether to join in.  You will be given a copy of this Consent Form to keep 
and refer to at any time.  
Statement of Parent or Guardian 
 
I       
x have read the notes written above and the Information Sheet, and understand what the study involves. 
x understand that if I decide at any time that I no longer wish to take part in this project, I can notify the 
researchers involved and withdraw immediately.  
x consent to the processing of my personal information for the purposes of this research study. 
x understand that such information will be treated as strictly confidential and handled in accordance with 
the provisions of the Data Protection Act 1998. 
x agree that the research project named above has been explained to me to my satisfaction and I agree to 
take part in this study.  
Signed:         Date:       
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Appendix 3.14 Referral form to the nutrition unit 
          MIRA Dhanusha  
Micronutrient follow-up programme 
Referral form for children with malnutrition 
Date: 
 
Name of child: 
 
Date of birth: 
 
Name of the mother: 
 
Name of the father: 
 
Address: 
 
Weight: 
 
 
Height: 
 
 
Weight for height Z score: 
 
 
BMI Z score: 
 
 
Mid-upper Arm Circumference: 
 
 
 
Comments: 
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Appendix 4 
Appendix 4.1 Technical effort of measurement data 
Table 1: Results for the technical error of measurement and coefficient of reliability 
assessments throughout the research project 
September 2011 (Piloting): 
 Observer 1 Observer 2 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Height 0.07 0.06 0.07 0.06 
Biceps SFT 0.12 3.36 0.06 1.29 
Triceps SFT 0.10 1.40 0 0 
Subscapular SFT 0.12 2.55 0 0 
Suprailiac SFT 0.10 1.92 0.06 0.98 
Head circum 0.05 0.10 0.03 0.06 
Chest circum 0.05 0.09 0.03 0.05 
Waist circum 0.07 0.14 0.03 0.06 
MUAC 0 0 0 0 
 
 Inter-observer TEM Inter-observer coefficient of reliability 
 First Second Third First Second Third 
Height 0.33   1   
Biceps SFT 0.17 0.89  0.23 0.98  
Triceps SFT 0.32   0.95   
Subscapular 
SFT 
0.25 0.06  0.63 1  
Suprailiac SFT 0.62 0.35  0.90 0.98  
Head circum 0.12   0.97   
Chest circum 0.77   0.96   
Waist circum 2.31 1.07 0.18 0.57 0.85 0.99 
MUAC 0.21   0.95   
 
 
February 2012: 
 Observer 1 Observer 2 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Height 0.05 0.05 0.04 0.05 
Biceps SFT 0.06 1.77 0 0 
Triceps SFT 0 0 0 0 
Subscapular SFT 0.13 2.80 0.13 2.93 
Suprailiac SFT 0.13 2.70 0.06 1.41 
Head circum 0.04 0.09 0.04 0.09 
Chest circum 0.06 0.12 0.04 0.08 
Waist circum 0.04 0.01 0.05 0.11 
Hip circum 0.04 0.08 0.04 0.08 
Upper leg circum 0.04 0.14 0 0 
MUAC 0.03 0.20 0.03 0.20 
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 Inter-observer TEM Inter-observer coefficient of 
reliability 
 First Second First Second 
Height 0.33  0.97  
Biceps SFT 0.21  0.94  
Triceps SFT 0.30  0.97  
Subscapular SFT 0.17  0.95  
Suprailiac SFT 0.25  0.95  
Head circum 0.37 0.14 0.82 0.99 
Chest circum 1.04 0.77 0.18 0.90 
Waist circum 1.27 0.35 0.13 0.97 
Mid-upper arm 
circum 
0.11  1  
Hip circum 0.13  0.96  
Upper leg circum 0.46  0.98  
 
 
May to July 2012: 
 Observer 1 Observer 2 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Height 0.03 0.03 0.03 0.03 
Biceps SFT 0.09 2.60 0.01 2.25 
Triceps SFT 0.10 1.54 0.01 1.22 
Subscapular SFT 0.09 2.11 0.01 1.87 
Suprailiac SFT 0.11 2.46 0.06 1.47 
Head circum 0.04 0.09 0.04 0.08 
Chest circum 0.04 0.07 0.06 0.11 
Waist circum 0 0 0.06 0.12 
Hip circum 0 0 0.03 0.05 
Upper leg circum 0.03 0.10 0.03 0.10 
MUAC 0.04 0.27 0.03 0.20 
 
 Inter-observer TEM Inter-observer coefficient of 
reliability 
 First Second First Second 
Height 0.16  1.00  
Biceps SFT 0.14  0.95  
Triceps SFT 0.22  0.99  
Subscapular SFT 0.13 0.20 0.94 0.90 
Suprailiac SFT 0.20  0.96  
Head circum 0.17  0.97  
Chest circum 0.95 0.63 0.89 0.92 
Waist circum 0.67 0.35 0.93 0.98 
Mid-upper arm 
circum 
0.07  0.99  
Hip circum 0.31  0.99  
Upper leg circum 0.60 0.64 0.93 0.93 
Appendices 
357 
 
 
 
October 2012: 
 Observer 1 Observer 2 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Intra-observer 
TEM 
Intra-observer 
TEM % 
Height 0.05 0.04 0.05 0.04 
Sitting height 0.05 0.04 0.02 0.02 
Biceps SFT 0.06 1.68 0 0 
Triceps SFT 0.06 0.86 0.09 1.20 
Subscapular SFT 0.08 1.64 0.06 1.36 
Suprailiac SFT 0.09 1.50 0.06 1.05 
Head circum 0.03 0.06 0.05 0.10 
Chest circum 0.04 0.07 0.06 0.11 
Waist circum 0.04 0.08 0.05 0.10 
Hip circum 0.04 0.08 0.04 0.08 
Upper leg circum 0.04 0.12 0.03 0.10 
MUAC 0.04 0.28 0.04 0.24 
 
 Inter-observer TEM Inter-observer coefficient 
of reliability 
Height 0.26 1.00 
Sitting height 0.39 0.96 
Biceps SFT 0.15 0.95 
Triceps SFT 0.30 0.98 
Subscapular SFT 0.16 0.93 
Suprailiac SFT 0.28 0.95 
Head circum 0.15 0.99 
Chest circum 0.53 0.97 
Waist circum 0.40 0.99 
Mid-upper arm circum 0.22 0.96 
Hip circum 0.29 0.99 
Upper leg circum 0.17 0.99 
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Table 2: Results split into intervention and control groups with and without the removal 
of measurement error. Lt = left, Rt = right 
 Control Intervention 
 Mean SD 95% CI SD after 
adjust-
ment for 
error 
95% CI 
after 
adjust-
ment for 
error 
Mean SD 95% CI  SD after 
adjust-
ment for 
error 
95% CI 
after 
adjust-
ment for 
error 
Standing 
height 
(cm) 
120.7
2 
5.91 120.16, 
121.29 
5.91 
 
120.16, 
121.29 
120.7
3 
6.06 120.15, 
121.31 
6.06 
 
120.15, 
121.31 
Sitting 
height (cm) 
64.14 2.94 63.86, 
64.42 
2.94 63.86, 
64.42 
64.16   2.96 63.87, 
64.44 
2.96 63.87, 
64.44 
Skin-fold thickness        
Triceps 
(mm) 
7.39 2.54 7.15, 
7.63 
2.54 7.15, 7.63 7.36 2.39 7.13, 
7.59 
2.39 7.13, 
7.59 
Biceps (mm) 3.95 1.34 3.83, 
4.08 
1.34  3.83, 4.08 3.95     1.38 3.81, 
4.08 
1.38 3.81, 
4.08 
Subscapular 
(mm) 
4.92      1.28 4.80, 
5.04 
1.28 4.80, 5.04 4.93     1.51 4.79, 
5.07 
1.51 4.79, 
5.07 
Suprailiac 
(mm) 
5.76 2.53 5.51, 
6.00 
2.53 5.51, 6.00 5.57 2.34 5.34, 
5.79 
2.34 5.34, 
5.79 
Body circumferences         
Head (cm) 49.19  1.48 49.05, 
49.33 
1.48 49.05, 
49.33 
49.37     1.47 49.23, 
49.51 
1.47 49.23, 
49.51 
Chest (cm) 55.59  3.39 55.27, 
55.91 
3.38 55.27, 
55.91 
55.74 3.64 55.39,  
56.09 
3.64 55.39,  
56.09 
Waist (cm) 49.01 3.76 48.65, 
49.37 
3.76 48.65, 
49.37 
49.20 3.96 48.82, 
49.58 
3.96 48.82, 
49.58 
Hip (cm) 57.30     4.00 56.91, 
57.68 
4.00 56.91, 
57.68 
57.36
301     
4.11 56.97,  
57.76 
4.11 56.97,  
57.76 
Upper leg 
(cm) 
31.11  2.91 30.84, 
31.40 
2.91 30.84, 
31.40 
31.21
456     
2.91 30.94, 
31.49 
2.90 30.94,  
31.49 
Mid-upper 
arm (cm) 
15.94 1.40 15.81, 
16.08 
1.40 15.81,  
16.08 
15.99      1.38 15.85, 
16.12 
1.38 15.85,  
16.12 
Kidney           
Rt length 
(cm) 
7.90    0.55 7.84,   
7.95 
0.49 7.85, 7.94 7.89 
 
0.57 
 
7.84,   
7.95 
0.54 7.84, 
7.94 
Rt anterior –
posterior 
(cm) 
2.99   0.26 2.95,   
3.00 
0.21 2.95, 3.00 3.00     0.28 2.97,  
3.03 
0.24 2.98, 
3.02 
Lt length 
(cm) 
8.25    0.57 
 
8.19,   
8.30 
0.55 8.19, 8.30 8.22     0.58 8.16,  
8.27 
0.56 8.16,  
8.27 
Lt anterior–
posterior 
(cm) 
3.31  0.32 3.28,  
3.34 
0.26 3.29, 3.34 3.30 0.32 3.27,  
3.34 
0.27 3.28, 
3.33 
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Appendix 4.2 Additional air pollution results 
Table 1: Change in mass of field blanks and Limit of detection value 
 Change in field blanks Limit of detection 
Batch 1 -0.000020 0.000069 
Batch 2 -0.000017 0.000072 
Batch 3 0.000033 0.000077 
Batch 4 0.000015 0.000076 
 
 
Table 2: DustTrak II correction factor. Two urban and two rural samples were taken 
with both the DustTrak II and the Apex to calculate a site-specific ratio for 
photometric:gravimetric sample conversion.  
 DustTrak II 
concentration  
(µg /m3) 
Apex 
concentration  
(µg /m3) 
DustTrak:Apex 
ratio 
Average 
correction factor 
Rural 1670 732 0.4387 0.43 
 1590 669 0.4211 
Urban 1370 660 0.4897 0.52 
 957 509 0.5438 
 
 
Table 3: DustTrak II 12-hour kitchen samples, showing the minimum, maximum and 
average concentrations in each location.  
 
  
 Length of 
sample 
Fuel used Minimum 
concentration 
(µg/m3 ) 
Maximum 
concentration 
(µg/m3 ) 
Average 
concentration 
(µg/m3 ) 
1. 12 hours Non biomass 0 425 53.0 
2. 12 hours Non biomass 53.6 1080 166 
3. 12 hours Wood 26.0 58 800 831 
4. 12 hours Wood 0 1930 167 
5. 12 hours Wood 40.6 10 500 498 
6. 12 hours Dung 58.5 41 400 684 
7. 12 hours Dung 0 52 000 718 
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Appendix 5 
 
Appendix 5.1 Multi-dimensional poverty index – distribution of dimensions 
 
 
Figure 1: Distribution of the MPI scores by dimension (education, health and standard 
of living) 
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Appendix 5.2: Food security criteria for calculation of the HFIAS access scale score 
 
 
Box 1: Levels of food security definition, using the HFIAS question numbering as shown 
in Section 5.3 (Coates et al, USAID Food and Nutrition Technical Assistance Project, 
Academy for Educational Development, 2007) 
  
Food Secure HFIA category if [(Q1a=no or Q1a=rare) and Q2=no and Q3=no and Q4=no 
and Q5=no and Q6=no and Q7=no and Q8=no and Q9=no] 
Mildly Food Insecure Access HFIA category if [(Q1a=sometimes or Q1a=often or 
Q2a=rare or Q2a=sometimes or Q2a=often or Q3a=rare or Q4a=rare) and Q5=no and 
Q6=no and Q7=no and Q8=no and Q9=no] 
Moderately Food Insecure Access HFIA category if [(Q3a=sometimes or Q3a=often or 
Q4a=sometimes or Q4a=often or Q5a=rare or Q5a=sometimes or Q6a=rare or 
Q6a=sometimes) and Q7=no and Q8=no and Q9=no] 
Severely Food Insecure HFIA category = 4 if [Q5a=often or Q6a=often or Q7a=rare or 
Q7a=sometimes or Q7a=often or Q8a=rare or Q8a=sometimes or Q8a=often or Q9a=rare 
or Q9a=sometimes or Q9a=often] 
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Appendix 6 
 
 
Appendix 6.1 Equations for calculating mortality 
 
Equations for calculating mortality rates: 
 
Miscarriage  rate  =  
number  of  deaths  before  23  weeks  gestation
number  enrolled  into  trial
   ×   1000 
 
 
Stillbirth  rate  =  
number  of  deaths  after  23  weeks  gestation
number  of  births
   ×   1000 
 
 
Neonatal  mortality  rate  =  
number  of  deaths  from  birth  to  28  days
number  of  livebirths
   ×   1000 
 
 
Post-­neonatal  infant  mortality  rate  =  
number  of  deaths  from  1  month  to  1  year
number  of  livebirths
   ×   1000 
 
 
Post-­infant  child  mortality  rate  =  
number  of  deaths  from  1  year
number  of  livebirths
   ×   1000 
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Appendix 6.2 Additional anthropometry results 
Table 1: Anthropometry results in the whole cohort 
  Number Mean Median Standard deviation Range 
Age  841 8.45 8.4 0.37 7.2 to 9.9 
       
Weight Weight (kg) 841 20.09 19.6 3.33 13.5 to 44.8 
Lean mass (arms 90°) (kg) 840 17.07 16.83 2.38 11.68 to 27.47 
Fat mass (arms 90°) (kg) 840 3.03 2.83 1.53 -0.0 to 17.6 
Lean mass (arms 180°) (kg) 628 17.32 17.09 2.46 11.7 to 27.6 
Fat mass (arms 180°) (kg) 628 2.97 2.73 1.61 -0.2 to 17.7 
       
Height Standing height (cm) 841 120.73 120.4 5.98 95.3 to 140.6 
Sitting height  (cm) 841 64.15 64.1 2.95 55.7 to 73.1 
       
BMI   841 13.71 13.57 1.31 10.8 to 24.4 
Z scores 
 
Weight-for-age 841 -2.06 -2.07 1.03 -4.8 to 2.7 
Height-for-age 841 -1.49 -1.51 0.94 -5.7 to 1.4 
BMI-for-age 841 -1.65 -1.67 0.97 -4.5 to 3.3 
       
Skin-fold 
thickness 
Triceps (mm) 841 7.38 6.98 2.49 2.7 to 27.5 
Biceps (mm) 841 3.95 3.67 1.37 2.0 to 17.3 
Subscapular (mm) 841 4.92 4.70 1.40 2.8 to 17.5 
Suprailiac (mm) 840 5.66 45.1 2.45 2.9 to 20.7 
       
Body Head (cm) 841 49.27 49.3 1.48 42.4 to 55.1 
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circumferences Chest (cm) 841 55.66 55.4 3.51 46.5 to 79.1 
Waist (cm) 841 49.11 48.7 3.86 39.2 to 77.1 
Hip (cm) 841 57.33 56.9 4.05 47.2 to 85.4 
Upper leg (cm) 841 31.17 30.7 2.91 23.6 to 51.8 
Mid-upper arm (cm) 841 15.96 15.8 1.39 12.7 to 27.2 
       
Kidney 
dimensions 
Right length (cm) 839 7.89 7.9 0.56 5.6 to 10.2 
Right anterior–posterior 
distance (cm) 
839 2.99 3 0.27 2 to 3.9 
Left length (cm) 839 8.23 8.2 0.58 6.5 to 10 
Left anterior–posterior distance 
(cm) 
839 3.30 3.3 0.32 2.3 to 4.6 
       
Blood pressure Systolic (mmHg) 841 98.07 98 7.63 63 to 143 
Diastolic (mmHg) 841 61.22 61 7.82 36 to 108 
 
Table 2: Anthropometry results applying exclusions that may affect growth 
  No illness Major or chronic illness 
  Number Mean Standard 
deviation 
Range Number Mean Standard 
deviation 
Range 
Weight Weight (kg) 807 20.13 3.30 13.5 to 44.8 34 19.31 3.94 14.5 to 34 
Lean mass (arms 
straight) (kg) 
604 17.34 2.45 11.7 to 27.6 24 16.64 2.51 12.2 to 22.9 
Fat mass (arms 
straight) (kg) 
604 2.98 1.59 -0.2 to 17.7 24 2.89 2.11 -0.7 to 11.1 
Height Standing height 
(cm) 
807 120.84 5.87 104.0 to 
140.6 
34 118.06 7.92 95.3 to 133.3 
Sitting height  807 64.21 2.93 55.7 to 73.1 34 62.80 3.13 57.1 to 70.7 
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(cm) 
          
Z scores Weight-for-age 807 -2.04 1.02 -4.8 to 2.7 34 -2.35 1.28 -4.4 to 1.6 
Height-for-age 807 -1.48 0.92 -4.0 to 1.4 34 -1.87 1.23 -5.7 to 0.4 
 BMI-for-age 807 -1.65 0.95 -4.5 to 3.3 34 -1.69 1.33 -4.3 to 2.1 
          
Skin-fold 
thickness 
Triceps (mm) 807 7.36 2.42 2.7 to 27.5 34 7.70 3.90 4.1 to 21.9 
Biceps (mm) 807 3.96 1.37 2.0 to 17.3 34 3.81 1.30 2.4 to 8.4 
 Subscapular (mm) 807 4.92 1.39 2.8 to 17.5 34 4.94 1.79 3.7 to 13.2 
 Suprailiac (mm) 806 5.66 2.41 2.9 to 19.9 34 5.76 3.32 3.3 to 20.7 
         
Body circum-
ferences 
Head (cm) 807 49.29 1.45 45.2 to 55.1 34 48.99 2.00 42.4 to 52.9 
Chest (cm) 807 55.67 3.47 46.5 to 79.1 34 55.65 4.44 49.4 to 72.5 
 Waist (cm) 807 49.08 3.81 39.2 to 77.1 34 49.67 4.88 43.1 to 68.1 
 Hip (cm) 807 57.38 4.01 48.1 to 85.4 34 56.09 4.88 47.2 to 73.2 
Upper leg (cm) 807 31.12 2.87 23.6 to 51.8 34 30.36 3.59 24.3 to 43.0 
Mid-upper arm 
(cm) 
807 15.98 1.37 12.7 to 27.2 34 15.68 1.79 12.7 to 23.0 
Kidney 
dimensions 
Right length (cm) 805 7.90 0.55 5.6 to 10.2 34 7.75 0.69 5.7 to 8.9 
Right anterior–
posterior distance 
(cm) 
805 2.99 0.27 2.0 to 3.9 34 2.98 0.30 2.4 to 3.7 
Left length (cm) 805 8.24 0.57 6.5 to 10 34 8.14 0.64 6.9 to 9.4 
Left anterior–
posterior distance 
(cm) 
805 3.29 0.32 2.3 to 4.6 34 3.30 0.35 2.6 to 3.9 
Blood 
pressure 
Systolic (mmHg) 807 98.00 7.39 63 to 119 34 99.65 7.68 36 to 85 
Diastolic (mmHg) 807 61.08 7.68 36 to 85 34 64.74 10.24 49 to 108 
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Appendix 6.3 Trial and two-year follow-up results by sex 
 
Table 1: Effect of MMN on weight at birth and 2.5 years 
Birth 
 
 Control  
Mean (SD) 
Intervention  
Mean (SD) 
Unadjusted difference  
(95% CI) 
Multivariable regression  
(95% CI) 
Weight  Girls 2.67 (0.4) 2.77 (0.4) 0.103 (0.032 to 0.174) 0.119 (0.040 to 0.199) 
 Boys 2.79 (0.4) 2.84 (0.5) 0.048 (-0.030 to 0.126) 0.043 (-0.039 to 0.125) 
      
Weight-for-age Girls -1.31 (1.0) -1.09 (1.1) 0.223 (0.052 to 0.394) 0.263 (0.073 to 0.452) 
 Boys -1.26 (1.0) -1.12 (1.1) 0.137(-0.044 to 0.317) 0.095 (-0.093, 0.282) 
 
2 years 
 
 Control  
Mean (SD) 
Intervention  
Mean (SD) 
Unadjusted difference  
(95% CI) 
Multivariable regression   
(95% CI) 
Weight  Girls 10.40 (1.3) 10.53 (1.4) 0.127 (-0.127 to 0.381) 0.269 (0.020 to 0.517) 
 Boys 11.00 (1.4) 11.24 (1.6) 0.244 (-0.026 to 0.514) 0.276 (0.012 to 0.540) 
      
Weight-for-age Girls -1.79 (1.0) -1.68 (1.0) 0.111 (-0.075 to 0.298) 0.204 (0.021 to 0.386) 
 Boys -1.73 (1.0) -1.57 (1.1) 0.159 (-0.027 to 0.346) 0.159 (-0.024 to 0.342) 
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Appendix 6.4 Additional spirometry results 
Table  1:  Spirometry  results  for  the  whole  cohort,  using  the  Global  Lung  initiative  (Quanjer  et  al,  ERS  2012)  ‘Caucasian’,  ‘African-American’  and  
‘South  East  Asia’  reference  ranges 
GLI Z scores Caucasian  Number Mean Standard deviation Range 
Lung function 
No exclusions 
FEV1 835 -1.16 0.83 -4.94 to 2.17 
FVC  835 -1.07 0.83 -4.11 to 2.19 
FEV1/FVC 835 -0.21 0.77 -3.62 to 1.99 
FEF25%-75% 831 -0.52 1.03 -5.33 to 4.45 
     
Excluding: poor technique FEV1  793 -1.14  0.82 -4.94 to 2.17 
FVC  793 -1.05 0.82 -4.11 to 2.19 
FEV1/FVC 793 -0.22 0.76 -3.62 to 1.95 
FEF25%-75% 793 -0.50 1.02 -5.33 to 4.45 
      
Excluded: poor technique values FEV1  42 -1.46 0.96 -3.07 to 1.97 
FVC  42 -1.46 0.97 -3.36 to 1.44 
FEV1/FVC 42 -0.06 0.90 -1.86 to 1.99  
FEF25%-75% 38 -0.76 1.19 -4.56 to 1.31 
      
Lung function applying all 
exclusions 
FEV1 707 -1.11 0.80 -3.15 to 2.17 
FVC  707 -1.03 0.81 -3.39 to 2.19 
FEV1/FVC 707 -0.19 0.73 -2.68 to 1.95 
FEF25%-75% 707 -0.46 0.98 -4.27 to 4.45 
      
All excluded values: poor technique, 
acute & chronic illness and 
FEV1  128* -1.43 0.93 -4.94 to 1.97 
FVC  128 -1.27 0.90 -4.11 to 1.44 
Appendices 
368 
 
GLI Z scores African-American  Number Mean Standard deviation Range 
Lung function 
No exclusions 
FEV1 835 0.04 0.89 -3.94 to 3.56 
FVC  835 0.20 0.89 -3.05 to 3.55 
FEV1/FVC 835 -0.32 0.78 -3.78 to 1.90 
FEF25%-75% 831 0.02 0.95 -4.35 to 4.56 
     
Excluding: poor technique FEV1 793 0.05  0.88 -3.94 to 3.56 
FVC  793 0.23 0.88 -3.05 to 3.55 
FEV1/FVC 793 -0.33 0.77 -3.78 to 1.87 
FEF25%-75% 793 0.03 0.94 -4.35 to 4.56 
      
Excluded: poor technique values FEV1 42 -0.30 1.05 -2.04 to 3.41 
FVC  42 -0.23 1.05 -2.25 to 2.97 
FEV1/FVC 42 -0.17 0.90 -1.96 to 1.90 
FEF25%-75% 38 -0.22 1.09 -3.65 to 1.70  
      
Lung function applying all 
exclusions 
FEV1  707 0.09 0.86 -2.04 to 3.56 
FVC  707 0.24 0.87 -2.30 to 3.55 
FEV1/FVC 707 -0.29 0.74 -2.83 to 1.87 
FEF25%-75% 707 0.07 0.90 -3.39 to 4.56 
      
All excluded values: poor technique, 
acute & chronic illness and 
pneumonia 
FEV1 128* -0.25 1.00 -3.94 to 3.42 
FVC  128 -0.01 0.97 -3.04 to 2.97 
FEV1/FVC 128 -0.45 0.94 -3.78 to 1.90 
pneumonia FEV1/FVC 128 -0.34 0.94 -3.62 to 1.99 
FEF25%-75% 124 -0.82 1.24 -5.33 to 1.84 
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FEF 25%-75% 124 -0.26 1.13 -4.35 to 2.18 
      
 
 
 
*6 children attempted spirometry but we could not get any data, therefore the total exclusions are 134.  
GLI Z scores SE Asia  Number Mean Standard deviation Range 
Lung function 
No exclusions 
FEV1 835 -0.36 0.87 -4.50 to 3.33 
FVC  835 -0.02 0.88 -3.44 to 3.64 
FEV1/FVC 835 -0.71 0.80 -4.26 to 1.52 
FEF25%-75% 831 -0.45 1.13 -5.89 to 5.01 
      
Excluding: poor technique FEV1  793 -0.34 0.86 -4.50 to 3.33 
FVC  793 0.00 0.87 -3.44 to 3.64 
FEV1/FVC 793 -0.71 0.79 -4.26 to 1.52 
FEF25%-75% 793 -0.44 1.12 -5.89 to 5.01 
      
Excluded: poor technique values FEV1 42 -0.63 0.97 -2.25 to 2.86 
FVC  42 -0.39 1.00 -2.35 to 2.56 
FEV1/FVC 42 -0.56 0.93 -2.43 to 1.51 
FEF25%-75% 38 -0.69 1.29 -5.04 to 1.50 
      
Lung function applying all 
exclusions 
FEV1  707 -0.30 0.84 -2.60 to 3.33 
FVC  707 0.02 0.86 -2.40 to 3.64 
FEV1/FVC 707 -0.68 0.76 -3.28 to 1.52 
FEF25%-75% 707 -0.39 1.07 -4.72 to 5.01 
      
All excluded values: poor technique, 
acute & chronic illness and 
pneumonia 
FEV1 128* -0.65 0.97 -4.50 to 2.86 
FVC  128 -0.24 0.95 -3.44 to 2.56 
FEV1/FVC 128 -0.84 0.97 -4.26 to 1.51 
FEF25%-75% 124 -0.79 1.36 -5.89 to 2.09 
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Table 2: Spirometry data stratifying  into  boys  and  girls,  using  the  ‘GLI  Caucasian’  reference  range  with  all  data 
  Boys   Girls  
 Number Mean Standard deviation Number Mean Standard deviation 
FEV1 433 -1.03 0.84 402 -1.30 0.78 
FVC  433 -0.91 0.79 402 -1.23 0.84 
FEV1/FVC 433 -0.23 0.76 402 -0.19 0.78 
FEF25%-75% 431 -0.39 1.08 400 -0.65 0.96 
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Table 3: Child lung function and anthropometry by allocation group 
  Control Intervention 
  Number Mean Standard 
deviation 
Range Number Mean Standard 
deviation 
Range 
Lung function 
z scores 
No exclusions 
FEV1 418 -1.14 0.85 -4.9 to 2.2 417 -1.19 0.81 -4.5 to 2.0 
FVC  418 -1.05 0.84 -4.1 to 2.2 417 -1.08 0.82 -3.4 to 1.4 
FEV1/FVC 418 -0.19 0.76 -2.6 to 2.0 417 -0.22 0.78 -3.6 to 1.9 
FEF25%-75% 416 -0.49 1.02 -4.8 to 3.6 415 -0.54 1.04 -5.3 to 4.5 
          
Excluding: poor 
technique 
FEV1 393 -1.11 0.84 -4.9 to 2.2 400 -1.18 0.79 -4.5 to 1.4 
FVC  393 -1.02 0.83 -4.1 to 2.2 400 -1.07 0.81 -3.2 to 1.3 
FEV1/FVC 393 -0.20 0.75 -2.6 to 2.0 400 -0.24 0.77 -3.6 to 1.9 
FEF25%-75% 393 -0.48 1.02 -4.8 to 3.6 400 -0.53 1.02 -5.3 to 4.5 
          
Excluded: poor 
technique values 
FEV1 25 -1.62 0.82 -2.9 to 0.2 17 -1.22 1.13 -3.1 to 2.0 
FVC  25 -1.57 0.88 -2.7 to 0.5 17 -1.29 1.11 -3.4 to 1.4 
FEV1/FVC 25 -0.17 0.92 -1.9 to 2.0 17 0.09 0.86 -1.5 to 1.6 
FEF25%-75% 23 -0.83 0.98 -2.7 to 0.6 15 -0.66 1.49 -4.6 to 1.3 
          
Excluding: acute 
& chronic illness 
FEV1 390 -1.12 0.83 -3.1 to 2.2 393 -1.18 0.79 -3.2 to 2.0 
FVC  390 -1.05 0.83 -3.4 to 2.2 393 -1.08 0.82 -3.4 to 1.4 
FEV1/FVC 390 -0.16 0.73 -2.5 to 20. 393 -0.21 0.75 -2.7 to 1.9 
FEF25%-75% 388 -0.45 0.97 -3.4 to 3.6 391 -0.52 1.01 -4.6 to 4.5 
          
Excluded values: 
acute and chronic 
illness 
FEV1 28 -1.45 1.07 -4.9 to 1.1 24 -1.36 1.01 -4.5 to 0.0 
FVC  28 -1.08 1.01 -4.1 to 1.2 24 -1.08 0.84 -3.0 to 0.7 
FEV1/FVC 28 -0.71 1.02 -2.6 to 1.3 24 -0.46 1.19 -3.6 to 1.7 
FEF 25%-75%  28 -1.08 1.43 -4.8 to 1.8 24 -0.87 1.46 -5.3 to 1.8 
          
Excluding: 
pneumonia 
FEV1 394 -1.12 0.85 -4.9 to 2.2 394 -1.17 0.81 -4.5 to 2.0 
FVC  394 -1.04 0.84 -4.1 to 2.2 394 -1.07 0.83 -3.4 to 1.4 
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FEV1/FVC 394 -0.18 0.76 -2.6 to 2.0 394 -0.23 0.77 -3.6 to 1.9 
FEF25%-75% 392 -0.47 1.01 -4.8 to 3.6 392 -0.52 1.04 -5.3 to 4.5 
          
Excluded values: 
pneumonia 
FEV1 24 -1.47 0.79 -3.1 to -0.0 23 -1.41 0.70 -2.7 to 0.0 
FVC  24 -1.22 0.78 -2.7 to 0.5 23 -1.31 0.65 -2.4 to -0.1 
FEV1/FVC 24 -0.50 0.75 -2.2 to 0.6 23 -0.19 0.89 -2.7 to 1.1 
FEF25%-75% 24 -0.83 1.15 -3.2 to 1.4 23 -0.75 1.00 -3.3 to 1.4 
          
Excluding: acute 
& chronic illness 
and pneumonia 
FEV1 371 -1.10 0.82 -3.1 to 2.2 374 -1.16 0.80 -3.2 to 2.0 
FVC  371 -1.04 0.82 -3.4 to 2.2 374 -1.06 0.83 -3.4 to 1.4 
FEV1/FVC 371 -0.15 0.73 -2.5 to 2.0 374 -0.21 0.75 -2.7 to 1.9 
FEF25%-75% 369 -0.44 0.97 -3.4 to 3.6 372 -0.51 1.02 -4.6 to 4.5 
          
Excluded values: 
acute & chronic 
illness and 
pneumonia 
FEV1 47 -1.44 0.96 -4.9 to 1.1 43 -1.41 0.85 -4.5 to 0.0 
FVC  47 -1.16 0.93 -4.1 to 1.2 43 -1.22 0.77 -3.0 to 0.7 
FEV1/FVC 47 -0.57 0.88 -2.6 to 1.3 43 -0.34 1.01 -3.6 to 1.7 
FEF25%-75% 47 -0.92 1.30 -4.8 to 1.8 43 -0.77 1.22 -5.3 to 1.8 
          
Excluding: poor 
technique, acute 
& chronic illness 
and pneumonia 
FEV1 350 -1.07 0.81 -3.1 to 2.2 357 -1.16 0.78 -3.2 to 1.4 
FVC  350 -1.01 0.81 -3.4 to 2.2 357 -1.05 0.81 -3.2 to 1.3 
FEV1/FVC 350 -0.15 0.72 -2.5 to 2.0 357 -0.22 0.74 -2.7 to 1.9 
FEF25%-75% 350 -0.42 0.97 -3.4 to 3.6 357 -0.50 1.00 -4.3 to 4.5 
          
All excluded 
values: poor 
technique, acute 
& chronic illness 
and pneumonia 
FEV1 68 -1.50 0.93 -4.9 to 1.1 60 -1.36 0.93 -4.5 to 2.0 
FVC  68 -1.29 0.93 -4.1 to 1.2 60 -1.24 0.87 -3.4 to 1.4 
FEV1/FVC 68 -0.44 0.89 -2.6 to 2.0 60 -0.22 0.98 -3.6 to 1.7 
FEF25%-75% 66 -0.89 1.20 -4.8 to 1.8 57 -0.74 1.28 -5.3 to 1.8 
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Appendix 6.5 Socioeconomic status and growth directed acyclic graph 
 
 
 
Figure 51: Directed acyclic graph 
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